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Parkinson’s disease (PD) is a progressive neurodegenerative disorder with cardinal signs of 
bradykinesia, tremor, rigidity and postural instability. Current PD treatment only alleviate 
symptoms of PD, however, there is an intense research focus on identifying disease-
modifying therapies. No biochemical or laboratory marker exists for PD progression. An 
objective and repeatable biomarker would allow assessment of the efficacy of novel disease-
modifying therapies, as well as allowing precisely tailored treatment. 
Saccadic eye movements are an accurately measured and easily repeatable performance 
measure. Saccades show characteristic impairments in PD and show promise as the basis of a 
novel biomarker. Our current understanding of the causes of saccade performance deficits in 
PD is speculative. This thesis will examine saccades in PD using MRI, aiming to develop a 
better understanding of PD processes affecting eye movements and assessing MRI analyses 
for future studies into this area. 
Eye movement and MRI data from 96 PD and 33 controls from the New Zealand Brain 
Research Institute was analysed in the first study using voxel-based whole-brain comparisons 
of structural, perfusion and diffusion MRI, with visually-guided and volitional saccade tasks. 
The results largely indicated no significant group differences; however subtle structural and 
perfusion group-differences were detected in the temporal lobe and precuneus. A 
characteristic PD-related perfusion pattern has been previously identified for 68 PD and 24 
controls of this study, the extent of which is expressed by a network score in a given 
individual. This network score was compared with saccadic eye movement performance of 
these participants. Every eye movement measure significantly correlated with the network 
score, supporting the use of this score as a biomarker of general PD status. Furthermore, 
increased hypoperfusion in the areas described by the network score may contribute, in part, 
to eye movement deficits in PD. 
In the next study, 16 PD and 16 controls underwent functional MRI scanning while 
performing reflexive and predictive saccades. Group-level activity differences were not 
detected, however, the medial frontal eye field (FEF) subregions demonstrated greater activity 
in the reflexive task compared to the predictive. This finding is novel and FEF subregions 
have not been explicitly described to relate to reflexive or predictive saccade tasks. This is 
relevant in the context of our overall understanding of eye movement control. 
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The final study investigated memory-guided saccades in PD using functional MRI. Blood-
oxygen level dependent (BOLD) activity in the bilateral posterior parietal cortex was altered 
in PD patients compared to controls during this task. Additional principal component (PCA) 
and K-means clustering analyses were able to identify regions exhibiting similar BOLD time 
courses during task performance. This supports the ability of PCA to identify key components 
patterns related to function, from BOLD time course data.  
This study of eye movements in PD using MRI has identified several areas for investigation 
in future studies. This study was cross-sectional but has allowed us to establish initial 
benchmark findings for future comparison, and has helped validate analysis methods for 
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359-360. 
A number of studies within this thesis were only made possible with the work and help of 
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Chapter 3 
The imaging data and eye movement measurements used in this chapter were collected as part 
of a long-term longitudinal PD study at the New Zealand Brain Research Institute. Eye 
movement tasks for this study were originally designed by Dr. Michael MacAskill. Eye 
movement performance measures were obtained by Dr. Toni Pitcher and Dr. Charlotte 
Graham. MRI preprocessing was done by Dr. Toni Pitcher for a portion of the participants 
and another portion by myself. Neuropsychiatric scoring and motor assessment were 
performed by Dr. Toni Pitcher, Dr. Charlotte Graham and Ms. Leslie Livingston. MRI data 
used for this chapter was collected by Dr. Tracy Melzer, with assistance from Christchurch 
Radiology Group technicians Mr. Gareth Leeper, Mr. Simon Felton and Mr. Steven Kingston-
Smith. I performed all the statistical analysis, using the post-processed MRI data and eye 
movement performance measures. I created all comparisons, tables and images for this 
chapter. 
Chapter 4 
The ASL network score was generated as part of a previous study investigating the potential 
of developing a perfusion based measure of PD progression by Dr. Tracy Melzer (2011). The 
original score used data from 61 PD patients. This score was updated with additional PD 
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patients, totalling 73 and was made using the same technique as described in the original 
Melzer paper. This updated network score is not yet published as of 2017. The participants 
used to construct the network score were from the same group used in the ongoing 
longitudinal PD study at the New Zealand Brain Research Institute as Chapter 3. Eye 
movement performance measures were obtained by Dr. Toni Pitcher and Dr. Charlotte 
Graham as in the previous chapter. Similarly, neuropsychiatric scoring and motor assessment 
were performed by Dr. Toni Pitcher, Dr. Charlotte Graham and Ms. Leslie Livingston, as in 
the previous chapter. I performed all the statistical testing using the ASL network score and 
eye movement measures.  The graphs were initially generated by myself and were graphically 
refined by Dr. Michael MacAskill. 
Chapter 5 
The participants in this study were recruited by myself, with the help of Ms. Leslie 
Livingston. These participants were newly recruited to be involved in both my study and the 
ongoing longitudinal PD study at the New Zealand Brain Research Institute. Eye movement 
tasks designed to be displayed during fMRI were initially developed by Dr. Michael 
MacAskill, based on the tasks used in the longitudinal studies. I further developed and refined 
the eye movement paradigms to be used with the fMRI scanning sequence by modifying the 
original code to construct the task sequence to be displayed in the MRI machine. I oversaw 
acquisition of the MRI data for these participants with supervision from Dr. Tracy Melzer, 
with assistance from Christchurch Radiology Group technicians Mr. Gareth Leeper, Mr. 
Simon Felton and Mr. Steven Kingston-Smith. I preprocessed all scan data for this chapter 
and collected and measured eye movement performance for all tasks used in this chapter. I 
attended a workshop for the software package SPM8, hosted in Sydney Australia, which 
provided me the knowledge in the use of this program for neuroimaging analysis. Dr Karolina 
Marak provided fMRI analysis advice. I performed all the imaging analysis for the fMRI 
experiments and all whole-brain comparisons between MRI data and eye movement 
measures. All figures and plots of the study results were produced by myself. 
Chapter 6 
The principal component analysis (PCA) and cluster analysis was performed by Dr Tracy 
Melzer, with interpretation by myself. Otherwise, the contributions for this chapter are as 
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Parkinson’s disease (PD) is a progressive neurodegenerative disorder, prominently affecting 
the motor pathway. First described in 1817 by James Parkinson in the essay “The shaking 
palsy”, the understanding of the disease was further developed from contributions most 
notably from Jean-Martin Charcot, who first used the term “Parkinson’s disease” to describe 
it (Goetz, 2011). PD is the most common neurodegenerative disease after Alzheimer’s 
dementia, with a prevalence of 210 people per 100,000 in NZ in 2013, with this number 
expected to double within 25 years (Myall et al., 2017). 
Classically, PD has the cardinal features of bradykinesia (slowness of movement), rigidity, 
tremor, and postural instability. Neuropathologically, PD is characterised by the selective 
degeneration of the dopamine-producing neurons within the substantia nigra pars compacta 
region, along with the presence of inclusion bodies known as Lewy bodies and Lewy neurites 
(Figure 1-3), within the substantia nigra and other susceptible neurological sites (Braak et al., 
2003). 
Parkinson’s-like motor symptoms can also be attributed to a number of other causes that 
mimic the physical symptoms of PD, under the umbrella term “parkinsonism”. Parkinsonism 
syndromes include progressive supranuclear palsy, multiple system atrophy and corticobasal 
syndrome. No diagnostic test for PD exists and diagnosis remains based on clinical criteria. It 
can prove difficult, particularly in the early disease stages, to accurately diagnose the disorder. 
Diagnostic errors are made (Hughes et al., 1992), but these are significantly less common for 
diagnoses by a movement disorders specialist (Hughes et al., 2002). Regular follow-up and 
repeated clinical assessment are vital for accurate diagnosis. Once a diagnosis has been made, 
disease progression is also assessed clinically by rating scales such as the Movement Disorder 
Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (Goetz et al., 2008). 
Currently, all available treatment for PD is symptomatic and does not alter disease 
progression. A significant body of research is dedicated to the discovery of new disease-
modifying therapies (AlDakheel et al., 2014; McGhee et al., 2016). Early, correct diagnosis 
and accurate monitoring of progression will be necessary for the development and use of 
future therapies. There is a need to develop objective biomarkers to assess disease 
progression. A good biomarker should ideally aid initial diagnosis as well as identify 
misdiagnosis, should progression not follow the disease profile. Imaging and saccadic eye 
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movement performance are potential avenues for biomarker development, with both showing 
significant changes in PD (Saeed et al., 2017; Srivastava et al., 2014). Eye movements are 
limited to three axes of rotation and are well-suited for laboratory testing. Eye movements are 
a precisely measured, easily implemented and easily repeatable measure of movement 
parameters, compared to, for example, measurements of a complex multi-joint limb. This 
thesis will investigate the structural and functional basis of saccadic eye movements in PD 
using MRI techniques. The understanding of cerebral changes underlying abnormal eye 
movement measures in PD could form the basis for future biomarker development. 
1.1.1 Causes	of	PD	
The causes of the majority of PD cases are unknown. A small proportion of the PD population 
have a familial genetic component. Familial genetic contribution to PD has been identified 
most commonly in mutations with the leucine-rich repeat kinase 2 (LRRK2) gene (Kumari & 
Tan, 2009). Other genes linked to PD include mutations of SNCA, Parkin, PINK1, DJ-1 and 
ATP13A2 (Klein & Westenberger, 2012). Only 10% of PD cases have a familial component 
however (Thomas & Flint Beal, 2007), with the majority being sporadic and of unknown 
cause, possibly with contributions from both genetic and environmental factors (Klein & 
Westenberger, 2012; Lill, 2016). Certain agents, most notably MPTP (1-methyl-4-phenyl-
1,2,3,6- tetrahydropyridine), are known to cause parkinsonism in some cases but cannot be 
responsible for PD itself. A recent meta-analysis of environmental associations with PD found 
physical activity and smoking to be associated with a lower relative risk for PD. The authors 
warn the reader that these are far from confirmed as causal factors and more evidence is 





The basal ganglia are a collection of nuclei (or clusters of neurons) which are located in the 
base of the forebrain (Figure 1-1) and have a key role in modulating movement. The striatum, 
composed of the caudate nucleus and putamen, form the main input region of the basal 
ganglia and receives inputs from nearly all cortical regions. The main output region is from 
the substantia nigra pars reticulata (SNr) and internal globus pallidus (GPi). The basal ganglia 
send modulatory outputs to the thalamocortical networks and brainstem motor networks 
which can inhibit or disinhibit motor activity (Albin et al., 1983; DeLong, 1990). Other 
nuclei, including the substantia nigra pars compacta (SNc), external globus pallidus (GPe) and 
subthalamic nucleus (STN), form interconnections within the basal ganglia structures and 
modulate basal ganglia output (a more detailed description of the basal ganglia circuit, with 
more emphasis on eye movement control, is provided in this chapter on page 34). In PD, 
selective loss of dopaminergic neurons in SNc occurs, which leads to the classically described 
depigmentation of the SN (Figure 1-2). The overall effect of dopaminergic neuron loss is that 
an increased inhibitory effect is present on motor output circuits, leading to some of the motor 
symptoms seen in PD. 
 
 





Figure 1-2 – Autopsy brain section at the level of the midbrain. Loss of dopaminergic neurons within the 
substantia nigra (SN) results in depigmentation, visibly seen on the left image compared to a control 
image on the right. Figure permission obtained. Adapted from Mandel et al., (2010). 
 






In recent years, PD has become thought of as a progressive multifocal neurological disease, 
with widespread α-synuclein pathology not limited to the substantia nigra. A prevalent theory 
regarding Lewy body/α-synuclein pathology is known as the Braak hypothesis (Braak et al., 
2003). Braak and colleagues, in their widely cited autopsy study, described a characteristic, 
non-random pattern of abnormal α-synuclein spread and accumulation through the CNS in 
PD. Braak et al. described nigral pathology as always accompanied by extra-nigral pathology 
in the region surrounding and containing the dorsal motor nucleus of the vagus nerve. They 
used an immunohistochemical stain for abnormal α-synuclein in brains of deceased patients 
with known PD, along with patients with no PD diagnosis but with Lewy body presence in 
the associated lesions sites near the vagal dorsal motor nucleus. A staging system was 
described relating to pathological α-synuclein spread, made up of 6 stages. Each stage evolves 
from the pathology of previous stages, with changes occurring in a progressive manner. Stage 
1 pathology was seen with lesions in the dorsal motor nucleus of the vagus nerve within the 
medulla. Stage 2 shows further lesions in the medulla, extending to the pontine tegmentum 
region. Stage 3 involves regions of the midbrain, notably including the SNc region. Stage 4 
shows lesions in the basal forebrain and Stages 5-6 show progressive lesions into the 
neocortex from the prefrontal and sensory association areas to the premotor and primary 
sensory/motor fields. The Braak hypothesis states that the motor manifestations of PD, in fact, 
represent the mid to late stages of PD, which occurs after a premotor prodromal phase, before 
the α-synucleinopathy reaches the basal ganglia in Stage 3 of the disease (Braak et al., 2004).  
1.1.1.3 Source	of	abnormal	α-synuclein	and	the	“dual	hit”	hypothesis	
The earliest sites of Lewy pathology are seen to develop in the olfactory bulb (Berendse & 
Ponsen, 2006; Duda, 2010; Pearce et al., 1995) and peripherally in the enteric nerve plexus 
(Braak et al., 2006; Wakabayashi et al., 1989). The occurrence of two initial, separate sites of 
Lewy pathology has led to what’s known as the “dual hit hypothesis” for PD pathogenesis 
(Hawkes et al., 2007). Hawkes et al. argue it is unlikely for two regions to develop 
simultaneous α-synuclein pathology independently and a more probable explanation is that a 
common pathogen initiates the abnormal α-synuclein formation in both regions. This external 
neurotropic agent, possibly viral, could at first affect the upper respiratory system and the 
olfactory mucosa, much like a common cold. The agent, along with saliva and mucous, is 
swallowed into the stomach. From there, the pathogen passes through the thin single cell 
layered epithelium into Meissner’s and Auerbach’s plexus of the enteric nervous system. 
Neurons within the enteric nervous system are interconnected with the vagus nerve, which has 
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projections to and from the dorsal motor nucleus of the vagus of the medulla (Braak et al., 
2003). Abnormal α-synuclein is thought to be transported through the vagus to the dorsal 
motor nucleus, where the pathological CNS aggregation process begins (Braak et al., 2003). 
The process by which abnormal α-synuclein develops into widespread aggregations is not yet 
certain but a prion-like mechanism has been postulated (Brundin et al., 2010; Dunning et al., 
2012; Frost & Diamond, 2010). 
1.1.1.4 Evidence	and	criticisms	of	the	Braak	hypothesis	
Evidence for the neural propagation of abnormal α-synuclein comes from human autopsy and 
animal studies. Deceased PD patients who previously received grafts of embryonic 
mesencephalic dopaminergic neurons showed aggregated α-synuclein presence in the grafted 
tissue (Kordower et al., 2008; Li et al., 2008). This suggests that abnormal α-synuclein is 
capable of progressively propagating into unaffected non-host tissue. In animal studies when 
α-synuclein was injected into the intestine, pathological spread of α-synuclein was seen in the 
dorsal motor nucleus via the vagus nerve (Holmqvist et al., 2014). A rotenone-induced animal 
PD model (Cannon et al., 2009) was also associated with Lewy bodies in the enteric nervous 
system, dorsal motor nucleus and substantia nigra (Pan-Montojo et al., 2010). Vagotomy 
(severing the vagus nerve) halted this spread (Pan-Montojo et al., 2012). While evidence is 
present for the neural propagation of misformed α-synuclein, a number of questions remain 
regarding the nature of the α-synuclein spread whether it can be truly called prion-like 
(Visanji et al., 2013), or whether the extent to which abnormal α-synuclein spread contributes 
to the aetiology of PD. For example, the prion process implies there should be a contagious 
element to PD, which is yet to be found (Beekes et al., 2014). The association of α-synuclein 
and cell death is thought to be related to certain toxic oligomers of α-synuclein (Conway et 
al., 2000; Stefanis, 2012), but this neurotoxic effect is not yet fully understood (Benskey, 
Perez, & Manfredsson, 2016; Roberts & Brown, 2015). The Braak grading scale itself is 
based on abnormal α-synuclein spread and not directly on dopaminergic cell loss (Dickson, 
2012) and it is possible for individuals to have widespread Lewy body pathology, even in the 
cortex, and yet not show signs of PD (Parkkinen et al., 2005). Longitudinal studies show that 
not all patients follow the Braak staging system (Halliday et al., 2008) and it may be that the 
Braak staging system may apply only to a certain subset of PD patients (Rietdijk et al., 2017). 
Numerous publications call for further research in this field to further elucidate and clarify the 




Alpha-synuclein is not alone in its contribution to neuronal death, with neuroinflammation 
(Hirsch et al., 2012; Tansey & Goldberg, 2010; Wang et al., 2015), abnormal toxic dopamine 
metabolite formation (Hastings, 2009; Munoz et al., 2012; Segura-Aguilar et al., 2014), and 
mitochondrial dysfunction (Henchcliffe & Beal, 2008; Moon & Paek, 2015; Winklhofer & 
Haass, 2010) all having a role to play in PD-related neurodegeneration. Oxidative stress is 
seen as the key underlying mechanism, stemming from a combination of the above factors, 
and ultimately leading to dopaminergic cell loss in PD (Blesa et al., 2015; Dias et al., 2014; 
Hwang, 2013). Oxidative stress results from an excess of reactive oxygen species, too much 
for natural cellular antioxidant activity to clear (Dias et al., 2014). Reactive oxygen species 
damage cellular components such as DNA, RNA and mitochondria, and affect cell signalling 
processes, leading to cell damage and potentially death (Brieger et al., 2012). The detection of 
changes relating to neuroinflammation and oxidative stress is possible using certain forms of 
MRI and PET, and underlie the basis for the development of novel imaging strategies and 
potential biomarkers for PD (see later Imaging section page 53). Neuroinflammation and 
oxidative processes may also be the targets for future neuroprotective or disease-modifying 
therapies for PD (Jin et al., 2014; Wang et al., 2015). 
1.1.2 Clinical	features	of	PD	
The cardinal features of Parkinson’s disease include the classical triad of bradykinesia, tremor 
and rigidity (Gelb et al., 1999). Postural instability is considered a fourth cardinal feature 
(Kim et al., 2013; Massano & Bhatia, 2012) but is more prominent in later stages of the 
disease (DeMaagd & Philip, 2015; Jankovic, 2008).  
1.1.2.1 Bradykinesia	
Bradykinesia, or the slowness of movement, is the defining clinical characteristic of PD. This 
causes difficulty initiating movements, prolonged reaction times and difficulties with 
sequencing movements or self-paced movements (Berardelli et al., 2001). It often presents as 
a slowness of everyday movements such a walking, putting on clothes and using utensils 
(Jankovic, 2008). Bradykinesia also causes a “poverty” of spontaneous movement, drooling 
from impaired swallowing, decreased facial expression, softer voice and smaller handwriting 
(Massano & Bhatia, 2012). Clinically, bradykinesia can be assessed by having the patient 
perform finger tapping and alternating hand/feet/limb movements as quickly and with as large 
an amplitude as possible (Goetz et al., 2007). Bradykinesia is thought to correlate with the 
degree of dopamine deficiency (off-medication or inadequately-medicated state) - more so 




A resting tremor is the most visible sign and is typically unilateral at onset and affects the 
distal extremities of the limb first. PD tremor has a frequency of 4-6 Hz and in the fingers 
often manifests as a “pill rolling” motion (Findley et al., 1981; Massano & Bhatia, 2012). It 
can on occasion be difficult to differentiate tremor from other causes, such as essential tremor. 
Essential tremor tends to be bilateral, occurs at a higher frequency, and is present on posture 
as opposed to rest. PD tremor often disappears with movement and is most clearly seen with 
the affected limb resting on a supporting surface (Bain, 2007; Bhidayasiri, 2005; Günther 
Deuschl et al., 1998).  
1.1.2.3 Rigidity		
Rigidity is the stiffness or increased resistance of limbs/joints to movement, due to increased 
muscle tone. This can be felt as “lead pipe” rigidity (constant resistance throughout the range 
of motion) or can be felt as a notchy or ratcheting style of resistance, called “cogwheel 
rigidity”, which is thought to be a superposition of tremor on top of increased tone (Berardelli 
et al., 1983; Guttman et al., 2003; Lance et al., 1963; Massano & Bhatia, 2012). 
1.1.2.4 Postural	instability	
PD patients will often show impairment of postural reflexes involved in maintaining balance. 
This can lead to a feeling of instability and a tendency for falls with risk of significant injury 
(Allen et al., 2013; Koller et al., 1989; Muslimovic et al., 2008). Postural instability can be 
tested by standing behind a patient (after explaining the test) and giving a firm rearward pull 
(Nonnekes et al., 2015). Patients with preserved reflexes should be able to maintain balance 
with no more than one step back. In PD however, multiple backward steps are often needed to 




Features of PD are not limited to the motor system. Most PD patients will experience 
cognitive decline, progressing to dementia, with a cumulative prevalence as high as 78% 
(Aarsland et al., 2003; Emre, 2004; Hely et al., 2008). Cognitive decline places a significant 
additional burden on the patient and caregivers and yet no diagnostic biomarker for cognitive 
decline exists (Goetz et al., 2008; Meireles & Massano, 2012). The Movement Disorders 
Society (MDS) have proposed diagnostic criteria for mild cognitive impairment (Litvan et al., 
2012). These criteria rely on prior history, requiring a gradual decline in cognition noted by 
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the patient/clinician, which doesn’t significantly impact daily life; impairment on a global 
cognitive test such as the Montreal cognitive assessment (MoCA) (Nasreddine et al., 2005) 
and impairment in two or more cognitive domains in a battery of neuropsychological tests 
assessing multiple cognitive domains (attention and working memory, executive function, 
language, memory and visuospatial function) (Litvan et al., 2012). The MDS have also 
published a set of guidelines for PD dementia diagnosis, which involves the onset of dementia 
after the diagnosis of PD, global cognitive score deficits, cognitive impairment significant 
enough to impair daily activities and impairment of at least two of the above-mentioned 
cognitive domains (Dubois et al., 2007).  
1.1.3.2 Mood	disturbances	
Mood disturbances such as depression are common symptoms in PD, affecting up to half of 
the PD population (Aarsland et al., 1999; Ravina et al., 2007) Mood disorders are rated as one 
of the most troublesome symptoms in advanced PD (Politis et al., 2010). Depression is 
considered undertreated in PD, yet has a significant impact on quality of life (Ravina et al., 
2007). There is a need to ensure the emotional disturbances are identified and treated 
alongside the motor symptoms (Zesiewicz et al., 2010). Anxiety was reported as the second 
most common mood disturbance after depression (Aarsland et al., 1999) and often co-exists 
with depression in PD (Wee et al., 2016). Apathy is also common in PD (Pedersen, Larsen, 
Alves, & Aarsland, 2009) and can be a component of depression but may also occur 
separately too (Richard, 2006). A number of imaging studies have identified frontal lobe and 
temporal lobe changes associated with increased apathy scores (Reijnders et al., 2010; Robert 
et al., 2012; Skidmore et al., 2013). 
 
1.1.3.3 Sleep	disturbances	
Sleep disturbances, including insomnia and excessive daytime sleepiness, affect nearly half of 
PD patients (Brodsky et al., 2003; Gjerstad et al., 2007). Fatigue is another common 
symptom, reported in up to half of one cohort (Alves et al., 2004). Alves et al. found fatigue 
commonly relates to depression and excessive daytime sleepiness but can exist as an 
independent symptom in the absence of these factors as well. Rapid eye movement (REM) 
sleep behaviour disorders are characterised by vivid, often frightening dreams, and loss of 
muscle atonia with resulting motor activity during sleep. This has been described as the 
acting-out of dreams and is seen in PD patients, and often precedes the development of PD 
(Poryazova & Zachariev, 2005). REM sleep behaviour disorders may form part of a screening 
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criteria used to identify patients at-risk of developing PD in the future (Mahlknecht et al., 
2015). 
1.1.3.4 Hallucinations	
Hallucinations, particularly visual, are commonly experienced in PD, with cognitive decline 
and advancing age thought to be predisposing factors (Fenelon et al., 2000; Sanchez-Ramos et 
al., 1996). PD medications may also induce hallucinations on their own, including both visual 
and auditory hallucinations, and need to be carefully monitored (Cummings, 1991; Goetz, 
Tanner, & Klawans, 1982). 
1.1.3.5 Autonomic	dysfunction	
Autonomic dysfunction, such as orthostatic hypotension, constipation, urinary difficulties and 
sexual dysfunction are all known to occur in PD (Asahina et al., 2013; Brown et al., 1990; 
Lemack et al., 2000; Verbaan et al., 2007). Of note, these symptoms are present in multiple 
system atrophy (MSA), but at a more severe level (Wenning & Colosimo, 2010) and can lead 
to misdiagnosis in early disease stages. Constipation is frequently seen in PD, affecting over 
50% of cases. From the Braak hypothesis (Braak et al., 2006), it is possible α-synuclein 
pathology affecting the enteric nervous system causes loss of gut motility, leading to 
constipation. Colonic biopsies have detected abnormal α-synuclein in PD patients (Shannon et 
al., 2012). Constipation can predate PD by a decade or more (Abbott et al., 2001; Savica et 
al., 2009). A meta-analysis by Bellou et al. (2016) found constipation to be associated with a 
relative risk of 2.6 for developing PD. Assessment of constipation may form a marker of early 
or prodromal PD (Postuma & Berg, 2016).  
1.1.3.6 Olfactory	loss	
Olfactory loss is predicted by the Braak hypothesis, with early α-synuclein pathology 
affecting the olfactory bulb (Braak et al., 2003). This symptom may not be noticed by the 
patient but when tested is extremely common in PD, present in up to 90% of patients (Doty et 
al., 1988). Abnormalities of the olfactory system can be detected using MRI techniques 
(Ibarretxe-Bilbao et al., 2010; Rolheiser et al., 2011; Scherfler et al., 2006). Smell testing, 
however, is easily performed without the need for imaging (Doty et al., 1984). Olfactory 
changes may form a part of an assessment for early PD (Mahlknecht et al., 2015; Postuma & 
Berg, 2016). 
1.1.4 Clinical	diagnosis		
There is no physiological or blood test available to diagnose PD. The diagnosis of PD remains 
clinical and is based upon the physician identifying the characteristic symptoms which make 
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up PD, while excluding other causes of parkinsonism. One widely-known diagnostic criteria 
was developed by the UK Parkinson’s Disease Society’s Brain Bank (Hughes, Daniel, 
Kilford, & Lees, 1992). The Movement Disorders Society has developed a diagnostic criteria 
more recently for clinical research (Postuma et al., 2015). The presence of bradykinesia, along 
with at least one other cardinal feature of PD, is needed at a minimum for considering PD as a 
diagnosis. A definitive response to dopaminergic medication is an important supportive factor 
and other factors, such as unilateral symptoms, rest tremor and progressive onset, all support 
the diagnosis of PD. The UK Parkinson’s Disease Society’s Brain Bank diagnostic criteria 
(Hughes et al., 1992) is included in the appendix (Table 9-3 page 358) 
1.1.4.1 Eye	movements	in	clinical	diagnosis	of	PD	
The current involvement of oculomotor features for diagnosis is only to exclude other causes 
of parkinsonism. Signs such as supranuclear gaze palsy and oculogyric crises (dystonic 
bilateral gaze elevation) are part of the UK Parkinson’s Disease Society’s Brain Bank 
diagnostic criteria (as an exclusion), and serving to exclude causes such as progressive 
supranuclear palsy (PSP) or encephalopathic causes.  
Current scales of PD progression do not have eye movement components. The Hoehn and 
Yahr scale (H&Y) is a simple, five-stage scoring scale, classifying only broad motor 
symptoms of PD occurring unilaterally or bilaterally. Compared to the H&Y, the MDS-
UPDRS covers a more in-depth range of PD symptoms. Part III of the MDS-UPDRS covers 
motor symptoms of PD such as the severity of tremor, rigidity and gait. However, the MDS-
UPDRS also currently does not have eye movement criteria as part of the scoring. By 
contrast, the Unified Huntington’s disease rating scale (UHDRS) (Huntington Study Group, 
1996), which is modelled on the UPRDS, has 6 oculomotor items as manifest disease 
markers. The oculomotor features of Huntington’s disease (HD), such as reduced saccade 
velocity, are however, more clinically obvious in HD than in PD. 
1.1.5 Parkinsonism	syndromes	
Symptoms such as bradykinesia, tremor and rigidity are not exclusively linked to Parkinson’s 
disease. A number of other neurodegenerative processes may also present with these features. 
These are collectively known as parkinsonism or parkinsonian syndromes and can be difficult 
to differentiate from PD in early stages of the disease. Many of the exclusion criteria in the 
UK PD society diagnostic guidelines are an attempt to exclude these disorders from the 




There is current discussion over what separates dementia with Lewy bodies (DLB) and 
Parkinson’s disease with dementia (PD-D) (Berg et al., 2014; McKeith, 2009; Richard, Papka, 
Rubio, & Kurlan, 2002). The diagnostic criteria of DLB were until recently based on the 1-
year rule, whereby if dementia develops 1 year or more after initial motor parkinsonism 
symptoms, a diagnosis of Parkinson’s disease with dementia is given. If dementia develops in 
the same year as or before parkinsonism motor symptoms, a diagnosis of dementia with Lewy 
bodies is given (Gomperts, 2016). The one year time period is an arbitrary length of time and 
the MDS have suggested omitting the 1-year rule, giving a diagnosis of PD to anyone who 
meets PD diagnostic criteria regardless of the timing of dementia onset (Berg et al., 2014). 
The underlying pathology of DLB and PD-D may differ, with an added vascular and amyloid 
pathological component in DLB as opposed to predominant α-synuclein pathology in PD-D 
(Berg et al., 2014). The Lewy Body Dementia Association Scientific Advisory Council argues 
for retaining the diagnosis of dementia with Lewy bodies as separate from PD-D, until 
underlying mechanisms are better understood (Boeve et al., 2016). The Dementia with Lewy 
Bodies Consortium has recently published recommendations for the diagnosis of DLB, with 
core clinical features including REM sleep disorder, visual hallucinations and fluctuating 
cognition, with at least one cardinal parkinsonism feature and existing dementia (McKeith et 
al., 2017). 
1.1.5.2 Progressive	supranuclear	palsy	(PSP)		
Also known as Steele-Richardson-Olszewski syndrome, classic PSP is characterised by an 
inability to voluntarily look up or down, axial rigidity, postural instability with falls and 
cognitive decline (Ling, 2016; Lubarsky & Juncos, 2008). PSP is a tauopathy. Tau is a protein 
found in neurons and it stabilises microtubules - structures needed for maintaining cell shape 
and axonal transport. Abnormal aggregations of tau can accumulate and give rise to a 
tauopathy (Buee, Bussiere, Buee-Scherrer, Delacourte, & Hof, 2000). A subset of PSP 
patients have bradykinesia, rigidity and tremor (PSP-P), and they are commonly 
misdiagnosed as PD (Williams et al., 2005).  
1.1.5.3 Multiple	system	atrophy	(MSA)		
MSA or Shy-Drager syndrome is characterised by autonomic dysfunction along with 
cerebellar ataxia and parkinsonism (Wenning et al., 2004). Microscopically, MSA is a glial 
disorder (Wenning et al., 2008) characterised by glial (oligodendroglial) cytoplasmic 
inclusions (Papp et al., 1989) that are stained by α-synuclein sensitive antibodies (Lin et al., 
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2004). MSA has a rapid onset, has more severe autonomic symptoms than PD, and has 
parkinsonism symptoms that are poorly responsive to levodopa (Wenning & Krismer, 2013). 
1.1.5.4 Corticobasal	degeneration	
Corticobasal degeneration, the commonest cause of corticobasal syndrome, is a rare tauopathy 
that presents with progressive asymmetric symptoms, usually affecting one limb at first. 
Corticobasal degeneration causes dystonia, rigidity, inability to mime hand gestures 
(ideomotor apraxia), a sensation of disconnect from the limb (alien limb phenomenon), 
cognitive decline and features of parkinsonism (Armstrong et al., 2013; Mathew et al., 2012). 
Corticobasal degeneration is associated with tau protein accumulation in the frontal, temporal 
and parietal lobe, along with the basal ganglia (Forman et al., 2002). The unilateral 
parkinsonism seen in corticobasal degeneration is poorly responsive to levodopa (Wenning et 
al., 1998). 
1.1.5.5 Vascular	parkinsonism	
Vascular parkinsonism refers to the idea that lacunar infarcts in the basal ganglia can cause 
parkinsonism (Sibon & Tison, 2004). This idea is controversial since not all basal ganglia 
infarcts cause parkinsonism and no correlation of infarct location and parkinsonism has been 
made (Peralta et al., 2004; Reider-Groswasser et al., 1995). Recently, attempts have been 
made to clarify features of vascular parkinsonism, with a call to develop clear diagnostic 
criteria (Kalra et al., 2010; Vale et al., 2015). 
1.1.5.6 Essential	tremor	
While not a parkinsonian disorder, essential tremor is prevalent among the general population 
and more importantly, can on rare occasion be difficult to distinguish from PD (Thenganatt, 
2012). Essential tremor classically affects both hands symmetrically and is postural or action-
related (Deuschl et al., 1998). More severe essential tremor can, however, manifest at rest 
(Cohen et al., 2003). Essential tremor may not always be bilateral (Louis et al., 1998) and 
even bradykinesia has been observed in essential tremor patients (Christian et al., 2006). 
Essential tremor can co-exist with PD (Benito-Leon et al., 2009) and misdiagnosis does occur 
(Jain et al., 2006). 
1.1.5.7 Diagnosing	“prodromal	PD”	
A concept of a “prodrome” phase of PD has emerged in recent years (Berg et al., 2014). The 
prodrome phase is described as a period when initial neurodegeneration has occurred, but 
before the development of the motor features needed for PD diagnosis. During the prodrome 
phase, other motor and non-motor aspects from initial neurodegeneration may be present, 
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which could herald the development of PD (Berg et al., 2015). This concept is in line with 
what we know from the Braak studies, which demonstrated α-synuclein pathology developing 
in the olfactory bulb and in the enteric nervous system before CNS involvement. This is 
supported by studies showing that olfactory loss and constipation have a possible association 
with future PD (Abbott et al., 2001; Berg et al., 2013; Ross et al., 2008; Tunc et al., 2015). 
Non-motor symptoms such as REM sleep behaviour disorder are also frequently reported 
prior to PD diagnosis (plus the other synucleinopathies, MSA and DLB) (Mahlknecht, et al., 
2015; Poewe, 2008; Postuma et al., 2012; Postuma et al., 2015). No single symptom can be 
considered a harbinger of PD but a combination may be able to give a good prediction of the 
risk of PD development (Berg et al., 2013; Mahlknecht, et al., 2015; Tunc et al., 2015). This 
idea has led the MDS to develop criteria for prodromal PD (Berg et al., 2015).  
The prodromal criteria developed by the MDS are intended purely as a research tool. Berg et 
al. (2015) state that the prodromal symptoms cannot be reliably used to predict the timing and 
development of PD in the individual, only overall risk. In the absence of disease-modifying 
drugs, ethical issues are encountered if discussing the future probability of developing PD. In 
addition, the number of studies used in the construction of the criteria was limited. The MDS 
does not recommend that this criterion be used in a clinical context at this stage, and state the 
need for these criteria to be continually updated as more information is available.  
Imaging has been considered as potential means of diagnosing a prodromal PD (Liu et al. 
2017) . PET techniques have been trialled using specially radioactively tagged compounds 
whose uptake in the GI system may reflect levels of parasympathetic dysfunction via impaired 
vagal nerve activity in PD (Gjerløff et al., 2015). Olfactory changes are also part of the 
prodromal PD concept. The use of MRI in detecting reduced olfactory bulb volume in PD 
patients has been the subject of a meta-analysis (Li et al., 2016), which did find significant 
olfactory volume differences in established PD patients and controls. This meta-analysis 
however did not track progression of non-PD patients into PD. As the bulb changes are 
known to occur before PD diagnosis, future studies could consider olfactory bulb imaging in 
patients meeting current prodromal criteria and validating the olfactory bulb MRI measures 
against progression of non-PD into PD patients as a longitudinal cohort study. 
1.1.6 PD	Treatment		
A number of pharmacological and surgical treatments are available for PD. Current medical 
therapy is focused on treating the symptoms of PD, but new neuroprotective strategies are 
being developed, with the aim of modifying disease progression. The decision to initiate PD 
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treatment depends on the extent of functional impairment experienced by each individual 
patient. Important factors to consider are the effect of the disease on the dominant hand and 
the extent to which the disease affects work or activities of daily living, particularly if 
significant bradykinesia is present or walking is affected (Olanow et al. 2001). A UK 
multidisciplinary panel, The National Institute for Health and Care Excellence (NICE) (2006), 
published a set of guidelines for PD management. Key suggestions were that patients with 
suspected PD be referred to a specialist service for diagnosis and that this diagnosis is 
reviewed every 6 to 12 months. Also noted was the importance of non-pharmacological 
management, such as physiotherapy and specialist nursing care, plus the need to treat the non-
motor symptoms of PD throughout the disease stages. The opportunity for people with PD 
and their family to discuss palliative care issues should also be given. 
1.1.6.1 Medication	use	in	PD	
A range of pharmacological classes are used in the treatment of PD. The goal is to provide the 
best relief of patient-specific symptoms, minimising off-time (the re-emergence of PD 
symptoms after levodopa treatment has worn off) and medication side-effects. The approach 
to PD medication is highly individual, needing to take into account patient preferences, with 
ongoing monitoring of patient symptoms needed (National Collaborating Centre for Chronic 
Conditions, 2006). 
 
Levodopa has been the gold standard treatment for PD for over 40 years (Davie, 2008). 
Levodopa provides the greatest symptomatic benefit for those with PD with fewer side-effects 
(such as sleepiness, impaired impulse control and hallucinations) compared to other classes, 
such as dopamine agonists (Davie, 2008). The need to treat Parkinson’s symptoms (too little 
voluntary movement) is balanced with the side-effect of dyskinesias (excessive involuntary 
movements). Young-onset PD patients are at an increased risk of dyskinesias and as a result, 
tend to be given dopamine agonists initially (Wickremaratchi et al., 2009). As PD progresses, 
medications are adjusted accordingly with regard to adverse effects such as dyskinesias. The 
elderly (age over 60) have a greater disposition to develop cognitive and psychiatric side-
effects from dopamine agonists and as a result, levodopa is preferred in the elderly patient 
population (Connolly & Lang, 2014). Monoamine oxidase inhibitors (MAOIs) are used in 
early and mild PD and have been shown to provide moderate benefit for mild PD symptoms 
(Parkinson study group, 1989). Medications such as anticholinergics and amantadine are also 
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occasionally used in younger PD. The use of each individual medication class is covered in 
further detail below.  
1.1.6.2 Levodopa	
Levodopa is the most effective treatment of motor PD symptoms, especially if used in treating 
bradykinesia that has reached the point of affecting daily life for the patient (Connolly & 
Lang, 2014; Ferreira et al., 2013). 
Pharmacology 
Levodopa is a dopamine precursor and is able to pass through the blood-brain barrier to reach 
the CNS. Here, the levodopa is converted to dopamine by the enzyme DOPA decarboxylase. 
This helps replenishes the dopamine deficit caused by the death of dopamine-producing cells 
in PD. Levodopa, before passing through the blood-brain barrier, is converted by peripheral 
decarboxylase into dopamine. This peripheral dopamine causes such side-effects as 
nausea/vomiting and orthostatic hypotension. To prevent this, levodopa is always used in 
combination with a peripheral decarboxylase inhibitor – examples include carbidopa and 
benserazide. This reduces this peripheral conversion process and hence side-effects from 
levodopa (Connolly & Lang, 2014). 
Dosing regimens 
Combination carbidopa and levodopa are available in different ratios and may come under the 
commercial name of Sinemet or Kinson. Benserazide and levodopa is also a common 
combination and is known as Madopar. Treatment begins with a small dose and is titrated up, 
according to effect. Tolerance and side-effects are monitored during this process. The 
majority of PD patients will have a clinical response at a moderate levodopa dose. If no 
response is achieved, the diagnosis of PD is placed in doubt and an alternative parkinsonism 
syndrome should be considered. 
A dosing strategy is needed to minimise off-time. Levodopa can be divided into smaller but 
more frequent doses to reduce off-time. Levodopa is started at two to three times a day, but 
this frequency can be increased if needed. Levodopa also comes in immediate-release and 
controlled-release formulations. The use of controlled formulations is often for convenience 
purposes once the therapeutic dose has been determined. These controlled-release 
preparations are often used at night to reduce nocturnal akinesias (loss of voluntary movement 
at night). There does not appear to be a difference in the symptom control between the use of 
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either long- or short-acting levodopa after several years of use (Koller, Hutton, Tolosa, & 
Capilldeo, 1999).  
Motor complications 
A phenomenon that affects levodopa users after a few years is known as motor fluctuations. 
These are fluctuating responses to the established levodopa dose, ranging from a faster 
transition to the “off” period, despite being on the same medication, to the other end of the 
spectrum, where patients experience abnormal involuntary movements (dyskinesias) while 
“on” levodopa. It is likely that the development of dyskinesias is due to progressive 
destruction of dopamine terminals in the nigrostriatum, limiting dopamine uptake and release 
(Olanow et al., 2001). The DATATOP study reported that up to 30% of patients developed 
motor complications after 2 years of levodopa use (Penney et al., 1996). A number of studies 
suggest these motor fluctuations are related to age of onset of PD and to higher levodopa 
doses. Block, Liss, Reines, Irr, & Nibbelink (1997) found a smaller proportion of patients 
developed motor complications after 5 years of treatment with relatively lower levodopa 
doses. Motor fluctuations were seen more in PD patients with a younger age of onset (Kumar 
et al., 2005; Quinn et al., 1987). Similarly, the STRIDE-PD study reported that the risk for 
dyskinesias and the wearing-off phenomena was most strongly related to age of PD onset and 
levodopa dose (Olanow et al., 2013). Some studies have suggested initial treatment with 
pramipexole (a dopamine agonist) is associated with a later onset of motor fluctuations 
compared with initial levodopa treatment (Holloway et al., 2004; Parkinson Study Group, 
2000). Other studies report no effect of initial medication on subsequent motor fluctuations 
and dyskinesias (Gray et al., 2014; Katzenschlager et al., 2008; Parkinson Study Group 
CALM Cohort Investigators, 2009).  
Despite an unclear picture on the cause of motor fluctuations, current recommendations are to 
use the lowest levodopa dose for therapeutic response. This potentially decreases the risk of 
motor fluctuations and increases quality of life through a better-titrated dose regime. If a 
repeatable biomarker can be developed without needing a subjective component, it may allow 
better titration of levodopa, minimising dose. 
1.1.6.3 Dopamine	agonists		
Dopamine agonists are synthetic compounds which directly stimulate dopamine receptors. 
There are five known dopamine receptor types: “dopamine receptor D1 – D5” or simply D1-
5. D1-like (D1 and D5) receptors are linked to adenylate cyclase. D2 like (D2, 3, 4) are not 
and have the opposite effect of D1 like receptors. D1 and D2 receptors are concentrated in the 
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striatum (caudate nucleus and putamen) and are considered important in movement control. 
D3 is also thought to be involved in movement control but is mainly located in the limbic 
system and is believed to play a role in behaviours and emotions (Missale et al., 1998). 
Dopamine agonists can be used as monotherapy for treating PD symptoms or in combination 
with other antiparkinsonian medication. Examples of dopamine agonists include lisuride 
(Dopergin), pergolide (Permax; but now rarely used), ropinirole (Requip or Ropin), 
bromocriptine (Alpha-Bromocriptine), apomorphine (Apomine) injections and rotigotine 
(Neupro) transdermal patches. 
Dopamine agonist use 
Initially, dopamine agonists were used as adjuvant therapy with levodopa to reduce off 
periods, but studies have shown that dopamine agonists are an effective monotherapy in their 
own right (Stowe et al., 2008), with a lower risk of developing dyskinesias (Rascol et al., 
2000). Levodopa, however, has been found to provide better symptom control (Holloway et 
al., 2004) and most patients will need levodopa eventually even if starting on dopamine 
agonists. By initially starting on dopamine monotherapy, it was believed the use of levodopa 
can be “saved” until later in the disease (Kurlan, 1988). The idea that levodopa response has a 
finite limit is, however, unproven as previously mentioned, with a number of studies showing 
initial therapy does not change motor fluctuation symptoms (Gray et al., 2014; 
Katzenschlager et al., 2008; Parkinson Study Group CALM Cohort Investigators, 2009). The 
dopamine agonists ropinirole and pramipexole are effective in early PD as monotherapy. 
Pramipexole also has antidepressant properties. Rotigotine is provided as a transdermal patch, 
which avoids food interactions and first pass metabolism. Apomorphine is given as a 
subcutaneous injection to treat (or “rescue”) off-episodes or as a continuous infusion to 
minimise fluctuations. 
Dopamine agonist side-effects 
Medication side-effects can be minimised by using the lowest possible dose. Side-effects of 
dopamine agonists include nausea and vomiting, orthostatic hypotension, peripheral oedema, 
confusion and hallucinations (Stowe et al., 2008). Valvular heart disease can be caused by 
pergolide (Baseman et al., 2004; Pritchett et al., 2002; Van Camp et al., 2004), which is no 
longer recommended in the treatment of PD. Dopamine dysregulation syndrome can occur 
with dopamine agonist use though more commonly encountered with excessive levodopa 
intake. Patients with this syndrome develop an addictive compulsive use of the medication, 
despite developing drug-related dyskinesias (Giovannoni et al., 2000). Impulse control 
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disorders, such as pathologic gambling, may also develop with dopamine agonist use in 
particular (Voon et al., 2006). On abrupt withdrawal, dopamine withdrawal syndrome can 
develop (Rabinak & Nirenberg, 2010). This resembles cocaine withdrawal, giving anxiety, 
panic attacks, depression, sweating, nausea, pain, fatigue and cravings. The dosing and 
tapering of dopamine agonists need to be carefully monitored. 
1.1.6.4 Monoamine	oxidase	type	B	(MAO	B)	inhibitor		
Monoamine oxidase type B (MAO B) inhibitors are used in the treatment of mild PD 
symptoms (Lewitt et al., 2009; Riederer & Laux, 2011). Monoamine oxidase is an enzyme 
that exists in two isoforms - Type A and B (Johnson, 1968). Both types are found throughout 
the periphery and CNS, but MAO B is the predominant form found in the basal ganglia 
(Youdim & Weinstock, 2004). Early use of non-selective MAO inhibitors caused serious 
side-effects in the form of food interactions, leading to severe headache and hypertensive 
crisis – known as the “Cheese effect” (Finberg & Rabey, 2016). Since then, the use of 
selective MAO inhibitors has reduced this occurrence. Some examples of MAO-B inhibitors 
include selegiline, rasagiline and safinamide. Selegiline (L-deprenyl) intake is associated with 
a significant increase in dopamine concentrations in the basal ganglia of PD patients (Riederer 
& Youdim, 1986). A meta-review by Ives (2004) reported improved UPDRS scores in PD 
patients on a MAO-B inhibitor vs placebo. The use of selegiline is reported to delay the 
initiation of levodopa. Selegiline treatment also lowers the dose of levodopa needed to 
provide symptomatic relief. A modest reduction in motor fluctuation, but not dyskinesia, was 
reported in patients taking both levodopa and selegiline relative to levodopa alone. This was 
thought to be an effect of either a lower levodopa dose with concurrent selegiline use or a 
neuroprotective effect of selegiline itself. No difference in mortality was noted by Ives. Other 
reviews have also supported the findings of Ives, but noted the neuroprotective properties of 
selegiline were not apparent (Turnbull et al., 2012). Most studies have used selegiline in their 
comparisons but a more recent alternative rasagiline has also shown benefit in the treatment 
of PD symptoms and also possible neuroprotection in animal models (Chen, Swope, & 
Dashtipour, 2007; Parkinson Study Group, 2002, 2004). Side-effects of MAO inhibitors 
include nausea and headache (Horn & Stern, 2004). Hallucinations may also be related to 
selegiline use in advanced PD patients on multiple other treatments (Kamakura et al., 2004). 
1.1.6.5 Anticholinergics	
Anticholinergics were the first medication used to treat PD, before the widespread use of 
levodopa (Olanow et al., 2001). This class of medication inhibits muscarinic acetylcholine 
receptors. The exact mechanism behind anticholinergic action in PD remains unknown 
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(Brocks, 1999) but it is thought that neurotransmitters dopamine and acetylcholine exist in an 
equilibrium state in basal ganglia. Dopamine depletion in PD creates an imbalance in the 
cholinergic system which an anticholinergic is thought to correct (Olanow et al., 2001). 
Examples of anticholinergics in use include trihexyphenidyl, benztropine, orphenadrine and 
procyclidine. Anticholinergics are mostly used in a relatively younger population (under 70 
years of age), experiencing tremor as the main symptom (Connolly & Lang, 2014). 
Anticholinergics are used with caution in the elderly population, as they are more susceptible 
to adverse effects including memory impairment, hallucinations and confusion. Other side-
effects include urine retention, constipation, dry mouth and blurred vision. A Cochrane review 
found the side-effects of anticholinergics to be a more common reason for discontinuation 
than lack of efficacy (Katzenschlager et al., 2003). 
1.1.6.6 Amantadine	
Amantadine is an antiviral that has some antiparkinsonian properties (Schwab et al., 1972). 
The mechanism of action is not entirely understood but is thought to be from antagonistic 
activity at N-methyl-D-aspartate (NMDA)-type glutamate receptors (Kornhuber et al., 1994), 
which increases extracellular dopamine levels (Mizoguchi et al., 1994). 
Trials have found amantadine improves bradykinesia and rigidity (Parkes et al., 1974; Schwab 
et al., 1972b). Guidelines have recommended the use of amantadine for PD treatment as 
monotherapy or adjuvant (Ferreira et al., 2013; Fox et al., 2015). Side-effects of amantadine 
include ankle oedema, confusion and hallucinations (Horn & Stern, 2004). 
1.1.6.7 COMT	inhibitors	
Catechol-O-methyl transferase (COMT) is an enzyme which metabolises levodopa and 
dopamine to 3-O-methyldopa (Axelrod & Tomchick, 1958; Guldberg & Marsden, 1975; Lotta 
et al., 1995). This decreases the concentration of available levodopa and dopamine. COMT 
inhibitors impede this process. Entacapone and tolcapone are both COMT inhibitors. 
Entacapone acts peripherally (Brooks, 2003) while tolcapone can cross the blood-brain barrier 
and act centrally in the CNS (Truong, 2009). COMT inhibitors are used to treat patients 
experiencing motor fluctuations while on levodopa. There appears to be no additional benefit 
in adding a COMT inhibitor to levodopa use if motor fluctuations are not present (Olanow et 
al., 2004). Side-effects of entacapone and tolcapone are due to increased dopamine 






Deep brain stimulation (DBS) 
Currently, deep brain stimulation is the preferred form of surgical management for PD (Wagle 
et al., 2014; Weaver et al., 2009). DBS of the STN is used in the advanced stages of PD for 
patients experiencing problematic motor fluctuation with levodopa (Günther Deuschl et al., 
2006; Limousin et al., 1998). From the physiology of PD, it is known the loss of 
dopaminergic neurons in the SN causes aberrant STN activity. This activity increases 
activation of the internal globus pallidus, which leads to increased inhibition of the outputs to 
the motor thalamic nuclei, and in turn, reduces excitation of motor cortical areas (Benazzouz 
et al., 2000). The mechanism of DBS is not fully understood. Initial studies found an 
inhibitory effect of DBS on the subthalamic nucleus (Benazzouz et al., 2000) but more recent 
observations have shown this idea to be too simplistic. The high-frequency impulses from 
DBS are now thought to modulate the basal ganglia-thalamocortical network through both 
excitatory and inhibitory effects, with an overall effect of decreasing pathological neural 
signals (Miocinovic et al., 2013). Surgical ablation techniques performed on the thalamus, 
subthalamic nucleus and globus pallidus have been used in the past (Krack et al., 2000; Patel 
et al., 2003; Tasker, 1990) but have largely been replaced by DBS (Bronstein et al., 2011). 
DBS electrodes can be situated in either the subthalamic nucleus or globus pallidus, both 
having good efficacy, and result in equal improvement in motor scores or quality of life 
measures (The Deep-Brain Stimulation for Parkinson’s Disease Study Group, 2001; Weaver 
et al., 2012). Some recent reports have also suggested that DBS of the pedunculopontine 
nucleus could improve PD with postural instability and gait disorder (Tykocki et al., 2011; 
Wang et al., 2017). STN DBS has been reported to allow a greater reduction in dopaminergic 
medication use compared to GP DBS (Liu et al., 2014). The risks of DBS include mainly 
surgical complications of bleeding, infection and dysfunction/displacement of the electrode 
leads (Bronstein et al., 2011).  
 Intestinal gel infusion 
Levodopa can also be combined with gel and continuously infused into the jejunum via a 
percutaneous endoscopic gastrojejunostomy tube (PEG-J) (Fernandez & Odin, 2011; Nyholm 
et al., 2003). This is an alternative to DBS and, has been shown to reduce levodopa “off time” 
(Olanow et al., 2014). The risks of continuous gel infusion relate to the surgical procedure to 
insert the PEG-J, abdominal pain from the device and device malfunction (Lang et al., 2016). 
Jejunal infusion is recommended to only be used in advanced cases with motor fluctuation 
and needs attention and monitoring to ensure the condition of the pump and infusion and to 
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monitor for potential infections. Regular monitoring by a gastrointestinal expert is 
recommended (Epstein et al., 2016). 
 Tissue transplantation 
Surgical transplantation of dopamine-producing neural tissue has been previously performed 
for PD, the idea being that the graft tissue can secrete dopamine, making up for host deficits 
(Olanow et al., 1996). This is no longer a recommended treatment due to conflicting study 
results on efficacy and observed side-effects of graft-related “runaway” dyskinesias (Freed et 
al., 2001; Kordower et al., 2017; Olanow et al., 2003). 
1.1.6.9 	Neuroprotective	treatments	
Neuroprotective or disease-modifying therapies would revolutionise PD treatment. 
Neuroprotection is the idea that a therapy is able to slow neurodegenerative disease 
progression. Currently, all available therapy for PD is considered symptomatic, giving relief 
of symptoms, but ultimately not affecting the progressive disease course. A number of trials 
have been undertaken in the past to test out potential neuroprotective agents.  
MAO-Is are thought to help prevent reactive oxygen species formation from the oxidation of 
dopamine and may prevent cell death by apoptosis. This, in theory, may confer a 
neuroprotective effect (Jenner, 2004). The TEMPO trial (Parkinson Study Group, 2004) found 
patients started on rasagiline earlier had a smaller increase in UPDRS scores than those with 
later treatment. However, this could have been from the symptomatic properties of rasagiline 
itself (Suchowersky et al., 2006). The ADAGIO trial (Olanow et al., 2009) found a potential 
disease-modifying effect of 1 mg rasagiline but not a 2mg daily when measured on week 72 
of the trial. The interpretation of this result is difficult, with the higher dose having less effect.  
The DATATOP study (Parkinson Study Group, 1993) investigated the use of selegiline for 
treating early PD. Selegiline was found to delay the initiation of levodopa treatment by 9 
months, but again, this could have been due to symptomatic improvements provided by 
selegiline itself, rather than a neuroprotective benefit. Olanow et al. (1995) did report a 
possible mild neuroprotective benefit with selegiline-treated patients having a slower decline 
in UPDRS after a two month withdrawal of the medication. This study lasted 14 months total. 
A study three years after the initial DATATOP results was published found no long-term 
effect of selegiline treatment on the original study group (Penney et al., 1996). Dopamine 
agonists have anti-oxidant properties and have been shown to protect dopaminergic neurons 
in cultures and animal models (Olanow et al., 1998). The REAL-PET study (Whone et al., 
2003) and CALM-PD study (Parkinson Study Group, 2002b) compared dopamine agonists 
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with levodopa treatment. Both studies found less reduction in positron emission tomography 
(PET) markers of dopaminergic neuron depletion in the dopamine agonist groups vs 
levodopa. These results are controversial due to a number of important limitations. For 
example, no placebo control group was used. The studies also did not have a washout period 
and the use of PET measures to assess neuron depletion is uncertain (Ravina et al., 2005). 
Coenzyme 10 is involved in mitochondrial function, which is known to be disrupted in PD. 
However, studies have found no support for neuroprotection with coenzyme 10 (Beal et al., 
2014; Storch et al., 2007).  
Vitamin E is an antioxidant and was included in the DATATOP study. No neuroprotective 
benefit was found (Parkinson Study Group, 1993). Uric acid, the precipitant for gout, also has 
antioxidant properties (Ames et al., 1981). Several epidemiological studies have noted a lower 
prevalence of PD in gout sufferers (Alonso et al., 2007; de Lau et al., 2005). Lower uric acid 
levels have even been described as a potential PD biomarker (Wen et al., 2017). No study has 
yet been completed showing a neuroprotective effect of uric acid but any benefit would need 
to be weighed against the increased risk of developing gout. 
Caffeine is an adenosine receptor agonist and caffeine intake has been linked with a lower 
relative risk of PD (Ascherio et al., 2001; Palacios et al., 2012). Adenosine receptor agonists 
are seen as a target for future investigation for therapeutic treatment and neuroprotection 
(Schwarzschild et al., 2006) but no studies have yet shown a neuroprotective effect with an 
adenosine receptor agonist. 
As neuroinflammation is considered to contribute to cell loss, anti-inflammatory medications 
such as ibuprofen have been investigated for possible neuroprotective benefits (Bassani et al., 
2015). Ibuprofen and non-aspirin NSAIDs were found to possibly contribute a 
neuroprotective effect for PD (Gagne & Power, 2010; Samii et al., 2009). 
As previously mentioned, PD pathogenesis is associated with accumulating α-synuclein 
pathology. Factors increasing α-synuclein toxicity such as phosphorylation processes, the 
formation of toxic oligomers and the prion-like properties of α-synuclein are all targets for 
potential neuroprotective treatments (Kalia et al., 2013). 
No current therapy is considered to be neuroprotective but vigorous research is ongoing in 
this field (AlDakheel et al., 2014; McGhee et al., 2016; Rascol, 2009). A reliable biomarker 
for PD progression is needed to aid identification and assessment of putative neuroprotective 
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The human eye is a light detecting organ that detects external visual stimuli, which are sent to 
and interpreted by the brain. In order to attain sharp central vision, the external light image 
must be focused on the fovea. The fovea is a pit in the retina at the back of the eye and offers 
the highest visual resolution (Rossi & Roorda, 2010). In order to keep images focused on the 
fovea, an adjustable lens is needed to account for varying image distances and also, a system 
for aligning the eye with the visual target and stabilising the eye in response to head/body 
motion. A number of eye movement classes exist to maintain this alignment of the image on 
the retina/fovea such as vestibular eye movements, smooth pursuit, vergence, saccades, 
nystagmus and fixation (Leigh & Zee, 2000). 
In Parkinson’s disease, an eye movement type known as saccades show characteristic 
changes. The most notable change is hypometria or the undershooting of the saccade, 
however, changes in saccade reaction time have also been demonstrated (Anderson & 
MacAskill, 2013; Chan et al., 2005). The primary aim of this thesis is to investigate the 
hypothesis that this altered saccade performance can reflect brain health in PD as detected 
using MRI. The aims of this thesis will be the subject of discussion in extensive detail in later 
sections. Prior to this, I present the fundamental background information regarding saccade 
testing and saccade control, which are essential to appreciate before a detailed discussion of 
the study aims and methods can take place.  
Saccades are a certain type of eye movement. For completeness, I have provided a brief 
description below of other non-saccade eye movement types. Although control of different 
eye movement types may interact, the non-saccade eye movements are controlled by different 
neural processes compared to saccades and are not related to the studies in this thesis. These 
non-saccade eye movements are listed in brief but not further discussed. In contrast, the 
neural control of saccades will be discussed extensively following this. 
1.2.1.1 Non-saccade	eye	movement	types	
Smooth pursuit 
Smooth pursuit is responsible for tracking continuously moving objects and keeping an image 
of the object constantly projected upon the fovea. Visual information is transformed into eye 
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movement commands to initiate the smooth pursuit movement. Separate mechanisms are 
thought to adjust the eye movement to match changes in target motion and to maintain steady-
state pursuit  (Ono, 2015). Smooth pursuit allows constant, clear vision of moving targets in 
the visual field. Smooth pursuit also interacts with the vestibulo–ocular reflex to allow the eye 
to continuously maintain gaze upon an object during self-motion (Huebner et al., 1992; 
Lanman et al., 1978).  
Vestibulo–ocular reflex 
The vestibulo–ocular reflex or VOR is a reflex for gaze stabilization during head and/or body 
movement detected by the vestibular system. This occurs by the generation of eye movements 
equal and opposite the displacement of the head. This system works by using vestibular 
signals from the labyrinth system, which is integrated with visual information in the brain to 
generate a compensatory eye movement (Dieterich & Brandt, 1995; Seidman et al., 1995). 
Vergence 
Vergence eye movements are simultaneous movements of each eye in the opposite direction 
i.e. towards (convergence) or away from the midline (divergence). As the two eyes are 
separated by a small distance, vergence movements are necessary to keep the same image 
focused on the fovea of each eye, with closer objects requiring a higher degree of midline 
convergence, and further objects requiring less (Mays, 1984). Of note, vergence movements 
were found to be slowed in PD, with patients also showing hypometric divergence 
movements  (Hanuska et al., 2015). As mentioned previously, vergence movements have a 
separate mechanism of control to saccades and are not further investigated in this thesis. The 
remaining sections on eye movements will focus solely on saccades. 
1.2.1.2 Saccadic	eye	movements	
Saccadic eye movements are fast ballistic movements. These rapid eye movements last only 
tens of milliseconds and quickly redirect the eye to new areas in the visual field. Saccadic 
movement occurs by a rapid acceleration of the eye which tapers with a rapid deceleration to 
standstill. The maximum speed of a saccade occurs from about one third to halfway through 
eye movement travel. Peak velocity is reached relatively earlier in larger saccades (Boghen et 
al., 1974; Robinson, 1964).  
After the initial saccade, the eyes may drift to compensate for slight undershoots and any eye 
disconjugacy (caused by the two eyes not moving exactly together). This drifting is known as 
a “glissade”. Another process called “dynamic overshoot” may occur. This is a small saccade 
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made in the opposite direction to the main saccade movement. Dynamic overshoots are 
thought to be caused by a reversal in saccadic neural input which stops the main saccade as 
well as moving the eye in the opposite direction (Bahill et al., 1975). However, another study 
has suggested that dynamic overshoot may also be a result of physical tissue properties rather 
than innervation changes (Robinson et al., 1990). 
The duration of movement has a linear relationship with the angular distance the eye has to 
travel and the peak velocity of the saccade is also dependent on the saccade amplitude but in a 
logarithmic fashion rather than linear (Bahill et al., 1975). Only the amplitude of the saccade 
can be controlled consciously. Once initiated, saccades cannot be modified: new corrective 
saccades are required if the original saccade does not fall on target (Leigh & Zee, 2000).  
There appears to be greatly reduced vision during saccadic movements. As the eye jumps to a 
new location, no rapid sweeping motion of the image is seen, despite the movement of light 
across the retina. One theory is that the blurred image during the saccade would be masked 
out by the stable images before and after the saccade. It has been shown that suppression of 
visual pathways occurs during saccadic eye movements: the magnocellular pathway (high 
temporal resolution with low spatial resolution) is found to be selectively suppressed, with the 






Saccadic behaviour can be experimentally classified into reflexive and volitional tasks. The 
tasks used in this study are the reflexive task, predictive task, memory-guided task and 
antisaccade task. Figure 1-4 and Figure 1-5 illustrate the task sequences which were presented 
to participants  
. 
 
Figure 1-4 – Diagram of the saccadic tasks, with coloured squares representing task stimuli and numbers 
on each frame indicating the task sequence. The grey arrow indicates the direction of the saccadic eye 
movement made for each task. (A) Reflexive task - participants followed a stimulus as it jumped 
horizontally at pseudo-random intervals and distances. (B) Predictive task - participants followed a 
stimulus as it jumped horizontally between two fixed positions at a regular interval. (C) Antisaccade - 
participants fixating on central green target made a saccade to the mirror opposite location of the 
stimulus. 
  
A  Reflexive 
B  Predictive 





Figure 1-5 – Memory-guided task. Numbers on each frame indicates task sequence with red squares 
representing stimuli and an arrow representing the saccade movement. The task begins with a fixation 
stimulus (1). A peripheral “flash” (2) occurs with the participants remembering the location of this flash 
while remaining fixated on the original stimulus (3). The fixation stimulus is then extinguished (4) and the 
participant made a saccade to the best remembered location of the flash (5) before the flash appears again 
and becomes the fixation for the next trial (6). 
 
1.2.2.1 Reflexive	saccades	
These are saccadic eye movements made to new unanticipated targets that appear or move 
suddenly in the environment. Reflexive saccades, also known as visually-guided saccades or 
prosaccades, are made by in the lab by instructing the subject to look at a stimulus as it 
appears, and presenting the subject with a series of stimuli that appear randomly in time or 
location, or both. Variations of the reflexive task can be used. The “gap” reflexive task has a 
short time period from when the original stimulus is extinguished until the new stimulus 
appears (Saslow, 1967). This offset of stimulus presentation has the effect of disengaging 
fixation before a saccade is made. The “overlap” reflexive task, by contrast, has a short time 
period after the appearance of the new stimulus when the previous stimulus remains (Ross & 
Ross, 1980; Saslow, 1967). This has the effect of requiring the subject to disengage fixation 
while the fixation stimulus is still present in order to make a saccade to the new stimulus 
(Leigh & Zee, 2000). 
1.2.2.2 Volitional	saccades	
These are deliberate saccades which can be classed by experimental requirements: 
Predictive saccades are a type of volitional saccade made to an anticipated appearance of a 




consist of an alternating stimulus, which jumps between two locations at predictable regular 
time intervals. 
Antisaccades are saccades required to be made in the opposite direction to a suddenly-
appearing target to its imagined, mirror-opposite position (Fischer & Weber, 1992; Hallett, 
1978). Antisaccade trials begin with a central fixation stimulus (illustrated as a green square 
in Figure 1-4). After a set time, a peripheral stimulus (a red square is used to illustrate) is 
presented to the left or right of centre, with participants instructed to make a saccade to the 
mirror opposite location of this stimulus as quickly as possible. This task involves the 
suppression of a reflexive saccade to the peripheral stimulus and the generation of a volitional 
saccade in the opposite direction. Error trials occur when the subject makes a saccade towards 
the target, as opposed to away from it.  
Memory-guided saccades are saccades made to a remembered location where a stimulus was 
previously (Figure 1-5) (Funahashi et al., 1993). Memory-guided tasks involve an initial 
fixation period, followed by a “cue” or “flash”, where a peripheral stimulus is briefly 
presented, with the subject required to maintain fixation during this period. The subject is 
required to retain the location of the cue stimulus for a “delay” period after the cue disappears. 
Then the fixation stimulus disappears, signalling the subject to make a saccade towards the 
position of the remembered cue. Error trials occur when the subject is unable to maintain 
fixation and makes a saccade directly to the cue. The memory-guided saccade task is 
sometimes known as the oculomotor delayed-response task (Tsujimoto & Postle, 2012). 
1.2.3 Saccadic	control	system	
1.2.3.1 Muscular	control	
 Extraocular motor muscles need to overcome viscous forces acting the eye and pull it to 
fixate a new target in the quickest amount of time (de Corte, 1982). Once the eye is in the new 
position, it must be held in a stable position for clear vision. This movement of the eye occurs 
with a powerful contraction of the extraocular muscles (Collins et al., 1975). This contraction 
is then followed by a stable tonic contraction to hold the eye in position (Robinson, 1964). 
The corresponding neural input has the characteristics of a “pulse-step” innervation, described 
by Robinson in his seminal work (Robinson, 1964). This is a simple model of saccade 
neurophysiology, with the “pulse of innervation” giving a brief period of intense stimulation 
of the extraocular muscles, which rapidly contract, moving the eye to a new position 
(Robinson, 1970). Following this, the muscles hold the eye in the new position against elastic 
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forces that tends to restore the eye to a central resting position. An isometric (muscle held in 
tension without changing in length) contraction of the extraocular muscles occurs after the 
pulse and is the result of a steady stream of action potentials to the extraocular muscle. This is 
known as the “step of innervation” (Leigh & Zee, 2000; Robinson et al., 1990).  
1.2.3.2 Saccade	neural	control	
In order to carry out a saccade, the brain converts the spatial coding of visual information to a 
motor command. The amount of motor activity in the muscle is determined by action 
potential frequency and duration (Robinson, 1970). 
Six extraocular muscles move the eye in three rotational axes. These muscles are controlled 
by the extraocular motor neurons which carry the neural impulses that shift the eye into the 
required spatial position  (von Noorden, 1996). The extraocular motor neurons arise from 
cranial nerves 3, 4 and 6 which correspond to the oculomotor, trochlear and abducens nuclei 
respectively (Sharpe & Wong, 2005). These nuclei receive inputs from various burst neurons 
which encode the saccadic movement (Henn et al., 1989). Outside of saccades, burst neurons 
are completely inactive. This is due to the gating effect of omnipause neurons (Furuya & 
Markham, 1982). Only during saccades do omnipause neurons deactivate, allowing burst 
neurons to fire (Evinger et al., 1982; Fuchs et al., 1985). 
 
1.2.3.3 Burst	neurons	
There are two main types of excitatory burst neuron, called the medium-lead burst neuron 
(premotor burst cells) and long lead burst neuron. Inhibitory burst neurons also exist (Leigh & 
Zee, 2000; Sharpe & Wong, 2005). 
Premotor burst neurons 
Premotor burst cells show excitatory activity approximately 12 ms before saccade initiation 
(Scudder et al., 2002; Van Gisbergen et al., 1981). This is responsible for the pulse of 
innervation. Premotor burst neurons can be excitatory or inhibitory (Strassman et al., 1986). 
Excitatory burst neurons are responsible for generating motor activity while inhibitory burst 
neurons fire to stop movement antagonist muscles during saccades (Leigh & Zee, 2000; 
Strassman et al., 1986). 
The control of horizontal saccades arises from premotor burst neurons within the paramedian 
pontine reticular formation (Henn et al., 1989). These reach the extraocular motor neurons via 
axons running in the medial longitudinal fasciculus (Horn et al., 1996). Vertical and torsional 
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saccades are controlled by midbrain premotor burst cells arising from the rostral interstitial 
nucleus of medial longitudinal fasciculus (riMLF) (Henn et al., 1989). riMLF pathology 
causes vertical gaze deficiencies in PSP (Bhidayasiri et al., 2001) and Niemann-Pick type C 
disease (Salsano et al., 2012). 
 
Long lead burst neurons 
Long lead burst neurons (LLBN) start to show activity 40 ms or more prior to the saccade and 
continue to fire during the saccade (Leigh & Zee, 2000). The LLBN are linked with the 
central mesencephalic reticular formation and receive input from the superior colliculus and 
have projections with the pontine excitatory burst neurons, medullary inhibitory burst neurons 
and omnipause neurons (Scudder et al., 1996). Other LLBN are found in the nucleus 
reticularis tegmenti pontis and project to the cerebellum (Scudder et al., 1996). Some neurons 
project from the cerebellum to the paramedian pontine reticular formation (Scudder et al. 
1996). Interactions of the LLBN are speculated to be involved in a feedback loop or a 
resettable integrator for saccades (Waitzman et al., 1996). The LLBN connection with 
omnipause cells also suggests a role in the start/stop control of saccades (Hepp & Henn, 1983; 
Scudder et al., 1996). 
1.2.3.4 Omnipause	neuron		
These neurons inhibit burst cells arising from the PPRF and riMLF (Nakao et al., 1989; 
Nakao et al., 1980). These cells are constantly firing (i.e. tonic) (Strassman et al., 1987) and 
only cease before and during saccades (Fuchs et al., 1985). In animal studies where the 
omnipause cells are chemically excited, saccade velocity is decreased,(Kaneko, 1996). It is 
believed omnipause neurons inhibit burst neurons until a saccade is made. This helps to 
control burst cells to ensure they fire only when necessary (Leigh & Zee, 2000). 
1.2.3.5 Cortical	and	subcortical	control	of	saccades		
Several cortical and subcortical areas are involved in saccadic control. These areas have 
mainly been investigated using functional MRI techniques and transcranial magnetic 
stimulation (TMS)(Milea et al., 2005). An illustration of cortical regions involved in saccade 
control is provided (Figure 1-6). A circuit diagram of saccadic eye movement control is 





Figure 1-6 – Diagram of cortical regions of eye movement control location. Figure permission obtained 
(Leigh & Kennard, 2004). 
 
 
Figure 1-7 – Circuit diagram of basal ganglia and cortical structures connecting to the brainstem saccade 
generator. Abbreviations: FEF - frontal eye field, SEF - supplementary eye field, DLPFC – dorsolateral 
prefrontal cortex, PEF – parietal eye field, IMP – internal medullary lamina, SNpr – substantia nigra pars 
reticulata, STN – subthalamic nucleus, NRTP – nucleus reticularis tegmenti pontis. Adapted with 




The superior colliculus (SC) is a major site for sensorimotor integration needed to direct the 
head and eyes towards objects of interest (May, 2005; Platt, Lau, & Glimcher, 2003; Sparks 
& Hartwich-Young, 1989; Sparks & Mays, 1990). The SC receives input from all cortical eye 
fields and the basal ganglia. The SC is in the final pathway where connections converge from 
basal ganglia and cerebral cortical regions (Hikosaka et al., 2000; Terao et al., 2013) and as a 
result, has been described as the bottleneck of neural structures responsible for saccades. The 
SC projects to critical brainstem areas that are involved in the circuits (comprising excitatory 
and inhibitory burst neurons) which generate premotor commands for saccades (Moschovakis, 
1996). These include the paramedian reticular formation of the pons, the nucleus prepositus 
hypoglossi and central mesencephalic reticular formation for horizontal saccades. Vertical 
saccades involve connections with the rostral interstitial nucleus of the medial longitudinal 
fasciculus, the interstitial nucleus of Cajal and the nucleus of the posterior commissure. The 
SC is also connected to omnipause neurons in the nucleus raphe interpositus (May, 2005). 
The SC anatomically consists of seven layers. The superficial layers (stratum zonale, stratum 
griseum superficiale, and stratum opticum) receive retinal information for visual processing. 
The intermediate and deep layers (stratum griseum intermedium, stratum album intermedium, 
stratum griseum profundum, and stratum album profundum) respond to a number of sensory 
modalities (visual, auditory, proprioception and vestibular input) and integrates these inputs 
into a topographic sensory map (Wallace, Wilkinson, & Stein, 1996). The intermediate layers 
also send motor output signals to brainstem saccade generating regions prior to saccades 
(Gandhi & Katnani, 2011; May, 2005; Moschovakis, 1996).  
The intermediate layers of the SC containing neurons coding for saccade output are organized 
to form a retinoscopic motor map, with the location of the neural activation in the SC 
corresponding to a specific saccade amplitude and direction. Rostral neurons within the SC 
discharge for small-amplitude saccades, whereas caudal neurons discharge for large saccade 
amplitudes. Medial SC regions are most active during upward saccades and the lateral regions 
for downward (Sparks et al., 1976). The saccade activity is not from single neuron activity but 
occurs as a Gaussian “mound”, involving a spread of SC neurons – up to 28% of saccade-
related neurons discharging for every saccade (Munoz & Wurtz, 1995), with the activity peak 
centred on the SC location corresponding to the desired saccade vector. Aside from location, 
the SC neural discharge also codes for saccade velocity by discharge firing rate (Sparks & 
Mays, 1990). Saccade-related output activity of the SC is thought to be mapped to retinal 
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coordinates and not the environment. Activation of a specific SC location corresponds to a 
fixed retinal location (Klier et al., 2001). 
The rostral pole of the SC was thought to contain a “fixation” zone (Munoz & Wurtz, 1992, 
1993a, 1993b). However, this has been debated recently. Neurons in this area were seen to 
fire during small saccades. Activity in this area doesn’t directly correspond with omnipause 
neuron activity and the rostral SC neurons have no different characteristics from the saccade-
related neurons aside from their location (Gandhi & Katnani, 2011; Krauzlis et al., 2017). A 
current proposal states that fixation is achieved with equilibrium between both SC 
hemispheres. Each SC simultaneously contributes a motor saccade signal for the target which 
is balanced out, achieving no overall eye movement, i.e. fixation. This is known as the 
“equilibrium hypothesis” (Goffart et al., 2012; Hafed et al., 2008; Krauzlis et al., 2017). 
SC ablation in the primate results in increased reflexive saccade latencies to the contralateral 
side, with an elimination of fast “express”-type saccades (Schiller  et al., 1987). Frontal eye 
field lesions (FEF) in the same study did not result in these findings, leading Schiller et al. to 
conclude that the SC, rather than the FEF, is responsible for saccade reaction times and 
express saccades. It is known that PD patients make more express-type saccades (Chan et al., 
2005), which could possibly indicate PD-related changes in the SC (or a circuit with inputs to 
the SC). The SC is a small structure deep within the brain and is located close to pulsating 
vessels (Poncelet et al., 1992). These factors make this region difficult to image using 
functional MRI (fMRI), but studies using cardiac gating have been able to identify SC 
activation (DuBois & Cohen, 2000; Guimaraes et al., 1998). 
1.2.3.7 Basal	ganglia		
As mentioned in the general introduction, the basal ganglia are a group of nuclei located in the 
base of the forebrain. Here, I discuss their role in eye movement control. The basal ganglia 
consists of the caudate nucleus (CN), putamen and the nucleus accumbens (collectively 
known as the striatum) (Hikosaka et al., 2000), substantia nigra (pars compacta and pars 
reticulata, SNc and SNr respectively), globus pallidus (internal and external, GPi and GPe 
respectively), subthalamic nucleus (STN), ventral tegmental area, and the olfactory tubercle 
(Heimer, 1978; Xiong & Wesson, 2016). The basal ganglia have been thought to have a role 
mainly in motor function as well as cognitive functions such as working memory and 
sequence learning (Helie et al., 2013). The basal ganglia are also involved in saccade control 
through a circuit which mainly involves the CN, SNr, STN and GPe (Figure 1-8) (Hikosaka et 
al., 2000). The basal ganglia control saccades by sending connections to the SC. Outputs from 
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the basal ganglia reach the SC via substantia nigra pars reticulata (SNr), which can be seen as 
the primary output region of the basal ganglia for saccade control. The SNr sends inhibitory 
connections to the SC that regulates the excitatory inputs entering the SC (Leigh & Kennard, 
2004). In primates, it has been observed that electrical stimulation of the SNr, which increases 
inhibition of the SC, reduces the amplitude of both visually-guided and memory-guided 
saccades (Basso & Liu, 2007). The influence of the SNr appears to be more prominent for 
volitional saccades, with SNr stimulation having a greater effect on memory-guided saccades 
than visually-guided saccades (Basso & Liu, 2007). A similar result was shown by Mahamed, 
Garrison, Shires, & Basso (2014). In a memory-guided task, when the SNr was stimulated 
during the memory period, saccades occurred less frequently in the contralateral direction (to 
the stimulation site), with a longer latency (slower reaction time). The SNr is modulated by 
the caudate nucleus. The caudate nucleus has an intermittent (i.e. phasic) suppressive effect 
on SNr activity which, in turn, transiently removes the SNr inhibitory effect on the SC 
(Hikosaka et al., 1989). These signals from the SNr and caudate nucleus are greatly 
influenced by behavioural contexts, such as attention and expectation (Hikosaka et al., 2000). 
The caudate nucleus can be seen as the input region for the basal ganglia. The caudate nucleus 
receives numerous connections from nearly every region of the cortex including the FEF, SEF 
and DLPFC (Graybiel & Ragsdale, 1979; Stanton et al., 1988), which are thought to modulate 




Figure 1-8 – A simplified diagram of the basal ganglia saccade circuit. The caudate nucleus (CN) is seen to 
have D1-expressing connections to the SNr (direct pathway) and D2-expressing connections to the GPe 
(indirect pathway). The SNc produces dopamine and is affected in PD leading to dopamine depletion of 
the basal ganglia system. Figure permission obtained (Watanabe & Munoz, 2011). 
 
Direct and indirect pathways 
Saccade-related neurons of the CN output to SNr neurons through the direct dopamine 
receptor  D1 (or simply D1) pathway. This inhibits the SNr, removing the SNr inhibitory 
effect on the SC and facilitating saccades. The CN can also exert influence on SNr indirectly, 
via the GPe in the indirect dopamine receptor  D2 (D2) pathway. The indirect pathway has an 
overall inhibitory effect on saccades – opposite to the direct pathway. Caudate projections 
inhibit the GPe, which normally inhibits the SNr. Therefore, an inhibited GPe, leads to 
increased SNr activity, which is inhibitory on the SC (Hikosaka et al., 2000; Watanabe & 
Munoz, 2011). 
Dopamine depletion causes opposite effects on D1 and D2 receptor-mediated neurons, with 
decreased D1 (direct pathway) activity and enhanced D2 (indirect pathway) activity. The 
increased indirect pathway activation means in theory, for parkinsonism syndromes, the 
inhibitory activity of the SNr will be enhanced, suppressing the SC and inhibiting eye 
movements. In primate studies with unilateral dopamine depletion limited to one side of the 
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CN, fewer spontaneous contralateral saccades are made. Decreased amplitude was seen for 
contralateral saccades for both visually-guided and memory-guided saccades but a decrease in 
latency was only seen for memory-guided saccades (Kori et al., 1995). This observation does 
mirror in some aspects that which is seen in PD eye movement studies. PD patients make 
frequent fast express saccades in visually-guided tasks and generate hypometric 
(undershooting) memory-guided saccades (Chan et al., 2005). However, the predominance of 
the indirect pathway in dopamine depletion and subsequent inhibitory effect on the SC does 
not explain the increased propensity for express saccades. PD patients also tend to make more 
reflexive erroneous anticipatory saccades in the antisaccade task and are less able to inhibit 
reflexive saccades in a delayed response task (Chan et al., 2005). It is possible other 
mechanisms are also contributing to eye movement changes in PD (van Stockum et al., 2008), 
such as attention deficits or dysfunctional signals from cortical regions causing an increase in 
excitability in saccade-related SC neurons. 
CN activation has been found to be stronger for antisaccades compared to prosaccades 
(Brown et al., 2006; Dyckman et al., 2007; Ettinger et al., 2008; Sweeney et al., 1996). 
Watanabe & Munoz (2009) postulated a conflict system within the CN which occurs during 
antisaccades. The caudate nucleus is proposed to have separate regions for automatic reflexive 
saccades, voluntary contralateral saccades and voluntary ipsilateral saccades. In the 
antisaccade task, competition is thought to occur between mechanisms behind the erroneous 
reflexive saccade and the correct voluntary saccade within the basal ganglia. The caudate is 
thought to help generate the correct voluntary saccade by facilitating a saccade via the direct 
pathway in the correct (opposite) direction, while using the indirect pathway to inhibit a 
saccade in the incorrect (reflexive) direction. 
The STN modulates SNr activity through a direct glutamatergic connection. The STN also has 
reciprocal connections with the GPe, which projects to the SNr itself. The STN is a key target 
for deep brain stimulation (DBS) in Parkinson’s disease (see treatment section). DBS of the 
STN is thought to modulate aberrant pathological signals which arise in the dopamine 
depleted basal ganglia. DBS is believed to enhance inhibition of the SNr via the STN 
connection and the STN, GPe, SNr circuit. DBS may inactivate the increased burst neuron 
activity of the STN, resulting in a decrease of SNr activity. DBS improves certain saccade 
performance measures in PD. Fawcett et al. (2010) found latencies for visually-guided 
saccades were decreased and saccade amplitude for memory-guided and antisaccades were 
improved. Similarly, Yugeta et al. (2010) found similar results with DBS improving reaction 
times and saccade amplitudes for reflexive and antisaccades. Memory-guided saccades only 
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showed improved amplitude. Error reflexive saccades were reduced in the memory-guided 
task with DBS. As the mechanisms behind DBS are not fully understood, from these studies, 
we can only speculate on the mechanisms behind eye movement changes in PD with DBS. 
One theory of basal ganglia function involves certain frequencies of neural oscillations, 
known as the “beta band”. These frequencies are detected in basal ganglia electrode 
recordings and are enhanced in PD patients “off” medication. The beta band is thought to be 
“akinetic” in nature (Brown & Williams, 2005; Weinberger et al., 2009). DBS could disrupt 
these pathological akinetic frequencies, facilitating the generation of saccadic eye movements 
(Yugeta et al., 2010). DBS leads to increased glucose metabolism (observed using PET) in 
cortical regions distant to the immediate electrode stimulation sites, including regions in the 
frontal lobe, temporal lobe and parietal lobe (Hilker et al., 2004). This observation may 
indicate increased activity in these distal cortical regions induced by DBS. Fawcett et al. 
(2010) speculated that cortical eye control regions such as the SEF may be influenced by 
DBS, leading to improvements in saccadic eye movement measures. Temel et al., (2008, 
2009) found decreased latencies in the reflexive task for DBS patients. When plotting the 
latencies Temel et al. found the results to correlate well with a statistical model predicting 
latency distributions called the LATER model (Carpenter & Williams, 1995; Noorani & 
Carpenter, 2016). The nature of the correlation indicated neural signals involved in reflexive 
saccade generation rose faster to saccade threshold in DBS patients.  
The remaining basal ganglia nuclei and the influence each has on eye movements are complex 
and incompletely understood. A review article by (Watanabe & Munoz, 2011) further 
explored the theories behind each individual nuclei but discussion on this aspect is beyond the 
scope of this discussion and the studies in this thesis. 
1.2.3.8 Frontal	eye	field	
The FEF is described as a cortical region within the frontal lobe involved in the control and 
triggering of saccadic eye movements (Pierrot-Deseilligny et al., 2002). FEF activity is 
consistently seen in imaging studies of eye movements: It is active in fixation (Petit et al., 
1995) and nearly all types of saccadic eye movement tasks: reflexive and memory-guided 
saccades (Anderson et al., 1994), delayed-response saccades (Sweeney et al., 1996), 
predictive saccades (O’Driscoll et al., 2000), antisaccades (Brown et al., 2006; Kimmig et al., 
2001; O’Driscoll et al., 1995; Darby et al., 1996; Matsuda et al., 2004; (McDowell et al., 
2005), saccade preparation (Connolly et al., 2005; DeSouza et al., 2003), suppression of 
reflexive saccades (Cornelissen et al., 2002) and self-paced saccades (McDowell et al., 2002). 
Much of our understanding of the FEF is derived from primate studies, with knowledge of a 
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frontal lobe region related to eye movements going back to the late 1800s. These early studies 
found electric stimulation of the monkey frontal lobe was able to trigger saccades (Ferrier, 
1874; Ferrier, 1876). Later studies localised this primate FEF to the arcuate sulcus in 
Brodmann’s area 8 (Tehovnik et al., 2000). Electrode recording and electrostimulation studies 
in epilepsy patients have found the human FEF equivalent in the posterior middle frontal 
gyrus and adjacent superior frontal sulcus (Blanke et al., 1999, 2000). Imaging studies in the 
human have found FEF activation in the precentral sulcus (Paus, 1996; Petit et al., 1995) 
precentral gyrus (Anderson et al., 1994; Fox et al., 1985; Sweeney et al., 1996) and middle 
frontal gyrus (Kawashima et al., 1998).  
The FEF receives connections from the substantia nigra pars reticulata, superior colliculus and 
cerebellar dentate nucleus (Lynch, Hoover, & Strick, 1994) as well as the supplementary eye 
field (SEF) (Schall, Morel, & Kaas, 1993), dorsolateral prefrontal cortex (DLPFC) (Pierrot-
Deseilligny et al., 2005), posterior parietal cortex (PPC) (Ferraina et al., 2002) and primary 
visual areas (Schall et al., 1995). The FEF projects connections to the contralateral FEF 
(Künzle & Akert, 1977), SEF (Stanton et al., 1993), the caudate nucleus, superior colliculus, 
pontine nuclei (Stanton et al., 1988) and the parietal cortex (Stanton et al., 1995). The FEF 
plays a key role in saccade initiation, with connections to SC. The saccade command is 
thought to arise from the FEF to SC to trigger a saccade (Helminski & Segraves, 2003; 
Komatsu & Suzuki, 1985; Schlag-Rey et al., 1992; Sommer & Wurtz, 2000). The SC also 
sends projections back to the FEF, with SC signals thought to modulate pre-saccade activity 
(Berman et al., 2009). 
The main role of the FEF is in triggering voluntary saccades, with less involvement in 
reflexive or visually-guided saccades (Müri & Nyffeler, 2008; Pierrot-Deseilligny et al., 
2004). The FEF in each hemisphere triggers saccades to the contraversive side (Connolly et 
al., 2005; Everling & Munoz, 2000). The FEF is seen to be involved in predictive, memory-
guided and antisaccade tasks – all voluntary saccade tasks (Everling & Munoz, 2000; 
Gaymard et al., 1999; Hanes & Schall, 1996; Müri & Nyffeler, 2008; Pierrot-Deseilligny et 
al., 2004). Single neuron studies in the primate show neurons in the FEF active only after 
purposeful saccadic eye movements (Bruce & Goldberg, 1985). Lesion studies by Gaymard et 
al. (1999) and Rivaud et al. (1994) have found the FEF to be associated with increased 
latencies for antisaccade and memory-guided saccades, and a decreased gain (decreased 
accuracy) in the predictive task. 
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In contrast to the strong evidence of FEF involvement in voluntary tasks, studies have 
produced mixed results on the impact of impaired FEF function in reflexive saccade tasks. A 
lesion study by Rivaud et al. (1994) found increased latencies in the reflexive overlap task and 
an increased gain in the gap reflexive task with FEF lesions. A lesion study carried out by 
Pierrot-Deseilligny et al. (1987) found the reaction time of gap reflexive saccades was 
shortened in patients with lesions affecting the FEF, but latencies were unchanged in a later 
study (Pierrot-Deseilligny et al., 1991). Further lesions studies by Gaymard et al. (1999) and 
Rivaud et al. (1994) described saccade latency to not be affected in the gap reflexive task in 
FEF lesions, but increased in the reflexive overlap task. From these observations, the authors 
have proposed that the role of the FEF relates more to fixation disengagement than reflexive 
saccade generation.  
Transcranial magnetic stimulation (TMS) studies have attempted to clarify FEF function in 
reflexive saccades. TMS can be thought of as generating temporary “lesions” by a focussed 
magnetic pulse delivered to a specific cortical region, temporarily disrupting function. TMS 
of the human FEF was found not to affect visually-guided saccades but caused significantly 
prolonged antisaccade latency (Müri et al., 1991). Priori et al. (1993) reported that TMS to the 
vertex (approximate FEF) can disrupt visually-guided reflexive saccades. TMS over the FEF 
increased the latency of reflexive prosaccades (Nagel et al., 2008) but van Donkelaar, Lin, & 
Hewlett (2009) observed that FEF TMS induced a greater proportion of saccades made with 
decreased latencies, along with hypometria, necessitating multiple corrective saccades. This 
pattern occurred on the side ipsilateral to the TMS application, suggesting a disruption in the 
balance between the hemispheres (van Donkelaar et al., 2009). As with lesion studies, 
conclusions from TMS studies into reflexive saccade FEF function remain uncertain. The 
application of TMS is also confounded by an audible click during stimulation, which may act 
as an auditory signal to initiate a saccade through a non-visual, auditory pathway. Despite the 
variable results from lesion and TMS studies, imaging studies have consistently observed FEF 
activity during reflexive saccades (Anderson et al., 1994; Connolly et al., 2005; Grosbras et 
al., 2001), indicating that the FEF is involved in the generation of reflexive saccades. Studies 
using pharmacological inactivation of the FEF report a resulting “ocular motor scotoma” 
(Dias, Kiesau, & Segraves, 1995; Dias & Segraves, 1999), with severe impairment in both 
visual and memory-guided saccades, with fewer saccades initiated to retinotopic sites of FEF 
inactivation.  
Much like the SC, the FEF is noted to have a spatial motor map (Bruce et al., 1985; Savaki et 
al., 2014; Schall, 2002) with smaller saccades arising from the ventral-lateral and larger 
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saccades from the dorso-medial region. Regions of the FEF are also involved in vergence 
movements (Alkan et al., 2011; Jampel, 1960). Stimulation of certain regions of the FEF can 
promote fixation (Hanes et al., 1998) and FEF microstimulation can also suppress saccades in 
visually-guided and memory-guided saccade tasks (Izawa et al., 2004a). Izawa, Suzuki, & 
Shinoda (2004b;2005) have suggested the FEF helps fixation by saccade inhibition, noting 
FEF lesions cause difficulty suppressing reflexive “express” saccades to inappropriate targets 
(Braun et al., 1992; Guitton., 1985). Pharmacological inactivation of FEF also impairs 
fixation control with deviation of gaze towards the inactivated FEF side (Dias et al., 1995; 
Dias & Segraves, 1999). 
The FEF exhibits preparatory activity before saccade generation for the antisaccade task 
(Connolly et al., 2002; DeSouza et al., 2003). Preparatory FEF activity correlates with 
saccade latency in fMRI studies of pro and antisaccade tasks (Connolly et al., 2005), an 
observation also made in monkey electrophysiology trials (Everling & Munoz, 2000). It is 
proposed that preparatory activity reflects some form of pre-saccade attention control (Smith 
et al., 2005).  
The FEF is part of an attention network involving a number of other cortical regions including 
the visual cortex, parietal lobe and superior colliculus (Armstrong & Moore, 2007; Bisley & 
Goldberg, 2010; Buschman & Miller, 2007; Coe et al., 2002; Corbetta & Shulman, 2002; 
Ignashchenkova et al., 2004; Noudoost et al., 2010; Premereur et al., 2014; Wardak et al., 
2011). The attention component of the FEF can influence saccade generation (Schafer & 
Moore, 2007). FEF neurons activate to form a visual saliency map which is involved in the 
direction of overt (with gaze shift) and covert (without eye movement) attention shifts (Awh 
et al., 2017; Beauchamp et al., 2001; Monosov & Thompson, 2009; Thompson & Bichot, 
2004). Certain neurons within the FEF have been shown to evaluate stimulus importance 
(Wurtz & Mohler, 1976) with the FEF implicated in maintaining spatial information and 
target selection (Armstrong et al., 2009; Cohen et al., 2010; Schall, 2002; Schiller & 
Tehovnik, 2005). Magnetic stimulation over FEF interferes with visual search tasks. and 
target discrimination (Muggleton, 2003; O’Shea et al., 2004). 
The FEF also has a role in error control. This is relevant to predictive and memory-guided 
saccades, which are made to a location with no visual target. Occasionally corrective saccades 
are made without any visual feedback. An investigation of these corrective saccades 
concluded that the FEF encodes for eye movement errors without external visual input 
(Ferrera & Barborica, 2010). Others have detected post-task FEF activity (albeit from a visual 
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selection task and not a saccade task), and proposed that the FEF optimises future responses 
by processing errors made in previous responses (Teichert, Yu, & Ferrera, 2014).  
Some have suggested the FEF may have functionally different subregions (Ettinger et al., 
2008; Grosbras et al., 2001; Lobel et al., 2001; Luna et al., 1998), with involvement in either 
reflexive or predictive type tasks (Gagnon et al,, 2002; Simo, 2005) but no firm conclusions 
have yet been drawn. This issue is discussed further in Chapter four. 
1.2.3.9 Supplementary	eye	field	
The supplementary eye field (SEF) is located in the medial frontal lobe in Brodmann area 6 
(BA6), rostral to the supplementary motor area (SMA) (Grosbras et al., 1999). The SEF is 
connected to all cortical eye movement control areas – the FEF, DLPFC and the parietal 
cortex as well as the caudate nucleus of the basal ganglia and SC (Huerta & Kaas, 1990; 
Schlag & Schlag-Rey, 1987; Shook et al., 1991). No cohesive theory of SEF function has thus 
far been put forward. Rather, the SEF is seen to be active in nearly every type of saccade task. 
SEF activity has been reported in imaging studies for visually-guided saccades (Luna et al., 
1998), self-paced saccades (Petit et al., 1993), memory-guided saccades (Heide et al., 2001) 
and antisaccades (Doricchi et al., 1997; O’Driscoll et al., 1995). For antisaccades, the SEF is 
thought to be more involved in antisaccade preparatory activity, rather than the antisaccade 
itself (DeSouza et al., 2003). Primate studies have detected SEF neural activity in relation to 
saccade performance and error/reward monitoring (Amador et al., 2000; Stuphorn et al., 
2000), saccade task instruction learning (Chen & Wise, 1995), determination of eye 
movements relative to object position (Olson & Gettner, 1995) and internally processing 
saccade-related decisions (Coe et al., 2002). A region immediately anterior to the SEF has 
been termed the pre-SEF (Pierrot-Deseilligny et al., 2003). The pre-SEF is more involved in 
the learning of the saccade sequence and the SEF proper responsible for initiating the saccade 
sequence.  
A consensus view is that the SEF is involved in internally generated complex eye movement 
tasks such as coordinating a memorised sequence of several saccades (Heide et al., 2001; Lu 
et al., 2002). This idea has been challenged by Parton et al. (2007) using a patient with a focal 
unilateral SEF lesion. This patient showed no impairment in sequencing learning but rather an 
impairment in switching between eye movement tasks and learning a new (arbitrary 
association) saccade task. Also of note was that this patient generated hypometric saccades in 
memory-guided saccades, similar to PD patients.  
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Outside of direct saccade control processes, the SEF is thought have a role in 
“metacognition”. Simply put, metacognition is thinking about one’s own thoughts. This 
process is thought to occur in animals as well as humans (Smith et al., 2014). In a saccade 
task involving a betting component, metacognitive thought processes are needed to monitor 
and make decisions as opposed to making arbitrary choices. Neural activity, specifically 
believed to be related to metacognitive processes, was detected in the primate SEF between 
the decision making process and executing the “bet” (making the saccade) (Middlebrooks & 
Sommer, 2012). 
1.2.3.10 Dorsolateral	prefrontal	cortex		
The dorsolateral prefrontal cortex (DLPFC) is located in the frontal lobe in area BA46 
(Pierrot-Deseilligny et al., 1991) and has connections with the FEF, SEF, PPC, PEF and SC 
(Pierrot-Deseilligny et al., 2005). The DLPFC is linked to executive processing functions. 
These are a set of higher-order cognitive processes such as decision making or adaptation of 
behaviour to changing rules and working memory (MacDonald et al., 2000; Mansouri et al., 
2009; Miller & Cohen, 2001; Petrides, 2005). Executive function processes are known to be 
deficient in PD (Monchi et al., 2007; Owen, 2004; Zgaljardic et al., 2004) and imaging studies 
have found altered DLPFC function in PD related to deficits in executive function tasks 
(Cools et al., 2002; Hirano et al., 2012; Lewis et al., 2003). 
DLPFC lesions were seen to have detrimental effects on saccade prediction, saccade 
inhibition and memory-guided saccade accuracy (Pierrot-Deseilligny et al., 2003). This 
suggests that the DLPFC plays a role in saccade response selection, prediction, inhibition and 
short-term spatial working memory i.e. saccade tasks requiring a component of executive 
function (Pierrot-Deseilligny et al., 2003; Pierrot-Deseilligny et al., 2005; Schall & 
Thompson, 1999). An electroencephalography (EEG) study found pre-saccade activity was 
higher in the prefrontal cortex in antisaccade trials compared to prosaccade trials. This was 
thought to fit with the DLPFC’s role in executive control (Clementz et al., 2007). The DLPFC 
is also involved in reflexive saccade inhibition. In the antisaccade task, a reflexive saccade 
needs to be suppressed during the presentation of a peripheral target. A higher number of 
error reflexive saccades are generated in patients with prefrontal impairment (Guitton et al., 
1985; Hodgson et al., 2007; Kitagawa, Fukushima, & Tashiro, 1994). Condy et al. (2004) 
proposed that the DLPFC suppresses reflexive saccades stimuli through direct SC inhibition.  
 
The DLPFC is consistently seen to be involved in memory-guided saccades in neuron 
recordings and imaging studies (Chafee & Goldman-Rakic, 2000; Chafee et al., 2011; 
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O’Sullivan et al., 1995; Pierrot-Deseilligny et al., 1991; Sweeney et al., 1996). The prevalent 
theory states that the DLPFC is involved in spatial working memory (Goldman-Rakic, 1995). 
Neurons in the DLPFC exhibit sustained activation during spatial memory retention 
(Funahashi et al., 1989) and DLPFC lesions cause deficits in spatial memory function 
(Funahashi et al., 1993). Spatial working memory processes are thought to involve a number 
of distributed regions including the PPC (Chafee & Goldman-Rakic, 2000; O’Sullivan et al., 
1995; Sweeney et al., 1996) and the parahippocampal cortex within the medial temporal lobe 
(Ploner et al., 2000; Ploner et al., 1999). A model proposed by Pierrot-Deseilligny et al. 
(2002) describes the PPC as being involved in the first 300 ms of visuospatial integration, 
with the DLPFC involved in short-term spatial memory subsequently afterwards, out to 
approximately 20 seconds. After this period, the parahippocampal cortex becomes involved in 
medium-term memory, from 20 seconds to several minutes, before long-term memorisation 
occurs in the hippocampus. Memory-guided saccades in PD are impaired, showing a greater 
impairment in accuracy during shorter (less than 20 seconds) delay periods compared to 
controls. DLPFC impairment in PD is thought to contribute to this difference (Le Heron et al., 
2005). 
The DLPFC is not exclusively involved in working memory processes even within the 
proposed 20-second window. A model involving the PPC, DLPFC and parahippocampal 
cortex has been proposed as the “serial information pathway” (Nyffeler et al., 2002). An 
alternative “parallel pathway”, involving visuospatial information passed directly from the 
PPC to the parahioppocampal cortex and bypassing the DLPFC has been posited (Nyffeler et 
al., 2004). Both pathways may operate together as a mixed model (Nyffeler et al., 2004). 
Other studies have observed frontal/FEF (Courtney et al., 1998; Gaymard et al., 1999; Srimal 
& Curtis, 2008) and visual cortex (Harrison & Tong, 2009; Serences et al., 2009) involvement 
in visual working memory tasks. A study by Mackey et al. (2016) has recently challenged the 
viewpoint of human DLPFC involvement in short-term visuospatial memory. Mackey and 
colleagues have shown, in their sample of patients with isolated DLPFC lesions, no 
impairment in a memory-guided saccade task, using delays of 3-5 seconds. Only patients 
having lesions extending into the FEF showed impairment in saccade accuracy. Mackey et al. 
(2016) have suggested these findings could indicate remodelling of cortical function, with 
other regions compensating for the loss of the DLPFC, or a more prominent role of the human 
FEF, rather than the DLPFC in visuospatial memory, which would indicate a mismatch 
between animal and human study findings.  
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Regarding functional imaging, Riggall & Postle (2012) have challenged the idea that working 
memory processes can be detected as sustained BOLD activity during the memory period. 
Instead, they state any sustained activity could relate to other task demands such as attention 
or preparation processes. Riggall and Postle argue memory processes may, in fact, be 
distributed amongst the multiple cortical regions, which may not reach detection threshold 
using current imaging analysis techniques. Riley & Constantinidis (2015) argue that persistent 
activity during memory periods does correspond to working memory processes in the 
DLPFC, with computational models of persistent prefrontal activity accurately predicting 
memory-related task outcomes (Wimmer et al., 2014). Riley and Constantinidis, however, 
similarly to Riggall and Postle, state that current MRI methods may be limited and do not 
offer the resolution necessary to accurately delineate activity from closely spaced prefrontal 
cortex regions. 
1.2.3.11 	Parietal	cortex	
The parietal cortex has a number of densely-packed regions responsible for the transformation 
of sensory information into spatial representations needed to guide motor output (Andersen, 
1989; Colby & Goldberg, 1999). One of these regions seen in the primate brain, named the 
lateral intraparietal cortex (LIP), is thought to be responsible for these spatial transformations 
needed for saccadic eye movements (Andersen et al., 1992; Barash et al., 1991; Colby & 
Goldberg, 1999). Every time an eye movement is made, the retinal image changes, yet we do 
not get a sensation of movement. This is because a stable internal image of the visual 
environment is maintained, despite changing visual input. The LIP, through constant 
calculations and compensation for eye position changes, is able to form this stable internal 
representation (Duhamel et al., 1992). The LIP is also involved in attention and responds to 
salient visual stimuli (Colby & Goldberg, 1999). LIP neurons are active when detecting 
environmental targets for possible saccades. LIP activity is detected during fixation tasks, 
even with no eye movements, if a novel visual stimulus appears in the visual field (Robinson 
et al., 1978). LIP neurons also fire when a stable object already present in the environment 
become salient e.g. cueing the monkey to make a saccade to the stable object without any 
change or new appearance of the object itself (Gottlieb et al., 1998). 
The LIP has projections to the SC (Lynch et al., 1985; Paré & Wurtz, 2001) and FEF (Barbas 
& Mesulam, 1981; Huerta et al., 1987; Tian & Lynch, 1996). The LIP has been described as 
the equivalent to the parietal eye field (PEF) in humans and the terms are often used 
interchangeably (Andersen et al., 1992; Culham et al., 2006). 
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Studies report the human LIP/PEF to be located in the intraparietal sulcus (IPS) (Astafiev et 
al., 2003; Brotchie et al., 2003; Culham et al., 2006; Konen & Kastner, 2008; Medendorp et 
al., 2003; Schluppeck et al., 2005; Sereno, 2001). The IPS divides the superior and inferior 
parietal lobules, which altogether forms the posterior parietal cortex (PPC). The PEF may also 
involve parts of the superior parietal lobule (Konen & Kastner, 2008; Sereno, 2001) or both 
the inferior and superior parietal lobule (Luna et al., 1998).  
The PEF is thought to have a role in the triggering of reflexive saccades (Pierrot-Deseilligny 
et al.,  2002). Lesion studies show reflexive saccade prolongation with parietal cortex damage 
(Gaymard et al., 2003; Heide et al., 1998; Pierrot-Deseilligny et al., 1987) with similar results 
from parietal TMS disruption (Kapoula et al., 2001).  
As mentioned previously (see DLPFC section), the PPC is thought to be involved in the early 
stages of visuospatial memory, up to 300 ms in a model known as the “serial information 
pathway” (Nyffeler et al., 2002; Pierrot-Deseilligny et al., 2002). TMS studies have found 
PPC disruption during this early memory phase to disrupt memory-guided saccade accuracy 
(Brandt et al., 1998). Despite being only supposedly involved for the first 300 ms of spatial 
memory, functional imaging has found sustained PPC (and IPS) activity during significantly 
longer memory periods, of up to 15 seconds, in memory-guided saccade tasks (Brown et al., 
2004; Curtis & D’Esposito, 2006; Schluppeck, 2006; Schluppeck et al., 2005). This may 
indicate memory, or an as-of-yet unidentified process, persists in the parietal cortex past the 
initial 300 ms memory period, which isn’t explained using the previously proposed “serial 
information pathway” of spatial memory. Figure 1-9 depicts the general location of regions 
involved in saccadic eye movement control (Pierrot-Deseilligny et al., 2004). 
In the antisaccade task, greater activity in the PPC is seen compared to prosaccades (Doricchi 
et al., 1997; O’Driscoll et al., 1995; Sweeney et al., 1996). This increase in activity occurs 
during the “preparatory” process, prior to generating the antisaccade (Ford et al., 2005). This 
is thought to be from vector transformation processes, i.e. the process of inverting the saccade 
direction for the antisaccade task, which is thought to occur in the PPC (Moon et al., 2007; 




Figure 1-9 – Regions involved in eye movement control (Charles Pierrot-Deseilligny et al., 2004). SEF - 
supplementary eye field; sfs - superior frontal sulcus; CEF - cingulate eye field; cs - central sulcus; 
DLPFC - dorsolateral prefrontal cortex; pcs -precentral sulcus; FEF - frontal eye field; ips - intraparietal 
sulcus; ifs - inferior frontal sulcus; SMG - supramarginal gyrus; PCC - posterior cingulate cortex; SPL - 
superior parietal lobule; IPA - intraparietal areas; ls - lateral sulcus; AG - angular gyrus; PEF - posterior 
eye field; sts - superior temporal sulcus; pos - parieto-occipital sulcus; PHC - parahippocampal cortex; 
HF - hippocampal formation; SC - superior colliculus; RF - reticular formations. Figure permission 
obtained (Pierrot-Deseilligny et al., 2004). 
 
PPC subregion anatomy 
Our knowledge of the role of the PPC in eye movement control is founded on primate studies. 
A summary diagram of primate neural recording study findings of the IPS is provided in 
Figure 1-10. This thesis will only discuss saccade functions of the IPS/PPC area. However,  
serves to illustrate the closely spaced and varied functions of regions within the primate IPS, 
highlighting the issues in identifying equivalent regions in the human brain using non-




Figure 1-10 – A summary diagram of neural recording findings of the IPS in the monkey (Colby & 
Goldberg, 1999), which illustrates the tightly spaced regions thought to be involved in multiple sensory-
motor integration systems, including for saccade control. Each cylindrical column represents a neural 
recording site of 10mm penetration. Each column is separated by 1mm. Visual and saccade functions are 
seen in the LIP with somatosensory and reach control areas in adjacent regions separated by millimetres. 
MIP, medial intraparietal area; LIP, lateral intraparietal area; VIP, ventral intraparietal area. Figure 
permission obtained (Colby & Goldberg, 1999). 
 
Interspecies differences exist in PPC anatomy between humans and primates. This was noted 
as early as 1909 by Brodmann, who reported the human PPC is much expanded compared to 
the primate (Brodmann & Garey, 2006). The human IPS contains more regions than seen in 
the primate, such as additional regions sensitive to 3D motion (Orban et al., 2006). Although 
challenging, human equivalents of PPC regions have been detected using fMRI (Orban, 2016; 
Shikata et al., 2008). However, there is no firm consensus on the location of the human LIP 
(PEF) equivalent. This region has been described to be located within the IPS and possibly 
SPL (Konen & Kastner, 2008). A diagram shown earlier in the introduction by Leigh & 
Kennard (2004) (Figure 1-6 page 32) places the PEF in the IPL. Likewise, no consensus 
exists for the human 7a location but it has been suggested to comprise Brodmann areas 39 and 
40 in the inferior parietal, as well as the IPS and SPL regions (Konen & Kastner, 2008; R J 
Leigh & Zee, 2000). Likely due to the lack of a consensus of human PPC subregion location, 
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studies have reported parietal activations using a number of anatomical descriptors including 
the IPS, LIP, PEF or PPC. This variability used in naming gives rise to confusion when 
comparing and interpreting the various studies reported in the literature. This is evident 
particularly in Chapter 6 of this thesis and has been the subject of further discussion further 
within that chapter. 
1.3 Eye	movements	in	PD		
Components of the saccadic eye movement control system are from the same circuits 
controlling skeletal muscle movements. Notable for PD research, the same basal ganglia 
circuit provides modulatory control of both skeletal and eye movements. The dopaminergic 
dysfunction within the basal ganglia in PD results in abnormalities for both movement types. 
As described in previous sections, pathological neurological changes in PD are not limited to 
the basal ganglia. Widespread cortical abnormalities such as grey matter atrophy and 
perfusion changes are present, particularly in later stages of the disease. These affect regions 
of the frontal lobe and parietal lobe, which are known to be involved in saccadic eye 
movements. The research into eye movements provide a window for researchers for 
investigating movement disorders such as PD (Leigh & Zee, 1999). The knowledge of the 
impact of PD progression on eye movement performance and cortical activity may form the 
basis of an easily administered and objective biomarker of PD progression in the future. 
1.3.1 Eye	movement	changes	in	PD	
A number of characteristic deficits in PD eye movements have been described. Hypometria is 
the dominant finding in saccades in PD, with volitional saccades showing more prominent 
amplitude deficits when studied in the laboratory (Anderson & MacAskill, 2013). The initial 
saccade made to a target tends to fall short and be compensated for by corrective saccades, 
with PD patients using a multistep sequence to reach the desired eye position (DeJong & 
Jones, 1971). This is sometimes called a fragmentation of gaze shift (Kimmig et al., 2002) 
and some even consider this fragmentation to be a biomarker of PD (Blekher et al., 2009). A 
number of eye movement task types have been used to assess saccade performance in PD. 
Findings are briefly summarised below in sections 1.3.1.1 to 1.3.1.4. 
1.3.1.1 Reflexive	saccades	
Studies of reflexive saccades in PD patients have shown mixed results in the past. Prolonged 
reaction times have been reported (Chen, & Tsai, 1999; Mosimann et al., 2005; Sauleau et al., 
2008; White et al., 1983) as well as reduced (Chan et al., 2005; Kingstone et al., 2002) or no 
change (Briand et al., 1999; Crawford et al., 1989; Shaunak et al., 1999; Ventre et al., 1992). 
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A meta-analysis by Chambers & Prescott (2010) suggested methodological differences for the 
disparity in results. Terao et al. (2011) found reflexive latencies to be prolonged in association 
with PD motor status but did not find a uniform association. A study by MacAskill et al. 
(2012), with 210 total participants, has shown impairments in reflexive saccade latency to be 
associated to with cognitive impairment in PD. Reflexive saccade amplitude has been shown 
to be reduced in a number of studies (Mosimann et al., 2005; Terao et al., 2011), with 
MacAskill and colleagues finding reflexive saccade amplitude influenced mainly by PD 
motor status, with cognitive status more related to latency. 
1.3.1.2 Predictive	saccades	
Studies investigating predictive saccades in PD have reported the tendency for PD patients to 
produce fewer anticipatory saccades in response to the predictable stimulus sequence of the 
task. PD patients, instead, tended to make visually-guided saccades after the stimulus 
appearance (Bronstein & Kennard, 1985). Another study showed PD patients eventually 
learned to anticipate the predictable target but were slower to implement this strategy 
compared to controls (Crawford et al., 1989). However, other studies have not found latency 
differences, nor predictable sequence learning differences between groups (O’Sullivan et al., 
1997; Ventre et al., 1992). The common finding with predictive saccades in PD is decreased 
saccade amplitude (hypometria) compared to controls (Bronstein & Kennard, 1985; Crawford 
et al., 1989; Ventre et al., 1992). 
1.3.1.3 Memory-guided	saccades	
PD patients tend to make multi-stepping saccades to memorised spatial locations with the 
initial saccade hypometric (Crawford et al., 1989; Hodgson et al., 1999; Lueck et al., 1992; 
Rivaud-Péchoux et al., 2000; Vermersch et al., 1994). Final eye position has been reported as 
reduced (Rivaud-Péchoux et al., 2000;  Vermersch et al., 1994) or normal (Crawford et al., 
1989; Hodgson et al., 1999). Latency has been reported as normal (Hodgson et al., 1999; 
Vermersch et al., 1994) or increased (Le Heron et al., 2005; Rivaud-Péchoux et al., 2000). 
Terao et al. (2011) has found memory-guided saccade latency to prolong relative to disease 
stage (Hoehn and Yahr scale) and also reported an increased number of inadvertent reflexive 
saccades made to the presented “cue” when fixation should have been maintained.  
1.3.1.4 Antisaccades	
PD patients show decreased gain, increased latency and a higher number of inadvertent 
erroneous saccades in the antisaccade task (Briand et al., 1999; Kitagawa et al., 1994). 
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Antisaccade latencies were slower and more errors were made particularly in PD with 
dementia compared to PD without dementia (Mosimann et al., 2005). 
1.3.2 Cortical	basis	for	eye	movement	changes	in	PD		
Excessive SC inhibition is thought to be a core factor contributing to saccade performance 
abnormalities seen in PD (Terao et al., 2013). In PD, basal ganglia dopamine deficiency 
causes reduced activity of the direct pathway, increased activity of the indirect pathway with 
the overall effect of increased activity of the inhibitory GABAergic neurons from the basal 
ganglia to the SC (see Figure 1-8 in basal ganglia section of eye movement control page 36). 
Therefore, the SC is excessively inhibited in PD, which should in theory exert a suppressive 
effect on all saccadic eye movements. This, however, does not explain the differences 
between voluntary and visually-guided saccades in PD. Both saccade types are hypometric 
but this effect is much more prominent in voluntary saccades. 
This may be explained by the two separate pathways controlling reflexive saccades and 
voluntary saccades, which converge in the SC (Hikosaka et al., 2000; Massen, 2004). It is 
believed that the initiation of reflexive saccades in response to visual stimuli arises in the 
PPC, which is directly connected to SC (Pierrot-Deseilligny et al., 2004). This route largely 
bypasses basal ganglia. As a result, visually-guided saccade impairments are thought to be 
mainly driven by excessive SC inhibition, without being influenced by excessive inhibitory 
activity from the basal ganglia (Terao et al., 2013). Hence visually-guided saccades 
experience inhibitory effects only at one point through its pathway. Voluntary saccades, 
however, have been shown to use a pathway involving the basal ganglia. Saccades made 
under voluntary control, such as the memory-guided saccade and antisaccade (Briand et al., 
1999; Kori et al., 1995; Pierrot-Deseilligny et al., 2004), are believed to be generated in the 
frontal cortex, which sends connections to the basal ganglia, which then travel to the SC via 
the substantia nigra (Kimmig et al., 2002; White, Saint-Cyr, Tomlinson, et al., 1983). Kimmig 
et al. (2002) have argued that the pathway through the basal ganglia to the SC becomes 
abnormally weak in PD. Terao et al. (2013) similarly posit that the basal ganglia to SC pre-
oculomotor drive becomes weak and in addition, the SC is also inhibited. This combined 
effect results in prominent voluntary saccade hypometria, more so than for reflexive saccades. 
Terao et al. (2011) investigated how eye movement performance changes with PD disease 
stage (Hoehn and Yahr scale). It was found that the amplitude of both visually-guided and 
memory-guided saccades were progressively impaired with PD disease severity. Reductions 
in visually-guided saccade performance stabilized after Hoehn and Yahr stage 1-2, with 
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memory-guided saccades showing increasing impairment with advanced disease. MacAskill 
et al. (2012) found that reflexive latency was impaired later in the disease in the presence of 
more substantial motor and cognitive impairment. Mosimann, Muri, et al. (2005) found 
antisaccade latencies were slower in PD in dementia patients compared to non-dementia PD 
patients. For voluntary saccades, Terao et al. (2011) speculate that the frontal cortex(thought 
to be involved more with voluntary saccades) and the basal ganglia circuit (as opposed to the 
parietal-SC circuit of reflexive saccades) deteriorates with the disease. Yet Shaikh et al., 
(2011) have hypothesised increased frontal eye field activity develops compensatory to an 
inhibited SC. The sources that lead to eye movement deficits in PD remain unresolved. 
1.3.2.1 Saccade	hyper-reflexivity	in	PD	
As well as impairments in voluntary saccade generation, some peculiar differences have been 
noted for certain types of reflexive saccade in PD. PD patients are noted to make express 
saccades (extremely rapid reflexive saccades made under laboratory conditions), more so than 
unaffected controls (Chan et al., 2005). Also, while PD patients show impairment in 
generating voluntary saccades, patients often cannot suppress reflexive saccades, even when 
instructed to. This leads to errors in the memory-guided task and the antisaccade task (Briand 
et al., 1999; Terao et al., 2011).  
Express saccades are thought to be generated by an increase in excitability of SC neurons 
during fixation point offset in a “gap” reflexive task (Munoz et al., 2000). Terao et al. (2013) 
have described a “leaky” inhibition of the SC in PD. Impaired basal ganglia inhibitory control 
of the SC or cortical changes can adversely affect the control of SC excitability, leading to 
more express saccades in PD. In addition, the DLPFC have projections to SC cells and have 
an inhibitory effect on saccade generation (described as the tonic inhibitory model) (Pierrot-
Deseilligny et al., 2005; Sereno, 1996). DLPFC impairment may release the inhibition applied 
to the SC, leading to more hyper-reflexive saccades (Crevits, & De Ridder, 1997; Pierrot-
Deseilligny et al., 2004). Thus, one possibility is that DLPFC dysfunction in PD contributes to 
the increase in hyper-reflexive “express saccades” and decreased ability to suppress reflexive 
saccades. 
Studies have attempted to reconcile the apparent disparity between impaired voluntary 
saccade generation and excessive reflexive saccade generation in PD. A model of inhibition 
control known as the tonic inhibition model has been proposed in a number of studies 
(Amador et al., 2006; Chan et al., 2005; Sereno & Holzman, 1995, 1996) which states the 
voluntary saccade system usually maintains an ongoing tonic inhibitory effect on the reflexive 
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saccade system. This function involves frontal-striatal processes which are disrupted in PD. 
This leads to impaired voluntary saccades and uninhibited, overactive reflexive saccades 
(Amador et al., 2006; Chan et al., 2005). However, this model predicts that impairment of 
voluntary saccade function should associate with excessive reflexive saccade generation, 
which was not clearly demonstrated (van Stockum et al., 2008), suggesting there may be 
alternative sources of reflexive saccade disinhibition in PD, possibly arising from the cortex 
or though impaired attention pathways. 
1.3.2.2 Medication	effects	on	eye	movements	
Studies have investigated the effect of PD medication on saccadic eye movements. The 
relationship between levodopa and eye movement performance is complex and not fully 
understood but it is thought that levodopa treatment may cause dopamine levels to exceed the 
natural optimum level, which may cause an increase in response time (Michell, 2007). 
Nakamura et al. (1991) have shown that in a group of 24 PD patients, the vast majority (21) 
showed eye movement performance abnormalities. When this group was given dopaminergic 
medication, only one patient showed improvements compared to before the treatment. Rascol 
et al. (1989) found that amplitude improved but no effect on latency was found. Later studies 
have, however, found prolonged saccade latency in patients on levodopa, but with high 
intersubject variability (Michell, 2007). In the review by Terao et al. (2013), it is reported that 
there does not appear to be a great change in saccade amplitude induced by levodopa. A 
recent study comparing levodopa and DBS with eye movement performance found levodopa 
to worsen saccade measures, leading to longer latency and smaller gain whereas DBS 
improved saccade performance (Dec-Ćwiek et al., 2017). 
1.4 Parkinson’s	disease	and	magnetic	resonance	imaging	
Recent years have seen a number of studies use advanced magnetic resonance imaging (MRI) 
techniques to further investigate the neurological basis and progression of PD. MRI is a non-
invasive radiological technique used for imaging various internal bodily structures, including 
the human brain. MRI is distinct from computed tomography (CT) or positron emission 
tomography (PET) in that it does not use ionising radiation. Instead, a powerful magnetic field 
and radio-frequency pulses are used to produce images. MRI is particularly suited for brain 
imaging, being able to clearly differentiate between grey matter, white matter and cerebral 
spinal fluid (CSF). Compared to CT, MRI scans give much improved soft tissue contrast 
between muscle, fat and blood. Regions such as the brainstem are shown with more clarity 
using MRI due to the increased contrast and the lack of artefacts from the surrounding bone 
structure. MRI also does not expose the patient to potentially harmful ionising radiation. The 
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principle on which MRI relies is that certain nuclei under a strong magnetic field will yield a 
net magnetization, and this magnetization can be perturbed by a radio-frequency pulse. A 
signal is then recorded by the scanner as the magnetization returns to equilibrium and 
information about the tissue composition of the scanned area can be used to render an image. 
1.4.1 Overview	of	the	MRI	process	
MRI relies on tissue properties at the subatomic level. In the nucleus of an atom, protons and 
neutrons spin on their axes, giving a small magnetic field. If there is an even number of both 
protons and neutrons in the nucleus, the spins of these particles cancel out, giving a spin 
number of 0. However, if the nucleus contains an odd number of protons or neutrons, the 
magnetic field in the nucleus cannot be fully cancelled out. The presence of this small 
magnetic field in the nucleus allows interaction with an external magnetic field. 
Medical MRI is mainly concerned with the hydrogen nucleus, which consists of a single 
proton. Hydrogen is found abundantly in the body, being part of the water molecule and fats. 
Normally, the axes on which the individual hydrogen nuclei spin are completely random. 
However, when exposed to a strong magnetic field, the spin axes of each of the nuclei tend to 
align with the direction of the external magnetic field, producing a small net magnetisation, 
and spins begin to precess. This magnetised sample is then subjected to a hydrogen-specific 
radio frequency pulse, which forces the net magnetization to tilt out of magnetic alignment. 
The net magnetization vector itself precesses (Figure 1-11), in which the axis traces out a 
cone-like shape as the net magnetization vector reverts back to the magnetic alignment. As the 
net magnetisation precesses, it induces an electromotive force in the detector coil (receive 




Figure 1-11 – Example of a precessing movement. The rotating object, in this case, a nucleus (blue), 
rotates around an axis (solid black to grey) which itself “precesses” or changes orientation along the 
arrows along a path represented by the curved grey line.  
1.4.1.1 Image	Generation	
The method used to obtain images from the raw measured signals is commonly achieved 
using a method called the “Fourier transformation”. Three “gradient magnets” are built into 
the MRI machine. These are much smaller and weaker than the main magnet and have a 
variable (linear) magnetic field. When applied briefly across the main field, the smaller 
magnetic field causes a magnetic “gradient” across the image plane. This causes the speeding 
up or slowing down of the precession movement of the nuclei, depending on the position of 
the nuclei within the magnetic field. The result of this is a “phase difference” between nuclei 
at different locations. The points then can be localised based on this phase difference. The 
field from the gradient magnets can be adjusted, giving the ability to image all parts of the 
body within the magnetic field without moving the patient. These images can be rendered in 
3D allowing the data to be seen as slices in any plane. 
1.4.1.2 Structural	MRI	-	T1	and	T2	Weighting	
A T1-weighted MRI scan is a basic scan with fats showing up as bright regions and water as 
dark. T2 is also a basic scan but with water showing up as bright instead. The differentiation 
of fats and water relies on the “relaxation” process. “Relaxation”, or the reverting of the 
excited nuclei to the original magnetised orientation, is a measurement used to give contrast to 
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different tissue types. The time taken for relaxation to occur is a constant for each specific 
tissue type.  
There are two relaxation constants, named spin-lattice relaxation time (T1) and spin-spin 
relaxation time (T2). Spin-lattice relaxation or T1 refers to the loss of energy by the transfer 
of energy to the other molecules surrounding the nuclei, termed the “lattice”. Spin-spin 
relaxation refers to the loss of phase between the spinning nuclei caused by interactions 
between the spins. Every tissue has a different T1 and T2 value which can be exploited to 
differentiate and highlight certain tissue types. Fats tend to have shorter T1 and T2 values 
while fluid has longer T1 and T2 values. By adjusting MRI settings, it is possible to highlight 
areas of different tissue composition such as grey and white matter in the brain. 
1.4.1.3 Diffusion	MRI	
Diffusion, or Brownian motion, refers to the random motion of molecules in a liquid. On the 
microscopic level, individual water molecules move in a random pattern due to their thermal 
energy and collisions with other molecules. Diffusion MRI causes the signal to be dependent 
on the diffusion of water and uses this information to infer tissue microstructure. Hence, 
diffusion MRI is a technique used for imaging fibre tracts within the body. In fibre tracts, the 
diffusion of water is limited by barriers such as cell membranes and myelin that prevent the 
water from diffusing randomly. Instead, the water tends to diffuse primarily along the fibre, 
instead of perpendicular to the fibre. This directionality can be detected by MRI and each 
voxel (3D pixel) can be given a shade reflecting the diffusion characteristic.  
A method by which diffusion is measured involves the spin-echo technique. Two 
radiofrequency pulses are applied to the magnetised scan area. The first is an excitation pulse 
90 degrees to the magnetic field, which causes the nuclei to tilt. The tilted nuclei are also 
precessing. This precessing movement, however, is not identical for all nuclei, due to 
inconsistencies in magnetic fields in different areas, with some nuclei precessing faster than 
others. A second, refocusing pulse at 180 degrees to the magnetic field is then applied 
afterwards. This flips the spins around so that the slower spins are now leading the faster 
spins. When the faster spins catch up to the slower spins, an echo signal is produced due to 
the alignment of the spins. In diffusion MRI, two diffusion weighting gradients are applied 
before and after the 180 degree refocusing pulse. These diffusion gradients are magnetic 
gradients deliberately affecting the speed of the precession of the nuclei depending on 
position. The two diffusion weighting gradients would cancel each other out if all nuclei 
remained in their initial positions. This is not the case, however, with water molecules in the 
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brain. The diffusion moves the molecule away from its original position and as a result, the 
second gradient does not completely cancel out the phase change from the first gradient. This 
causes dephasing among areas of high water diffusion, as not all of the spins are aligned for 
the echo sequence, which gives a lower signal.  
This process, however, is only sensitive to information along the direction of the two 
weighting gradients. In order to provide a three-dimensional assessment of diffusion, multiple 
diffusion-weighted acquisitions must be performed in multiple, non-colinear directions. The 
data from these acquisitions is entered into a mathematical model called a “tensor”, which is 
used to describe the direction and degree of water diffusion. This process is used to visualise 
fibres and connections within the brain, as well as to derive quantitative metrics throughout 
the brain. 
1.4.1.4 Arterial	Spin	Labelling	MRI	
Arterial spin labelling (ASL) is a non-invasive imaging technique used to measure perfusion 
in the brain. This has the advantage over traditional blood flow imaging in that ASL does not 
require the injection of a radioactive or exogenous tracer. Instead, ASL relies on magnetically 
“labelling” the water within the normal arterial blood supply via an external radio-frequency 
pulse, with no need for injections (Liu & Brown, 2007). Another advantage is the ability to 
characterise absolute perfusion values in ml min-1 to a tissue-specific weight (e.g. ml min-1 
100g-1), as opposed to relative blood flow measures as from PET (unless the concentration of 
radiotracer is determined by direct arterial sampling – often not done). Lastly, ASL is easily 
and immediately repeatable, whereas repeat PET scanning requires a delay and the injection 
of additional radioactive material. 
For ASL imaging, a radiofrequency inversion pulse is applied to a volume under the region of 
interest, for example, the neck, containing the carotid arteries supplying the brain. This 
inversion pulse results in the demagnetisation of the water in the arteries within that volume. 
When this demagnetised or “tagged” water enters the brain tissue, it reduces the MR scanning 
signal and image intensity. This image is called the “tag image”. This procedure is repeated, 
this time without the inversion pulse, which produces the “control image”. The “tag image” is 
subtracted from the “control image” giving a resulting “perfusion-weighted image”. The 
difference between the intensity of the control image to the tag image is proportional to blood 




As opposed to structural MRI, which can be considered a three-dimensional still-photograph 
of the brain, functional MRI aims to detect and show the active regions in the brain involved 
in a particular task over time. Neurological activity is not measured directly by the MRI 
machine. Rather, it is the change in blood oxygenation level during cortical activity that is 
detected. This is known as the blood-oxygen-level dependent (BOLD) contrast. Oxygenated 
and deoxygenated haemoglobin each give a different MR signal. This phenomenon was first 
noted using T2 MRI, where it was seen that highly oxygenated areas would give a stronger 
MR signal to those areas less oxygenated (Ogawa et al., 1990). The BOLD contrast depends 
on the balance of oxygenated haemoglobin supply in the brain and consumption (Hyder, 
2004). Explained in the most simplistic terms, active neurons need oxygen and glucose to run 
cellular processes, such as transmitting action potentials and releasing neurotransmitters 
(Shulman et al., 2004). During cortical activity, vascular processes occur which increase the 
blood flow to the active neurons for a task. This supplies the active cortical region with 
oxygenated haemoglobin and carries away the deoxygenated haemoglobin. This regional 
change in blood oxygenation then is able to be detected by the MRI machine by the BOLD 
signal (Logothetis & Wandell, 2004). The interaction between BOLD contrast and underlying 
neurological activity is complex and a complete model that describes this relationship has not 
been developed. The BOLD contrast is related to the concentration of deoxyhaemoglobin, 
which is affected by a combination of cerebral blood flow (CBF), cerebral metabolic rate of 
oxygen (CMRO2) and cerebral blood volume (CBV) (Buxton, 2013; Ekstrom, 2010). 
Neurological activity increases all three but increasing each value has a different effect on the 
BOLD signal. For example, a higher CBF is able to remove deoxygenated haemoglobin 
whereas a higher CMRO2 increases the deoxyhaemoglobin. An increase in arterial CBF 
decreases deoxyhaemoglobin and the opposite occurs with venous CBF increases (Buxton, 
2013).  
1.4.1.6 Metabolism	and	contribution	to	BOLD	
The metabolic processes that affect CBF and CMRO2 have a direct effect upon the BOLD 
signal, so having a basic appreciation of these processes is necessary prior to making 
interpretations of BOLD signal changes. These processes were historically studied using 
positron emission tomography (PET). PET is a functional imaging technique, which unlike 
fMRI, can directly measure the uptake of oxygen and glucose through the use of radioactive 
tagging. Respiration is the process by which compounds such as glucose are broken up by 
enzymes to release energy for cellular processes. This process can involve oxygen (aerobic 
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respiration) or not (anaerobic respiration). Aerobic respiration is an energy generating 
oxidative process, converting glucose and oxygen to carbon dioxide and water. In anaerobic 
respiration, a process called glycolysis occurs, where glucose is converted to lactate without 
needing oxygen. Should glycolysis occur in the presence of oxygen, it is termed aerobic 
glycolysis. A PET study by Fox & Raichle (1986) found during visual stimulation that 
glucose metabolic rate (and CBF) increased by about 50%. However, the metabolic rate for 
oxygen only increased 5%. Reasons for this apparent mismatch are not fully understood, with 
some studies suggesting aerobic glycolysis occurs (Lunt & Vander Heiden, 2011; Vaishnavi 
et al., 2010). Other studies have suggested a mostly oxidative metabolism providing the 
energy for cortical processes (Buxton, 2013; Chih et al., 2001; Lin et al., 2010). Some studies 
suggest an initial non-oxygen-requiring process occurs which switches to an aerobic process 
during longer sustained activation (Frahm et al., 1996; Mintun et al., 2002). A complex 
mechanism through which metabolic processes within the neuron interact with surrounding 
astrocyte cells, called the “astrocyte neuron lactate model” has been described (Magistretti & 
Pellerin, 1999; Pellerin et al., 2007; Shulman et al., 2001). For a review of this process, see 
Magistretti & Allaman, (2015).  
The BOLD signal depends on the concentration of deoxyhaemoglobin. For the BOLD signal 
to increase, the concentration of deoxyhaemoglobin must decrease. In order for this to occur 
while oxygen is being consumed by cellular processes, an excess of oxygenated haemoglobin 
must be supplied to the region, above what oxygen is consumed by respiration - this is exactly 
what occurs. PET studies found oxygenated blood supplied by the CBF far exceeded what is 
consumed (Fox et al., 1988; Fox & Raichle, 1986). This gives an overshot of oxygenated 
haemoglobin, flushing out deoxygenated haemoglobin and giving the BOLD MR signal. 
Buxton & Frank (1997) have suggested a disproportionate increase in CBF is needed to 
maintain oxygen supply, due to a decrease in oxygen extraction fraction during higher blood 
flow rates. Another study by Mintun et al. (2001) has found that the increased CBF is not 
necessary to maintain tissue oxygen concentration and have speculated that other factors may 
be behind the CBF increase. There is little oxygen reserve to act as a buffer in the brain 
(Leithner & Royl, 2014) and more recently, it has been proposed that CBF oversupply may be 
necessary to provide adequate oxygen to cortical regions more distant from the vascular 
supply (Devor et al., 2011) and to act as a safeguard to prevent damage from potential 





As the BOLD signal does not directly measure neural activity, it was necessary for studies to 
show how much the BOLD signal correlates with actual measured neural activity. A summary 
of the sources and detection methods of neural activity can be found in a review by Buzsáki, 
Anastassiou, & Koch (2012). Put simply, electrode recordings can detect the “spike” activity 
related to the action potentials of single or multiple neurons, which occur at a frequency 
above 300 Hz (Logothetis & Wandell, 2004) or a summation of electrical activity from a 
wider area called a local field potential (LFP), which occurs at a frequency under 100 Hz 
(Buzsáki et al., 2012; Katzner et al., 2009). The LFP is thought to reflect an “average” of all 
neural signals within a small volume of neural tissue surrounding an electrode (Ekstrom, 
2008; Herreras, 2016). A study by Logothetis et al. (2001) using simultaneous fMRI, action 
potential recordings and LFP recordings found the BOLD signal correlates more strongly with 
lower frequency LFP recordings compared to higher frequency unit recordings or spike 
activity. 
A review by Ekstrom (2008) describes how different cortical regions vary in BOLD signal 
correlation to either LFP or high-frequency neural spiking activity. In general, the BOLD 
response has been shown to correlate well with LFP (Brinker et al., 1999; Goldman et al., 
2002; Huttunen et al., 2008; Martin et al., 2006), however, the reader is warned that there are 
exceptions to this, pointing to particular examples such as the hippocampus, where a 
significant correlation between LFP and BOLD signal was not found (Ekstrom et al., 2009). 
A number of potential reasons for this were mentioned, including the hippocampus being 
active in baseline fMRI conditions, giving at times a negative overall activation when 
compared to an active task. The hippocampus also receives a number of inhibitory 
connections, which may decrease measured neural activity but still demand metabolic energy 
processes, giving an increased BOLD signal. For a full table and summary of studies 
investigating metabolic (using both fMRI and PET) correlations with neural activity 
measurements, see Table 1 in Ekstrom (2008). In general, it was stated by Ekstrom that 
particularly within the neocortex, BOLD is often correlated with LFP. However, care must be 
taken when making direct inferences about underlying neural activity from the BOLD 
response alone and having correlations with other modalities such as Electroencephalography 
(EEG) would be beneficial (Ekstrom, 2008). 
1.4.1.8 Haemodynamic	response	
The shape of the BOLD signal during cortical activity is known as the haemodynamic 
response or haemodynamic response function (HRF). Compared to neural events, which occur 
61 
 
within tens of milliseconds, the haemodynamic response is slow and begins approximately 2 
seconds after neural response. This is due to the slower occurrence of vascular events 
compared to neural signalling. The haemodynamic response has a characteristic shape, known 
as the canonical HRF (Figure 1-12). Many studies have shown an initial dip in the first 2 
seconds following the event (Menon et al., 1995). This is thought to possibly represent a rapid 
increase in oxygen utilisation before the blood flow changes to compensate (Kim & Ogawa, 
2012). This finding, however, remains inconsistent between studies (Hu & Yacoub, 2008). As 
the subsequent increase in blood flow to neurologically active regions occurs, the BOLD 
signal begins to increase as the deoxyhaemoglobin is washed out. This signal reaches a peak 
in about 5 seconds. Single fast events will give such a peak. In response to sustained stimuli, 
consecutive peaks may form a broad plateau. Following peak activity, the signal decreases 
and will often have an undershoot period, known as the post-stimulus undershoot, before 
returning to baseline (Buxton et al., 1998; Chen & Pike, 2009; van Zijl et al., 2012). The 
cause of this undershoot is still debated (Kim & Ogawa, 2012; van Zijl et al., 2012; 
Yablonskiy et al., 2013) but may be due to a decrease in blood flow with high venous blood 
volume maintained, giving a higher concentration of deoxyhaemoglobin (Chen & Pike, 2009) 
or be due predominantly to a sustained increase in oxygen metabolism, with minor 




Figure 1-12 – The canonical haemodynamic shape. Source - Wikimedia Commons 
1.4.1.9 Noise	
The components of the measured BOLD signal contain other elements such as a drift 
component, heart rate and respiratory-related signal change and also noise alongside the 
actual response. It is thought these other components are of a low frequency and so typically a 
high pass filter is used to help remove these signals as much as possible (Kruggel et al., 
1999). 
1.4.2 fMRI	Experiment	design	
There are two basic types of fMRI experiment design – the block and event-related design. 
1.4.2.1 Block	fMRI	design	
A block design is a type of fMRI procedure where the experimental task is presented multiple 
times in series e.g. 20 consecutive saccade trials. This is then followed by the control task, 
e.g. fixation, which is presented for the same duration as the series of saccade trials. These 
task sequences are known as “blocks”. During analysis, the BOLD signal from the control 
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task block is subtracted from the experimental task block signal, giving activation specific to 
the experimental task. 
When performing a block design experiment, multiple factors are at play. Many trials within 
each experimental block are desirable, in order to increase the detectable BOLD response, but 
timing and minimising patient fatigue must be considered. If the experimental block is too 
long, fatigue may set in, leading to a drop in performance approaching the last few tasks 
within the block. Tasks within a blocked design should also be relatively brief, to allow 
enough task repetitions within a block for meaningful BOLD activity to build up. A blocked 
design is well suited for experiments using saccades. Saccades by definition occur rapidly and 
many trials can be carried out within a reasonable timeframe. The blocked design generates a 
summation of all the BOLD responses for many repetitions of a task. Because of this, it is 
very good at detecting regions that show task-related activity in the brain. A drawback of a 
blocked design is that it does not provide information regarding the timing of the task-related 
activity. Using the memory-guided task as an example, a sequence of events must occur in the 
brain to process and generate each memory-guided saccade. A blocked design will only 
capture the summation of all the activity from the memory-guided trials without information 
on the timing and time course of the activity. An event-related fMRI design is needed to 
investigate the timing of BOLD activity. 
 
1.4.2.2 Event-related	design	
An event-related design is used to study the haemodynamic response following individual 
stimuli or “events”. This type of design assumes there will be neural activity occurring for a 
short and discrete amount of time following the presentation of a stimulus.  
The event-related design treats neural activity for each task component as a discrete 
occurrence or “event” - as opposed to a blocked design that sums up activation from many 
repetitions of a task. The event-related design can show regions active at specific time points 
or intervals during the task whereas a block design shows consolidated activation across the 
task, with no timing discrimination. Each neural impulse has a corresponding haemodynamic 
response which can be detected by BOLD signal changes. Event-related trials are presented 
one at a time, and are separated by an inter-trial interval. An inter-trial interval can be set up 
to be long enough for the haemodynamic response to return to baseline before the next trial, 
this being known as a slow event-related design. In contrast, for rapid event-related design, 
events are spaced closer than would allow the haemodynamic response to reach baseline 
64 
 
before the next task. This causes an overlap between two haemodynamic responses. This does 
not pose a problem as it has been shown that haemodynamic activity summates linearly with 
repeated trials (Pollmann et al., 2000) and can be taken into account with convolution. An 
advantage of having a short inter-trial interval is the ability to have a higher number of trials 
within a set period, giving more power. This results in short inter-trial interval experiments 
being more powerful at detecting task-related activity. Longer inter-trial intervals allow better 
depiction of time courses due to trials being adequately spaced to minimise overlap (see time 
course section in Chapter 6, page 195 for an explanation of how fMRI software accounts for 
overlap during time course generation). Practical elements such as patient fatigue must be 
considered when designing event-related studies. The study duration should be kept to a 




Raw MRI data needs to go through a series of adjustments, known as preprocessing, before 
being able to be used for statistical analysis. fMRI has a number of unique pre-processing 
steps, of which slice timing usually occurs first. In each repetition time (TR), a scan of the 
whole brain (or selected scanning area) is made. fMRI acquires this whole-brain image by a 
series of slices in 2D, which are put together in a stack to form the 3D whole-brain image. 
Commonly, an interleaved slice acquisition sequence is used. This means the slices are not 
taken in a consecutive order. Rather, if the image slices were numbered consecutively i.e. 1, 2, 
3 and so on, starting from the bottom of the brain to the top, the odd-numbered slices (1, 3, 5, 
…) are taken first and then once the last odd-numbered slice is acquired, the sequence moves 
back to the bottom of the brain to then acquire the even-numbered slices. The time interval 
between the acquisition of spatially neighbouring slices 1 and 2 for example, even though 
they occur within one TR, are separated temporally by around half the TR duration, or from 
1-2 seconds if using a 3 second TR. This can make a significant difference to activations in an 
event-related design. A process known as temporal interpolation is used to account for this. 
This estimates the activation difference needed to account for timing differences of a specific 
slice in relation to a selected reference slice (Henson et al., 1999; Sladky et al., 2011). 
Temporal interpolation options are usually provided in fMRI analysis software such as 
Statistical Parametric Mapping (SPM) (Friston, 2007). 
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Head motion has a potentially large impact on data, confounding the relationship between 
voxel activation and voxel location in fMRI studies (Friston et al., 1996; Maclaren et al., 
2013). Excessive head motion can also lead to incorrect measurements of brain structure 
(Reuter et al., 2015; Savalia et al., 2017) The first step to correcting for motion is to shift all 
the fMRI scans using a “rigid body” transformation, translating and rotating the scans to a 
selected reference scan (Jiang et al., 1995). Motion correction parameters generated from this 
step can be later entered into the statistical model as “nuisance variables”, or covariates of no 
interest, to help eliminate effects caused by motion and not actual activation (Johnstone et al., 
2006). The images are then resampled so the motion-corrected changes are applied to the 
image by a process called spatial interpolation, available in most fMRI analysis programs 
(Friman & Westin, 2005; K. Friston, 2007). 
Functional scans have a low spatial resolution. In order to make inferences on BOLD 
activation changes, the active functional areas need to correspond with known structural 
locations. Structural MRI generally gives higher spatial resolution and functional images are 
aligned to this in a step called co-registration. This co-registration step is used for all 
modalities, including DTI and ASL scans, which are all aligned to the reference structural 
image.  
Co-registration occurs firstly at an individual level. For comparing group-level differences, 
every voxel from all MRI imaging modalities must correspond to the same spatial location for 
every subject. However, each subject’s brain is of varying size and shape. Normalization is 
the process by which the scans from each individual are warped and morphed into a 
standardised shape and size. As our patient sample is from an elderly population, a 
probabilistic elderly brain template (Lemaître et al., 2005) was used for this study, in order for 
the normalisation step to reflect age-related changes. Normalization is an automated process 
within fMRI analysis programs such as SPM (Friston, 2007). 
The final preprocessing steps involve removing noise by filtering and smoothing. Low-
frequency signals that are unrelated to the underlying haemodynamic response can arise from 
signal drift and cardiac and respiratory drift (Cordes et al., 2001). Filtering strategies exist in 
an attempt to remove signals from these confounding sources (Kruggel et al., 1999). 
Smoothing combines each voxel point with the weighted average of neighbouring voxels, 
effectively “blurring” the image. This blurring is a result of the removal of sharp contrasting 
intensities from neighbouring voxels and helps improve the signal to noise ratio (SNR) by 
averaging out random noise values. This does have an effect of decreasing effective spatial 
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resolution but the improvement of SNR helps with the detection of significant cortical activity 
(Parrish & Gitelmant, 2000). 
1.4.2.4 Group	analysis	–	general	linear	model	
fMRI analysis uses a general linear model (GLM). Essentially, a GLM is run at every voxel - 
for example a multiple regression at every voxel. This type of analysis is known as a mass 
univariate statistical analysis.  
The general linear model/multiple regression equation can be written as: 
Y = β0 +β1X1 + β2X2 + … βnXn + ε 
Where, 
Y = dependent variable – e.g. actual measured BOLD signal in a voxel.  
Xi = independent variables - as in a multiple regression. These can be age, sex, motion 
parameter corrections and estimated BOLD response. N represents the total number of 
independent variables used in the analysis. 
β= Beta weight - The beta weight is a regression coefficient of the independent variable. Beta 
0 (a constant) models an offset representing all the factors held constant.  
ε = Error - a measure of the deviation of the actual signal from the expected signal due to 
noise and other un-modelled factors 
In multiple regression, multiple independent variables are used to predict a single dependent 
variable. In fMRI analysis, the onsets and durations of the task are convolved with a 
haemodynamic response – often the canonical HRF. This gives an estimated BOLD signal 
which is expected to occur with task-related activity and is an independent variable of the 
regression analysis or the GLM. Other possible confounders such as motion can be added as 
independent variables into the GLM analysis, which may help explain some of the observed 
variance in the BOLD signal. The recorded BOLD signal is the dependent variable. In GLM 
analysis, the model containing each independent variable is fitted to the BOLD signal by 
minimising residual error e.g. by least squares. This process generates weighting parameter 
estimates at every voxel (B1 to Bn, called beta weights or regression coefficients) for each 
independent variable. An error value for each voxel is also calculated which represents the 
deviation between the observed voxel value and the expected voxel value, due to noise and 
other un-modelled factors. Every beta weight is tested for statistical significance, with the null 
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hypothesis being that the beta weight = 0 (no correlation between BOLD signal and 
independent variable). The beta weight for each individual independent variable can be 
selectively displayed in a statistical parametric map. This visually highlights voxels which 
meet the significance threshold to reject the null hypothesis. In an example of displaying 
significant beta weight for expected task BOLD activation independent variable, highlighted 
voxels can be considered regions active for the experimental task. 
The GLM equation can be equivalently written in matrix notation as 𝑌#= 𝐵#𝑋# + 𝜀.̅	𝑌# represents 
the column of values for the dependent variable, 𝐵#  the beta weight column, 𝜀	̅the error column 
and 𝑋# the design matrix. This is fit at every voxel. 
A design matrix (Figure 1-13) can be used to visualise the independent variables in the GLM 
analysis, with one row per observation and one column per independent variable. The colour 
intensity of the boxes represents the numerical values of each variable. 
 
Figure 1-13 – Design matrix construction. A design matrix is a convenient way to visualise the 
independent variables added into the general linear model. In the diagram above, task-related neural 
events are convolved with the HRF (1) to form an estimated BOLD response for the task (2). The columns 
in the design matrix can be thought of as flipping BOLD response vertically (3) and converting the BOLD 
signal change values into a corresponding shade i.e. lighter shades for lower values and darker shades for 
higher (4). Additional values such as motion parameters or age or sex can be added as additional columns 
forming the design matrix (5). Each column represents each independent variable and each row 
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represents a scan image in time in a first level analysis and subject for a second level analysis. Each 
column represents an X value in the GLM equation and has a corresponding beta weight. Voxels with 
significant beta weights can be highlighted in a brain map to show regions corresponding to the 
independent variable, i.e. the expected task-related BOLD activity. Note the figures above are 
representative only and do not reflect actual experimental values. 
The GLM allows us to localise brain activation (Friston et al., 1995). This approach can be 
applied to a single subject, known as a first-level analysis, and as a group analysis after the 
individual analysis, known as a second-level analysis.  
In a second-level analysis, parameters such as age and sex are typically added as independent 
variables, while motion parameters are generally added at the first level. In a second level 
analysis, it is possible to test whether activation differences seen in the first level (i.e. within 
subjects) are significantly different at a group-level (e.g. between Parkinson’s patients and 
controls).  
A similar process is used in a voxel-based analysis (VBA). Instead of fMRI BOLD activation 
however, values such as grey matter volume, blood flow perfusion values in ASL and FA and 
MD values in DTI can be examined. This can be used to detect group differences in those 
values or assess correlations with variables such as eye movement performance (Ashburner & 
Friston, 2000). 
1.4.2.5 Multiple	comparisons	problem	
A sequence of fMRI scans for one subject can contain over 100,000 voxels, with every voxel 
undergoing a statistical test of its change over time. Even if no actual activation changes were 
present, if the usual p-value of 0.05 is used, we could expect 5% of the 100,000 voxels to give 
a type 1 error (false positive). This equates to 5000 voxels which would be seen as 
significantly active purely due to chance. This effect was amusingly illustrated by Bennett et 
al. (2009) by using fMRI to scan a deceased Atlantic salmon. On presenting the fish a series 
of photographs, “significant” activation was seen in the salmon brain responding to the photo 
presentation compared to rest, even when using a p-value of 0.001.  
This is an example of what is known as the multiple comparisons problem. The higher the 
number of statistical tests performed, the greater the chance of obtaining a false positive 
result. This needs to be accounted for and the process is known as correction for multiple 
comparisons. The correction method used in this study is called family-wise error (FWE). 
FWE is the probability of obtaining a type 1 error in all (a family) of statistical tests. FWE can 
be controlled using Bonferroni correction, permutation tests and random field theory. 
Bonferroni correction is simply dividing the p threshold by the number of tests being done. 
This assumes all tests to be independent of one another, which is not valid in smoothed fMRI 
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data and hence typically is not used in fMRI studies. That is Bonferroni correction is overly 
conservative when applied to fMRI studies and risks type 2 errors (true positive being 
rejected) (Nichols & Hayasaka, 2003). Permutation testing involves reshuffling the design 
matrix into different orders. For example, an experimental condition can be switched with the 
control condition and the statistical analysis re-run. This reshuffling is repeated until all 
possible permutations of the design matrix have been analysed, giving a distribution of beta 
weights. The original beta weight is then compared to this distribution and a result is 
considered significant if above a defined significance level. This requires significant 
computing power (Nichols & Hayasaka, 2003) and was not used in this study. 
Random field theory works by accounting for the relatedness of neighbouring voxels, i.e. it 
does not apply the crude assumption that all voxels are independent. Random field theory can 
calculate the likelihood of type 1 errors occurring for a given statistic level in data of a certain 
smoothness (referring to not the smoothing process, but rather as a measure of how well 
correlated each voxel is with adjacent voxels). This is an efficient means of calculating 
family-wise error and is less stringent than Bonferroni correction (Brett, Penny, & Kiebel, 
2003). 
1.4.2.6 Imager’s	fallacy	
Another comparisons problem was noted by Henson (2005), who described a certain type of 
reporting which he termed the “imager’s fallacy”. This occurs by reporting a group difference 
based only on a visual difference between two cortical activation maps without explicitly 
testing the statistical difference between the two groups. That is, it is possible for one image 
to show a difference which does not remain when directly tested with the other image. For 
example, a region seen to be significant in one map may have only just exceeded the 
significance threshold, whereas the corresponding region in the other map may have only just 
failed to reach that threshold. Testing the two directly would show no significant difference 
between the two. That is, the difference between significant and not significant is not 
necessarily itself significant (Gelman & Stern, 2006). It is thus insufficient to report group 
differences using only a visual comparison. If a claim is to be made, there is a need to report 
the statistical measure used to test the group differences (Poldrack et al., 2008). 
1.4.3 Parkinson’s	disease	and	Imaging		
MRI techniques have been applied to PD in an attempt to further characterise the disease and 
understand the process by which it occurs. The latest MRI machines give more contrast and 
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resolution than previous generations, providing a powerful tool for brain research (Stéphane 
Lehericy et al., 2017). 
 
The diagnosis of parkinsonian syndromes can prove difficult. Parkinsonian disorders 
encompass Parkinson’s disease (PD) as well as multiple system atrophy (MSA), progressive 
supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). Clinicians often make 
errors in the correct diagnosis of the disease especially in the early stages, with error rates as 
high as 24% (Hotter et al., 2009). Correct diagnosis is very important due to the different 
pathogenesis and treatment involved in different parkinsonian syndromes. The use of MRI to 
provide more objective data in regards to diagnosis is being investigated (Barber et al., 2017; 
Brooks & Tambasco, 2016; Niethammer et al., 2011; Saeed et al., 2017) but has not yet been 
incorporated in diagnostic criteria, which remains clinically based. 
With new neuroprotective techniques being developed, it is important to be able to reliably 
track the progression of PD (Stocchi & Olanow, 2003). Current measures for assessing PD 
severity, such as the MDS-UPDRS (Goetz et al., 2008) are subjective rating scales. Imaging 
may provide more objective values which can mark disease progression (Tuite, 2017). 
	
1.4.3.1 Structural	imaging	in	PD	
Studies into structural changes in PD have yielded varying results. However, disease-related 
changes have consistently been identified with changes in cognitive status in PD and disease 
state in PD using various MRI modalities. 
The basal ganglia are severely affected in PD, resulting in the degeneration of the nigrostriatal 
system (Jellinger, 2012) which leads to neuron atrophy in the striatum (Stephens et al., 2005; 
Zaja-Milatovic et al., 2005). Consistent evidence from imaging studies points to atrophy in 
the putamen and caudate nucleus in PD. A number of studies report atrophy of the caudate 
head (Apostolova et al., 2010; Lee et al., 2011; Pitcher et al., 2012; Sterling et al., 2013). 
Likewise, putamen atrophy has been reported (Atasoy et al., 2004; Geng, Li, & Zee, 2006; 
Krabbe et al., 2005; Lisanby et al., 1993; Melzer et al., 2012; Pitcher et al., 2012; Tinaz, 
Courtney, & Stern, 2011; Weintraub et al., 2011). It is thought the atrophy of the striatum 
may be affected early in the disease (Tessa et al., 2014) and “bottoms out” after 5 years 
(Lewis et al., 2016). However, other studies have reported no change in striatal volume 
(Almeida et al., 2003; Ghaemi et al., 2002; Messina et al., 2011; Schulz et al., 1999). A 
possible reason for this may be due to the scanners used by the studies not able to detect a 
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group difference being of 1.5T or less. This study uses a 3T scanner, which provides 
improved spatial resolution compared to a 1.5T scanner. 
The thalamus is a major relay station for brain structures, including connections from the 
basal ganglia to the cortex (Herrero et al., 2002). Shape differences in the thalamus, with no 
volume changes, have been reported in PD (McKeown et al., 2008), but atrophy has been 
reported also (Summerfield et al., 2005).  
The substantia nigra, a site of cell death in Parkinson’s disease, is difficult to define using 
structural MRI due to its small size and low contrast (Cho et al., 2011; Lehericy et al., 2014). 
Likely due to these reasons, the findings of SN volume in PD are conflicting and it has been 
reported as unchanged (Geng et al., 2006; Oikawa et al., 2002), decreased (Krabbe et al., 
2005; Menke et al., 2009; Minati et al., 2007; Ziegler et al., 2013) or even increased (Kwon et 
al., 2012). More recently, significant SN area and volume differences were found by Aquino 
et al. (2014) correlating to different stages of the disease. Newer, high field 7T MRI studies 
have shown “smudging” in the SN and crus cerebri boundary (Cho et al., 2011) and another 
study has boldly stated that PD is able to be radiologically diagnosed with 7T MRI, using 
abnormalities seen in SN structure, reporting a 100% sensitivity and 96.2% specificity in 
group discrimination between 19 PD and 17 controls (Cosottini et al., 2014). 
There is a lack of reliable segmentation to define the globus pallidus in MRI, making this area 
difficult to visualise using non high-field MRI (Iacono et al., 2011). However, studies have 
reported atrophy (Geng et al., 2006; O’Neill et al., 2002) which is possibly more pronounced 
with impaired cognition in PD (Tambasco et al., 2011). 
The hippocampus and amygdala are structures linked with memory and dementia (Barnes et 
al., 2006; Eichenbaum, 2004; Phelps, 2004). Both hippocampus and amygdala atrophy have 
been found to occur with cognitive decline in PD (Beyer et al., 2007; Bouchard et al., 2008; 
Camicioli et al., 2003; Ibarretxe-Bilbao et al., 2008; Junque et al., 2005; Laakso et al., 1996; 
Melzer et al., 2012; Nagano-Saito et al., 2005; Riekkinen et al., 1998; Summerfield et al., 
2005; Tam et al., 2005; Weintraub et al., 2011). Hippocampal atrophy is less certain in PD 
without dementia, with some studies reporting atrophy (Brück et al., 2004; Summerfield et al., 
2005) while others show no hippocampal atrophy in cognitively normal PD (Burton et al., 
2004; Camicioli et al., 2004; Nagano-Saito et al., 2005). Similarly, non-demented PD patients 
may show amygdala atrophy, thought to be related to depression (Surdhar et al., 2012), or no 
amygdala atrophy (Huang et al., 2015). 
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Voxel-based morphometry studies of structural MRI have shown a number of differences in 
cortical grey matter volume in PD patients, including regions outside of the basal ganglia. 
Grey matter volume loss was seen in the frontal lobe (Burton et al., 2004), regions of the 
hippocampus, thalamus, and anterior cingulate (Summerfield et al., 2005), caudate nucleus 
and putamen (Pitcher et al., 2012). Melzer et al. (2012) found grey matter atrophy in the 
temporal, parietal and frontal lobe and the caudal hippocampus, correlating with cognitive 
state.  
Other forms of structural imaging such as R2 (inverse of T2) have been investigated for the 
use for diagnosing and rating PD progression. R2 is a form of structural MRI and, as 
mentioned, is the inverse of T2 (R2 = 1/T2). T2 was discussed on page 56, but to summarise, 
T2, also known as spin-spin relaxation, is a relaxation constant referring to the loss of phase 
between spinning nuclei caused by interactions between spins. Different tissue types have 
different T2 values, and hence, different R2 values. The differences in value give different 
signal profiles, which is used in MR imaging to distinguish between tissue types. 
Iron accumulations in the brain are thought to reflect oxidative stress, leading to neuronal 
damage in PD (Napolitano & d’Ischia, 2011). Autopsy studies have shown higher iron 
accumulations in the SN for PD brains (Dexter et al., 1987). Iron accumulations can be 
imaged using R2, which is thought to reflect non-haem iron concentration (Graham et al., 
2000). A number of studies have reported R2 differences in PD, showing increased SN iron 
content (Graham et al., 2000; Martin et al., 2008). Iron accumulations were even seen in 
asymptomatic LRRK carriers (Pyatigorskaya et al., 2015), potentially indicating this could be 
a PD diagnostic tool and biomarker (Hopes et al., 2016). However, other studies have shown 
conflicting results (Dashtipour et al., 2015; Reimão et al., 2016) and more trials are needed 
before this can be established as a biomarker, potentially requiring a combined R2 analysis 
with other MRI modalities, such as DTI (Du et al., 2011).  
A recently validated MRI technique known as quantitative susceptibility mapping (QSM) has 
been shown to provide better detection of iron levels within the brain by compensating for 
non-homogenous magnetic fields by deconvolution (Langkammer et al., 2012; Wang & Liu, 
2015). Studies employing this technique have found a greater significance of iron 
accumulations within the substantia nigra in PD compared to findings from previous R2 
experiments (Du et al., 2016). A preliminary study was able to describe a progressive pattern 
of iron accumulation in the PD brain (Guan et al., 2017), showing the QSM technique to be a 
promising new means for detecting progressive iron deposition in PD. 
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Nigrosomes are groupings of dopaminergic cells within the SN, characterised by specific 
immunohistochemical staining (Damier et al., 1999a). Five nigrosome groups were described 
by Damier et al., with nigrosome-1 being proportionally the most affected in PD (Damier et 
al., 1999b). Nigrosome-1 can be seen using 7T (Blazejewska et al., 2013) and 3T (Schwarz et 
al., 2014). The appearance of a healthy nigrosome-1 has been likened to the shape of a 
swallow tail by Schwarz. Identifying abnormal nigrosome-1 could provide a relatively simple 
diagnostic means for PD, using relatively common 3T MRI scanners (Schwarz et al., 2014). 
Neuromelanin can also be visualised using MRI (Nakamura & Sugaya, 2014). Neuromelanin 
is a dark pigment contained in SNpc which is typically lost in PD (Zecca et al., 2001). Using 
MRI sensitive to neuromelanin, differences in SNc volumes have been reported by 
Castellanos et al. (2015). This has shown promise for the diagnosis and use as a biomarker of 
PD progression in a number of reports (Hatano et al., 2017; Reimão & Ferreira, 2016; Tuite, 
2017). This neuromelanin-sensitive MRI technique was also found to be able to differentiate 
essential tremor from PD (Reimão et al., 2015) and enhances the robustness of another 
imaging modality (DTI) when used to identify regions of interest for DTI testing of PD-
related changes (Langley et al., 2016). 
1.4.3.2 Diffusion	tensor	imaging	(DTI)	in	PD	
DTI MRI can produce a number of metrics: the two most studied are fractional anisotropy 
(FA) – the direction preference of diffusion, and mean diffusivity (MD) – the rate of 
diffusion, without a directional component (Soares et al., 2013). Studies, in general, report 
decreased FA values of the SN in PD (Chan et al., 2007; Peran et al., 2010; Vaillancourt et al., 
2009) along with increased MD values the SN in PD (Du et al., 2014; Nagae et al., 2016; 
Scherfler et al., 2013). 
Findings have been mixed for differences in DTI values in other subcortical nuclei. Shape 
analysis has found altered right pallidum shape, with fibre tracts arising from the altered 
pallidus region having lower FA and higher MD in PD vs controls (Menke et al., 2014). MD 
has been found increased in globus pallidus itself (Nagae et al., 2016), with FA and MD 
differences in the thalamus (Peran et al., 2010) and putamen as well (Jiang, Shi, Niu, Xie, & 
Yu, 2015).Other studies have shown no difference in DTI values of non-nigral subcortical 
nuclei (Gattellaro et al., 2009; Loane et al., 2016). 
A number of factors may contribute to the variability in subcortical nuclei DTI findings, 
including scanner protocol, strength and experimental analysis type. Subcortical nuclei are 
also subject to increased iron deposition with age. These iron deposits can affect DTI 
74 
 
measures, making it difficult to differentiate group changes (Pfefferbaum et al., 2010; 
Schwarz et al., 2013). A systematic review by Cochrane & Ebmeier (2013) stated that larger 
studies are needed in order to develop a valid repeatable biomarker using DTI, and that it will 
likely need to be used in conjunction with other imaging modalities. 
Free water, e.g. cerebrospinal fluid or oedema - water molecules not restricted by the cellular 
environment, can be detected using DTI (Pasternak et al., 2009). Free water shows an MD 
value many times greater than water within cellular structures and was found to be elevated in 
the SN in PD. Free water also increased with PD progression (Ofori et al., 2015). A technique 
called fibre tracking, which reconstructs the direction of white matter tracts using DTI (Mori 
& Van Zijl, 2002) has been used to map the nigrostriatal tract connecting the SN to the 
striatum (putamen and caudate) (Lehéricy et al., 2004). Using fibre tracking, Menke et al. 
(2009) found decreased connectivity while Sharman et al. (2013) found no anatomical 
nigrostriatal connectivity difference in PD (but did find functional connectivity differences 
using resting-state fMRI).  
1.4.3.3 Arterial	spin	labelling	(ASL)	in	PD	
Studies using ASL have found a number of perfusion deficits in PD. An established disease-
related perfusion pattern has been seen in PET with decreased metabolic activity in the 
posterior parietal cortex, lateral premotor cortex and supplementary motor area with increases 
seen in the pontine, pallidothalamic and cerebellar regions (Ma et al., 2007). An ASL 
perfusion network has been found to correlate closely with this network (Ma et al., 2010). 
Kamagata et al. (2011) found hypoperfusion in the posterior cortex. Melzer et al. (2011) 
described an ASL PD-related perfusion network which correlated with cognition, as assessed 
using the Montreal cognitive assessment (MoCA), and motor status as assessed using the 
UPDRS part III. This network score showed absolute perfusion deficits in the parietal-
occipital cortex, cuneus, precuneus and middle frontal gyrus. Intact perfusion was seen in the 
globus pallidus, putamen, anterior cingulate and postcentral gyri. Al-Bachari et al. (2014) 
found a diffuse widespread increase in arterial arrival time (time taken for tagged blood to 
reach the imaged areas), suggesting a compromised neurovascular status in PD. Lin et al. 
(2016) found widespread hypoperfusion in PD, similar to the previous ASL PD studies, but 
also found further decreases in the frontal lobe in non-dementia PD patients (PD-N) and 
cerebellum in PD dementia (PD-D) patients on dopaminergic (levodopa or equivalent) 
medications. This difference in perfusion was thought to relate to cognition or disease severity 
and could potentially be used for disease management planning. Lin et al. (2017) found ASL 
perfusion deficits in the middle frontal gyrus that correlated with clinical severity (UPDRS 
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part I score) and perfusion deficits in autonomic control regions (within the frontal lobe and 
insula) correlated with impaired autonomic function scores (score described by Low (2003)). 
1.4.3.4 Functional	MRI		
The human brain functions as a collection of multiple networks, with individual cortical 
regions continuously sending and receiving information as an integrative network - even at 
rest (van den Heuvel & Hulshoff Pol, 2010). Resting-state fMRI is used to investigate 
functional connectivity, or the temporal correlation of neural activity in anatomically separate 
cortical regions (Barkhof et al., 2014; van den Heuvel & Hulshoff Pol, 2010). This is done 
using fMRI at rest, with no explicit task. A number of such studies in PD have found 
functional connectivity disruptions in a large number of networks. The motor network showed 
decreased connectivity in the supplementary motor area, DLPFC and striatum (Hacker et al., 
2012; Wu et al., 2009, 2011) and increased connectivity of the left cerebellum, left primary 
motor cortex, left parietal cortex (Wu et al., 2009). Increased functional connectivity was also 
seen from STN to cortical motor regions and posterior putamen (Baudrexel et al., 2011; 
Rolinski et al., 2015). Studies into pre-symptomatic LRRK2 mutation patients found altered 
resting-state connectivity in striatocortical and nigrocortical circuits compared to controls 
(Vilas et al., 2016), which are similar to changes seen in PD (Helmich et al., 2015). Resting-
state fMRI also shows potential as a biomarker and has been able to differentiate PD from 
controls (Szewczyk-Krolikowski et al., 2014) and PD from AD (Rolinski et al., 2015). 
Overall, these studies have identified a large number of potentially affected cortical regions in 
PD during rest, including regions such as the fronto-parietal visual area (Prodoehl et al., 2014) 
which could suggest the activity of these regions may also be altered during task performance. 
Movement abnormalities have been investigated in PD using functional imaging techniques. 
A consistent picture of cortical motor differences in PD has not yet been described, with 
studies reporting varying locations and sizes of PD motor activation changes (Grafton, 2004; 
Rowe & Siebner, 2012). A meta-analysis of 24 functional imaging movement studies by Herz 
et al. (2014) found the changes converged into a fronto-parietal region, lateralized to the left, 
containing the pre-supplementary motor area, primary motor cortex, inferior parietal cortex, 
and superior parietal lobule. However, both increases and decreases in activity were seen in 
this region depending on motor task timing and movement selection. Within the basal ganglia, 
posterior motor putamen activation was found to be decreased in PD. This decrease in motor 
putamen activity was more likely detected in PD patients with more significant motor 
impairment measured by mean UPDRS III scores (Herz et al., 2014).  
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Functional MRI studies of saccade performance in PD are scarce. While no consensus exists 
on the cortical basis of saccadic eye movement abnormalities in PD, fMRI studies have 
reported activation differences in PD in the FEF and parietal cortex during saccades. Using 
blood oxygen level dependent (BOLD) activation and functional MRI, Rieger et al. (2008) 
observed marked hypoactivity in frontal eye fields and supplementary eye fields during a 
simple self-paced saccadic task. The activation pattern was also different in PD patients, 
showing more above-threshold voxels in general, despite the frontal hypoactivity, with greater 
BOLD activity in posterior parietal, temporal and occipital lobe regions. Cameron et al. 
(2012) found altered preparatory FEF and DLPFC activity in PD compared to controls in the 
antisaccade task. Lemos et al. (2016) found hypoactivity in the left FEF during prosaccades 
and hyperactivity in the right parietal cortex for both prosaccades and antisaccades.  
The overall goal of this study is to add to the understanding of the basis of eye movement 
performance deficits in PD. This thesis will use MRI as a means to assess the extent of which 
PD-related changes within the brain contribute to saccade deficits. I will first be using a 
voxel-based analysis on structural, ASL and DTI scans to make comparisons with eye 
movement performance measures. The second part of this thesis will focus on fMRI of eye 
movements in PD. Reflexive and predictive tasks are used in the first part of the fMRI 
section, followed by an investigation into memory-guided saccades in PD. No study has yet 
investigated predictive and memory-guided saccades in PD using fMRI. Memory-guided 
saccades encompass activation in frontal and parietal eye fields as well as DLPFC activation. 
The contribution of functional brain imaging with eye movement performance changes from 
ongoing longitudinal studies could be used to develop biomarkers of PD progression. The 
findings in this thesis will provide increased understanding of the disease-related brain 
changes contributing to eye movement deficits in PD.  
 
1.5 Overall	thesis	aims	
The overarching aim of this thesis is to determine if saccadic eye movement abnormalities can 
reflect brain health in PD and controls. Certain saccade performance measures show 
correlation to PD severity as measured by cognitive impairment and motor impairment. 
Similarly, brain changes in PD have been detected with a number of MRI modalities, which 
are more severe in later disease states. These correlations, in turn, support the idea that 
saccade measures may correlate with disease-related brain changes and thus reflect brain 
health in PD. As covered previously, certain saccadic eye movement measures show 
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characteristic deficits in PD. However, the changes in the brain leading to these deficits 
remains unknown. Perfusion and white matter tract changes in the frontal and parietal cortices 
have been reported in PD, even early in disease (Melzer et al., 2011; Melzer et al., 2013). 
fMRI studies have revealed possible altered FEF and parietal lobe activity during the 
antisaccade task in PD but, as previously discussed (page 76), no consensus over 
characteristic functional changes in PD have been made. It is known that the frontal and 
parietal cortices contain key eye fields involved in saccade control. It would be then feasible 
that disease-related brain changes involving the eye fields in the disease could contribute to 
PD-related saccade abnormalities. However, to date, no study has compared structural, ASL 
and DTI measures to saccadic eye movement performance in PD using a voxel-based analysis 
to determine if this is true. In this thesis, I aim to determine if eye movement performance in 
PD is reflected by corresponding disease-related changes in eye fields in the brain, by 
comparing saccade performance to a number of MRI measures. Secondly, due to the 
comparatively large numbers of participants used in this study, I also aim to provide better 
understanding of general eye movement control of non-PD people to expand our present 
knowledge of saccade control.  In regards to this aim, I emphasise that every study in this 
thesis contains a control group, used as a comparison to the PD group. Should novel findings 
be detected in controls, this would allow comment on saccade control for the general non-PD 
population. 
Each chapter has a specific section dedicated to outlining the aims of its study and how these 
contribute to answering my overall questions. In summary, Chapter 3 will compare saccadic 
eye movement performance to structural, ASL and DTI modalities using a voxel based 
analysis. This will determine if differences in correlation exist between eye movement 
performance and MRI measures, e.g. volume or perfusion, in the PD brain compared to 
controls. Chapter 4 will compare eye movement performance to expression of a characteristic 
PD perfusion network, aiming to determine if saccade performance may be a reflection of a 
higher expression of a PD-related perfusion pattern seen across multiple regions. Chapter 5 
will investigate reflexive and predictive saccades in PD and control groups using fMRI and 
will determine if functional activity in eye fields is altered in PD for these tasks. This study 
also allows comparisons of brain activity between reflexive and predictive tasks and allow 
comment upon saccade control for these tasks in PD and the general population. Lastly, 
Chapter 6 will investigate memory-guided saccades, using the same technique as Chapter 5 at 
first, but, in addition, will use an event-related fMRI design. This will allow a timecourse to 
be generated of BOLD activity during task performance and would determine if altered 
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BOLD activity during task performance is present in the diseased group compared to controls. 
Furthermore, I plan on applying a principal component analysis (PCA) to extract common 
patterns from the BOLD timecourses, which may not be immediately visually obvious. The 
technique is only used in Chapter 6 and will be further discussed within that Chapter. The use 
of PCA would allow comment upon the use of this technique in the fMRI investigation of eye 
movements and may provide further insights into eye movement control for both PD patients 





All participants were recruited through the New Zealand Brain Research Institute, where this 
study took place. The diagnosis of PD for study participants was made by a movement 
disorders specialist (TJA) using the UK Parkinson’s Disease Society Brain Bank diagnostic 
criteria for PD (Hughes et al., 1992). Patient exclusion criteria were the presence of atypical 
PD, past moderate to severe head injury, previous stroke, major depression, past history of 
neurosurgery, learning disabilities, cardiovascular disease, insulin-dependent diabetes, the use 
of medications known to affect the central nervous system and uncorrected visual acuity 
worse than 6/12 in the best eye. Consent was provided by all participants with 
families/caregivers providing consent for cognitively impaired patients. This study was 
approved by the Upper South A Ethics Committee of the New Zealand Ministry of Health. 
2.1.2 Cognitive	testing	
All participants underwent a series of cognitive tests covering five cognitive domains 
(executive function; attention; learning and memory; visuospatial/visuoperceptual and 
language), as part of the level II criteria for PD-MCI (Litvan et al., 2012). MCI participants 
had unimpaired functional activities of daily living, as verified by interview with a significant 
other, and scored 1.5 standard deviations or below normative values on at least two measures 
within at least 1 of the five MDS cognitive domains. PD dementia was determined using the 
Movement Disorder Society (MDS) Task Force criteria, as set out by Dubois et al. (2007). 
Additionally, general cognitive testing was performed using the Montreal Cognitive 
Assesment (MoCA). Within each cognitive domain, standardized scores from the constituent 
neuropsychological tests were averaged to provide individual cognitive domain scores; global 
cognition for each participant was expressed as an aggregate z-score, obtained by averaging 
four domain scores (language was excluded due to low variability), reflecting overall 
cognitive status. 
2.1.3 Parkinson’s	motor	symptoms	testing	
Many participants involved in this study were recruited over time and are part of a 
longitudinal study of PD. The UPDRS (Fahn & Elton, 1987) was initially used to assess 
motor function. A portion of the subjects in this study were originally recruited and assessed 
before the introduction of the revised MDS-UPDRS (Goetz et al., 2008). The UPDRS part III 
score of these participants was converted using the process described by Goetz, Stebbins, & 
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Tilley (2012) to be equivalent to the revised MDS-UPDRS III. To note, for convenience, all 
mentions of UPDRS collected for the studies of this thesis refers to the MDS-UPDRS. 
2.1.4 Eye	movement	laboratory	
All eye movements in the laboratory were recorded using an iView X high-speed infrared 
pupil and corneal tracking system (SMI Berlin), generating monocular (left) video eye 
recordings at 1250 Hz. Participants were instructed in the process around eye movement 
recordings, which involved sitting behind the eye tracker, with head resting on an adjustable 
chin rest. Patients were instructed to minimise head movements, with seating and eye tracker 
heights adjusted to patient comfort before commencing the task. Task stimuli were presented 
on a screen located 160.5 cm in front of the participant.  
For Chapters 3 and 4, task stimuli were projected onto the screen with a resolution of 800 × 
600 pixels and 100 Hz refresh rate. Red squares of 12 × 12 pixels, subtending 0.75 degrees of 
visual angle, were used as fixation and target stimuli, appearing on a grey background. The 
display was situated 160.1cm away from the particilant. The screen measured 109.2cm × 
82.9cm. A second green stimulus of the same size and shape was used for the antisaccade 
task. iView calibration took place using a 13 point system before each trial. 
Eye movements for Chapters 5 and 6 were recorded and tracked using the same eye-tracking 
setup, however, a display of 1280 × 720 resolution was used. The display was situated 164.9 
cm away from the participant’s eye and measured 111.4 × 85.3 cm. Red square targets 
subtending 1.25 degrees were used as stimuli and were projected onto a grey background. 
Calibration was carried out using the iView (SMI) software before each task, using 13 points 
covering the entire task area. 
The fMRI studies used the Real Eye imaging system (Avotec, Inc). This comprised four 
subsystems: eye illumination, eye imaging, camera interface and the tracker interface. This 
allowed the eye movement task to be displayed to the participant whilst in the MRI scanner 
using a goggle setup, with the tracker interface allowing iView to be used by the experimenter 
to record eye movements. Unlike the eye movement tasks performed in the laboratory, the 
field of view and visual angles have not yet been determined by the goggle manufacturer. A 9 
point eye calibration was carried out before each task. An important point to acknowledge 
early is that, this system proved unreliable in maintaining tracking of gaze in the scanner and 
was not able to reliably track saccades. This proved a limitation, as in-bore eye movement 
performance was not able to be factored into the study analysis. The eye tracker did not allow 
accurate discernment of error trials from correct and hence all trials, correct and error trials, 
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were included in the final analyses and timecourses for the event-related memory guided task 
(Chapter 6). This is a noted study limitation. Thus study results are carefully interpreted 
acknowledging this limitation. 
Ideally, trials with error anticipatory saccades should be excluded as these are likely to arise 
from a different mechanism from the main memory-guided task. One effect from this is the 
potential for error saccades to influence activity measured during what is named the 
“memorisation” event, or the event when the flash appears but the participant is instructed to 
maintain fixation on the original stimuli. Should an error reflexive saccade be made at this 
stage, this would activate a separate reflexive saccade mechanism, rather than the expected 
fixation/spatial memory mechanism for this event. 
2.2 MRI	modalities	
No single MRI modality is able to provide all the information regarding the nature of the 
brain tissue changes which may affect eye movement performance. Hence various MRI 
modalities are used to provide an insight into the various potential changes in the brain, be it 
structural or functional, which could lead to saccade performance changes in PD and controls. 
Pathological processes in PD develop at different rates over time e.g. cortical atrophy is most 
clearly demonstrated only late in the disease with dementia (Melzer et al., 2012; Nagano-Saito 
et al., 2005; Ramirez-Ruiz et al., 2005; Sanchez-Castaneda et al., 2009; Summerfield et al., 
2005; Weintraub et al., 2011), however blood flow changes have been demonstrated in earlier, 
non-demented PD patients (Fernandez-Seara et al., 2012; Melzer et al., 2011). QSM (briefly 
summarised on page 72 of introduction) has been used to detect very early nigrosome 1 
changes in PD and is a potential development in an imaging-based diagnosis of PD ( Kim et 
al., 2018). There is therefore a need for multiple measures to capture these pathologies. Each 
subsequent chapter deals with a different imaging technique. Information detailing each 
imaging technique is discussed within each chapter. The sections below contain a critical 
analysis of the advantages and disadvantages of each scan type: 
2.2.1 Structural	MRI	
Structural MRI gives the advantage of high spatial resolution, providing an excellent picture 
of structure and tissue type within the brain. As previously discussed, structural MRI has the 
advantage over other types of 3D brain imaging, such as CT, in that it provides high contrast 
between fat-containing structures such as white matter over grey matter. MRI also does not 
use ionising radiation (e.g. X-ray, SPECT and PET imaging), which is harmful with 
prolonged or repeated exposure. A disadvantage of structural scanning is that it does not give 
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any temporal information or information regarding neural processes during task activity. 
However, structural imaging is necessary to provide the structural information for scan 
preprocessing for other MRI modalities, such as functional MRI. The use of structural MRI is 




ASL has the advantage of being a non-invasive method to measure bloodflow within the 
brain, as opposed to PET. This scan type was chosen as this offers significant advantages in 
convenience and safety for patients, who are able to be scanned and re-scanned using the ASL 
technique in a standard MRI machine, without the need to order radioactively-tagged 
compounds from a cyclotron, of which there are very few operating in New Zealand. In 
additional, local expertise in the use of ASL was available. Comparison of saccade 
performance to ASL data is novel, both in PD and the general population. The use of ASL 
would satisfy the aim of providing new insights into eye movement control of these two 
populations. The advantages of ASL have been previously covered in section 1.4.1.4 on page 
57 in the introduction chapter. For example, ASL provides a non-invasive means of 
determining a functional measure, perfusion. However, this can also be a disadvantage, as a 
recent review identified 58 potential non-pharmacological perfusion modifiers, including a 
number of modifiers with large impact (caffeine, aging, blood gases, and drowsiness) on 
perfusion values (Clement et al., 2018) . Another disadvantage of ASL is the relatively low 
resolution (voxels used are roughly 4 × 4 × 4 mm ), compared to other MRI types. Another 
disadvantage is the relatively long repetition time between individual volumes, giving poor 
temporal resolution. This limits the use of ASL as a functional scan during live task 
performance, however long duration or slowly changing tasks (e.g. sleep) may still be 
investigated using functional ASL. For this reason, ASL was not used for functional imaging 
in my studies and instead was employed to determine blood flow in resting state only. For 




DTI detects white matter tract change and this sequence is conveniently able to be completed 
in the same MRI scanner used for other experiments in this thesis. As with ASL, the 
investigation of DTI in eye movements is novel for PD. DTI has revealed pathological 
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diffusion metric changes (decreased FA) in the substantia nigra in PD, as well as similar, 
albeit less consistent findings in other subcortical nuclei (summarised in section 1.4.3.2 in the 
introduction chapter regarding DTI in PD). For these reasons, DTI scans were used in my 
study to test if diffusion changes within the brain could relate to eye movement performance 
deficits in PD and also in the general population.  
 
The use of DTI is limited in my thesis, with only one chapter (Chapter 3) containing a DTI 
study. This study is intended to be an initial comparison of MRI modalities to eye movement 
performance and thus a simple whole brain voxel-based method was used. More advanced 
DTI techniques can be used to map out fibre tracts through the brain using a process called 
probabilistic tractography. This however comes with its own complexities and was hence not 
used in my study. DTI resolution is low and is sensitive to normalization, with individual 
fibre tracts running very closely together. There is significant individual variability which 
needs to be accounted for when running tractography analyses.  In addition, the DTI 
acquisition we used is now relatively old. At the time, it was a simple and robust sequence to 
estimate DTI metrics in the brain, however, with the evolution of both acquisition and 
modelling techniques, there are many more options available that attempt to overcome 
limitations of the DTI model. For example, HARDI acquisitions and associated models 
(constrained spherical deconvolution and diffusion kurtosis imaging) now allow more 
accurate treatment of multidirectional, crossing fibres by allowing detection of diffusion in 
multiple directions and by using more sophisticated models of water diffusion (Tournier et al., 
2008; Tuch et al., 2002). These techniques have been suggested for future studies, particularly 
in conjunction with findings from other imaging modalities such as fMRI. 
 
2.2.4 Functional	MRI	
fMRI is used extensively in this thesis. The fMRI technique employed in this study is a 
widely-used and validated method of investigating brain activity during task performance by 
contrasting BOLD activity between a baseline state (fixation) and task activity (saccade 
tasks). fMRI offers the advantage of providing temporal information but is restricted in the 
amount of spatial resolution it provides compared to structural MRI. Compared to PET, fMRI 
offers faster detection time (seconds compared to tens of second in PET) and generates 
images which can be overlayed on the high resolution structural images. The timing of BOLD 
fMRI detection also allows a timecourse of BOLD activity changes to be generated in an 
event-related fMRI design. fMRI is also non-invasive compared to PET, and is able to be 
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carried out in the same MRI scanner as the other imaging modalities and repeated safely. For 
these reasons, I chose to use fMRI to investigate functional activity during saccades for my 
thesis. 
 
A disadvantage of fMRI compared to PET is that the detected BOLD response itself tells us 
very little about the components which make up the BOLD signal, which is affected by a 
combination of cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2) and 
cerebral blood volume (CBV). This has been previously discussed in depth, along with known 
issues in correlating the BOLD signal to neural activity in the introductory chapter section 
1.4.1.6 page 58 - 59. This is opposed to PET, which, using directly tagged compounds, can 
directly measure the uptake of glucose and oxygen. ASL can also directly quantify bloodflow, 
which fMRI is unable to. These disadvantages can be minimised using information from a 
combination of each MRI modality. In addition, BOLD fMRI volumes acquired with an echo 
planar imaging sequence are particularly susceptible to geometric distortion as a consequence 
of the image acquisition (Poustchi-Amin et al. 2001). There are methods to minimize the 
impact of these distortions, but such extreme distortions are not generally present in 
functional PET data. This thesis contains studies using structural, ASL, DTI and fMRI 
allowing possible cross-comparison, should similar regions are found to be affected across 
multiple modalities. A further issue when using fMRI, though common to all functional 
imaging, is the need for patients to remain still for scanning during task performance. This 
was minimised by using a head brace and foam. This requirement for minimal movement did 
mean that I was limited to testing relatively mildly-impaired PD patients (noted in discussion 
section 6.5.1 page 257). 
2.3 Other	techniques	
2.3.1 PET	
PET can also be used for functional imaging of the brain. This was not employed in this study 
as it would involve a separate scan in addition to the MRI, which would be difficult given 
resources (PET is approximately twice as expensive as an MRI session in New Zealand) and 
time constraints.  In addition, PET has an added invasive element - leading to possibly more 
difficult recruiting, and subjecting participants to an increased risk of complications from the 
scan. As mentioned previously, PET can directly measure the uptake of glucose and oxygen, 
which gives different information on the nature of the brain changes compared to MRI. 
Logistically, PET also requires the ordering of specialist radioactively tagged compounds 
from a cyclotron; currently radioactive tracers are sourced from either Wellington, New 
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Zealand, or Melbourne, Australia, making logistics more complicated. PET tasks need to be 
in long blocks of tens of seconds, as the tracer needs this time to reach and be utilised by the 
brain. This would make it more challenging to create an event related timecourse, as opposed 
to using fMRI. PET in general also gives comparatively poorer resolution without the ability 
to overlay findings on a high quality structural MRI image (unless a separate MRI session 
was completed) – only CT is currently available in Christchurch to provide concurrent 
structural imaging to PET.  An advantage is that the PET scanner is quieter, which may be a 
consideration should a planned experiment contain an auditory component, but this was not 
needed for my studies. For these reasons, fMRI was chosen over PET for the functional tasks 
of my thesis. 
2.3.2 MEG/EEG	
Other functional brain analysis techniques include EEG and MEG (Babiloni et al., 2009). 
EEG detects neural activity measured directly on the scalp. MEG detects the same activity 
from the electromagnetic signal generated by neural activity just inside the scalp.  The 
advantage of EEG and MEG are that they have no haemodynamic response lag as opposed to 
the BOLD signal detected by fMRI, providing superb temporal resolution, and potentially a 
more direct measure of neuronal activity. EEG is also relatively inexpensive. The 
disadvantage of EEG is poor spatial resolution, of several centimetres, with neural signals 
having to go through multiple layers of tissue and the skull to be detected, compared to the 
millimetre resolution of fMRI. EEG is also unable to detect activity within deeper brain 
structures such as the basal ganglia. MEG is more able to detect activity within the sulci and 
offers slightly better resolution. MEG however requires an extremely specialised scanner, 
costing several millions, to be able to detect the miniscule magnetic fields generated by the 
neurons in the brain and is not currently available in New Zealand. It is possible, although 
technically challenging, to combine fMRI and EEG, using the strengths of each technique to 
provide both improved spatial and temporal resolution (Huster et al., 2012). This may be an 
option for future studies to consider by building from the results of this thesis, investigating 
specific regions of interest. 
 
2.4 Magnetic	resonance	imaging	protocol	
All MR images were obtained from a 3.0 Tesla General Electric HDx scanner (GE 
Healthcare, Milwaukee, WI, USA) with an eight-channel head coil. 
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Structural images used a 3D T1 weighted spoiled gradient recalled echo acquisition or SPGR. 
Repetition time (TR) = 6.6 s, echo time (TE) = 2.8 s, inversion time (TI) = 400 ms, flip angle 
= 15 deg, FOV = 250 mm, acquisition matrix = 256 × 256 × 170, slice thickness = 1 mm, 
voxel size 0.98 × 0.98 × 1.0 mm³), bandwidth = 32 kHz, scan time = 5 min 3 s. 
ASL scans were obtained using a stacked spiral, fast spin echo acquisition with pseudo-
continuous ASL and background suppression: TR = 6 s, echo spacing 9.2 ms, post-labelling 
delay = 1.5 s, labelling duration 1.5 s, 8 interleaved spiral arms with 512 samples at 62.5 kHz 
bandwidth and 30 phase coded 5 mm thick slices, NEX = 5, voxel size = 3.75 × 3.75 × 5.0 
mm³, scan time 8 min 11 s. 
DTI scans were obtained using a 2D diffusion-weighted spin echo, echo planar imaging 
sequence, with diffusion weighting in 28 uniformly distributed directions ( b = 1000 s/mm²) 
and 4 acquisitions without diffusion weighting ( b = 0 s/mm²): TE/TR 84.4/13000 ms, flip 
angle = 90 deg, acquisition matrix = 128 × 128 × 48, reconstruction matrix = 256 × 256 × 48, 
FOC = 240 mm, slice thickness = 3 mm, reconstructed voxel size = 1.07 ×1.07 × 3 mm³, scan 
time = 7 min 9 s. 
fMRI scans took place over four separate runs, with the first run being the block design task 
(the subsequent three runs being memory-guided tasks, to be covered in Chapters 5 and 6). 
Each run followed the same scanning protocol, differing only in length: TR = 3000 ms, TE = 
35 ms, flip angle = 90 deg, FOV =220 mm, acquisition matrix = 64 × 64, 44 slices per 
volume, slice thickness = 3 mm, voxel size = 3.4 × 3.4 × 3mm³. Scan time = block/event 
durations (See Chapters 5 and 6). 
2.5 SPM8	
For MRI analysis, I used the program SPM8. SPM or statistical parametric mapping, is a 
MATLAB-based program widely used for imaging analysis, which allows a whole-brain 
voxel-based comparison of various MRI values to another measurement, such as eye 
movement performance. SPM also allows contrasting of an active task BOLD signal to a 
baseline signal to detect functional brain activity specific to task performance.  
 
This section focuses on detailing potential sources of error when using SPM. The use of SPM 
for preprocessing has been previously described in the introductory chapter (section 1.4.2.3 
page 64). The first preprocessing step in SPM is an attempt to minimise the effects of 
movement. Excessive head movement leads to errors and motion artefacts during recording. 
SPM applies motion correction through the use of a “rigid body” transformation applied to all 
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scans. In addition, motion parameters generated during MRI pre-processing were used in the 
statistical model for all first-level (individual) models as a way to attempt to account for gross 
motion. Head movement was monitored during live scanning. Scans showing significant 
movement were repeated. The head was semi-immobilised in our study, using foam padding 
within a plastic head brace.  
 
Segmentation is a preprocessing step in which the types of brain tissue - white matter, grey 
matter and CSF are divided and analysed separately. This is an automated process and the 
potential for error exists (Despotović et al., 2015). SPM employs a unified segmentation 
algorithm and a tissue probability template (Ashburner & Friston, 2003). This technique has 
been continually refined in later versions, with recalculated tissue probability maps and more 
refined algorithms. To minimize error, it is recommended to use the latest software version 
(Ashburner et al., 2013; Kazemi & Noorizadeh, 2014) - which was SPM8 at the time of my 
studies. 
 
Normalization or the warping of an individual scan to a standardised brain template presents 
as another opportunity for error within the preprocessing steps in SPM. The normalization 
process is an automated process of spatial transformation, where the differing brains of all 
participants are stretched and warped to fit a standardised template (Ashburner et al., 2013). 
To assist the normalization process, it is important to ensure the images are aligned as much 
as possible prior to the normalization process. For this, the co-registration step is employed 
(Ashburner et al., 2013). This ensures the 0 0 0 co-ordinate (placed at the anterior 
commissure) is placed in the same location for all scans prior to the normalization process. 
Visual inspection after this process is important, to ensure the co-registration process has 
correctly occurred for all scan types. To minimize error, it is again recommended to use the 
up-to-date software. The later SPM versions allow the use of further improved normalization 
techniques - a newer method has been developed named “Diffeomorphic Anatomical 
Registration Through Exponentiated Lie Algebra”, or DARTEL (Ashburner, 2007). DARTEL 
uses an updated non-linear warping algorithm, giving improved localisation and registration 
between individuals of different brain shapes, compared to the warping algorithm used by 
SPM8 by default (Ashburner & Friston, 1999). This requires the use of an additional toolbox 
package for SPM8 and was not employed in this thesis. Shoot is an even newer toolbox made 
for SPM12 and is considered a further improvement over DARTEL (Ashburner & Friston, 
2011). The Shoot toolbox is intended to supersede DARTEL in the near future (The FIL 
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Methods Group, 2013). Future studies will undoubtedly make use of these ongoing 
improvements to further minimise error. 
 
Another source of error in the normalisation process is encountered with abnormal brain 
pathology. The automated image matching process used in normalization can mismatch 
abnormal or absent structures to the template, leading to decreased sensitivity or the 
attribution of false positives to lesion-containing regions (Crinion et al., 2007). Scans were 
inspected by a specialist radiologist and any scans with significant pathology were excluded 
from the study. Another effect important to account for is the effect of aging on the brain. 
Brain atrophy is a commonly seen in the elderly population. Should the template brain not 
closely match the expected age-related changes of participant brains, normalization errors 
may occur. An elderly person template was used in my experiment to minimize potential age-
related mismatches compared to using a template constructed from a younger population 
(Lemaître et al., 2005). 
 
Despite our best efforts in terms of realignment, segmentation and normalization, there could 
still be some residual misalignment or real individual anatomical differences still present. In 
order to meet assumptions for the random field theory, and as an attempt to account for any 
residual misalignment, smoothing was used as part of the preprocessing steps (See 
preprocessing 1.4.2.3) (Ashburner & Friston, 2000). As previously covered, smoothing is also 
used to suppress noise and increase signal to noise ratio as well as accounting for residual 
variability. Smoothing is done through a convolution of voxel values with the averages of its 
surrounding voxels using a gaussian kernel, specified as a full width at half maximum 
(FWHM) value. This value is specified by the experimenter. The choice of the FWMH value 
needs to be carefully considered, as selecting a too-small or too-large value can lead to errors. 
Investigations have found  that a FWHM value that is too high gives an overestimation of the 
spatial extent of the activations, i.e. clusters appear larger, and as noted, too small a value 
gives poor ability to suppress noise and individual variability (Liu et al., 2017; Mikl et al., 
2008). Mikl et al. (2008)  had suggested approximately 8 mm as a good optimum for fMRI 
and reiterated the importance of testing for multiple comparisons. 
2.6 Principal	component	analysis	
Principal component analysis (PCA) is a type of analysis used to determine patterns or 
“components” which make up complex datasets which may not be immediately visually 
obvious. This can be used for example to determine patters within BOLD activity during task 
89 
 
performance, giving further insight into the functions of each region (Sugiura et al., 2004). 
This analysis technique is only used in Chapter 6 so a detailed discussion of this technique is 











PD has been classically described as a disease involving the basal ganglia, but widespread 
cortical abnormalities are also evident, particularly in later stages of the disease (Braak et al., 
2003). Neuroprotective therapies are the subject of ongoing clinical trials and a reliable and 
objective marker of PD progression is needed for the development and implementation of 
these future treatments. Aside from clinical rating scales such as the MDS-UPDRS, there is 
currently no accepted objective measure of PD progression or biomarker. Eye movements 
form one potential avenue for the development of PD biomarkers. Saccadic eye movement 
control is modulated by a number of cortical regions known as eye fields (Müri & Nyffeler, 
2008; Pierrot-Deseilligny et al., 2003; Pierrot-Deseilligny et al., 2004), which show 
connections to much of the same basal ganglia circuit known to be impaired in PD (Hikosaka 
et al., 2000). Characteristic eye movement abnormalities have been found to be related to 
motor severity and cognitive impairment in PD (MacAskill et al., 2012). Using fMRI, frontal 
lobe hypoactivity with parietal lobe hyperactivity has been reported in the self-paced saccade 
task (Rieger et al., 2008) and during pro and antisaccade tasks (Lemos et al., 2016) in PD. 
Saccadic eye movement impairments such as hypometria and antisaccade errors were 
associated with decreases in functional resting-state connectivity within the default mode 
network in PD compared to controls (Gorges et al., 2013, 2016). To date, no study has 
compared structural, ASL and DTI scans to saccadic eye movement performance in PD using 
a voxel-based analysis. 
The use of MRI modalities such as structural MRI, perfusion MRI and DTI may reveal 
abnormalities not able to be detected with functional MRI, therefore, complementing 
functional imaging findings. As opposed to functional MRI, structural imaging provides 
excellent information about the anatomy of the brain. Structural MRI provides a much higher 
spatial resolution, allowing detection of small anatomical changes. The BOLD signal detected 
in fMRI is influenced by a combination of cerebral blood flow (CBF), cerebral metabolic rate 
of oxygen (CMRO2) and cerebral blood volume (CBV) (Buxton, 2013; Ekstrom, 2010). It is 
not possible to tell, from measured BOLD signal alone, which parameter is responsible for 
driving BOLD signal change. Perfusion MRI is able to measure absolute blood flow values 
which can aid fMRI interpretation, as well as providing information on perfusion value 
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changes in PD directly. DTI can detect microstructural cellular damage, which may, in turn, 
contribute to the task-related or connectivity fMRI abnormalities seen in the prior studies in 
the literature. 
3.1.1 Voxel-based	analysis	of	eye	movement	performance		
A number of MRI analysis methods can be used to investigate changes in the brain. A voxel-
based analysis (VBA) is one such technique which performs a statistical test at every voxel in 
the brain (or within a large selected masked population, such as the grey or white matter or 
cortex). This is opposed to a region of interest (ROI) analysis, where selected voxels in 
specific regions are compared. VBA is able to compare voxels within the whole brain despite 
different brain sizes/shapes/orientations using unified segmentation and spatial normalization, 
where every participant’s brain image is spatially warped into standardised stereotactic space 
(Ashburner & Friston, 2000). The advantage of the VBA technique is that it requires no a 
priori hypotheses or assumptions on regions involved with a particular measure, whereas 
manually identifying regions of interest can lead to subjectivity and bias. A disadvantage is 
the number of voxel calculations being performed at a whole-brain level, leading to the 
multiple corrections problem, where a large number of voxels are bound to be found as false 
positives. Correction for multiple comparisons needs to be applied, although should a too 
stringent correction threshold be used, actual difference may not survive. 
3.1.2 Summary	of	eye	movement	findings	in	PD	
I have previously discussed eye movement findings in the introduction (see Introduction 
chapter page 49). To summarise, the most widely reported finding in saccadic eye movements 
is hypometria, or undershooting, of saccades. This is particularly evident in voluntary 
saccades, however, reflexive saccades show a similar undershoot, which correlates mainly 
with motor impairment. Reaction times for reflexive saccades are impaired in later disease 
stages and increase with cognitive decline (MacAskill et al., 2012). PD patients also make fast 
express saccades more often and have difficulty inhibiting unintended reflexive saccades 
when instructed not to in voluntary tasks (Chan et al., 2005). An undershooting initial saccade 
with a number of corrective step-like saccades is typically seen in memory-guided saccades in 
PD. Reaction time is slower in antisaccade tasks and more error prosaccades are made by PD 





As discussed in the introduction, reports of structural disease-related change in PD are 
variable, with individual differences such as disease duration or clinical subtype (i.e. tremor 
dominant vs impaired postural gait subtype) thought to contribute to cortical structural 
differences (Benninger et al., 2009; Rosenberg-Katz et al., 2013). One consistent finding is 
cortical atrophy/thinning in the presence of cognitive impairment and dementia. A number of 
studies have consistently reported temporal, frontal and parietal, along with limbic and 
paralimbic atrophy in PD with dementia (Burton et al., 2004; Melzer et al., 2012; Nagano-
Saito et al., 2005; Ramirez-Ruiz et al., 2005; Sanchez-Castaneda et al., 2009; Summerfield et 
al., 2005; Weintraub et al., 2011). Cortical thickness has been found to be reduced in frontal, 
parietal, temporal and occipital lobes in PD with cognitive impairment (Hwang et al., 2013; 
Pagonabarraga et al., 2013; Pereira et al., 2014). In PD patients with mild cognitive 
impairment (MCI), cortical atrophy was seen in the temporal, parietal and frontal cortices, in a 
less extensive pattern compared to PD-dementia patients, (Beyer et al., 2007; Melzer et al., 
2012). While patients with cognitive impairments (either MCI or dementia) show consistent 
atrophy, the evidence for cortical changes in non-dementia PD patients is inconsistent. 
Atrophy in non-dementia PD patients has been reported in the prefrontal and frontal lobe 
(Brück et al., 2004; Burton et al., 2004), temporal lobe (Beyer et al., 2007; Joana Braga 
Pereira et al., 2012; Summerfield et al., 2005), parietal and occipital lobe (Nishio et al., 2010). 
Other studies have reported no cortical volume changes in non-dementia PD patients, possibly 
due to non-dementia classification criteria varying between studies (Ellfolk et al., 2013; 
Melzer et al., 2012; Weintraub et al., 2011). 
Eye movements have been shown to correlate with aspects of disease state and cognition in 
PD (MacAskill et al., 2012; Terao et al., 2011). Eye movements, therefore, may be a 
reflection of general disease and cognitive state In this study, I compare eye movement task 
performance to structural imaging in PD to investigate the cortical changes related to eye 
movement deficits in PD. This will add to our understanding of the sources of saccadic eye 
movement performance deficits in PD, with the overall aim of assessing and validating the 
relationship between eye movements and brain health 
3.1.3.2 ASL	in	PD	
As mentioned in the introduction (page 74), ASL studies have described extensive perfusion 
changes in PD and support the idea that ASL changes correlate with disease severity and 
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cognition. A PD-related perfusion pattern has been identified, describing hypoperfusion of the 
parieto-occipital cortex, precuneus/cuneus and middle frontal gyri (Melzer et al., 2011). This 
pattern was found to correlate with scores of cognitive impairment and PD motor impairment. 
PD-related perfusion deficits are also seen early in the disease, with hypoperfusion seen in 
frontal, parietal and occipital cortices along with the caudate nucleus in non-demented PD 
patients (Fernandez-Seara et al., 2012).  
Using manually-defined ROI around the caudate nucleus, ASL perfusion differences between 
opposite sides of the caudate nucleus were seen to be associated with PD disease status as 
measured by the Hoehn and Yahr scale (Yamashita et al., 2017). A dual analysis of ASL and 
cortical atrophy in PD showed a pattern of hypoperfusion in the precuneus and thinning of the 
parietal cortex in PD. There was, however, preserved blood flow and cortical thickness in the 
cingulate and frontal lobe. This pattern was found to correlate with motor symptoms in PD 
(Madhyastha et al., 2015).  
Saccadic eye movement measures have been found to reflect elements of motor or cognitive 
impairment. In a number of studies, ASL changes have been related to motor symptoms and 
cognitive impairment. I suggest that ASL changes may relate to saccadic eye movement 
measures. In this chapter, I compared ASL perfusion values to eye movement performance in 
a voxel-wide approach in grey matter regions. This may provide insight into the relationship 
between functional blood flow deficits and their effects on eye movement performance 
abnormalities and disease severity. 
3.1.3.3 DTI	in	PD	
DTI has not been used to compare to eye movement performance, but has been compared to 
other metrics such as cognition and clinical severity scores. FA and MD values of the 
substantia nigra have been shown to correlate with disease severity as measured by the H&Y 
and UPDRS in some studies (Chan et al., 2007; Scherfler et al., 2013; Zhan et al., 2012), but 
not all (Du et al., 2011). Zhang et al., (2016) found the DTI properties (FA, along with radial 
and axial diffusivity) of the nigrostriatal tract to be abnormal in PD and to correspond with 
motor deficits assessed using UPDRS-III.  
DTI studies of cortical regions have found changes in the temporal lobe and cingulate cortex, 
which show decreased FA and increased MD in PD (Deng et al., 2013; Price et al., 2016; 
Zhan et al., 2012). These changes may be related to cognitive decline (Auning et al., 2014; 
Kamagata et al., 2012; Rae et al., 2012), however, frontal lobe and anterior cingulate FA 
changes have been found in non-demented PD patients in other studies (Kamagata et al., 
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2013; Karagulle et al., 2008). These inconsistencies may be attributable to the differences in 
populations investigated. For example, the inclusion of MCI patients within a non-dementia 
group may make it more likely to show abnormal DTI metrics, while samples comprising 
mostly PD with normal cognition, may show less severe DTI differences, or none at all. 
Furthermore, differing criteria for classifying mild cognitive impairment may contribute to the 
differences in findings (Melzer et al., 2013).  
Extensive white matter changes appear to be associated with cognitive impairment in PD, 
with DTI measures of the corpus callosum (and the adjoining region of the anterior cingulate) 
in particular having been noted to correlate with cognitive state (Deng et al., 2013; Kamagata, 
Motoi, et al., 2013). Widespread changes in MD value throughout white matter fibre tracts 
have been found in even mild cognitive impairment in PD patients (Melzer et al., 2013). 
Using an ROI analysis of over 40 fibre tracts, both FA and MD values of numerous tracts 
showed correlation with cognitive measures, such as attention and executive/visual function 
(Zheng et al., 2014). Interestingly, a number of tracts such as the corticospinal tract and 
thalamus-motor cortex tract have been found to show an FA increase. This may represent 
some compensatory reorganisation of certain white matter tracts in PD or preferential loss of a 
single fibre population in an area of crossing fibres (Mole et al., 2016).  
Following the Braak hypothesis (Braak et al., 2003), smell is noted to be significantly affected 
in PD, and changes in olfactory regions (and oddly the cerebellum) have been found using 
DTI, relating to olfactory dysfunction (Ibarretxe-Bilbao et al., 2010; Rolheiser et al., 2011; 
Scherfler et al., 2013; Zhang et al., 2011). Zhang et al. (2011) were one of the few studies to 
use a whole-brain voxel-wise approach to determine a correlation between a score (olfactory 
detection and discrimination scores) and DTI value. Other studies use tract-based analyses 
(Ibarretxe-Bilbao et al., 2010) or DTI values from ROIs (Scherfler et al., 2013). While it is 
possible the cerebellum may indirectly influence olfactory function through an as-yet-
unknown mechanism, the study by Zhang and colleagues may highlight an issue with doing a 
whole-brain analysis, being the multiple comparisons problem. While Zhang et al. corrected 
for multiple comparisons (using a calculated random distribution of cluster size for p < 0.001 
using Monte Carlo simulation), a possibility exists, due to the sheer number of statistical tests 
performed at a whole-brain voxel-level, that a portion of the results may be false positives, 
particularly for small unilateral effects as reported in the study, with no known neurological 
mechanism to explain the correlation between altered DTI values of the cerebellum and 





Previous studies have used a voxel-based group comparison to determine grey matter changes 
with discrete cognitive impairment category in PD (Melzer et al., 2012). In studying the 
cognitively-impaired PD population, the definition of groups can cause differences in results, 
e.g. if MCI participants are not analysed as a separate group but are included in a general “PD 
non-dementia” group. This may cause the “non-dementia” group to show changes due to 
contributions largely driven by the MCI sub-group, which would not be evident if the PD-
MCI were separated out. Another voxel-based analysis method exists without the need to 
categorise groups. This approach compares a covariate of interest to whole-brain voxel 
values. This is in effect a multiple regression, with the values at every voxel tested with a 
regressor or covariate of interest, for example, a continuous cognitive score or measure of eye 
movement performance. This allows an association to be established between voxel values 
and the covariate, with regions showing significant association able to be displayed on a map 
of the brain. An advantage of this method is there is no need to define and categorise separate 
groups based on regressor values, e.g. classifying unimpaired, MCI and dementia groups from 
cognitive scoring, eliminating the variability due to different methods of group categorisation. 
The patient group used in this study is from the same sample as in the study by Melzer et al. 
(2012). Previously, this group of patients was analysed using a group-based comparison. 
Here, using the same pool of PD patients, I investigated voxel-wise correlations of grey 
matter volume and cognitive scores using a continuous regressor of interest. For example, 
instead of using discrete categories such as PD-N, PD-MCI and PD-D, I used a continuous 
measure of cognition (global cognitive Z-score). I would expect to see similar regions to 
correlate between grey matter volume and cognitive impairment severity as those regions 
described as varying between cognitive groups in a voxel-based group comparison by Melzer 
et al. (2012). 
But more importantly, this voxel-wise comparison will also be performed with eye movement 
measures. There is currently no established categorisation of patients for degree of saccadic 
eye movement impairment severity. Characteristic deficits are noted in PD, with reflexive 
latency and gain shown to relate to cognitive and motor components of PD. Studies using 
structural MRI have found correlations between cerebellar and frontal lobe grey matter 
volume with pro and antisaccade performance in healthy controls (Ettinger et al., 2005). No 
study has yet used eye movement performance measures to correlate with grey 
matter/ASL/DTI measures in PD. Using this VBA technique, we can compare the association 
between multiple MRI measures (grey matter volume, ASL, and DTI) and measures of eye 
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movement performance. This will assess if eye movement measures directly reflect cortical 
change as detected by MRI. 
3.1.4 Aims	of	study	
This initial study allows us to test the idea that eye movement performance reflects brain 
health in PD which may be detected using various MRI modalities. My hypothesis is that 
these eye movement performance changes in PD will also manifest as meaningful structural, 
fibre tract and perfusion changes, as assessed by structural, ASL and DTI modalities. I 
hypothesise these changes will be in regions known to be involved in eye movement control, 
namely the eye fields, showing less volume, reduced bloodflow and lower measures of intact 
white matter structure in PDs with impaired eye movement performance, compared to 
controls. 
Secondly, I aim to use each MRI modality to gain a better understanding of the types of 
changes which may be occurring in PD that are related to eye movement deficits. Each 
modality provides a different type of information regarding brain structure - structural scans 
give insight into atrophy, ASL into perfusion and DTI into white matter fibre tract integrity. 
My question is which of these changes that occur in PD relate to eye movement deficits. I 
hypothesise any could contribute, but it may be a combination. A stronger finding would be 
having concordant regions show changes across various modalities. This would indicate 
several changes have occurred in a given area resulting in eye movement deficits, and 
therefore could indicate a region of interest which could be targeted in future studies. Chapter 
3 is a cross-sectional study using voxel based morphometry. 
3.2 Methods	
3.2.1.1 Participants	
A convenience sample of 96 PD patients (68 male, 28 female) and 33 controls (22 male, 11 
female) were recruited for this study at the New Zealand Brain Institute matched for age and 
sex ratio. The average age of PD patients was 67 (range 46 to 84) with an average MDS-
UPDRS-III score of 41 (range 6 to 97), average global cognitive Z-score of -0.3 (range -2.7 to 
1.1) and average MoCA of 24 (range 10 to 30). The average age of controls was 69 (range 45 
to 83) with an average global cognitive Z-score of 0.5 (range -0.4 to 1.5) and average MoCA 




Cognitive and motor symptom testing are described in Chapter 2. To briefly summarise, all 
participants underwent a series of cognitive tests covering cognitive domains as part of the 
level II criteria for PD-MCI (Litvan et al., 2012). General cognitive testing was performed 
using the Montreal Cognitive Assesment (MoCA). The MDS UPDRS part III (motor 
component) was used to assess the majority of our participants, with a scaling factor applied 
to scores of earlier patients scored using the previous UPDRS system, to make scores 
comparable MDS-UPDRS III (Goetz et al., 2008). 
3.2.1.3 Eye	movements	
Eye movements were recorded using an infrared eye-tracking system as described in Chapter 
2 and were previously gathered as part of an ongoing longitudinal eye-movement trial. Four 
eye movement tasks were analysed in this study: the reflexive, predictive, memory-guided 
and antisaccade tasks. These represent a spectrum from reflexive saccades (saccadic eye 
movements made to new unanticipated targets that appear in the environment) to volitional 
saccades (deliberately-made saccades to a pre-determined location). 
The accuracy of the first saccade (primary gain) and reaction times (latency) were measured. 
Saccade gain was calculated as the ratio of the angular amplitude of the primary saccade to 
the angular amplitude of the target. Saccade latencies were defined as the time from stimulus 
occurrence until the onset of the corresponding saccade towards it.  
3.2.1.4 Reflexive	task	
The reflexive task was presented via a red square target that jumped horizontally in 5, 10, 15 
or 20 degree steps at an unpredictable, pseudorandom interval varying between 550 ms and 
1800 ms. Participants were instructed to look at and follow this stimulus as quickly and 
accurately as possible. This was presented in a block of 108 trials. Within these trials, variants 
of the reflexive task were present, namely, the step task, gap-reflexive task and the overlap-
reflexive task. The step task presents one stimulus immediately after another, with no delay 
in-between stimulus presentation. The gap reflexive task had a period in-between successive 
stimulus presentations, with a temporal “gap” of 200 ms, before the next stimulus appears. 
The overlap task had a period of 200 ms when the previous stimulus continued to be 
presented, along with the new stimulus, before the previous stimulus was extinguished. The 
gap and overlap variants were designed to investigate the effects of fixation disengagement on 
reflexive saccades which are not investigated in this current study. Consequently these 
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reflexive saccade variants were not included, with only the step reflexive trials used in this 
study. 
3.2.1.5 Predictive	task	
The predictive task used an alternating red square target, which jumped at a regular intertrial 
interval between two fixed positions at -10 to 10 degrees visual angle from the screen centre. 
Three durations of inter-trial interval were used: 750 ms, 1400 ms and 2050 ms in separate 
blocks. This study analysed only 750 ms trials. Longer predictive inter-trial intervals become 
more difficult to accurately predict and become closer to visually-guided reflexive saccades 
performance wise. Each inter-trial interval was presented as a block of 20 trials. Only 
predictive saccade trials employing 750 ms duration were used in this study. 
3.2.1.6 Memory-guided	task	
The memory-guided task began with an initial red square fixation stimulus. After two 
seconds, a peripheral “flash” was presented for 400 ms at 5, 10, 15, or 20 degrees left or right 
of center in the horizontal plane. Participants were instructed to maintain fixation during the 
flash appearance but to memorise the spatial location of the flash. At 2.5 seconds after the 
disappearance of the flash, the fixation stimulus was extinguished, with a simultaneous tone. 
This cued the participants to make a saccade to the remembered location of the flash. After 3 
seconds, the position of the target “flash” stimulus was re-illuminated and formed the fixation 
stimulus for the next trial. The first trial began with the fixation stimulus in the centre. The 
next trial begins from last stimulus location (the flash location of its preceding trial). A total 
of 2 runs of 17 trials each were used. A 10 trial practice block was used for task 
familiarisation before the actual trial commenced.  
3.2.1.7 Antisaccade	task	
The antisaccade trial began with a central green square fixation stimulus. After periods of 1.5 
s, 2.0 s or 2.5 s, the fixation stimulus was extinguished. Simultaneously, a red square 
peripheral stimulus appeared at 5, 10 or 15 degrees left or right of the fixation stimulus. 
Participants were instructed to make a saccade to the mirror opposite position of this 
peripheral stimulus as quickly as possible. The reappearance of the central fixation stimulus 
then commenced the next trial. Participants were instructed to correct erroneous antisaccades 
(reflexive saccades made to the red stimulus target, instead of in the mirror opposite location) 
as quickly as possible. As with the memory-guided task, a 10 trial practice block was used for 
task familiarisation before the actual experimental task commenced. Gain was measured from 
the initial central fixation to the mirror opposite of the stimulus, i.e. positive gain values were 
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in the correct direction, away from the visible target. Error antisaccades were excluded from 
the analysis. 
3.2.1.8 Error	exclusion	
Saccades performed less than 70 ms were classed as anticipatory saccades and were excluded 
from reflexive, memory-guided and antisaccade task analysis. To note, for the predictive task, 
saccades are often made in anticipation of the stimulus before the stimulus actually shifts, 
resulting in a negative latency. Hence, saccades with negative latency were not excluded from 
the analysis of the predictive task. Primary gain values of under 0.2 were excluded from 
analysis as these may represent small fixational movements, such as square wave jerks, which 
were not true target-related saccades. In the memory-guided task, trials with saccades which 
occurred during the fixation or “flash” period were considered error trials and were excluded 
from analysis. In the antisaccade task, saccades made to the peripheral stimulus, as opposed to 
the mirror opposite location, were classed as errors. Comparisons using eye movement 
measures were limited to primary gain and latency only. This study is a preliminary study 
using eye movement measures to compare to MRI measures in PD and I chose to only use 
these two primary measures of eye movement performance. Error saccade measurements i.e. 
error gain and latency were not used and all error saccades were excluded from analysis.  
3.2.1.9 MRI	acquisition	
MRI scans were acquired using a 3 Tesla General Electric MRI scanner. Structural, ASL and 
DTI scans were acquired using the protocol described in Chapter 2. 
3.2.1.10 	MRI	preprocessing	
Before analysis of MRI data can take place, the raw scans must be pre-processed. This is a 
series of steps needed to adjust the raw data from the MRI scanner into a workable 
standardised form, necessary for analysis. This process is done through the program SPM8 
(Wellcome Department of Cognitive Neurology, University College London, UK) – a 
MATLAB (7.10.0 R2010a, Mathworks, MA, USA) based toolbox specifically designed for the 
analysis of brain imaging data. Scans were converted to NIFTI format and reoriented using 
the anterior commissure as the 0,0,0 co-ordinate.  
Structural: The T1 image was segmented using unified segmentation and normalization, 
outlined in Ashburner & Friston (2000). This process segments the white matter, grey matter 
and CSF using a tissue probability map from an older person atlas (Lemaître et al., 2005). 
This was done in order to minimise possible bias associated with age. The segmentation 
process produced separate grey matter, white matter and CSF files, which were normalized (to 
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Montreal Neurological Institute (MNI) space) and modulated. Modulation preserves the actual 
volume of a given voxel by adjusting the signal proportional to the amount of warping. 
ASL: Quantified cerebral blood perfusion images (ASL) were coregistered to the T1 image, 
and normalized using the structurally-derived normalization parameters.  
DTI: Image processing employed both FSL 4.1.6 (www.fmrib.ox.ac.uk/fsl) and SPM8. 
Diffusion-weighted images were motion- and eddy current distortion-corrected. The diffusion 
tensor was then calculated at each voxel using DTIFIT, producing fractional anisotropy (FA) 
and mean diffusivity (MD) images, and then brain-extracted using BET. The b0 image (as 
well as the FA and MD) was then coregistered to the high resolution, T1-weighted SPGR 
image using mutual information in SPM8. Normalization parameters produced during unified 
segmentation of the T1-weighted image were applied to the FA and MD images to warp them 
into standard space and resliced to 1 mm3 isotropic. 
 All normalised images were then smoothed using a Gaussian kernel with a full width at half 
maximum (FWHM) value of 8 × 8 × 8 mm for structural and DTI images and 10 × 10 × 10 
mm for ASL images. 
3.2.1.11 MRI	statistical	analysis	
Statistical analyses of structural, ASL and DTI scans were performed using SPM8. A general 
linear model (GLM) was used to assess voxel-based associations between eye movement 
metrics (saccade latency and primary gain) and MRI metric (grey matter volume, perfusion, 
FA, and MD). Separate models were constructed to investigate each MRI metric with 1) 
latency and 2) primary gain. Patient age, sex, group (Control/PD) and intracranial volume 
(calculated as the summation of GM, WM, and CSF segments, included only in the T1 
comparisons) were entered as covariates in each model.  
Additional models were constructed to investigate cognitive Z-scores and MDS-UPDRS part 
III, with patient age, sex, group and intracranial volume as covariates (latency and primary 
gain were not included in these models). Every model was analysed for within-group and 
between-group differences. 
3.3 Results	
 In this chapter, results tables from all analysis carried out are provided in the tables below, 
listing the findings of every comparison. Only corrected values can be considered valid 
results, however, it can often be useful to visualise the uncorrected (p < 0.001 in this study) 
results of correlation in some cases. Corrections for multiple comparisons establish a 
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threshold which is considered significant at a family-wise error (FWE) of p < 0.05. This 
correction, in effect, shows only the voxels having the most significant correlation, which can 
be mentally visualised as a “tip of the iceberg”, arising from uncorrected voxels not visible 
below the significance threshold. The uncorrected results can often give insight into the 
overall pattern of any significant correlation, allowing us to determine if significant clusters 
arise from randomly distributed voxels, or from a symmetrical distribution, of which only one 
side remains above threshold to be seen once corrected. Uncorrected results are only shown 
for findings where significant voxels showed a bilateral appearance and located within 
functionally relevant regions. These are only provided for illustrative comparison with 
corrected results. Result images from all the analyses cannot be reasonably displayed in the 
results section. In this chapter, images are only shown of voxels which were significant across 
a number of correlations, within areas known to be involved in eye movement control, known 
to be affected in PD or which occurred in a bilateral pattern. Figures of all other detected 
significant results, such as those seen isolated to one single correlation analysis, or located in 
undefined regions (often subgyral, deep within the brain, outside of known BAs and of any 
defined cortical/subcortical structure), can be found in the Appendix. 
3.3.1 Grey	matter	volume	associations	with	eye	movement	measures	
Table 3-1 and Table 3-2 show regions having a significant association between grey matter 
volume and eye movement performance measures. In addition, Figure 3-1 and Figure 3-2 
visually display voxels showing significant association as glass brain images in three planes. 
The significant areas refer to the presence of voxels which show correlation for that 
comparison which are significant after correction for multiple comparisons using family wise 





Table 3-1 – Grey matter (GM) volume association with saccade latency. Dash ( - ) indicates no significant 
regions showing correlation seen. 
 GM volume and 
reflexive latency 
GM volume and 
predictive latency 
GM volume and 
memory-guided 
latency 
GM volume and 
antisaccade 
latency 
Positive association - 
PD group - - - - 
Positive association - 





Negative association - 
PD group - - - - 
Negative association - 
Control group - - 
Left temporal pole  
(Figure 3-1 A) - 
PD group association 
more positive than 
control group 
- - 
Left temporal pole 
(Figure 3-1 B) - 
Control group 
association more 







Table 3-2 – Grey matter (GM) volume association with saccade primary gain. Dash ( - ) indicates no 





GM volume and 
predictive 
primary gain 
GM volume and 
memory-guided 
primary gain 
GM volume and 
antisaccade 
primary gain 
Positive association - 
PD group - - - - 
Positive association - 
Control group - - - 
Left temporal pole  
(Figure 3-2 A) 
Negative association - 
PD group - - - - 
Negative association - 
Control group - - - - 
PD group association 
more positive than 
control group 
- - - - 
Control group 
association more 
positive than PD group 
- - - 
Left Brodmann 






Figure 3-1 (A) shows voxels with a negative association (i.e. decreased volume with 
increasing saccade latency) for the memory-guided task in the control group. Those voxels 
were clustered in the left temporal pole, significant at FWE p < 0.05. The same analysis 
within the PD group showed no significant voxels.  
 
Figure 3-1 (B) shows voxels with significantly more negative association (i.e. decreased 
volume with increasing saccade latency) in the control group compared to PD for the 
memory-guided task. A cluster in the same region in the left temporal pole showed a 
significantly more negative grey matter volume association with increasing memory-guided 





Figure 3-1 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 






Voxels showing decreases in grey matter 
volume relative to increasing memory-
guided saccade latency in controls - 
within-group analysis 
Voxels showing decreases in grey matter 
volume relative to increasing memory-
guided latency that were greater in controls 








Figure 3-2 (A) shows voxels with significant positive grey matter volume association with 
increasing antisaccade gain (i.e. increased volume with increasing antisaccade gain) in the 
control group. Again, the left temporal pole is significant. Within-group PD correlation 
showed no significant voxels and a between-group comparison did not show significant group 
correlation differences in the temporal lobe pole.  
 
Figure 3-2 (B) shows voxels which have a more positive association (i.e. increasing grey 
matter volume with increasing antisaccade gain) in the control group compared to the PD 
group. An alternative interpretation is that the images show voxels in the PD group showing a 
more negative association (decreased grey matter volume associated with increasing 
antisaccade gain) compared to the control group. An extremely small cluster in Brodmann 
area (BA) 6 was significant. In within-group analyses, no voxels in BA6 were seen to 




Figure 3-2 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 




Voxels showing increases in grey matter 
volume with increasing antisaccade gain 
in controls – within-group analysis 
 
Voxels showing increases in grey matter 
volume with increasing antisaccade gain 
seen greater in controls compared to PD – 
between-group analysis 
 








Table 3-3 and Table 3-4 show regions having a significant association between ASL perfusion 
values and saccadic eye movement performance measures. In addition, Figure 3-3 and Figure 
3-4 visually display voxels showing significant association as glass brain images in three 
planes. 














Positive association - PD 
group - - - - 
Positive association - 
Control group - - - - 
Negative association - 
PD group - - 
Precuneus (Figure 
3-3 A) - 
Negative association - 
Control group - - - - 
PD group association 
more positive than 
control group 
- - - - 
Control group 
association more 
positive than PD group 
- - - - 
 















Positive association - 





Positive association - 
Control group - - - - 
Negative association - 
PD group - - - - 
Negative association - 
Control group - - - - 
PD group association 
more positive than 
control group 
- - - - 
Control group 
association more 
positive than PD group 




Figure 3-3 (A) shows voxels which have a negative association of perfusion with memory-
guided saccade latency in the PD group (i.e. decreasing perfusion associated with increasing 
memory-guided saccade latency). Once corrected for multiple comparisons, a cluster in the 
precuneus remained significant. In contrast, within-group correlation in controls showed no 
significant voxels and a between-group comparison did not show significant group-level 
correlation differences between PD and controls in the precuneus. 
Figure 3-3 (B) shows voxels with positive associations of perfusion value with antisaccade 
gain (i.e. increasing perfusion associated with increasing antisaccade gain) in the PD group. 
Once corrected for multiple comparisons, a cluster in the precuneus remained significant. In 
contrast, within-group correlation in controls showed no significant voxels and a between-
group comparison did not show significant group-level correlation differences between PD 
and controls in the precuneus. 
 
 
Figure 3-3 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 
for the described saccade task and group. 
  
Voxels showing decreases in ASL perfusion 
with increasing memory-guided latency in 
PDs - within-group analysis 
 
Voxels showing increases in ASL 
perfusion with increasing antisaccade 
gain in PDs – within-group analysis 
 
 
   Precuneus 
 
 






Figure 3-4 shows voxels where perfusion correlated positively with memory-guided saccade 
gain (i.e. increasing perfusion associated with increasing memory-guided saccade gain) for 
the PD group. Clusters in the caudate nucleus were seen bilaterally. No caudate voxel clusters 
were seen to be significantly correlating with memory-guided saccade gain within the control 
group and a between-group comparison did not show significant group correlation differences 
in the caudate nucleus. 
 
Voxels showing increases in ASL perfusion relative to increasing memory-guided saccade 
gain in PDs - within-group analysis 
 
 
Figure 3-4 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 


















Table 3-5 and Table 3-6 show regions having a significant association between FA values and 
eye movement performance measures. 
Table 3-5 – FA values association with saccade latency. 











Positive association - PD 
group - - - - 
Positive association - 
Control group - - - - 
Negative association - PD 
group - - - - 
Negative association - 
Control group - - - - 
PD group association more 
positive than control group - - 
Right BA 6 
(Figure 3-5) - 
Control group association 
more positive than PD group - - - - 
 
Table 3-6 – FA values association with saccade primary gain. 











Positive association - PD 
group - - - - 
Positive association - 
Control group - - - 
Right BA 8 
(Appendix Figure 
9-3) 
Negative association - PD 
group - - - - 
Negative association - 
Control group - - - - 
PD group association more 
positive than control group - - - - 
Control group association 
more positive than PD 
group 





Figure 3-5 shows voxels having a more positive association (i.e. increasing FA value with 
increasing antisaccade gain) in the PD group compared to the control group. This is 
equivalent to the alternative interpretation, that it shows voxels where the control group had a 
more negative association (decreased FA value associated with increasing memory-guided 
saccade latency) compared to the PD group. Once corrected for multiple comparisons, a 
cluster in BA6 remained significant. No within-group correlation between FA and memory-
guided latency in BA6 was seen for both PD and control groups. 
 
Voxels showing increases in FA value with increasing memory-guided saccade latency seen 
greater in PD compared to controls – between-group analysis 
 
Figure 3-5 – Voxels showing significantly more positive correlation (increasing FA value with increasing 
memory-guided saccade latency) in the PD compared to the control group – equivalent to voxels showing 
a more negative correlation (decreasing FA value correlated with increasing memory-guided saccade 
latency) in the control group compared to the PD group. An area in Brodmann area 6 is significant for 







Table 3-7 – MD values association with saccade latency. 

















Left middle frontal 
gyrus   





(Figure 3-10 B) 
Positive association - 
Control group - - 
Left temporal pole 
(Figure 3-6 A) - 
Negative association - 
PD group - - - - 
Negative association - 
Control group - - 
Precuneus 
 (Figure 3-8 A) - 
PD group association 




 (Figure 3-8 B) - 
Control group 
association more 
positive than PD 
group 
- - 
Left temporal pole 
(Figure 3-6 B) - 
 
Table 3-8 – DTI MD values association with saccade primary gain. 














(Appendix Figure 9-6) 
- - - 
Positive association - 
Control group 
 - - 
Left BA 6  
(Figure 3-9 B) 





- - - 
Nnegative association - 







3-7 A)  
PD group association 









3-7 B)  
Control group 
association more 
positive than PD 
group 
Left BA 17 (Appendix 
Figure 9-8) - - 







Table 3-7 and Table 3-8  show regions having a significant association between MD values 
and saccadic eye movement performance measures. Figure 3-6 to Figure 3-16 display voxels 
showing significant association as glass brain images in three planes 
Figure 3-6 (A) shows voxels having a positive association between MD value and memory-
guided saccade latency (i.e. increased MD value with increasing memory-guided saccade 
latency) in the control group. Once corrected for multiple comparisons, a cluster in the left 
temporal pole remained significant. Additionally, smaller clusters showing correlation are 
visible in the right superior temporal gyrus, right middle temporal gyrus and right superior 
frontal. The same analysis within the PD group showed correlation in the left insula, with no 
correlation in the left temporal pole (see Appendix Figure 9-5).  
Figure 3-6 (B) - shows a group comparison between PD and controls. This figure shows 
where thre was significantly more positive association (i.e. increased MD value with 
increasing memory-guided saccade latency) in the control group compared to the PD group. 
Once corrected for multiple comparisons, a cluster in the left temporal pole remained 
significant. Less prominent clusters showing the same correlation group difference are visible 




Figure 3-6 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 
for the described saccade task and group.   
Voxels showing increases in MD value 
with increasing memory-guided saccade 
latency in controls - within group 
analysis 
Voxels showing increases in MD value 
with increasing memory-guided saccade 
latency seen greater in controls compared 







Figure 3-7 (A) shows the voxels having a significant negative association between MD value 
and antisaccade gain (i.e. decreasing MD associated with increasing antisaccade gain) in the 
control group. Once corrected for multiple comparisons, a cluster in the left temporal pole 
remained significant. The same analysis within the PD group showed no significant clusters 
for this correlation. 
Figure 3-7 (B) shows a group comparison between PD and controls. These images show 
where there was a more negative association of MD value with antisaccade gain (i.e. 
decreased MD value with increasing antisaccade gain) in the control group compared to the 





Figure 3-7 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 
for the described saccade task and group. 
  
Voxels showing decreases in MD value with 
increasing antisaccade gain seen greater in 
controls compared to PD – between-group 
analysis 
Voxels showing decreases in MD value 
with increasing antisaccade gain in 











Figure 3-8 (A) shows voxels having a significant negative association between MD values 
and memory-guided saccade latency (i.e. decreasing MD with increasing memory-guided 
saccade latency) in the control group. Once corrected for multiple comparisons, a cluster in 
the precuneus remained significant. The same analysis within the PD group showed no 
significant voxels for this correlation. 
Figure 3-8 (B) shows a group comparison between PD and controls. These images show 
where there was a more negative association with memory-guided saccade latency (i.e. 
decreasing MD value with increasing memory-guided saccade latency) in the control group 
compared to the PD group. Once corrected for multiple comparisons, a cluster in the 




Figure 3-8 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 
for the described saccade task and group. 
  
Voxels showing decreases in MD value 
with increasing memory-guided saccade 
latency in controls – within group 
analysis 
Voxels showing decreases in MD value 
with increasing memory-guided saccade 
latency seen greater in controls compared 
to PD – group analysis 
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Figure 3-9 (A) shows voxels having a significant positive MD value correlation with 
predictive saccade latency (i.e. increasing MD with increasing predictive latency) for the PD 
group. Once corrected for multiple comparisons, a cluster in the left middle frontal gyrus 
remained significant. The same analysis within the control group showed no significant 
voxels for the same correlation and similarly, a between-group comparison did not show 
significant group-level correlation differences.  
Figure 3-9 (B) shows voxels having a positive association with antisaccade gain (i.e. 
increasing MD with increasing antisaccade gain) in the control group. Once corrected for 
multiple comparisons, a cluster in the left BA6 remained significant. The same analysis 




Figure 3-9 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 
for the described saccade task and group. 
  
Voxels showing increases in MD value 
with increasing predictive latency in PDs 
– within-group analysis 
Voxels showing increases in MD value 
with increasing antisaccade gain – 













Figure 3-10 (A) shows a group comparison between PD and controls. These images show 
voxels having a more positive association with antisaccade gain (i.e. increasing MD value 
associated with increasing antisaccade gain) in the control group compared to the PD group. 
Once corrected for multiple comparisons, a cluster in the left BA 6 remained significant. 
Figure 3-10 (B) shows voxels having a positive association with antisaccade latency (i.e. 
increasing MD with increasing antisaccade latency) in the PD group. Once corrected for 
multiple comparisons, a cluster in the anterior cingulate remained significant. The same 
analysis within the control group showed no significant clusters and a between-group 





Figure 3-10 – Significant voxels showing association, corrected for multiple comparisons (FWE p < 0.05) 
for the described saccade task and group. 
  
Voxels showing increases in MD with 
increasing antisaccade latency - PD 
within group analysis 
Voxels showing increases in MD value 
with increasing antisaccade gain seen 














Figure 3-11 shows uncorrected (A) and corrected (B) voxels which have a negative 
association with predictive saccade gain (i.e. decreasing MD with increasing predictive 
saccade gain) in the control group. Uncorrected images are shown to illustrate the bilateral 
appearance with the more lenient threshold criteria. In the uncorrected images, bilateral 
cerebellum clusters show correlation between MD values and predictive gain. Once corrected 
for multiple comparisons, only the left cerebellum cluster remained significant. The same 
analysis within in the control group showed no significant voxels. A group comparison 
showed a significant difference in the cerebellum cluster correlation between PD and control 
groups (See Figure 3-12). 
 
Voxels showing decreases in MD value with increasing predictive saccade gain in controls 
– within-group analysis 
 
 
Figure 3-11 – Significant voxels showing a negative association (decreasing MD value with increasing 
predictive saccade gain) in the control group. Left set of images (A) show a glass brain representative of 
uncorrected voxel of correlation with right set of images (B) show voxels for the same correlation 
















Figure 3-12 shows uncorrected (left) and corrected (right) group comparisons between PD 
and controls. Uncorrected images are again shown to illustrate the bilateral cluster appearance 
with the more lenient threshold criterion. These images show voxels having a more negative 
association with predictive saccade gain (i.e. decreased MD value associated with increasing 
predictive saccade gain) in the control group compared to the PD group. Once corrected for 
multiple comparisons, only a cluster in the left cerebellum remained significant. 
 
Voxels showing decreases in MD values with increasing predictive saccade gain seen 
greater in controls compared to PD – Between-group analysis 
 
 
Figure 3-12 – Voxels showing significantly more negative association (decreasing DTI MD value with 
increasing predictive saccade gain) in the control group compared to the PD group. Left set of images (A) 
show a glass brain with uncorrected voxels. Right images (B) show voxels for the same correlation 

















Table 3-9 and Figure 3-13 to Figure 3-15 display results of voxel-based analyses of cognitive 
Z-score correlation with imaging measures. Findings of correlation from undefined subgyral 
regions are provided in the Appendix.  








DTI FA and 
cognitive Z-score 
DTI MD and 
cognitive Z-score 
Positive association - 
PD group 
Left BA 6 and 
Right BA 44 
(Figure 3-13) 
Precuneus  
(Figure 3-14) - - 
Positive association - 
Control group - - - - 










Negative association - 
Control group - - - - 
PD group association 
more positive than 
control group 
- - - - 
Control group 
association more 
positive than PD 
group 





Figure 3-13 shows voxels which have a positive association with cognitive Z-score 
(increasing grey matter volume with increasing cognitive Z-score) in the PD group. Once 
corrected for multiple comparisons, clusters within the left BA 6 and right BA 44 remained 
significant. The same analysis in the control group showed no significant clusters. No group 
difference was found in a between-group comparison between PD and controls. 
 




Figure 3-13 – Significant voxels showing a positive association (increasing grey matter volume with 




area 6 and 44  
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Figure 3-14 shows voxels having a positive association with cognitive Z-score (i.e. increasing 
ASL perfusion with increasing cognitive Z-score) in the PD group. A cluster within the 
precuneus, along a much smaller cluster in BA 19, were seen to be significant. The same 
analysis in the control group showed no significant voxels. No group difference was found in 
a between-group comparison between PD and controls. 
 




Figure 3-14 – Significant voxels showing a positive association (increasing ASL perfusion correlated with 
increasing cognitive Z-score) in the PD group. Images corrected for multiple comparisons (FWE p < 0.05). 
  
Precuneus 
Brodmann area 19  
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Figure 3-15 shows voxels having a negative association with cognitive Z-score (i.e. 
decreasing MD values with increasing cognitive Z-score) in the PD group. Small, scattered 
clusters in the temporal and frontal lobe were seen to be significant. The same analysis in the 
control group showed no significant voxels. No group difference was found in a between-
group comparison between PD and controls. 
 




Figure 3-15 – Significant voxels of negative association (decreasing DTI MD values correlated with 
increasing cognitive Z-score) in the PD group. Images corrected for multiple comparisons (FWE p < 0.05). 








Brodmann areas 1, 




Table 3-10 shows the results of a voxel-based analysis of MDS-UPDRS part III with 
structural and ASL and DTI scanning data. Figures of voxels showing significant correlation 
in undefined subgyral regions are provided in the Appendix.  
 








UPDRS part III 
DTI FA and MDS-
UPDRS part III 
DTI MD and 
MDS-UPDRS part 
III 
Positive association - 
PD group - - - - 
Negative association - 







Aside from a single cluster in subgyral regions deep within the cortex, not within defined BAs 
or cortical/subcortical structures (see Appendix Figure 9-10), no voxels were seen to show 
correlation between imaging measures and MDS-UPDRS part III score. 
 
3.4 Discussion	
Significant correlation was seen between multiple MRI modalities and saccadic eye 
movement measures in both PD and controls. These regions included the left temporal pole, 
caudate nucleus, precuneus, anterior cingulate and cerebellum. Other smaller regions 
throughout the cortex and in subgyral regions (not within defined BAs or defined 
cortical/subcorical regions) were also seen to correlate in isolated, single analyses (see 
Appendix for results from all comparisons). What makes findings from the mentioned regions 
more likely indicative of true correlation are: 
• A bilateral appearance where relevant. 
• The repeated finding of correlation across multiple MRI scan types or comparisons.  
• Findings in regions known to be affected in PD or involved in eye movement control. 
• Associations in an expected direction e.g. lower perfusion correlating with poorer eye 




Conversely, individual regions showing correlation in a single result only, may raise 
suspicions that they result from the multiple comparisons problem. The voxel-based analysis 
technique used in this study carried out large numbers of statistical tests at an individual voxel 
level (see multiple comparisons problem in the Introduction chapter (page 68)). In addition, as 
previously mentioned, nearly 200 eye movement and imaging measure comparisons were 
carried out in total in this study. Despite our efforts to control this with correction for multiple 
comparisons, results must be carefully interpreted to avoid ascribing function to single small 
clusters, which are significant, but may be false positives. However, we must also look at the 
wider picture and look for consistent patterns across the multiple analyses.  
 
3.4.1 Left	temporal	lobe	pole	
The left temporal pole showed an association between memory-guided latency in both grey 
matter volume and MD for the control group but not in PD. Similarly, both grey matter and 
MD value correlation was seen with antisaccade gain within the control group but not in PD 
The left temporal pole is not classically considered an eye movement control region, but has 
been described to have an integrative function, with connectivity studies revealing left 
temporal pole connections to widespread cortical and subcortical regions, including regions 
involving working memory and executive functions, such as the DLPFC, parahippocampal 
cortex and hippocampus (Pascual et al., 2015). This may explain temporal pole volume and 
diffusion correlations with the saccade tasks that require some degree of executive function as 
in the memory-guided and antisaccade tasks. The results show only the control patients, not 
PD patients, having an association between temporal pole MRI values with eye movement 
performance. As the correlation found does not indicate impairment, rather only that an 
association exists between recorded MRI values and saccade performance in one group, 
which is significantly different from the other, we cannot directly infer that a particular group 
has temporal pole dysfunction from these results. However, this may be tested with a voxel-
based morphology (VBM) analysis, using the same participant sample in a future study. We 
can speculate, however, that from impairments in eye movement performance recorded in PD 
for both memory-guided and antisaccade tasks, that regions involved in these eye movement 
tasks may be impaired in PD. Supporting the idea of impaired temporal lobe function in PD 
are studies showing grey matter atrophy in the temporal lobe (Burton et al., 2004; Melzer et 
al., 2012; Nagano-Saito et al., 2005; Summerfield et al., 2005) and temporal lobe deficits in 
DTI in PD (Auning et al., 2014; Deng et al., 2013; Rae et al., 2012). Particularly relavent is 
the study by Melzer and colleagues, who showed large areas of temporal lobe atrophy in PD-
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dementia patients using a similar patient sample as this study. Should cortical degenerative or 
cortical reorganisation processes in PD lead to less temporal pole involvement in the memory 
and antisaccade tasks, this may show as a non-significant association between temporal pole 
MRI values and saccade measures compared to unaffected controls as seen in this study. It 
should be noted this region lies on the boundary of brain at the very tip of the temporal lobe. 
A potential possibility is that inaccuracies in segmentation may have some contribution to this 
finding (see sections 2.5 and also 3.4.9). The discussion above is speculative and I stress 
again that the temporal lobe pole currently is not known to contribute to saccade function. 
Furthermore, this finding is seen only unilaterally, whereas most saccade regions are bilateral. 
Despite left temporal lobe pole findings in multiple modalities, these issues do raise the 
possibility that left temporal pole findings are artefact driven. 
3.4.2 Precuneus	
ASL blood flow values to the precuneus were seen to negatively correlate with memory-
guided latency within the PD group, i.e. lower blood flow was associated with higher latency. 
This was not observed in the control group, and a between-group comparison showed no 
significant group difference. Higher ASL blood blow to the precuneus was also seen to 
correlate with increasing gain in the antisaccade task in the PD group. This correlation was 
again not observed in the control group with a between-group comparison showing no 
significant group difference. 
 
The precuneus is commonly activated in functional imaging and is thought to be integrated 
with a wide range of activities, including visuospatial processing and episodic memory recall 
(Cavanna & Trimble, 2006). The precuneus is also involved with a number of networks 
including the resting-state default-mode network and fronto-parietal attention network 
(Utevsky, Smith, & Huettel, 2014). Either directly or indirectly through network connections, 
the precuneus is likely to be involved in some form with memory-guided saccades and 
antisaccades, with both tasks containing visuospatial processing and attention elements. 
Memory-guided saccades in PD will be examined in Chapter 6 later in this thesis using fMRI. 
The ASL-derived PD-related perfusion pattern was characterised by precuneus hypoperfusion 
in PD (Melzer et al., 2011). The correlation detected in precuneus perfusion with memory-
guided and antisaccade performance in PD, but not in controls, could potentially reflect a 
broader range of precuneus perfusion values in PD, which is not seen in controls. The ASL 
network score states the expression of this perfusion pattern correlates with disease severity. 
Hence, with a spread of PD disease severity of the patients in this study, we would expect 
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precuneus perfusion values to span a greater range in the PD group than controls. Having this 
range, along with a greater range of impairments in saccade performance may allow a 
correlation to be detected in the PD group with eye movement performance more easily, 
whereas a tighter perfusion range and performance in controls may be too narrow to detect the 
same correlation. However, between-group differences in precuneus and eye movement 
correlation were not significant so this remains speculation. 
 
Conversely, a relationship between MD values and memory-guided saccade latency was seen 
in the precuneus in controls, so performance variability across subjects is sufficient to detect 
relationships. This relationship was negative (i.e increasing MD with decreasing latency) and 
did remain significant in a between-group comparison. Increasing MD values indicate a 
higher level of diffusion, which indicates that more water diffusion in the precuneus is related 
to lower latencies in the control group. This is an unusual result, as higher MD values usually 
indicate cell damage, which should not correspond with decreased saccade latency, or a better 
reaction time. This result cannot be easily explained, however, it is known that DTI values are 
highly sensitive to preprocessing steps such as normalisation. This will be discussed in more 
detail in a section below, but DTI values can vary greatly between different tissue types, e.g. 
white matter and CSF. If normalisation is not accurate or distorted by the presence of atrophy, 
a small misalignment, particularly around tissue transition zones, can give large changes in 
diffusion values. The precuneus borders the CSF between the two brain hemispheres and has 
been shown to atrophy in patients with early Alzheimer’s (Karas et al., 2007). Should 
cognitively-impaired controls show precuneus atrophy, this may affect normalization, 
potentially giving falsely positive results. The interpretation of MD value is also not 
necessarily straightforward. A higher MD, for example, may not necessarily indicate cell 
damage - a study into cortical lesions in multiple sclerosis demonstrated that acute lesions 
showed higher MD whereas chronic lesions, in fact, showed mildly reduced MD values 
(Tievsky et al., 1999). Hence increased MD values do not always imply detrimental 
microstructure changes. Seeing MD correlation in controls with eye movement measures and 
not PD patients could indicate the precuneus is more involved in saccadic eye movements in 
the control group compared to the PD group. However, without being sure of the pathological 
microstructure changes in PD and how this relates to MD value changes, it is difficult to 
deduce further conclusions. This result, showing a counterituitive direction of correlation, 





Focal perfusion changes to bilateral regions in the head of the caudate nucleus were seen to be 
positively associated with memory-guided saccade gain in the PD group - that is, increased 
perfusion to the caudate head corresponded to an increase in memory-guided saccade 
amplitude. The caudate nucleus has been reported to be involved in memory-guided saccades 
from a previous lesion study (Vermersch et al., 1999), which showed a patient with a caudate 
lesion generated memory-guided saccades of reduced gain. This lesion was mainly located in 
the body of the caudate and it was suggested the body of the caudate is involved in a network 
controlling visuospatial memory. Supporting this are studies showing connections of the 
caudate to regions thought to be involved in visuospatial memory – the DLPFC has 
connections with the body and head of the caudate nucleus (Yeterian & Pandya, 1991) and 
FEF has connections to the body of caudate, rostral to the genu (Stanton et al., 1988). Caudate 
neurons have been seen to discharge for memory-guided saccades (Hikosaka et al., 1989), 
which is thought to indicate that the caudate is part of a mechanism for initiating saccades 
under a memory or learnt context (Hikosaka et al., 1989).  
As noted previously, the correlation seen in our study does not directly indicate impairment, 
only that the perfusion values of a region significantly correlated with a saccade measure. 
However, if the correlation were to reflect a range of caudate function ranging from aberrant 
to normal in PD, providing the spread in perfusion values needed to see a significant 
correlation with an eye movement measure, this may potentially indicate abnormal caudate 
function in PD. This effect was not seen in control groups and a between-group comparison 
between controls and PD yielded no significant difference. As a result, the discussion of 
potential caudate dysfunction in PD compared to controls remains speculative at this stage. 
Future studies investigating differences in the caudate nucleus between PD and controls may 
consider a more targeted method, such as an ROI analysis, to further investigate. 
 
3.4.4 Anterior	cingulate	
Higher MD diffusion values in the anterior cingulate were seen to correlate with longer 
antisaccade latency in the PD group. This was not seen in the control group and a between-
group analysis found no group difference. Cingulate cortex correlation between predictive 
latency and MD values can also be seen in the PD group, but only in uncorrected data. 
Anterior cingulate DTI value changes have been previously reported in other studies with the 
progression of cognitive impairment in PD (Deng et al., 2013) and the cingulate gyrus was 
found to be associated with the attention domain in cognitive testing (Zheng et al., 2014). 
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Impaired attention processing in PD could possibly prolong antisaccade latency, and is a 
possible mechanism by which higher MD values, should increasing MD values indicate cell 
damage, correlate with prolonged antisaccade latency. No significant group difference in 
cingulate and eye movement performance was found, so this is speculative. 
3.4.5 Cerebellum	
Once corrected for multiple comparisons, unilateral (left) cerebellar tonsil MD values 
negatively correlated with predictive saccade gain in the control group. That is, a higher MD 
value was associated with a decreased gain value. The uncorrected findings, however, show a 
bilateral correlation pattern in the cerebellum. The PD group did not show this correlation in 
the same task and a between-group comparison showed a significant group difference. 
Cerebellum volume association has been reported in VBA of prosaccade eye movements in 
healthy controls (Ulrich Ettinger et al., 2005). The cerebellum itself is thought to be involved 
in predictive movements (Miall, 1998) including predictive saccades (Lee et al., 2016). A 
possible explanation for these findings is that PD-related neural changes lead to decreased 
involvement of the cerebellum in predictive saccades. This, in turn, may lead to no significant 
correlation in DTI MD values with predictive saccade performance, whereas in unaffected 
controls, changes in cerebellar cellular structures may negatively influence predictive saccade 
performance, which are reflected by increasing MD values correlating with impaired 
predictive saccade gain. 
3.4.6 BA	6	and	middle	frontal	gyrus	
DTI MD and FA diffusion values were seen to correlate with saccade performance measures 
in small unilateral clusters within BA 6 in a number of comparisons between MD values 
within-groups. Between-group association differences (but not within-group correlation) with 
eye movement performance were detected using FA and grey-matter volume - also in small 
unilateral FEF clusters These results may be expected, as BA 6 contains the human FEF 
(Vernet et al., 2014), which is known to be involved with nearly all saccadic eye movement 
tasks. In fact, it is surprising to note that these areas were not seen to correlate to a greater 
extent, or in a more bilateral pattern. If these small correlated regions were to represent a 
subtle subthreshold correlation, we may expect the uncorrected data, which has a lower 
threshold (but as a result, shows more noise), to show a pattern involving more widespread 
and bilateral FEF correlation with eye movement measures. This was not observed, with the 
significant regions arising from single unilateral clusters, even in the uncorrected data. 
Findings of small clusters in isolated, single correlations make it conceivable these findings 
are from noise or are false positives rather from true correlations. Should these findings reflect 
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actual correlation however, a mechanism for this may be that comporomised cellular integrity 
from disease processes in PD results in increased MD, decreased FA or decreased grey matter 
volume. These altered metrics may in turn correlate with impaired saccade performance 
measures.  
For example, increased MD values are usually thought to indicate decreased cellular integrity, 
which should correlate with more impaired saccade performance, however, as previously 
mentioned, MD values may not always indicate cellular structure deficits. Increasing MD 
correlated with increasing antisaccade gain in controls. From eye movement measures in the 
laboratory, the average antisaccade gain was 0.96 for the control group, indicating the control 
group did not tend to overshoot, and a higher gain (up to 1.0) indicates more accurate 
saccades. Therefore, it is unlikely that an increased MD value is associated with increased 
cellular damage, as this should not correlate with increased antisaccade accuracy. A remote 
possibility remains that microstructure changes, not necessarily detrimental, causes an 
increased MD value, and also correlates with improved antisaccade accuracy within a small 
unilateral cluster in BA 6. More plausibly however, this result may represent a false positive 
finding. The small and unilateral nature of this finding supports this conclusion, and the 
location of the cluster, even in uncorrected images, show that this result arises from a single 
unilateral cluster in BA 6, more posterior than where we would expect the BA 6 eye control 
region (the FEF) to be located.  
3.4.7 Other	areas	
Other comparisons did yield small areas of statistically significant voxel value correlation 
with eye movement performance. In one-off comparisons, significant regions were seen in 
BA 27, BA 17, superior temporal gyrus and insula (see Appendix). A number of comparisons 
showed voxels associated with eye movement performance located in undefined subgyral 
regions, which are uninterpretable using the current VBA method. These results possibly arise 
from inaccuracies in computer automated segmentation in grey matter structural scans, 
normalisation inaccuracies in DTI scans, or could be false positives as a result of multiple 
comparisons. Scattered subgyral DTI value changes could also represent white matter 
microstructure changes in PD, commonly reported with cognitive impairment (Auning et al., 
2014; Rae et al., 2012), which would require a separate tract-based analysis to detect - this 
could be the focus of future studies. We have only discussed regions which have been 
observed in more than one comparison, show in a bilateral pattern, are from regions 
previously described to be affected in PD, or known to be involved in eye movement control. 
These regions, seen in in isolated, single correlations, were of small unilateral clusters, and 
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when observing the uncorrected results, appeared to arise from clusters of an asymmetrical 
distribution from no known regions of eye movement control. Hence we must be cautious in 
our interpretation of significant results seen in one-off comparisons as these findings are 
likely to represent error/noise or a false positive. 
3.4.8 Regions	of	significant	association	with	Z	score	and	MDS-UPDRS	measures	
We tested the sensitivity of the VBA method by using the cognitive Z-score and MDS-
UPDRS part III score as a covariate of interest. This acted as a sort of reference level to 
compare to the results of our oculomotor measure analysis. Past studies have shown extensive 
grey matter volume and DTI changes in VBA group comparisons once patient groups were 
classed into separate cognitive groups, e.g. PD-unaffected, PD-MCI and PD-dementia (Burton 
et al., 2004; Hattori et al., 2012; Melzer et al., 2012;  Nagano-Saito et al., 2005).  
We would, therefore, expect regions seen to be affected in cognitive decline in PD to be 
correlated with the cognitive Z-score. Results from this current VBA correlational approach 
found only small scattered clusters of voxel correlation with both cognitive Z-score and 
MDS-UPDRS part III score. In a grey matter volume comparison with cognitive Z-score, the 
PD group showed small clusters in BA6 and BA44 which showed positive correlation 
between grey matter volume and cognitive Z-score. No regions of association were seen in 
controls and no group difference was detected. ASL scans showed a significant positive 
correlation between precuneus blood flow and cognitive Z-score within the PD group, with no 
significant correlation in the control group and no significant between-group difference. DTI 
MD scans showed scattered clusters negatively correlating with cognitive Z-score within the 
frontal and temporal lobes. These DTI MD correlations were not seen in the control group and 
no significant group difference was detected. Using a similar group of patients, widespread 
frontal and temporal lobe atrophy was found by (Melzer et al., 2012) once the patients were 
classified into PD-unaffected, PD-MCI and PD-dementia groups and compared between 
groups. The ASL network score, also using a similar patient group, developed by Melzer and 
colleagues describes precuneus hypoperfusion in PD (Melzer et al., 2011). What was not 
observed using a VBA in this study was the extent of the regions described as being affected 
in PD by the ASL network score (Melzer et al., 2011) or from cognitive group comparisons in 
PD (Melzer et al., 2012). Instead, comparisons between voxel values and global cognitive Z-
score yielded low numbers of small clusters showing significant correlation in single groups 
and with no significant group difference. Similarly, voxel-based analysis of the MDS-UPDRS 
part III score with structural ASL and DTI scans found one small subgyral cluster showing 
correlation, located outside of defined regions or BAs, likely a false positive. Not being able 
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to detect the same extent of atrophy or blood flow changes with a voxel-based correlational 
approach suggests that this method is a less sensitive technique for detecting all changes when 
compared to a VBA group-based comparison. This can potentially be addressed in future 
studies. Should saccade performance measures be further developed into a group 
classification system for PD patients based on eye movement impairment (similar to cognitive 
scoring and MCI/dementia groups), future studies could compare eye movement impairment 
groups using a VBA group-based comparison, which could, in turn, be compared with our 
current results. 
3.4.9 VBA	limitations	
VBA has a number of known limitations. The normalization process or the spatial warping of 
brains of different size can lead to analysis errors in regions where variance is high. A disease 
state may further increase the chance of normalisation errors. For example, small regions such 
as the hippocampus have high variability in disease and dementia groups, which may decrease 
sensitivity to changes in these regions (Burton et al., 2004). Segmentation is another pre-
processing step which can potentially induce errors. Segmentation is an automated process 
which separates grey matter, white matter and CSF-based on tissue probability maps. In the 
elderly population, grey matter volume declines while CSF increases. This may be accounted 
for by using an elderly-specific tissue probability template for the segmentation step, 
however, it may still be possible for incorrect tissue types to be segmented for a severely 
atrophied or diseased population. Burton et al. (2004) noted in the PD dementia population, 
even when using elderly specific templates, grey matter “atrophy” was detected in regions in 
the occipital lobe that lay very close to the skull, making it possible that other tissue types on 
the inner skull surface were included during segmentation for this group. Other anatomical 
factors, such as large ventricle size, were also thought to lead to possible CSF inclusion after 
segmentation in deep subcortical nuclei (Good et al., 2001).  
Other types of analyses, such as using ROI, may be more suited for detecting subtle changes 
in smaller regions. Schwarz et al. (2013) have found a number of studies that detected 
significant changes in subcortical nuclei using only an ROI approach, and not with a whole-
brain VBA analysis. ROI analysis involves defining a specific region rather than running a 
statistical test on every voxel in the whole-brain. The advantage to the ROI method is a 
reduction in the multiple comparisons problem, due to fewer statistical tests being run. The 
counter-argument, however, is that if an actual significant difference exists, they should be 
expected to show in the whole-brain analysis without potentially biasing results by pre-
selecting regions. Previous studies using VBA have, however, failed to detect PD group 
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changes in smaller subcortical structures such as the basal ganglia in relatively unimpaired PD 
patients, but these were able to be detected with manual ROI tracing methods (Lee et al., 
2011; Menke et al., 2014). Likewise, Rae et al. (2012) reported ROI analyses using tract-
based statistics was able to detect DTI changes that VBA was unable to detect, unless having 
to resort to a more liberal threshold criteria. In this current study, using a relatively large 
number of participants, we were able to detect differences in voxel value and eye movement 
performance correlation in a number of regions using a voxel-based analysis approach and a 
strict family-wise error correction. An ROI approach could be used in the future to further 
investigate the regions found in this current study in an independent sample. 
3.4.9.1 DTI	limitations	
The pattern of correlation in DTI FA data was seen to form an unusual pattern in uncorrected 
results, often just on the very edges of the brain (Figure 3-16). These did not fit into any 
defined cortical regions and were not significant after adjusting for multiple comparisons. I 
am highly suspicions the findings shown in Figure 3-16 arise from artefacts and use this 
figure to demonstrate the possibility of error.  
 
 
Figure 3-16 – Example of the artefact pattern seen in the uncorrected DTI FA images. “Significant” 
regions are all located on the very edges of the grey matter and in CSF transition zones. 
 
DTI has particular issues regarding normalisation and analysis. The nature of the diffusion of 
water within the brain, being directed by cellular structures, means that on the boundaries 
between tissue types, there can be large variations in diffusion measures over very small 
distances. This may explain the peculiar patterns formed from regions of “correlation” 
Regions showing correlation 
between FA and reflexive latency 
Regions showing correlation 





between DTI measures and eye movement performance. Due to the issues mentioned above, 
DTI imaging is sensitive to normalisation. If normalization is not accurately achieved, large 
changes can be observed due to misalignment of close regions, with large signal changes. 
Cortical atrophy in the diseased population could lead to distortions during computer driven 
normalisation. This could potentially cause a misalignment of areas of high diffusivity and 
low diffusivity, particularly on the boundaries of tissue transition, which may give rise to the 
patterns as “significant” regions, but do not actually correspond with eye movement control. 
Due to these issues, techniques such as tract-based spatial statistics (Smith et al., 2006) have 
been developed to improve the sensitivity of group DTI analysis, by using a mean fibre tract 
skeleton of all patients, onto which FA values are projected. The advantage of this technique 
is that it reduces the impact of misalignment. This may be an option to explore for future DTI-
related analysis. 
3.4.10 Discussion	-	Study	aims	
These findings address the first aim of this investigation, detecting areas showing correlation 
between voxel value and eye movement performance. These correlations however occur in 
areas not explicitly known to be involved in eye movement control and were located in 
regions such as the temporal lobe and precuneus. It may be possible these areas make indirect 
contributions to eye movements, however the possibility of these being a type 1 error (i.e. a 
false positive) is also discussed. The lack of significant changes in the eye fields, and a lack of 
significant group difference between PD and controls, argue against my initial hypothesis that 
adverse changes in eye fields will be greater in PD compared to controls. With the relatively 
large numbers of participants used in this study, it is likely that any disease-related structural 
or perfusion changes in the brain within the eye fields are small and unable to be detected 
using the current voxel-based analysis technique. Suggestions for improvements for future 
studies are discussed in section 3.4.9, entitled “VBA limitations”. 
The areas found in these results are also able to satisfy the second question of allowing 
comparison of different imaging modalities to gain more insight into affected areas. The use 
of multiple modalities gives a more complete picture of possible sources of dysfunction 
within the brain, which a single modality is not able to. The use of multiple modalities in 
current imaging research allows measure of different aspects of a sequential disease process. 
For example, we have reason to believe that white matter fibre tract changes would precede 
cortical atrophy - studies using very similar patient groups have found miscrostructural white 
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matter changes in early non-dementia PD (Melzer et al., 2013) and structural changes 
manifesting most clearly in late, demented PD states.  
In this study, aside from the temporal lobe, there was little crossover in findings between the 
different MRI modalities used. This demonstrates that findings from one modality which 
correlate with eye movement performance may not necessarily be demonstrated in another. 
For example, areas showing perfusion deficits with impaired eye movement performance did 
not consistently show atrophy or fibre tract changes in the same regions. This does not 
necessarily mean a conflicting result, as each scan type gives different information. Overall, 
as mentioned previously, from the limited areas found to correlate with eye movement 
performance within our large PD sample, it is likely that any disease related brain changes 
which can be reflected by eye movement performance are small and poorly-detected using the 
current VBA technique. 
3.5 Conclusions		
Significant areas of correlation in the left temporal pole, caudate nucleus, precuneus, anterior 
cingulate and cerebellum were seen in PD and control groups for a number of saccade tasks. 
Group differences in correlation were detected in the left temporal pole, precuneus and 
cerebellum. From the large number of participants in our study, findings of relatively few 
areas of correlation and group differences of imaging and eye movement performance 
measures, particularly in cortical regions known to be involved in eye movement control, 
suggests that differences between PD and controls in eye movement regions, while present, 
are subtle when detected using a voxel-based approach. Future studies could consider an ROI 
approach or more refined DTI techniques, such as tractography, to compare eye movement 
performance and voxel values using regions found in this study. Overall, this study shows that 
using a voxel-based analysis of structural, ASL and DTI scans, we are unable to detect 
significant brain changes in PD reflecting saccade performance deficits within known regions 
of eye movement control. This does not however exclude the possibility of functional changes 
during task performance, which can be present despite normal structural anatomy. The brain 
is also known to operate not as isolated regions but in interconnected networks. Therefore a 
network-based measure may be a better reflection of brain function than an individual voxel 
based measure. For these reasons the next chapter will investigate the possibility of 
correlation between a PD-based perfusion network score. Chapters 5 and 6 will use functional 







Using ASL MRI, a PD-related cerebral perfusion network has been identified, using the same 
patient group as the participants in Chapter 3 (Melzer et al., 2011). This network describes a 
global decrease in perfusion in PD, with several areas of characteristic hypoperfusion in the 
posterior parieto-occipital cortex, precuneus, cuneus and middle frontal gyri compared to 
healthy controls. Meanwhile, relatively preserved perfusion was found in globus pallidus, 
putamen, anterior cingulate, and post and precentral gyri. This pattern is depicted in Figure 
4-1. Each individual can be assigned a single score indicating the extent to which this 
individual expresses the characteristic pattern, with a higher score corresponding to a more 
“Parkinson’s-like” perfusion pattern in the brain. The development of this ASL-derived 
network score brings the potential of a new tool to track PD progression with an objective and 
repeatable measure. Using a similar approach, previous studies using radiotracer methods 
such as positron emission tomography (PET) have reported changes in brain 
metabolism/perfusion specific to motor or cognitive aspects of the disease (Eidelberg, 2009). 
In contrast, the study by Melzer and colleagues (2011) identified only one PD-specific 
perfusion pattern, with multiple regression analysis finding significant correlation of this 
overall PD perfusion pattern with both the Montreal Cognitive Assessment (MoCA) and the 
motor component of the UPDRS part III). 
 
Figure 4-1 – PD-related ASL perfusion pattern (Melzer et al., 2011). Blue areas indicate markedly 




The PD perfusion network describes characteristic hypoperfusion in the middle frontal gyrus 
and posterior parietal-occipital cortex, regions containing the human FEF and PPC. Therefore, 
should the expression of the PD-related perfusion network correlate with saccade 
performance, it may indicate that hypoperfusion within these regions described by the PD 
perfusion pattern relate to saccadic eye movement performance deficits in PD. 
4.1.1 Saccadic	eye	movements	in	PD	
Saccade performance in PD has been previously covered in the Introduction chapter (page 
49). To summarise, the classical finding for saccades in PD is hypometria – that is, the initial 
saccade made to a target falls short and is compensated by subsequent corrective saccades 
(Chan et al., 2005; White Saint-Cyr, & Sharpe, 1983; White et al., 1983). It has also been 
shown that the extent of the performance degradation is correlated with PD severity and 
cognitive status, as assessed by the UPDRS and MoCA (MacAskill et al., 2012). Complex 
volitional eye movement tasks such as the antisaccade task are more affected than simple 
visual guided tasks (Anderson & MacAskill, 2013). The sources of PD eye movement deficits 
are unclear, with imaging studies so far managing to find frontal eye field and parietal cortex 
BOLD activation changes in functional imaging during self-paced and antisaccades in PD 
(Lemos et al., 2016; Rieger et al., 2008). 
4.1.2 Aims	of	study	
This study will test if eye movements correlate with another objective measure of PD 
progression, namely an ASL-derived perfusion pattern, which has been previously shown to 
reflect PD motor status and cognition (reference network score paper). The aim of this 
comparison is to see if two objective measurements can be shown to correlate in PD. This 
would allow us to test the hypothesis that impaired eye movement performance reflects an 
abnormal disease-related perfusion pattern in PD, giving more insight into the nature of the 
causes of eye movement deficits in PD. The network score is not developed enough at this 
stage to be used as a gold standard of PD progression, thus the aim of this investigation is not 
to develop a functional biomarker from eye movements alone, but is limited to an initial test 
to investigate if these two objective markers of PD status show any association. Chapter 4 is a 





MRI and eye movement data were collected from a convenience sample of 68 PD (49 male 
and 19 female) and 24 controls (15 male and 9 female) at the New Zealand Brain Research 
Institute. The average age of the PD participants was 68 years (range 46 to 84), with average 
years of education of 13.5 years (range 8 to 19) and an average MoCA of 23.4 (range 10 to 
30). The average age of controls was 69 (range 50 to 79), with 13.3 years of education (range 
10 to 19) and average MoCA of 27.1 (range 23 to 30). Cognitive and PD motor symptom 
testing was carried out for every participant using the methods described in Chapter 2. 
4.2.2 Imaging	procedure	and	ASL-derived	network	score		
A PD-related ASL perfusion network was identified in a previous study by Melzer et al. 
(2011). A voxel-based principal component analysis (PCA), as described by Spetsieris et al. 
(2009) was used to derive a perfusion pattern in the study participants from ASL data (Melzer 
et al., 2011). A grey matter mask was applied to the ASL perfusion images which were then 
log transformed, de-meaned and entered into a PCA. Principal component images were 
calculated and a backward stepwise binomial logistic regression was performed to identify 
disease-related principal components. The model expressing the smallest Akaike information 
criterion was chosen to best distinguish PD from control.  
The disease-related principal components were used in linear combination (based on the 
parameters derived from the logistic regression) to form a single characteristic PD-related 
perfusion pattern, which was Z-scored. The network score, indicating the expression of the 
PD-related perfusion pattern in each individual (or the similarity between each individual’s 
ASL scan and the characteristic PD-related pattern), was determined by applying the same 
linear combination of model parameters to PD-related principal component scores. This 
network score was standardised, with control mean set to 0. Reliability of the spatial extent of 
the derived PD-related perfusion pattern was estimated using a bootstrap estimation procedure 
(Efron & Tibshirani, 1986). Since the original study by Melzer and colleagues (2011), an 
updated network, incorporating additional participant scans enrolled in the longitudinal PD 







We chose four standard eye movement tasks to compare with the network score: The 
reflexive, predictive, memory-guided and antisaccade tasks. The saccade paradigms and 
measures in this study were the same as employed by Chapter 3 (see page 98). 
4.2.4 Data	Analysis	
All data was analysed using R version 3.2.0 (R Development Core Team, 2008). Eye 
movement parameters from each participant were averaged for each task and plotted against 
their individual network score. The network score was also plotted against MoCA and MDS-
UPDRS III scores. The lm function was used to calculate regression models. Graphs were 
generated using ggplot2 (Wickham, 2009). The first regressions performed were simple linear 
regressions between eye movements and network score. Additional comparisons were 
performed between eye movement measures and UPDRS III scores and cognitive Z-score. 
Multiple regressions were then performed with the network score along with the cognitive Z-
score and UPDRS III to assess the relationship of other PD measures on eye movement 
performance. This is important to assess the potential contribution of other regressors 
(independent variables), not limited to the network score, on eye movement performance 
(dependent variable). 
4.3 Results	
The results of simple linear regressions between eye movement performance measures and 
network score are provided in Table 4-1, Figure 4-2 and Figure 4-3. In the PD group, there 
was a significant relationship, in all tasks, between the gain of the primary saccade and the 
network score, with a higher network score being associated with a smaller gain. Significant 
regressions between the network score and saccadic latency were also seen in the PD group, 
in all tasks, with a higher network score being associated with a longer reaction time to 
initiate a saccade. The controls showed a smaller network score (mean score = 0) compared to 
PD patients and did not show this relationship with eye movement performance, which 
perhaps is expected due to controls showing a much-reduced range of network scores. 
Additional figures of regressions between eye movement measures and UPDRS III scores and 




Figure 4-2 – Linear regressions between network score and saccadic eye movement gain from the 
reflexive, predictive, memory and antisaccade tasks. The x-axis represents the network score of each 
participant. The y-axis represents primary gain in each task. Straight lines indicate least squares 
regressions for each measure. The grey intervals around each regression line indicate the 95% confidence 
interval of the regression. The cognitive category of PD participants (PDN - normal, PD-MCI - PD mild 




Figure 4-3 – Linear regressions between network score and saccadic eye movement latency from reflexive, 
predictive, memory and antisaccade tasks. The x-axis represents the network score of each participant. 
The y-axis represents latency. Straight lines indicate least squares regressions for each measure. The grey 
intervals around each regression line indicates the 95% confidence interval of the regression. The 
cognitive category of PD participants participants (PDN - normal, PD-MCI - PD mild cognitive 




Table 4-1 – P and R squared values for each eye movement and network score comparison.  
  Estimate (gain) Std. Error t value p-value r squared 
Reflexive gain 
Intercept 0.93 0.02 59 < 0.001  
Network score -0.04 per point 0.01 -4.1 < 0.001 0.2 
Predictive gain 
Intercept 0.80 0.02 32 < 0.001  
Network score -0.05 per point 0.02 -3 0.004 0.1 
Memory-guided gain 
Intercept 0.80 0.03 27 < 0.001  
Network score -0.06 per point 0.02 -3 0.003 0.11 
Antisaccade gain 
Intercept 0.86 0.04 21 < 0.001  
Network score -0.01 per point 0.03 -3.4 0.001 0.15 
      
      
  Estimate (ms) Std. Error t value p-value r squared 
Reflexive latency 
Intercept 218 8.6 25 < 0.001  
Network score 13.5 per point 5.7 2.3 0.021 0.06 
Predictive latency 
Intercept 71 19 3.8 < 0.001  
Network score 37 per point 13 2.9 0.004 0.11 
Memory-guided latency 
Intercept 297 34 8.7 < 0.001  
Network score 132 per point 24 5.6 < 0.001 0.32 
Antisaccade latency 
Intercept 446 27 16 < 0.001  






Table 4-2 and Table 4-3 show the results of the multiple regression analyses. The significant 
linear regressions in individual comparisons between network score and eye movements do 
not remain in a multiple regression, likely due to association between the“independent” 
variables. 
Table 4-2 – Table of multiple regression between saccade gain values, with network score, cognitive Z-
score and MDS UPDRS part III score used as predictors. 
Reflexive gain 
  Estimate Std. Error t value p-value 
Intercept 0.93 0.03 36.9 < 0.001 
Network score -0.02 per point 0.01 -1.6 0.12 
Cognitive Z-score 0.03 per point 0.02 1.8 0.08 
MDS-UPDRS III -0.0002 per point 0.0006 -0.4 0.73 
     
Predictive gain 
  Estimate Std. Error t value p-value 
Intercept 0.86 0.04 22 < 0.001 
Network score -0.03 per point 0.02 -1.5 0.14 
Cognitive Z-score -0.01 per point 0.03 -0.4 0.72 
MDS-UPDRS III -0.002 per point 0.001 -2.1 0.04 
     
Memory gain 
  Estimate Std. Error t value p-value 
Intercept 0.86 0.04 20.2 < 0.001 
Network score 0.003 per point 0.02 0.1 0.89 
Cognitive Z-score 0.05 per point 0.03 1.7 0.08 
MDS-UPDRS III -0.003 per point 0.001 -2.7 0.01 
     
Anti gain 
  Estimate Std. Error t value p-value 
Intercept 0.89 0.07 13.2 < 0.001 
Network score -0.06 per point 0.04 -1.6 0.12 
Cognitive Z-score 0.04 per point 0.05 0.7 0.47 





Table 4-3 – Table of multiple regression between saccade latency values, with network score, cognitive Z-
score and MDS UPDRS part III score used as predictors. 
Reflexive latency 
  Estimate (ms) Std. Error t value p-value 
Intercept 200 11.2 17.8 < 0.001 
Network score -11 per point 6.3 -1.7 0.09 
Cognitive Z-score -25 per point 8.1 -3.1 0.003 
MDS-UPDRS III 0.9 per point 0.3 3.3 0.002 
 
Predictive latency 
  Estimate (ms) Std. Error t value p-value 
Intercept 22 28.9 0.8 0.45 
Network score 16 per point 16.8 1 0.34 
Cognitive Z-score -1.4 per point 20.7 -0.07 0.95 
MDS-UPDRS III 1.9 per point 0.7 2.6 0.01 
     
Memory latency 
  Estimate (ms) Std. Error t value p-value 
Intercept 185 42.5 4.4 < 0.001 
Network score 28 per point 24.5 1.1 0.26 
Cognitive Z-score -81 per point 31.5 -2.6 0.01 
MDS-UPDRS III 5.1 per point 1.1 4.5 < 0.001 
     
Anti latency 
  Estimate (ms) Std. Error t value p-value 
Intercept 380 39.5 9.6 < 0.001 
Network score 0.7 per point 24.1 0.03 0.98 
Cognitive Z-score -39 per point 29.5 -1.3 0.2 
MDS-UPDRS III 3.0 per point 1 2.9 0.005 
 
4.4 Discussion	
For the PD-related ASL network score to be a viable biomarker, we would expect it to be 
associated with the established measures of PD status. Melzer et al. (2011) demonstrated that 
the network score shows significant correlation with the MoCA, which itself is associated 
with PD progression (Dalrymple-Alford et al., 2011; Emre, 2003; Janvin et al., 2006). The 
network score was found to correlate with motor symptom severity as assessed by the MDS-
UPDRS part III. This current study demonstrates that consistent correlations are present in 
comparisons between the network score and saccadic eye movement measures in PD. While 
this correlation does not imply causation, the consistent correlations with eye movement 
measures, seen to be characteristically impaired in PD, helps to validate that an ASL-derived 
perfusion network may be a viable biomarker for disease status and progression. Significant 
correlation with eye movement performance also shows that the perfusion impairments 
144 
 
described by the PD network may contribute partly to the causes of saccadic eye movement 
deficits in PD. 
From Figure 4-2 and Figure 4-3, the control group showed a smaller network score expression 
range compared to the PD group – this is expected as a PD-like perfusion pattern should be 
expressed only weakly in controls. PD-N (non-cognitively impaired) patients tended to show 
lower network score expression and better eye movement performance, with PD-MCI and 
PD-D groups showing worse eye movement performance and higher network score 
expression. This is, again, expected due to the known correlation of both network score and 
eye movements with cognitive impairment. A control subject was noted to have a very low 
antisaccade gain value. On further investigation, this subject had only made one “correct” 
antisaccade at a gain value of 0.2 - all other saccades made were direction errors and were 
excluded from analysis. A weakness of this study was that a minimum number of correct 
saccades wasn’t specified to account for performance anomalies demonstrated by this patient. 
The presence of the gain measurement of this participant does not change the study 
conclusions as the correlation between antisaccade gain and network score did not reach 
significance for controls. However future studies would benefit by specifying a minimum 
number of correctly performed saccades to include for study analysis. 
 
In simple linear regressions between network score and eye movement measures, the spread 
of eye movement values around the predicted regression line, indicated by the R squared 
value (with higher values indicating lower spread) ranged from approximately 0.1 to 0.2 for 
all eye movement task comparisons, except for memory-guided latency, which showed an R 
squared value of 0.3, indicating a tighter spread. Visual evaluation of the memory-guided 
latency and network score comparison (Figure 4-3) suggests a non-linear relationship between 
memory-guided saccade latency and network score. Below a network score of approximately 
1.0, latency values tend to remain low. Above network scores of 1, latency values were seen 
to steeply increase and spread. This non-linear effect was seen also in comparisons of UPDRS 
III scores and cognitive Z-scores with memory-guided latency (see Appendix). Latency 
values appeared to abruptly increase above a UPDRS-III score of approximately 40, and with 
global cognitive Z-scores below -0.75. In contrast, memory-guided gain was seen to correlate 
in a roughly linear pattern. Other graphs also appear to show this linear trend of saccade 
performance values. This could potentially indicate that as the disease progresses, a point is 
reached, specifically in memory-guided saccade latency values, where values fall “off a cliff”, 
145 
 
with non-linear deterioration. If this drop-off point can be determined, this could potentially 
form a categorical marker of PD progression for the future. This could be further tested using 
a segmented “broken stick” regression to see if two linear functions are a better description 
for the data versus one linear function. 
Multiple regressions were also performed with network score, cognitive Z-score and MDS-
UPDRS-III score as predictors of saccade performance in order to test if the association seen 
between network score and eye movements may be explained by other measures of PD 
progression. It is known that the network score correlates with cognitive impairment (as 
measured by the MoCA) and motor status (Melzer et al., 2011). This, therefore, makes 
multiple regression potentially difficult to interpret, due to multicollinearity (i.e. having 
correlated predictors). Multiple regressions involving the mentioned predictors with reflexive 
latency and memory-guided latency showed significant correlation with cognitive Z-score and 
UPDRS, but the correlations seen in simple regression between network score and eye 
movement measures did not remain significant. Multiple regression of predictive latency, 
predictive gain and memory-guided gain showed only significant correlation with the 
UPDRS. The network score and MoCA, both showing correlation with the listed eye 
movement measures in simple regression, did not show significant correlation within multiple 
regression. Antisaccade latency, antisaccade latency and reflexive gain showed the most 
marked demonstration of the effect of multicollinearity, with no significant correlation with 
any predictor value, despite each predictor showing significant correlation individually. The 
ASL network is known to relate to both cognition and motor status. Previous perfusion 
studies using PET have found separate metabolic patterns in PD linked to motor and cognition 
(Eidelberg, 2009). The motor pattern, described as the “Parkinson’s disease-related pattern” 
or PDRP, is characterised by increased pallidothalamic and pontine metabolic activity, with 
reduced activity seen in the frontal premotor cortex, inferior parietal and parietal-occipital 
areas (Eidelberg et al., 1994). The metabolic cognitive pattern, described as the “PD-related 
cognitive pattern” or PDCP, showed increased metabolic activity in the cerebellar cortex and 
dentate nuclei with reduced activity in the frontal lobe premotor cortex, SMA, precuneus and 
inferior parietal lobule (Huang et al., 2007). The network as described by Melzer et al. did not 
produce a separate perfusion pattern distinct for motor and cognitive symptoms, but was 
formed from principal components relating to both aspects. The effect of multicollinearity 
seen in the multiple regressions in this study suggests that the network score reflects both 
motor status and cognition in PD, which supports the premise that the ASL network score is a 
measure of general disease status, including both cognitive and motor components in PD. 
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The ASL-derived network describes widespread cortical hypoperfusion in PD, including the 
posterior parieto-occipital cortex, precuneus/cuneus and middle frontal gyri, with unchanged 
perfusion in the globus pallidus, putamen, anterior cingulate and post- and precentral gyri. 
The Eidelberg PD pattern was interpreted as showing regions of decreased perfusion and 
surprisingly, regions of increased perfusion in the pallidothalamic and pontine regions. Using 
absolute perfusion values possible with ASL, it was determined that PD patients showed no 
areas of increased perfusion, with an overall reduction in perfusion, with particular regions of 
severe hypoperfusion. Regions interpreted as having increased perfusion by Eidelberg et al. 
were found to have, instead, preserved perfusion using ASL (Melzer et al., 2011). Additional 
evidence suggests that this subcortical hypermetabolism in PD could be explained as an 
artefact of biased global mean normalization (Borghammer et al., 2010; Borghammer et al., 
2009). 
The ASL-derived network shows hypoperfusion in many areas known to be involved in eye 
movement control. Areas of saccadic control have been investigated using functional MRI 
techniques and transcranial magnetic stimulation (TMS). Pierrot-Deseilligny et al. (1995, 
2003) and Milea et al. (2005) identified the frontal eye field (middle frontal gyrus), 
supplementary eye field (supplementary motor area), parietal eye field (posterior parietal 
cortex), dorsolateral prefrontal cortex (prefrontal cortex), basal ganglia and superior colliculus 
as involved in saccadic eye movement control. In general, FEF is thought to be involved in 
triggering voluntary saccades, with the parietal eye field thought to be more involved in 
reflexive saccades (Müri & Nyffeler, 2008; Pierrot-Deseilligny et al., 2004). The SEF is 
thought to have a role in memorised saccade sequencing (Pierrot-Deseilligny, Müri, Ploner, 
Gaymard, & Rivaud-Péchoux, 2003) and the DLPFC to be important in saccade tasks 
involving working memory (Pierrot-Deseilligny et al., 2003).  
The circuits controlling saccadic eye movements share paths in parallel with the skeletal 
movement control pathway in the basal ganglia. Saccadic eye movements are thought to 
reflect aspects of motor dysfunction. Characteristic changes in saccadic eye movement 
performance are seen in PD. In the voluntary (antisaccade) task, PD patients initiate saccades 
later, make smaller, undershooting saccades and make more errors compared to controls 
(Briand et al., 1999). PD patients make undershooting initial saccades to memory-guided 
targets, necessitating multiple step-like corrective saccades (Crawford et al., 1989) and show 
an increase in unsuppressed reflexive saccades towards the target “flash” in memory-guided 
or delayed response saccade tasks (Chan et al., 2005). Terao et al. (2011) showed that 
memory-guided saccades were impaired, even early in the disease. Previous studies have 
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found mixed results regarding visually-guided reflexive saccades impairment in PD, with 
several studies finding no difference compared to controls (Briand et al., 1999; Crawford et 
al., 1989), a subtly prolonged latency (Chambers & Prescott, 2010) or prolonged latency and 
gain-related to PD motor status and cognitive impairment respectively (MacAskill et al., 
2012). With knowledge of widespread cortical pathology in PD (Braak et al., 2003), it is 
likely that disease-related change, not limited to the basal ganglia, play a role in causing 
saccadic eye movement deficits in PD. 
 
Imaging studies have supported the idea that cortical structural and functional abnormalities 
in PD affect eye movement performance. Using structural MRI, Perneczky et al. (2011) found 
a negative correlation between grey matter volume in PD patients and the variability of 
saccade latency in the frontal and parietal eye fields. This suggests that PD-related saccadic 
changes may be associated with grey matter atrophy in saccade-generating cortical regions. A 
study by Rieger et al. (2008) using functional imaging, found decreased BOLD activity in the 
frontal cortex during self-paced saccades. ASL has not previously been used to characterise 
perfusion deficits related to saccadic eye movement measures. However, the correlation of the 
ASL network score with eye movement measures suggests that this perfusion pattern could 
reflect abnormalities which may be part of the causes behind saccadic eye movement 
performance deficits in PD, particularly changes in the posterior parieto(-occipital) cortex and 
middle frontal gyri. 
 
4.4.1 Discussion	-	Study	aims	
The results show general correlation between every analysed measure of eye movement 
performance and ASL network score expression. As the results do show a general pattern, this 
supports the hypothesis of the study that eye movement performance is able to reflect a PD- 
specific perfusion pattern, a pattern which has been previously shown to correlate with motor 
and cognitive impairment in PD. The results however do not suggest that eye movements are 
sufficiently discriminating at an individual level to be used in a patient-specific measure of 
disease progression. A large spread in correlation data is evident. From this, the results of this 
study suggest it is unlikely that eye movements alone can be used as a biomarker at an 




In summary, the relationships between the network score and measures of eye movement 
performance may indicate that decreased perfusion values in the posterior parietal-occipital 
cortex, cuneus, precuneus and middle frontal gyrus, as described by the ASL PD network, 
could reflect part of the cause of saccadic eye movement performance impairments in PD. 
The ASL derived network score was also seen to correlate with both cognitive and motor 
status, along with all eye movement measures, supporting the idea that the network score may 
represent a general measure of overall disease status. An ongoing longitudinal study, with 
follow-up imaging, is currently being undertaken to further refine and validate this network 








Visually-guided saccades are saccades directed in response to a simple external visual 
stimulus, while voluntary saccades are saccades made by more deliberate, conscious control. 
Reflexive saccade paradigms, consisting of following an unpredictable jumping visual 
stimulus, are used to investigate visually-guided saccades. For voluntary saccades, a type of 
experimental paradigm such as the predictive saccade task can be used. In this task, the 
participant is instructed to follow a visual stimulus which alternates between two fixed 
positions at regular intervals. Instead of making saccades only in response to the stimulus 
movement, participants performing the predictive task will eventually learn the set pattern of 
the stimulus movements and can make anticipatory or early saccades to the predicted location 
of the next stimulus.  
Our experimental aim is to investigate the pathophysiological processes underpinning the 
differences in saccadic eye movement performance between PD and controls using fMRI. Eye 
movement laboratory-based studies of reflexive saccades have found reflexive saccade 
latency to be affected by cognition late in the disease and saccade amplitude by motor 
impairment (MacAskill et al., 2012). Studies of predictive saccades have found a mixed 
picture of performance deficits in PD. Studies such as by Crawford et al. (1989), Ventre et al. 
(1992), Duval, Beuter, & Gauthier (1997) and O’Sullivan et al. (1997) reported PD patients 
having normal saccade reaction times (normal latency) but undershooting amplitudes 
(reduced primary gain). Others (Bronstein & Kennard, 1985; Ying et al., 2008) have found 
longer predictive latency in PD while Ventre-Dominey et al., (2001) reported longer latency 
with normal gain in PD. These variations in findings could be due to variation in motor and 
cognitive status of PD patients participating in these studies (MacAskill et al., 2012; van 
Stockum et al, 2008). Our study comprised a PD group with relatively unimpaired cognition 
to minimise this effect. 
Despite the reported saccade performance deficits in PD, fMRI studies investigating eye 
movements and the cortical function underlying these deficits in PD have been scarce. No 
study to date has investigated predictive saccades in PD compared to controls using fMRI. 
Rieger et al. (2008) used a “self-paced” saccade task, consisting of internally generated 
alternating saccades between two targets left and right of centre. Reiger and colleagues 
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reported that BOLD-related activity was reduced in the FEF and SEF in PD compared to 
controls, but increased in the posterior cingulate, parahippocampal gyrus, inferior parietal 
lobule, precuneus and the middle temporal gyrus. The PEF and occipital regions showed no 
activation differences. This study was limited, however, by the nature of the task. The self-
paced saccade task is an entirely volitional task with no cue to indicate when the participant 
should make a saccade. Instead, participants make saccades between two fixed points at their 
own pace. This introduces the frequency of saccades made by each participant as an 
uncontrolled variable. Saccade frequency is known to correlate with BOLD activity (Kimmig 
et al., 2001). Secondly, the results reported were not a result of a direct voxel-wise 
comparison between the PD and control groups. Rather, the active areas reported were 
generated within the control and PD groups separately. As a result, the apparent differences 
might not remain if a direct voxel-based comparison was done between the two groups. This 
can result in an effect known as the “imager’s fallacy”, where a visually-identified activation 
difference between two separate group analysis does not imply an actual difference when the 
groups are compared directly within a single model (Henson, 2005; Poldrack et al., 2008).  
Reflexive saccades have been investigated using a prosaccade task contrasted to an 
antisaccade task in PD (Cameron et al., 2012; Lemos et al., 2016). The prosaccade task used 
by Cameron et al. had only saccade direction as an unpredictable component, with timing and 
amplitude kept the same for every trial and thus able to be predicted. This may lead to 
preparatory cortical activity and so may not completely reflect true reflexive saccade activity. 
A study by Cameron et al. (2012) used fMRI to investigate differences in antisaccade 
performance in PD and controls. Cameron et al. found the FEF in the PD group showed 
reduced activity immediately before antisaccade generation. They describe this hypoactivity 
due to PD patients being less able to establish preparatory activity for saccade execution. A 
recent paper by Lemos et al. (2016) used a block design fMRI task to investigate the 
differences between PD prosaccades and antisaccades (in horizontal and vertical saccades – 
we focus on horizontal). For saccades in the horizontal direction, this study found unilateral 
hypoactivity in the left FEF for prosaccades and hyperactivity in the right parietal cortex for 
prosaccades and antisaccades for the PD group. This was thought to represent disease-related 
hypoactivity in the left frontal cortex, with compensatory changes in the parietal lobe during 
saccade tasks in PD. It is unclear how a unilateral FEF deficit develops in PD but this does 
remain somewhat consistent with the idea that FEF hypoactivity is present in PD.  
In this study, I investigated cortical activity involved in reflexive and predictive saccades in 
PD. This study will be a novel fMRI investigation into predictive saccades in PD. We will 
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control for the number of saccade cues, ensuring each participant is cued to make the same 
number of saccades - a component which was missing in the self-paced task used by Reiger et 
al. (2008). For this study, the reflexive task used unpredictable timing, amplitude and 
direction components, as opposed to past studies using a direction unpredictable component 
only, with predictable amplitude and timing. Potential group differences in task activity would 
add significantly to our knowledge of cortical changes in PD. Imaging has long been 
investigated as a potential tool for diagnosing and tracking Parkinson’s disease progression 
(Brooks, 2010; Pavese & Brooks, 2009; Weingarten et al., 2015; Politis, 2014). Having group 
differences able to be detected using fMRI could prove to be a useful tool in the future. In 
combination with studies investigating eye movement abnormalities over the course of PD, 
novel biomarkers could be developed to help assess PD severity and progression.  
As discussed previously in the Introduction chapter (see page 29), knowledge of the cortical 
regions involved in saccadic eye movement control was initially derived from primate studies 
(Bizzi, 1968; Robinson & Fuchs, 1969; Barash et al., 1991; Schlag & Schlag-Rey, 1987; 
Lynch & McLaren, 1989;Thier & Andersen, 1996). Later, human lesion, stimulation and 
imaging studies sought to clarify and further investigate the regions of eye movement control 
first identified in primate trials (Pierrot-Deseilligny et al., 1987; Anderson et al., 1994; Paus, 
1996; Gaymard et al, 1998; Grosbras & Paus, 2002; Müri & Nyffeler, 2008). Today, many 
imaging studies have been carried out, indicating the frontal eye field (FEF) and parietal 
cortex, containing the posterior parietal cortex (PPC) and the parietal eye field (PEF), are 
involved in saccadic eye movement control (Mort et al., 2003; Sugiura et al., 2004;Grefkes & 
Fink, 2005; Parton et al., 2007; Jamadar, Fielding, & Egan, 2013; Vernet et al , 2014). A 
number of findings remain unclear, however. The FEF has been implicated in nearly every 
type of eye movement: the preparation and execution of saccades (Bizzi, 1968; Bruce & 
Goldberg, 1985; Everling & Munoz, 2000; Hanes & Schall, 1996), optokinetic nystagmus, 
smooth pursuit (Bizzi, 1968; MacAvoy et al ., 1991) and fixation (Yoshiko Izawa et al., 
2004a, 2004b) but the location of FEF activity found in different experiments varies. 
Additionally, there are a number of studies that indicate the FEF isn’t a single homogenous 
region but rather is split into multiple subsections, each with different connections and roles. 
A medial/lateral split has been described (Gagnon et al, 2002; Simo, 2005) while others have, 
instead, reported inferior-superior FEF regions (Heide et al., 2001; Luna et al., 1998; Petit et 
al, 1997). A number of interpretations have been made of the functional differences between 
these FEF subregions. Petit et al. (1997) reported specific smooth pursuit and saccade 
subregions within the FEF, with the smooth pursuit region more lateral and inferior than the 
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saccade region. Both Gagnon et al. (2002) and Heide et al. (2001) interpreted medial and 
lateral FEF activity to correspond to the generation of small and large size saccades, with 
larger saccades thought to involve the ventro-lateral FEF. The saccade size theory, however, 
is in conflict with other sources. Monkey neuro-stimulation studies have shown that large 
saccades involve the ventro-medial portion of the FEF as opposed to the ventro-lateral (Leigh 
& Zee, 1999;  Bruce & Goldberg, 1985). There does not, therefore, appear to be a consensus 
on the functional subdivision of the FEF. Our experiment used a block fMRI design, making 
it possible to compare reflexive and predictive task activity. As a result, in addition to the 
primary study aim of comparing PD and control activity differences, I am also able to form a 
discussion regarding the potential subdivision and function of the FEF for the reflexive and 
predictive task.  
5.1.1 Aims	of	study	
Using functional MRI, I ask if performance changes in reflexive and predictive task saccadic 
eye movement performance PD are reflected in a corresponding functional change, detectable 
using fMRI in known eye movement control regions. This is linked to the overall aim of the 
thesis in testing the feasibility of using saccadic eye movement performance as a marker of 
brain health. My hypothesis is that PD patients will show a functional difference, namely 
diminished BOLD levels during saccade performance, within regions known to be involved in 
eye movements, namely the eye fields. The overall number of study participants used in this 
study (32 total including PD and controls) is larger than many of the present studies of fMRI-
based PD studies (Herz et al., 2014). From this, we are also able to compare our findings of 
regions involved in general eye movement control with previous findings in the eye fields. As 
will become evident in later sections, findings involving frontal eye field subregions were 
found in both the PD and control groups, which allowed new interpretations of FEF subregion 
function. I pose the pre-experimental question broadly in asking if the regions known to be 
involved in general saccade control are firstly, able to be detected within our relatively large 
group of study participants, validating our methods; and secondly, if any novel activation 
differences can be found specific to the study tasks which may help broaden our knowledge of 







Thirty five participants were initially recruited for this study, comprising nineteen PD patients 
meeting the UK Parkinson’s Disease Society Brain Bank Clinical Diagnosis criteria (Hughes 
et al, 1992) and sixteen healthy controls matched for sex ratio, mean age and years of 
education (see Table 5-1 and Table 5-2 for patient demographics). Patients were recruited 
from a database of participants who had previously undertaken eye movement experiments in 
our laboratory. Participants who had stated an interest in participating in future PD research 
were sent an information sheet and cover letter regarding the project. This initial phase was 
followed up by a phone call confirming interest and setting an appointment. The Montreal 
cognitive assessment (MoCA) was assessed for all participants and the MDS-UPDRS part III 
(Goetz et al., 2008) for PD patients. 
Three of the nineteen PD patients recruited were excluded from this study with fatigue 
affecting their ability to correctly perform the eye movement tasks. Controls were healthy 




Table 5-1– Clinical and demographic characteristics of the PD and Control groups. 
  PD SD   Control SD 
 (n=16)   (n=16)  
Age 67.3 7.5  68.1 6.2 
Sex M:F 13:03   13:03  
MoCA 26.8 2.2  27 2 
Years education 13.6 2.8  13.7 2.4 
UPDRS III 29.1 10.5  - - 
 
Table 5-2 – Individual study participant demographics and characteristics. 
Group Age Sex Years of education MoCA UPDRS III 
    
  
PD 49 M 18 30 19 
PD 56 M 16 30 29 
PD 60 M 18 29 32 
PD 62 M 14 30 23 
PD 65 M 11 27 13 
PD 66 M 17 27 21 
PD 67 F 12 28 29 
PD 68 M 11 24 32 
PD 70 M 11 27 25 
PD 70 F 11 25 29 
PD 71 M 10 25 27 
PD 73 M 12 27 41 
PD 74 M 12 23 36 
PD 75 M 16 27 51 
PD 75 M 12 26 45 
PD 75 F 16 24 14 
      
Control 53 M 18 28 - 
Control 60 M 17 28 - 
Control 61 M 17 30 - 
Control 65 M 11 28 - 
Control 66 M 16 26 - 
Control 67 M 13 28 - 
Control 67 F 13 22 - 
Control 67 M 14 27 - 
Control 70 M 11 25 - 
Control 71 M 10 27 - 
Control 71 F 15 29 - 
Control 73 M 12 25 - 
Control 74 M 12 25 - 
Control 74 M 15 28 - 




The first part of this study involved a single session at the New Zealand Brain Research 
Institute eye movement laboratory. This visit consisted of participants undergoing the same 
saccadic tasks that would be used subsequently in the MRI machine. Eye movements were 
recorded and tracked using the eye-tracking system detailed in Chapter 2 (see page 80). 
Eye movements tasks carried out in the MRI scanner were presented and recorded using the 
Real Eye imaging system (Avotec, Inc).As mentioned previously, this setup proved to be 
unreliable for the most part and prone to losing tracking of gaze position. Hence in-bore eye 
movement data was not used in this study, although eye video was able to be used to confirm 
task compliance within the scanner. 
5.2.3 Eye	movement	task	types	
Three eye movement tasks were used: reflexive, predictive and fixation. These represent 
reflexive and volitional eye movements, with fixation representing a control task with no eye 
movements. 
The reflexive task involved the participant following a square stimulus, which jumped left and 
right at pseudorandom amplitudes and intervals. The target for the reflexive task was 
randomised to jump left or right horizontally in 10, 15 and 20 degree increments in the 
horizontal plane at one of 7 locations, each separated by 5 degrees visual angle (7 possible 
target locations at -15, -10, -5, 0, 5, 10 and 15 degrees of visual angle). The time between 
each jump was pseudo-randomised in 500, 750 or 1000 ms interval balanced across trials so 
that the mean inter-trial interval was 750 ms. Hence, 36 trials occurred in each 27 second 
block. The total stimulus amplitude for each block was kept equal for leftward and rightward 
directions i.e. each stimulus jump was pseudo-randomised left or right, moving either 10, 15 
or 20 degrees each time so that the total amplitude of rightward stimuli shifts were kept equal 
to total leftward shifts. 
The predictive task involved the participant following a stimulus as it jumped back and forth 
between two fixed locations at a constant interval. The stimulus moved back and forth 
horizontally at regular intervals between two positions at -10 degrees and +10 degrees 
horizontally from centre at 750 ms intervals. 36 predictive trials occurred in each 27 second 
block. Thus the number of trials per block (36) matched the reflexive trials. 
For fixation, a square stimulus simply remained stationary at the centre of the screen for 27 
seconds, upon which participants were instructed to maintain gaze. 
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The eye movement tasks were arranged as a block design for fMRI scanning. Each block was 
a set time period in which the participants performed one of the eye movement tasks 
continuously. A block was made for each eye movement task - reflexive, predictive and 
fixation. A pilot study was used to determine the number of trials within each block needed to 
give a reliable task contrast. The resulting stimulus sequences were found to provide 
significant activation in the known areas of eye movement control, while keeping the overall 
task duration within reasonable time limits to minimise patient fatigue. A reflexive block was 
presented first, followed by the predictive block followed by fixation. Each task block lasted 
27 seconds for each task. This three-block sequence was repeated four times, giving a total 
task duration of 324 seconds ((27 s × 3 block repetitions) × 4 = 324 s), or 5 min 24 seconds.  
5.2.4 Magnetic	resonance	imaging	protocol	
Images were obtained from a 3.0 Tesla General Electric HDx scanner (GE Healthcare, 
Milwaukee, WI, USA) with an eight-channel head coil as detailed in Chapter 2 (see page 85). 
The scanning protocol included T1 structural MRI, arterial spin labelling (ASL), diffusion 
tensor imaging (DTI) and functional MRI (fMRI). The scans took place within one session, 
with a total scanning time of approximately 1 hour per participant. Participants lay supine on 
the scanner bed and were instructed to remain as still as possible for the scanning duration. To 
further minimize movement, foam padding was placed around the head. Headphones were 
provided to allow instructions to be conveyed to the patient and to protect against scanner 
noise. Scanning parameters can be found in Chapter 2 (see page 85). 
5.2.5 Data	processing	
Scans were pre-processed using the software SPM8 using the technique desribed in section 
1.4.2.3 page 64.  
Functional images were then realigned to minimise the impact of head movement. The mean 
functional image was co-registered to the T1 weighted image, shifting all scans from all tasks 
to be aligned with the structural scan using the anterior commissure as the [0 0 0] co-ordinate. 
The normalization parameters produced during the unified segmentation and normalization 
step were then used to warp the slice timing-corrected, co-registered functional images into 
MNI space. The final step was to smooth the pre-processed images using an isotropic 
Gaussian kernel with a full width at half maximum of 8 × 8 × 8mm. 
5.2.6 Statistical	analysis	
A first-level analysis was performed for every subject. Scans were entered into a model with 
the onsets and duration of each block specified in SPM8. The reflexive task and the predictive 
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task were entered as two conditions. Fixation, being the third condition, was not entered into 
the model as it was the baseline condition, a value which is calculated by SPM8 as the 
constant. Having both a fixation and constant would mean a partial correlation between the 
two data sets which produces inefficient statistical estimation of voxel activation (Pernet, 
2014). Motion correction parameters in 6 axes produced during pre-processing were added 
into the model as regressors. Contrast files between the reflexive task and baseline (equivalent 
to fixation), the predictive task and baseline, reflexive activity greater than predictive activity 
and predictive activity over reflexive activity were generated for every participant (see Figure 
5-1 for an example of the design matrix for a first level or single subject analysis). These 
contrast files were entered into a second level comparison between the two experimental 
groups – PD and controls. Age, Sex and MoCA were entered into the second level analysis as 
covariates. Figure 5-2 shows the design matrix for this second level or group analysis. A 
display of the regions of BOLD activation was generated using SPM8. 2D slice images of 
BOLD activation were generated using the program xjView and were superimposed over a 
normalised structural MRI scan from an elderly brain template. Locations for each brain 
region were determined using xjView. Second level comparisons were corrected for multiple 
comparisons using voxel-wise FWE with p < 0.05. 
 
Figure 5-1 – Graphical representation of the first-level design matrix for a single participant. Columns A 
and B represent the conditions of the block trial – “A” represents reflexive BOLD activity, “B” for 
predictive activity. Columns C to H represent motion correction adjustment parameters generated during 
the pre-processing step. Column I is the constant or baseline activity of the fMRI scans. The brightness or 
intensity of each area represents the numeric values of each parameter. Moving from the top to the 






Figure 5-2 – Second-level design matrix for the block design task. The brightness of each area represents a 
numerical value. The first two columns are formed from the average of the contrast files for PD in group 1 
and controls in group 2. Columns further to the right represent covariate values for age and sex. 
5.3 Results	
5.3.1 Eyelab	results	
Saccade performance measures of task latency and primary gain are reported in Table 5-3. 
There was a significant difference in the primary gain between PD and controls in both the 
reflexive and predictive task. In both reflexive and predictive tasks, the PD group made 
shorter saccades, initially undershooting the target compared to controls. The PD group also 
initiated saccades significantly earlier than controls in the predictive task, indicated by a lower 
latency. In comparison, for the reflexive task, there was no statistical difference between PD 
and controls in latency. 
Table 5-3 – Group mean and standard deviation (SD) values for saccade performance values as measured 
in the eyelab. The PD group made undershooting saccades (i.e. significantly reduced in gain) compared to 
controls and initiated saccades earlier in the predictive task (i.e. with a significantly lower latency). 
Task parameter   Control (SD)   PD (SD)   t-Test p-value 
         
Reflexive latency (ms)  201 -19  194 -33  0.54 
Reflexive primary gain  0.91 -0.04  0.81 -0.09  < 0.001 
         
Predictive latency (ms)  88 -80  -41 -146  0.005 




The fMRI findings are presented either as a transparent "glass brain" view of the activations, 
in which the active areas are seen as grey-black regions, or transverse slices of the 3D fMRI 
brain image, in which BOLD activity is coloured yellow-red and is overlaid on axial slices of 
a structural elderly brain template. 
5.3.2.1 Reflexive	vs	Fixation	
In the control group, significant areas of activation were seen in the FEF, SEF, PPC, PEF, 
precuneus, cuneus, middle temporal gyrus and occipital lobe. FEF activity was bilateral and 
formed a wide area in Brodmann’s area 6 in the middle frontal gyrus and the precentral gyrus 
(For a review of FEF location, see Vernet et al. 2014). From this, the FEF cluster visually 
appears as an adjoining medial and lateral clusters, within the total FEF activation (see Figure 
5-3). I term these areas the medial FEF and lateral FEF.  
 
Figure 5-3 – Medial and lateral FEF regions labelled using a sample fMRI image. Activations are seen in 
orange. The two slices pictured are the same image. The rectangle highlights the FEF regions in the left 
image. In the right image, the region labelled “L” represents the lateral FEF and “M” represents the 
medial FEF. 
SEF activation was seen centrally in the medial frontal gyrus. Parietal lobule and Brodmann 
area 7 activations were seen, corresponding to the PPC/PEF (as described in Muri et al., 
1996). Parietal activation also appeared as two adjoining clusters, with one cluster located in 
the superior parietal lobule and the other in the inferior. For the PD group, the active areas 
were very similar to what was seen for the controls, with significantly active areas in the FEF, 
SEF, PEF, PPC, middle temporal gyrus, precuneus and cuneus, cingulate cortex and occipital 
cortex. These imaging results for the control and PD group can be seen in Figure 5-4 and 
Figure 5-5 respectively. Table 5-4 and Table 5-5 show the peak voxel locations of the active 
regions. Visually, controls showed activity in the right thalamus, Brodmann areas 22 and 13 
(located in the superior temporal gyrus) and Brodmann area 40 (in the inferior parietal 
lobule), which were not seen in the PD group. These apparent differences did not survive a 









Figure 5-4 – Voxels showing reflexive saccade activity greater than fixation for the control group only. (A) 
shows BOLD activation (black) for reflexive vs fixation overlaid on a transparent brain in coronal, sagittal 
and transverse planes. (B) shows the same areas of activation (orange) overlaid on an average elderly 
brain template in the transverse plane through the 3D scan. All areas of activation are corrected for 
multiple comparisons FWE, p < 0.05). BOLD activation can be seen in the thalamus, precuneus, posterior 
parietal cortex, the occipital lobe, FEF and SEF. The FEF region appears as a wide cluster with what 
appears visually to be two sub-clusters, one medial and one lateral. The parietal activation can also be 









Figure 5-5 – Voxels showing reflexive saccade activity greater than fixation for the PD group only. (A) 
shows BOLD activation (black) for reflexive vs fixation overlaid on a transparent brain in coronal, sagittal 
and transverse planes. (B) shows the same areas of activation (orange) overlaid on an average elderly 
brain template in a transverse plane through the 3D scan. All areas of activation are corrected for 
multiple comparisons FWE p < 0.05). BOLD activation can be seen in the precuneus, posterior parietal 
cortex, the occipital lobe, FEF and SEF. As with controls, the FEF region appears as a wide cluster with 
medial and lateral sub-clusters. The parietal activation also appears as sub-clusters in the superior and 




Table 5-4 – Locations of peak BOLD activation for the Control group: reflexive greater than 
fixation contrast. 
   MNI coordinates 
Frontal lobe T value Z value X Y Z 
Lateral FEF Brodmann Area 6 L 11.95 6.99 -40 -6 48 
lateral FEF Brodmann Area 6 R 11.45 5.85 46 -2 50 
Medial FEF Brodmann Area 6 L 10.45 5.56 -28 -10 54 
Medial FEF R 11.83 5.95 24 -5 54 
SEF Medial Frontal Gyrus 10.34 5.52 2 2 52 
Inferior Frontal Gyrus R 7.24 5.35 52 6 18 
      
Parietal lobe           
Superior Parietal Lobule L 12.12 7.04 -26 -60 60 
Inferior Parietal Lobule L 5.93 4.7 -48 -38 30 
Inferior Parietal Lobule R 7.67 5.54 30 -55 48 
Precuneus L 10.85 5.58 -22 -55 52 
Precuneus R 8.55 5.94 8 -52 58 
Brodmann Area 40 Inferior Parietal Lobule L 5.4 4.95 -45 -40 50 
Brodmann area 40 Inferior Parietal Lobule R 6.31 4.9 44 -45 48 
      
Occipital lobe           
Lingual Gyrus L 9.75 6.33 -10 -82 -2 
Lingual Gyrus R 9.96 6.4 8 -80 0 
Middle Occipital Gyrus R 7.77 5.58 32 -75 14 
Cuneus L 7.55 5.49 -20 -74 12 
Brodmann area 19 – lingual Gyrus R 7.13 5.3 15 -55 -4 
      
Temporal Lobe           
Middle Temporal Gyrus L 8.09 5.72 -44 -55 4 
Brodmann Area 22 Superior Temporal Gyrus R 7.69 5.55 58 -48 8 
Brodmann Area 13 Superior Temporal Gyrus R 6.87 5.18 52 -46 20 
      
Cingulate cortex and thalamus           
Brodmann Area 24 Cingulate Gyrus R 7.9 5.54 16 6 52 
Thalamus R 5.8 4.63 10 -16 2 
Cingulate Gyrus L 11.12 5.75 -12 -2 50 
       




Table 5-5 – Locations of peak BOLD activation for the PD group: reflexive greater than fixation 
contrast. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
Lateral FEF Brodmann area 6 L 10.05 6.43 -40 -4 48 
Lateral FEF Brodmann area 6 R 10.44 6.56 46 2 50 
Medial FEF Middle Frontal Gyrus L 8.09 5.72 -25 0 56 
Medial FEF Middle frontal gyrus R 9.91 5.39 22 -5 50 
SEF Medial Frontal Gyrus 9.53 5.29 2 2 52 
Brodmann Area 9 - Precentral Inferior Frontal Gyrus L 5.89 4.58 -48 4 35 
Brodmann Area 44 L 5.76 4.61 -52 10 8 
Brodmann Area 44 R 6.96 5.22 54 10 18 
      
Parietal lobe           
Superior Parietal Lobule L 10.94 6.71 -26 -60 60 
Superior Parietal Lobule R 8.26 5.79 28 -56 46 
Postcentral Gyrus L 7.43 5.44 -36 -50 60 
Inferior Parietal Lobule L 7.34 5.4 -38 -42 46 
Brodmann Area 7 Precuneus L 5.79 5.14 -15 -55 64 
Precuneus R 7.99 5.68 24 -52 52 
      
Occipital lobe           
Lingual Gyrus L 8.58 5.95 -18 -82 -2 
Lingual Gyrus R 9.04 6.08 8 -80 0 
Cuneus 5.84 4.66 -22 -88 10 
Brodmann Area 19 - Fusiform Gyrus R 5.81 4.64 24 -74 -8 
      
Temporal lobe           
Middle Temporal Gyrus R 7.22 5.34 46 -48 6 
      
Cingulate cortex           







Increased bilateral FEF and SEF activity was seen in the control group while performing the 
predictive task. In addition, activity was seen in the superior parietal lobule bilaterally, the 
right inferior parietal lobule, the superior temporal gyrus, the middle temporal gyrus and the 
lingual gyrus. These findings can be seen in Figure 5-6. A table of the peak voxel locations 
for each cluster is shown in  
Table 5-6. Areas seen to be active for the PD group were the FEF, the SEF and the left 
superior temporal gyrus. Interestingly, no significant parietal activation was seen in the PD-
only analysis. These findings are displayed in Figure 5-7 with Table 5-7 showing the 
locations of peak voxel activation for each cluster. A direct voxel-based comparison of these 









Figure 5-6 – Voxels showing predictive saccade activity greater than fixation for the control group only. 
(A) shows BOLD activation (black) overlaid on a transparent brain in coronal, sagittal and transverse 
planes. (B) shows the same areas of activation (orange) overlaid on an average elderly brain template in a 
transverse plane through the 3D scan. All areas of activation are corrected for multiple comparisons FWE 










Figure 5-7 – Voxels showing predictive saccade activity greater than fixation for the PD group only. (A) 
shows BOLD activation (black) overlaid on a transparent brain in coronal, sagittal and transverse 
planes. (B) shows the same areas of activation (orange) overlaid on an average elderly brain template in 
the transverse plane through the 3D scan. All areas of activation are corrected for multiple 
comparisons FWE p < 0.05). Activity is seen in the FEF, SEF and in the left superior temporal gyrus. 







Table 5-6 – Locations of peak BOLD activation for the control group: predictive greater than fixation 
contrast. 
   
Frontal Lobe T value Z value X Y 
Lateral FEF Brodmann Area 6 L 6.62 5.06 -42 -5 
Lateral FEF Precentral Gyrus R 9.58 6.27 48 -4 
Medial FEF Brodmann Area 6 L 7.2 5.33 -30 -8 
Medial FEF Brodmann Area 6 R 6.64 5.07 30 -5 
SEF Brodmann Area 6 9.08 6.1 4 6 
Parietal Lobe         
Brodmann Area 7 Superior Parietal Lobule L 6.38 4.94 -28 -58 
Superior Parietal Lobule R 7.46 5.45 22 -66 
Inferior Parietal Lobule R 5.56 4.5 30 -54 
     
Temporal Lobe         
Middle Temporal Gyrus L 6.88 5.19 -46 -62 
Middle Temporal Gyrus R 7.15 5.31 44 -66 
Superior Temporal Gyrus R 6.93 5.21 56 -42 
     
Occipital Lobe         
Lingual Gyrus L 6.61 5.05 -10 -74 
Brodmann Area 18 - Lingual Gyrus L 6.19 4.84 -22 -75 
Brodmann Area 19 - Lingual Gyrus R 5.72 4.59 18 -64 
 
 
Table 5-7– Locations of peak BOLD activation for the PD group: predictive greater than fixation contrast. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
Lateral FEF Precentral Gyrus L 6.59 5.05 -48 -6 52 
Lateral FEF Precentral Gyrus R 10.1 6.45 48 -4 50 
Medial FEF Middle Frontal Gyrus L 5.5 4.47 -28 -4 48 
Medial FEF Middle Frontal Gyrus R 5.88 5.19 30 -5 48 
SEF Superior Frontal Gyrus 9.43 6.22 6 6 62 
      
Temporal lobe           






A contrast of the reflexive over the predictive task shows which areas were more active 
specifically in the reflexive task compared to the predictive. Notably, greater bilateral medial 
FEF activity is seen in the control group (Figure 5-8) and PD group (Figure 5-9). No 
difference in lateral FEF activity was seen for either group for this comparison. Within the PD 
group, significantly greater activity was also seen in the PPC and PEF for the reflexive task vs 
the predictive task. These parietal activations were located in the superior and inferior parietal 
lobules and Brodmann area 7. Unlike the PD group, no parietal activation reached significant 
levels within the control group in this comparison. When a direct voxel-based comparison 
was made between the PD and controls, however, there were no significant group differences 
(FWE-corrected p < 0.05). Peak voxel locations for each group is shown in Table 5-8 and 
Table 5-9. 
Figure 5-10 and Figure 5-11 give a side-by-side view of all the comparisons which have been 









Figure 5-8 – Voxels in control group-showing activation greater for the reflexive task compared to the 
predictive task. (A) shows BOLD activation (black) overlaid on a transparent brain in coronal, sagittal 
and transverse planes. (B) shows the same areas of activation (orange) overlaid on an average elderly 
brain template in the transverse plane through the 3D scan. All areas of activation are corrected for 
multiple comparisons FWE p < 0.05). Greater activity was seen in the medial frontal eye field bilaterally. 









Figure 5-9 – Voxels in PD group showing activation greater for the reflexive task compared to the 
predictive task. (A) shows BOLD activation overlaid on a transparent brain in coronal, sagittal and 
transverse planes. (B) shows the same areas of activation overlaid on an average elderly brain template in 
a transverse plane through the 3D scan. All areas of activation are corrected for multiple comparisons 
FWE p < 0.05). Activity is seen in the medial frontal eye field bilaterally as well as the superior parietal 




Table 5-8 – Locations of peak BOLD activation for the Control group - reflexive greater than predictive 
comparison. 
   MNI coordinates 
Frontal lobe T value Z value X Y Z 
Medial FEF L 5.89 4.68 -24 -4 56 
Medial FEF R 7.4 5.42 22 -2 54 
 
Table 5-9 – Locations of peak BOLD activation for the PD group – reflexive greater than predictive 
comparison. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
Medial FEF L 7.16 5.32 -22 -4 56 
Medial FEF R 8 5.68 22 -4 56 
    
Parietal lobe          
Brodmann Area 7 L 7.95 5.66 -16 -66 62 
Brodmann Area 7 R 8.08 5.71 22 -62 44 
Precuneus L 6.08 4.78 20 -60 48 
Precuneus R 7.58 5.5 18 -66 52 
Superior Parietal Lobule L 6.82 5.16 -24 -66 60 
Inferior Parietal Lobule R 5.5 4.46 42 -44 38 






Control activation comparison for all tasks 
 
Figure 5-10 – Summary of the activation differences for controls in the reflexive task greater than fixation, 
the predictive task greater than fixation and the reflexive task greater than predictive task. BOLD activity 
is seen in orange. In the reflexive greater than predictive comparison, the medial FEF subregion was 
significantly more active in the reflexive task than the predictive. 
 
PD activation comparison for all tasks 
 
Figure 5-11 – Summary of the activation differences for PDs in the reflexive task greater than fixation, the 
predictive task greater than fixation and the reflexive task greater than predictive task. BOLD activity is 
seen in orange. In the reflexive greater than predictive comparison, the medial FEF subregion was 
significantly more active in the reflexive task than the predictive. Parietal regions in the superior parietal 




No significant differential activity was observed either within PD or control groups or in a 

















From our results, we are able to comment on general eye movement control from our 
findings. Overall, there were no significant functional group differences able to be detected 
between PD and controls. This argues against my initial hypothesis, with the results of this 
study suggesting saccade performance differences between groups are not reflected in a 
significant functional difference detectable using fMRI. The possible reasons behind these 
findings are covered further in the discussion section below. To list briefly, it is likely that 
PD-related functional changes are small and are unable to be detected using the limitations of 
our current fMRI setup. The lack of significant change may be due to inadequate patient 
numbers, however it should be noted that our study is a comparatively large one in the fMRI 
literature (Herz et al., 2014). The results may also be due to the relatively mild severity within 
the patient group, with the study confined to mainly PD-N and PD-MCI patients.  
The finding of a differentiation between medial and lateral FEF activation satisfies the goal 
posed initially regarding broadening our knowledge of general eye movement control. This 
finding allowed new interpretations of FEF subregion function. The details of this finding are 
discussed in sections 5.4.3 titled “FEF subregions” below. 
5.4.2 Discussion	of	study	findings	
Several differences, mainly seen in the parietal lobe, were noted between PDs and controls 
from their separate group analysis. The PD group visually showed less parietal lobe activity 
for the predictive task compared to controls. In the reflexive task, both groups showed large 
areas of parietal and frontal activation. When comparing reflexive activity to predictive 
activity, the PD group showed bilateral parietal activity in the superior and inferior parietal 
lobule specific to the reflexive task over the predictive task whereas controls did not show 
this. Taking the findings from each group separately, it would appear that parietal lobe 
activity in PD patients was more prominent in the reflexive task and less in the predictive task 
compared with controls. All these differences were significant after correcting for multiple 
comparisons within each single group, however, when PD and controls were directly 
compared, there were no significant differences. Hence we must bear in mind the “imager’s 
fallacy” noted earlier – although there appear to be compelling visual differences in group 
activations, these did not survive when directly compared in the model. 
fMRI studies of eye movement performance in PD are limited but a number have reported 
parietal lobe activity differences in PD. A recent study by Lemos et al. (2016) comparing 
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antisaccade activation to prosaccades in a block fMRI paradigm suggests compensatory 
parietal lobe activity in prosaccades may be present in PD. Rieger et al. (2008) reported 
increased inferior parietal lobule activity in PD for a volitional (self-paced) saccade task over 
fixation compared to unaffected controls. Reiger et al. reported these differences using an 
indirect, visual-based comparison, which might not have remained in a direct voxel-wise 
comparison as described by the imager’s fallacy. When a voxel-wise whole-brain comparison 
was made between PD and controls in our study, no significant difference remained. This 
suggests no significant group differences in cortical function for the reflexive and predictive 
task. Thus, either any possible differences between PD and controls in the reflexive and 
predictive task are too subtle to survive our correction criteria, or were not suitably elicited 
using our specific experimental paradigm.  
 
FEF activity was observed as medial and lateral sub-clusters, in both the reflexive task and the 
predictive task for both groups. The medial FEF was more active in the reflexive task than the 
predictive task in both groups. This would suggest that while both the medial and lateral FEF 
are active in the reflexive and predictive tasks, the medial FEF has activity specific to the 
reflexive saccade task. In this next section, I discuss the present knowledge on FEF subregion 
function before presenting further evidence to support this claim. 
5.4.3 FEF	subregions	
Both medial and lateral FEF activity was observed in our reflexive saccade task. When 
reflexive activity was compared to the predictive task, in each group we saw distinct medial 
FEF activation in the reflexive task over the predictive task, with no difference in the lateral 
FEF. The results of this study support the notion that the FEF comprises of functional 
subregions, with one region involved more in the process underlying saccade generation to 
unpredictable targets, and another region more involved in saccades to known predictable 
locations at known times. This idea of the FEF operating as separate subregions has been 
discussed in the introduction and there is uncertainty on the specific function of each 
subregion, or even how the FEF is functionally organised: A medial/lateral division has been 
described (Gagnon et al., 2002; Simo, 2005) as well as a superior/inferior division (Luna et 
al., 1998). 
One unlikely but potential cause of task activation differences is the difference in cumulative 
total saccade amplitude between the reflexive and predictive tasks blocks in this study. This 
cumulative total saccade amplitude across all trials in a reflexive task block was not equal to 
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the cumulative total saccade amplitude in the predictive task. In the reflexive task, the mean 
saccade amplitude was 15 degrees of visual angle while the predictive task has an average 
saccade amplitude of 20 degrees. The number of trials per block was the same between 
reflexive and predictive task (36 trials) - thus the total saccade amplitude per predictive task 
block is greater than in each reflexive task block.  
A possible mechanism by which this could cause activation differences is from the increase in 
time spent in saccade travel due to the greater visual angle “distance” covered. This may 
cause increased cortical activity, should the time spent in saccade travel relate to an increased 
duration of cortical activity needed to maintain the saccade over a longer distance. This 
increase in time, however, would be in the region of milliseconds per movement, but 
accumulated over multiple trials in a block-design task, could potentially cause activation 
differences. I am not aware of any functional imaging studies investigating the effect of 
cumulative saccade amplitude on BOLD signal changes and this is an unlikely cause for task 
activation differences. It has been shown before that saccade amplitude itself (from single 
saccades, not cumulative) does not correlate with BOLD signal changes (Kimmig et al., 
2001). Rather it is the number of saccades generated which correlates with BOLD activity, a 
factor which was kept constant between tasks in this study. It is pertinent to note that the 
reflexive task showed increased FEF activity compared to the predictive, despite having a 
lower cumulative saccade amplitude. No cortical regions were significantly more active in the 
predictive task when contrasted with the reflexive task. Thus, from our results, no increase in 
cortical activity was observed in the task with the higher cumulative saccade amplitude, 
making it impossible to argue that cumulative amplitude causes any increase in BOLD 
activity. The alternative, opposite possibility of an increased cumulative saccade amplitude 
leading to decreased activity does not fit into any currently proposed mechanism of eye 
movement control I am aware of. The FEF is known to have a neural distribution reflecting a 
topographic map of saccade direction and size. Micro-stimulation of the FEF at any site 
produces a saccade with a specific amplitude (Bruce et al., 1985). At a cortical level, at least, 
a large saccade is generated not by an increase in signal, but by activation of the FEF area 
corresponding to the specific size of the saccade. This makes it less likely cumulative total 
saccade amplitude corresponds to greater activation. Rather it is more likely individual 
saccade size variation contributes to FEF sub-region activation. By design, the reflexive task 
elicits variable saccade amplitudes, while the predictive task elicits one single amplitude, 
which may contribute to differences in FEF activity. This will be discussed further but 
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beforehand, I will briefly summarise other potential functions of FEF subregions described in 
the literature. 
5.4.3.1 FEF	subregion	function	in	saccade	tasks	
Petit et al. (1997;1999) and Berman et al. (1999) identified an FEF region related to smooth 
pursuit, located more inferior and lateral, than the saccade-related FEF. In attention studies, 
separate superior and inferior activations in the FEF for overt attention shifts that occur with 
eye movements and covert attention shifts with no eye movement have been reported 
(Beauchamp et al., 2001). In saccade-only trials, divisions of the FEF into a superior and 
inferior region have been described (Heide et al., 2001). In their self-paced task, a more 
inferior (and posterior) activation within the FEF was seen when compared to memory or 
visually-guided saccades. 
 
A medial and lateral FEF division as described in our study has also been reported previously. 
Ettinger et al. (2008) found the (right) lateral FEF had a more selective involvement in 
antisaccade generation, with the medial FEF more associated with saccade inhibition than 
generation. Lobel et al., (2001) contrasted an fMRI study with a human intracerebral electrical 
stimulation study performed prior to surgery. They observed that the lateral FEF region was 
more active in the repetition of newly memorised saccade sequences than the medial portion. 
Their findings show similarity to our findings whereby the lateral FEF region was active in 
the predictive saccade task in which participants execute a saccade to a newly memorised 
location. 
Grosbras et al. (2001; 2005) described dorso-medial and lateral FEF subregions. They 
reported that the dorso-medial FEF had more activity during novel saccades sequences while 
the lateral FEF showed no significant difference. They speculated, based on the study by 
Koyama et al. (2004) that the dorso-medial cluster is likely to represent the “proper” frontal 
eye field, equivalent to that in the macaque, whilst the ventral lateral cluster could be 
equivalent to part of the macaque pre-motor area. Luna et al., (1998) described a superior and 
inferior FEF in their reflexive saccade fMRI study, the Talairach (Talairach & Tournoux, 
1988) coordinates of their superior FEF located roughly at the location of our medial FEF 
(See Table 5-10). 
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Table 5-10 – Superior and inferior FEF location in Talairach space as reported by Luna (1998) and Heide 
(2001) compared to our study. MNI coordinates from our study were transformed to Talairach 
coordinates using a process described by Lacadie, Fulbright, Constable, & Papademetris (2008) for 
comparison. 
Study Region     Left       Right   
   x y z  x y z 
Luna FEF - superior  -30.2 -4.1 49.1  34.2 -3.4 46.9 
-1998 FEF - inferior  -42.6 7.3 40.6  43.7 7.5 38.3 
 
FEF - superior  -32 -8 52  32 -4 56 Heide 
-2001 FEF - inferior  -48 -4 40  44 -8 48 
          
          
Feng FEF - medial  -29 0 49  24 -2 50 
-2017 FEF - lateral  -39 -2 44  44 0 47 
 
[(Lacadie, Fulbright, Constable, & Papademetris, 2008) ] 
Luna et al. (1998) found a higher degree of activation in the superior than inferior FEF for the 
reflexive task. The reported results are broadly consistent with our observation that the medial 
FEF demonstrated greater activity in the reflexive task than the lateral FEF. 
Other studies using different paradigms have described alternative functions for each FEF 
region. A combined electroencephalography/magnetoencephalography (EEG/MEG) study by 
McDowell et al. (2005) into pre-saccadic activity for anti and prosaccades found lateral FEF 
activity appeared first but levelled off 70 ms before antisaccade generation, whereas for 
prosaccades, the level of lateral FEF activity continued to rise until saccade generation. This 
pattern was said to reflect an inhibitory signal reaching the lateral FEF in the antisaccade task, 
preventing a programmed reflexive saccade made towards the cue. In contradistinction, the 
medial FEF showed a consistent rise in activity immediately prior to both pro and 
antisaccades, with no levelling off, resulting in higher pre-saccade activity in the medial FEF 
for antisaccades compared to prosaccades. 
On initial reading, this report of higher medial FEF activity in an antisaccade (volitional) task, 
compared to a prosaccade (reflexive) task appear to contradict our own findings of more 
activity in the medial FEF for reflexive saccades compared to predictive (volitional) saccades. 
However, differences in test paradigm used by McDowell et al. mean the observations from 
their study cannot provide meaningful comparison with our results. The prosaccade task used 
by Mcdowell et al. has similar elements to both the reflexive and predictive task used in our 
study - the time interval between each trial was kept the same in each task. This introduced a 
predictable timing element to their prosaccade task, with only direction remaining as an 
unpredictable factor, as in our reflexive task. The antisaccade task is a more complex type of 
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volitional saccade task than the predictive task. It requires reflexive saccade suppression, as 
well as a self-generated saccade to a mirror-opposite location (to the target). The study by 
McDowell and colleagues examined pre-saccade activity at 150 ms before the saccade was 
made. Our block design fMRI activation also encompasses pre-saccade activity, in addition to 
the activity during and after the saccade. In spite of these experimental differences, it remains 
pertinent to note the antisaccade task is also associated with medial and lateral FEF specific 
activations, supporting the idea that the FEF may operate as functionally separate medial and 
lateral subregions.  
5.4.3.2 FEF	subregions	and	saccade	size	contribution	
As previously mentioned, one hypothesis to account for the functional differences between 
the medial and lateral FEF includes the influence of saccade size (Gagnon et al., 2002; Heide 
et al., 2001). Heide et al., suggest the FEF comprises superior and inferior regions, 
corresponding to the medial and lateral FEF in our experiment respectively (Table 5-10). In 
their experiment, internally-triggered self-paced saccades showed a more inferior (lateral) 
FEF activation than a visually-guided (reflexive) or memorised saccades. These differences 
were attributed to saccade size; the self-paced task elicited a larger amplitude saccade and was 
said to activate the inferior (lateral) FEF, compared to the smaller amplitude saccades elicited 
in the reflexive and memorised saccade task, said to involve the superior (medial) FEF region. 
Gagnon et al. provided a similar explanation for medial and lateral FEF activations in their 
study. Gagnon et al. studied reflexive and predictive saccades and maintained a consistent 14-
degree amplitude for all saccade tasks in their study. Participants were described as needing to 
generate a large initial saccade with smaller corrective saccades to reach the final eye 
position. These large and small saccades were thought to correspond with saccade size 
specific regions in the medial and lateral FEF, although it is not directly stated which FEF 
sub-region is responsible for larger or smaller saccades. 
The explanations for medial and lateral FEF activation discussed above conflict with 
observations in other studies. In primate electrostimulation studies, large saccades (20-60 
degrees) were generated by the dorso-medial FEF and smaller saccades (1-5 degrees) by the 
ventro-lateral FEF (Bruce et al., 1985; Robinson & Fuchs, 1969) in contradiction to the 
observations by Gagnon, Heide and colleagues. Paus (1996), who was referenced by both 
these studies, did address this issue in his review. Paus noted a variability of FEF location on 
the X-axis (left to right). The left FEF was seen to vary from X= -20 to -40 mm and the right 
from X = 21 to 40 mm using the Talairach co-ordinate system (Talairach & Tournoux, 1988) 
and Paus proposed that the apparent variation in FEF location could reflect regions of the FEF 
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being active for different saccade sizes related to the different types of task. Paus did concede 
that the study by Robinson & Fuchs (1969) did not support the notion that larger saccades 
involved lateral FEF. Paus concluded, however, that the medial FEF region was involved in 
the generation of comparatively small saccades and lateral FEF region in large gaze shifts 
involving simultaneous eye and neck muscle activation, rather than large saccades alone. The 
studies reviewed by Paus used saccade amplitudes from 5 degrees to 90 degrees, with the 
larger stimulus amplitudes likely to involve some inadvertent gaze-related neck muscle 
activation. In eye movement laboratory testing, our study employed a maximum of 20 degrees 
of gaze shift for both reflexive and predictive tasks. Gaze shifts of under 20 degrees do not 
require a head movement contribution (Freedman & Sparks, 1997). It is important to note the 
visual angle of the stimuli presented using the goggle system within the MRI machine has not 
yet been determined by the manufacturer. The visual angles, however, are unlikely to differ 
from laboratory measures by significant amounts. While inadvertent neck muscle activation 
was not able to be directly controlled, patients were asked to remain as still as possible during 
testing and used head braces and chin rests as appropriate. Our comparatively small saccade 
amplitudes compared to studies described by Paus makes it less likely that recruitment of 
regions involved in large gaze shifts occurred in our tasks. Hence, we do not attribute lateral 
FEF activation seen in our study to larger saccades or gaze shifts and believe other processes 
may be involved.  
Having reflexive saccades jump in 10, 15 and 20 degree increments and the predictive task all 
jumping in 20 degree increments allows an interesting comparison between saccade amplitude 
and cortical activation. The medial FEF has been previously noted to be responsible to 
generate saccades 20-60 degrees. Every cued saccade in the predictive task is 20 degrees of 
visual angle. Only a portion of the reflexive task saccades are 20 degrees, with 15 and 10 
degree saccades mixed within the trial. Should saccade amplitude be the cause behind FEF 
activation differences, we would expect to see greater medial FEF activity in the predictive 
task, due to the higher number of saccades falling within the amplitude which is controlled by 
the medial FEF compared to the reflexive task. This was not seen, and instead, higher medial 
FEF activity was seen in the reflexive task, despite fewer saccades made in the amplitude 
range thought to be controlled by the medial FEF. Hence it is unlikely the cause of activation 
differences in the medial FEF is due to the generation of certain saccade amplitudes. 
Another possible explanation for the differences observed is that in the predictive task - more 
corrective – and thus smaller saccades were required to reach target position, particularly 
when anticipatory saccades were generated prior to target illumination. Indeed, average initial 
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saccade gain was lower in the predictive task compared to the reflexive task - significantly so 
for the PD group. This should manifest as increased activity in the lateral FEF region 
responsible for smaller saccades. However, no FEF region, or indeed any region, was more 
active for the predictive task in comparison to the reflexive task. In contradistinction, the 
medial FEF demonstrated higher activity in the reflexive task compared with the predictive 
task. Thus the functional difference between medial and lateral FEF activation is likely more 
complex than can be explained by saccade size difference alone.  
5.4.3.3 FEF	subregions	–predictive	and	reflexive	task	differences	
Gagnon et al. (2002) found greater fMRI activity in the FEF in both medial and lateral regions 
in predictive tasks - where participants had advanced knowledge of target direction and timing 
- compared to a non-predictive, visually-guided reflexive saccade task. The authors argued 
that eye movements are controlled by systems within the FEF processing two parameters: 
saccade amplitude and timing of execution. They proposed that FEF activity is modulated by 
prior knowledge of both the timing and amplitude of a saccade. For the reflexive task, timing 
and amplitude are unknown in advance, while in the predictive task both these parameters are 
known. Gagnon and colleagues reported that in predictive tasks, both medial and lateral FEF 
activity increased over time as participants became aware of the predictive pattern and state 
functions were shared between FEF regions. They concluded that FEF neural processes 
involved in saccade timing and amplitude are highly overlapping.  
Simo et al. (2005), in a similar saccade study, found more prominent FEF activity in visually-
guided saccades than predictive saccades, contrary to the findings of Gagnon et al. (2002). 
Simo and colleagues used direction as the only unpredictable element in their visually-guided 
saccade trial, with inter-trial interval and saccade amplitude kept constant. This differs to the 
study by Gagnon et al. which used a variable trial interval, which was said by Simo et al. to 
contribute to the difference in findings between the two studies. Simo and colleagues reported 
the prefrontal and inferior parietal cortical regions, striatum, dorsomedial thalamus, 
cerebellum and hippocampus were more active in the predictive task compared to the 
visually-guided task. The authors observed that medial FEF, along with the superior parietal 
lobule and lingual gyrus (forming a fronto-parieto-occipital system) was more active in their 
visually-guided task over the predictive task. They proposed that these areas of activation 
reflected different processes, with the predictive task involving a learning and memory 
network and the visually-guided task involving sensory processing areas. Simo et al. 
suggested that the visually-guided saccade task was associated with a higher attention load, 
giving rise to greater activation in cortical regions related to attention processes. 
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Our study supports the idea proposed by Simo et al. (2005) with greater medial FEF activity 
in a reflexive than predictive saccade task. Our reflexive task differed in some key aspects to 
the visually-guided tasks employed by Simo et al., and Gagnon et al. The inter-stimulus 
interval was peudo-randomised, so that target illumination occurred with unpredictable timing 
in our study, but were kept constant by Simo and colleagues. The amplitude and direction of 
the stimulus jumps were also randomised in our study, whereas the amplitude was constant in 
both the Simo et al. and Gagnon et al. studies. The presence of one predictable element, be it 
timing or saccade size could give rise to preparatory activity even in so-called “visually-
guided” tasks. The variation in saccade size and timing ensured unpredictability in our 
reflexive task and minimised ability of participants to formulate any pre-emptive saccade 
plans. The limitation of keeping inter-trial intervals constant in a reflexive-type trial is that it 
introduces the potential for a participant to make anticipatory saccades, once the participant is 
familiar with the timing of the trials, even if they do not know the direction. With the study of 
Simo et al., therefore, it is not possible to determine whether the medial FEF activation was 
truly related to generating a saccade in reaction to the appearance of a stimulus or rather, 
whether it was related to error/corrective anticipatory saccades at the predicted trial intervals. 
By varying the trial timing and saccade distance, our study avoided these potential 
shortcomings. Significant activation of the medial FEF in the reflexive task over the 
predictive task in our study lends support to the notion that the medial FEF has activity 
specific to processing reflexive saccades and is functionally different to the lateral FEF. 
Connectivity studies have demonstrated that medial and lateral FEF have different cortical 
connections, supporting the notion that the FEF operates as functionally distinct subregions. 
In macaque monkeys, there are separate connections between medial and lateral FEF to the 
SEF and temporal sulcus (Schall et al., 1993; 1995). Further, medial FEF receives peripheral 
visual field representations and the lateral FEF foveal representations (Schall et al., 1995), 
consistent with their putative respective size-specific saccade roles, with the more medial FEF 
region being concerned with large saccades and lateral FEF region with smaller saccades 
(Bruce & Goldberg, 1985;Robinson & Fuchs, 1969) as discussed above. Babapoor-
Farrokhran et al. (2013) investigated the coupling of large saccades with reaching movements 
and small saccades with manual manipulation and object processing. Medial and lateral FEF 
demonstrated separate involvement in the two distinct visuospatial networks. Tomassini et al. 
(2007) using DTI-MRI, found that the medial FEF region has connections with superior 
parietal lobe, dorsal prefrontal cortex and cingulate gyrus with the lateral FEF region having 
connections with the anterior inferior parietal lobule and ventral prefrontal cortex. De Weijer 
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et al. (2010) also found the two FEF subregions to have differing connections. The authors 
used DTI to map white matter connections between the FEF and the SC or CN, with the right 
and left FEF containing two sub-areas, each with connections to the ipsilateral SC or CN, or 
both. While the delineation between the FEF-SC and FEF-CN areas were not a clean divide, 
FEF regions connecting to the CN tended to be located more inferior and lateral than FEF 
regions connecting to the SC. All FEF zones exhibited higher activity during antisaccades 
compared to prosaccades, with greater activation in FEF regions connected to the SC than the 
CN in the antisaccade task. The authors proposed that the FEF-SC connected region was 
responsible for antisaccade generation and the CN connected region active in withholding a 
prosaccade. 
5.4.4 FEF	-	PD	and	control	differences		
No significant differences in FEF activity were observed in our study between PD and control 
groups in either reflexive or predictive tasks. Eye lab analysis did reveal significant 
differences in saccade performance, consistent with the wider literature of PD saccade 
abnormalities. The initial saccade made by PD patients was smaller (lower gain) than in 
controls. We might have expected expect to see this reflected by increased FEF activity 
ventro-laterally, the FEF region responsible for smaller saccades, but this was not observed. 
PD patients were also seen to initiate predictive saccades sooner than controls in the eye 
movement laboratory. Significant eye movement performance differences in the absence of 
significant differences in fMRI activity suggest that either the PD-control differences are too 
subtle to be detected by our current block MRI design, or the oculomotor control region was 
either too small an area to be detected at the resolution. The lack of a difference between PD 
and controls may also be a result of overall FEF hypo-activity, as reported by Rieger et al. 
(2008) and Lemos et al. (2016). Should there be a relative increase in lateral FEF activity, 
potentially due to the PD group making more small corrective saccades, but within an overall 
underactive FEF, the increased activity that would be expected to show may not reach 
detection threshold. However, this is speculation given the failure to show activation 
differences between the PD group and controls. 
5.4.5 Parietal	cortex	
Parietal activation was seen as two adjoining clusters for both groups in the reflexive task. 
The two adjoining parietal areas are located in the superior and inferior parietal lobules, 
continuous with the intraparietal sulcus in between – these regions form the PPC. Superior 
parietal lobule activity was also seen to be greater in the reflexive task than predictive task 
within the PD group only comparison. However no significant difference was evident in 
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between-group comparisons. The PPC is known as a complex area, having a number of 
tightly positioned regions with a number of functions such as memory/attention/saccade 
generation. As no significant group difference was seen, we are unable to make further 
inferences on group differences in PPC function at this stage. However, further discussion 
will take place within the next chapter regarding PPC function, which was investigated using 
a different saccade paradigm and fMRI design (memory-guided saccades using an event-
related fMRI design). 
In general, parietal cortex activity has been reported in nearly all saccadic eye movement 
studies for visually guided saccades, predictive saccades, memory-guided saccades and 
antisaccades (Anderson et al., 1994; Colby et al., 1996; Dyckman et al., 2007; Gaymard et al., 
1998; Heide & Kömpf, 1998; Heide et al., 2001;Pierrot-Deseilligny, et al, 1991; Simo et al, 
2005). It is thought that reflexive saccades are triggered by the parietal eye field (Pierrot-
Deseilligny et al., 2004). Our findings are consistent with this proposal, with substantial areas 
of the parietal cortex active in the reflexive task but smaller areas of parietal activation in the 
predictive task, for both groups. In the single group analyses, and in contrast to controls, no 
parietal activity was seen for the PD group in the predictive task. This difference within 
groups was not evident in the direct comparison between PD and control groups. When the 
reflexive was compared with the predictive task, no difference in parietal activity was seen in 
controls, but bilateral posterior parietal activations were apparent in the PD group. Again, this 
within-group difference did not remain significant in the between-group comparison. A raised 
level of parietal cortex activity in PD for reflexive saccades would fit with the suggestion by 
Lemos et al. (2016) that the parietal cortex shows compensatory hyperactivity during 
prosaccades, but though the within-group analyses might be supportive of this hypothesis, the 
lack of significance in the between-group comparison does not allow such a conclusion. 
Lesion and TMS studies have found that PPC dysfunction increases reflexive and predictive 
saccade latency (Braun et al., 1992; Gaymard et al., 2003; Heide & Kömpf, 1998; Machado & 
Rafal, 2004). We did not observe any such increase in reflexive latency in the eye movement 
laboratory recordings, perhaps due to the relatively small sample size, but larger studies have 
reported that reflexive saccade latencies are increased in PD, particularly in later disease 
states with cognitive decline and dementia (MacAskill et al., 2012; Mosimann et al., 2005). It 
might be expected then that PD patients would exhibit altered activation – either reduction or 
compensatory increase - in cortical regions controlling reflexive saccades underpinning 
performance deficits, particularly at later stages of the disease. Failure of the present study to 
reveal such differences may be because there is no such altered cortical function in PD, or 
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because the disease status of the PD participants was not sufficiently severe enough to be 
associated with a detectable change in activation as major cognitive impairment was an 
exclusion criteria in this study. 
5.4.6 Other	activations		
5.4.6.1 Visual	cortex	
Significant lingual gyrus activity was observed in both PD and control groups for the 
reflexive task and to a lesser extent in the predictive task. The lingual gyrus corresponds to the 
visual areas V1, V2 and the lower V3 (McKeefry et al., 1997). Visual information is first 
captured by the retina and relayed via optic nerve and thalamus to primary visual cortex (V1). 
This visual information then passes to the V2/V3 regions in the extrastriate cortex for visual 
information processing (Orban, 2008) and thence to the parietal cortex via a hypothetical 
pathway termed “the dorsal stream”. Here, these signals contribute to an integration of visual 
environment information with viewer/self factors. Such integration is considered essential for 
eye movement control (Greenlee, 2000). 
No occipital lobe activation differences between control and PD groups were observed in the 
reflexive task. In the predictive task, the control group, when analysed separately (i.e. within-
group comparison), exhibited lingual gyrus activity but the PD group did not. This 
observation might reflect more reliance by the control group on visual information than the 
PD participants who exhibited greater anticipatory and, therefore, less stimulus-driven 
behaviour, evidenced by more pre-emptive, negative latency saccades in the predictive task, 
which, in turn, may be compensation for their hypometria. This difference in activation is, 
however, rather only slight, and did not survive the between-group comparison. 
5.4.6.2 Supplementary	Eye	Field	
The SEF was active in both the reflexive task and predictive task, for both PD and control 
groups. These results are consistent with the general literature, with a number of studies 
reporting SEF activity in functional imaging saccade studies for both reflexive and predictive 
saccade paradigms (Gagnon et al., 2002; Lukasova et al., 2014; Simo, 2005). There were no 
differences in SEF activation for reflexive or predictive saccades in both groups. This 
indicates likely no significant functional SEF differences between PD and controls for both 
tasks.  
The SEF has neural connections to every cortical eye control region (Huerta et al., 1986; 
Shook et al., 1990). The SEF is believed to be important in the temporal control of memorised 
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saccade sequences (Gaymard et al., 1998 ; 1993) and antisaccades (Dyckman et al., 2007). 
There is some debate over SEF function, with Parton et al. (2007) arguing against a proposed 
SEF role in memorised saccade sequences, reporting a patient with a focal SEF lesion who 
would still perform memorised saccade sequences correctly but with hypometria. A hallmark 
of PD saccadic deficit is hypometria, particularly during voluntary saccades (Anderson & 
MacAskill, 2013; Crawford et al., 1989b; Ventre et al., 1992) . This was observed in the 
laboratory-based predictive saccade recordings in the PD group in the present study. There 
was, however, no difference in SEF activity between the PD and control groups, hence 




When analysed as individual groups, temporal lobe activations in the middle and superior 
temporal gyrus were seen in the reflexive task for the control group, while the PD group only 
showed middle temporal gyrus activation. In predictive saccades, both middle and superior 
temporal gyrus activation was seen in controls while the PD group showed superior temporal 
gyrus activation only. These differences were not significant in the group comparison, 
indicating no significant temporal lobe activity differences between PD and controls for 
reflexive and predictive saccade tasks.  
The middle and superior temporal gyrus is not well known as a saccade control region. 
Instead, this region contains the middle temporal area (area MT) and medial superior temporal 
area (MST), which are well known for visual motion and smooth-pursuit-related activity 
(Bremmer et al., 1997; Komatsu & Wurtz, 1988). However, saccade-related activity of these 
pursuit-related regions has been demonstrated in the primate (Bakola et al., 2007). A number 
of human imaging studies have reported superior temporal lobes activity in reflexive (Law et 
al., 1997; Simo, 2005), predictive (Simo, 2005) and memory-guided tasks (Anderson et al., 
1994; Ozyurt et al., 2006). Studies are limited regarding the nature of superior temporal cortex 
involvement for saccadic eye movements but this region is thought to encode for oculomotor 
information on top of its usual smooth-pursuit-related functions (Bakola et al., 2007). 
Another region located in the superior temporal lobe is the superior temporal polysensory 
region (STP) (Bruce et al., 1981).This region is thought to be involved in visuospatial 
processes and lesions of this area have produced an increase in reflexive saccade latency, 
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similar to lesions of the posterior parietal cortex (Scalaidheet al., 1995). Superior temporal 
lobe activity may reflect STP visuospatial processes during saccade generation. 
Limited information is available regarding middle temporal gyrus involvement in saccade 
control. The middle temporal gyrus is involved in cognitive processes such as episodic 
memory and object naming (Cabeza & Nyberg, 2000; Chao et al., 1999). Middle temporal 
lobe activity could reflect these processes occurring, unrelated to the main saccade task, for 




In summary, PD participants in our study had a reduced primary gain in the predictive task 
and to a lesser extent, the reflexive task, in the laboratory-based eye movement recordings. 
These differences have not been explained by any corresponding observable imaging 
differences in the comparison between PD and control groups. Differences seen in individual 
group analyses (i.e. “within-group” analysis) did not remain after the “between-group” 
comparison analysis. While differences in cortical activity between the two experimental 
groups were not definitively demonstrated in this study, the differences seen in separate 
within PD and control analyses could indicate potential eye field differences, possibly in the 
parietal cortex, which may not be identifiable with a block fMRI design. Thus there is a need 
for more detailed fMRI study designs. An event-related fMRI design would add a temporal 
resolution to the cortical activity for each task. The next chapter concerns event-related fMRI 
to investigate memory-guided saccades in PD and controls. Future studies should use the 
event-related design for reflexive and predictive task studies. The predictive task involves a 
preparatory element before the saccade is generated. A block design study is unable to 
separate pre-task preparatory activity but future event-related study design would, potentially 
giving further insight into the functional nature of the FEF division. 
This study supports the proposition that rather than being a single functional area, the FEF 
operates as separate subregions for saccade control. Comparisons between reflexive and 
predictive activity revealed more medial than lateral FEF involvement in unpredictable, 
reflexive saccade tasks. Both medial and lateral FEF were seen to be active in the reflexive 
task over the fixation baseline, showing that lateral FEF regions do have a role in the reflexive 
task too. Further research is needed to show how the increased medial FEF activity relates to 
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The memory-guided saccade task, also known as the oculomotor delayed response task, is a 
type of volitional or voluntary saccade task used to investigate saccadic eye movement 
performance. It requires the subject to initially remain fixated on the fixation stimulus while a 
target is briefly flashed to either side. This target position must be kept in working memory 
while the patient continues to remain fixated on the original stimulus. After a certain interval, 
the fixation stimulus disappears, cueing the patient to make a saccade to the memorised 
location of the flash (see Figure 1-5 in the Introduction on page 28). The first part of this task 
involves deploying visual attention to the flashed target while also suppressing a reflexive 
saccade to the target. The next part of the task involves maintaining memory of the target 
location and then a production of a saccade to the target when the fixation stimulus 
disappears. 
Studies of memory-guided saccades have shown task-related activations in the FEF, regions 
of the posterior parietal cortex (PPC), as well as the SEF and DLPFC (Anderson et al., 1994; 
Chafee & Goldman-Rakic, 2000; Geier et al., 2007; Pierrot-Deseilligny, Ploner et al., 2002; 
Sweeney et al., 1996) (See introduction chapter for an overview of these areas. Section 1.2.3.8 
to section 1.2.3.11 covers cortical control of saccadic eye movements). 
6.1.1 Aims	of	study	
The aim of this study follows from the previous chapter, which is to test the hypothesis that 
abnormal memory-guided saccade performance in PD will be reflected in functional changes 
within the brain able to be detected by fMRI. I hypothesise that the eye fields and also the 
DLPFC, which is a region known to be specifically involved in memory-guided saccades, 
would show a decrease in functional activity as measured by the BOLD signal compared to 
controls. In addition, this study will use an event-related MRI sequence in addition to the 
block design, allowing the construction of a BOLD timecourse. My hypothesis was that the 
BOLD timecourse will show diminished BOLD activity during memory guided saccade 
execution within regions known to be involved in memory-guided saccade control in PD.  
As previously stated, given this was a reasonably large study in this field, we had a secondary 
aim of improving our understanding of eye movement control in the general population. In 
this study, I aimed to use the technique previously described by Sugiura et al., (2004), using a 
principal component analysis (PCA) of BOLD data to extract components of the functional 
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time course. PCA allows us to find patterns from complex data sets that may not be 
immediately obvious visually. This analysis can potentially give us more insight into what 
constitutes the BOLD timecourse pattern for the memory-guided task for each of the analysed 
regions of interest. My hypothesis was that these principal components will be able to reflect 
specific elements of saccade control (e.g. saccade generation), with regions known to be 
involved in these elements expressing more of that principal component, and regions not 
involved, expressing less. Furthermore, I am to use a cluster analysis to group functionally-
related regions based on PC expression. Should the amount of expression of a principal 
component reflect function, my hypothesis is that a cluster analysis, with no prior 
information, should be able to group functionally similar regions together, using only PC 
expression values. 
Using PCA, I also aim to test if PC expression is able to detect PD related changes during 
saccade task performance. Should regions in the brain be adversely affected in PD, for 
example, having less involvement in saccade generation, this should be reflected either as a 
separate PD distinct PC, or regions that are affected in PD being clustered separately.Chapter 
6 is a cross-sectional study using a block and event-related fMRI design and principal 
component analysis. 
6.1.2 Memory-guided	saccades	in	PD		
PD patients make abnormal memory-guided saccades, of smaller amplitude (hypometric) and 
longer latency compared to controls (Le Heron et al., 2005; Lueck, Crawford, et al., 1992; 
Lueck, Tanyeri, Crawford, Henderson, & Kennard, 1990; MacAskill, Anderson, & Jones, 
2002). PD patients also have impairments in the suppression of erroneous reflexive saccades 
(van Stockum et al, 2008) during the delay period. The mechanism of reflexive saccade 
disinhibition in PD and the source of hypometric saccades remain speculative. 
It has been proposed that the voluntary saccade system is responsible for the inhibition of 
reflexive saccades (Amador et al, 2006). A study by Chan et al. (2005) found PD patients 
made more erroneous anticipatory saccades, being less able to maintain their gaze on central 
fixation. This is thought to be a result of a general deficit in reflexive response inhibition, by 
which a defective voluntary saccade system in PD is less able to control and inhibit the 
reflexive saccades. van Stockum et al. (2008) have suggested there may be other mechanisms 
leading to saccade disinhibition rather than just an impaired voluntary saccade system, such as 
an increased excitability of saccade triggering SC neurons, due to a dysfunctional basal 
ganglia and cortical inputs, or a general deficiency in maintaining the focus of attention in PD. 
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The programming of volitional saccades for the memory-guided task also involves the 
manipulation of spatial information. Spatial working memory may be impaired in PD (Chan 
et al., 2005) with disruption of the DLPFC (a region known to be involved in working 
memory processes) suggested as a possible cause of memory-guided saccade deficits in PD 
(Le Heron et al., 2005; MacAskill et al., 2002). 
Previous functional imaging studies have yet to reveal a definitive source for PD-related 
impairment in saccade disinhibition and working memory. Some have reported dissimilarities 
between PD and control cortical activity during certain saccade tasks but these findings still 
do not fully explain the differences in parameters. Cameron et al. (2012) probed the 
antisaccade task using fMRI and suggested that the observed diminished FEF activity in the 
PD group could represent decreased neural signals from other cortical areas; signals needed to 
establish correct saccade task programming, source unknown. Rieger et al. (2008) also 
reported reduced FEF activation in PD, but with a self-paced task and variations between 
individuals in the number of saccades completed may have contributed to differences in 
activation. These two studies did not involve tasks with a working memory component and so 
their results do not allow any conclusions to be drawn about the memory-guided task in PD. 
Our study aims to investigate underlying cortical mechanisms that might explain the 
impairment in PD task performance in memory-guided saccades. The memory-guided task is 
unique in that it allows separation of the attention and motor components of saccade 
production. It has not been previously studied with functional imaging in PD. Thus the 
present study aimed at investigating differences between PD and controls in cortical 
activation during the memory-guided task so as to provide further insights into potential 
sources of deficiency in PD eye movement control. 
6.1.3 Parietal	subregions	
The PPC is a key region for memory-guided saccade control. It contains subregions 
responsible for attention (Corbetta & Shulman, 2002; Rushworth et al., 2001), working 
memory (Brown et al., 2004; Gaymard et al., 1998) and saccade execution (Pierrot-
Deseilligny et al., 2002; Rushworth et al., 2001; Sweeney et al., 1996). The PPC is an 
anatomical area comprising the superior parietal lobule (SPL), inferior parietal lobule (IPL) 
and intraparietal sulcus (IPS). Like the FEF, the PPC has been extensively examined in 
monkeys. A region within the monkey PPC called 7a is thought to be involved in attention 
processes, whereas the lateral intraparietal area (LIP) is involved in generating visually-
guided saccades (see the Introduction page 45 for further background). It is believed that there 
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are human homologues of these monkey parietal regions. The human parietal eye field (PEF) 
corresponds to the monkey LIP (Culham et al, 2006) and may lie in the horizontal portion of 
the IPS (Müri et al. 1996) and regions of the superior parietal lobule (Konen & Kastner, 
2008). The Area 7a equivalent has not been determined but is thought to correspond to 
portions of Brodmann areas 39 and 40 in the inferior parietal lobule in humans (Leigh & Zee, 
2000) and may also comprise parts of the SPL and IPS (Konen & Kastner, 2008). The 
anatomical mapping of this area has proven difficult in humans and uncertainties remain over 
the exact location of each parietal region. Often, the term “PPC” is used as a broad area 
description to refer to these parietal regions. As a result of the usage of broad anatomical 
areas, some questions arise when discussing the PPC involvement in memory-guided 
saccades (Chen & Crawford, 2017; Christopoulos et al., 2015; Kapoula et al., 2011; Sweeney 
et al., 1996) For example, does the PPC refer to one or both of areas 7a and LIP? 
The PEF surprisingly is seldom referred to in human eye movement studies. The LIP tends to 
be the preferred term despite being strictly speaking a region defined in monkey rather than 
man. The terms PEF and LIP are used often used interchangeably and the areas are considered 
homologous (Culham et al, 2006). For these regions to be so used requires valid human 
studies that demonstrate that the two are indeed functionally equivalent. There is a need for 
better consistency in the naming of the parietal cortex subregions Here I aim to clarify what 
has been reported about these areas by incorporating my results with the available to 
literature, in order to assist understanding our own results and those from studies in the future. 
6.1.4 Principal	component	analysis		
In complex datasets, it can be difficult to determine important overall patterns which may not 
be immediately apparent within the abundance of information. Principal component analysis 
(PCA) is a technique which can be used to capture the underpinning patterns which make up 
complex data sets. This analysis can be used to express data using functions or “principal 
components” (PCs), which account for most of the variance in the data. This allows the 
dimensions (size) of the data to be reduced and allows the PCs that capture most of the 
variance in the data to be visualised.  
PCA can be used to extract key features from complex data in many settings. For example, 
PCA has been widely employed to develop computer facial recognition systems by detecting 
characteristic feature patterns from facial images (Turk & Pentland, 1991). Likewise, it has 
been employed in neuroimaging studies to identify spatial patterns in samples of diseased and 
control study participants (Eidelberg et al., 1994; Huang et al., 2007; Melzer et al., 2011). 
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PCA has also been used to characterise patterns in event-related time courses of BOLD 
activity (Sugiura et al., 2004), a technique which was employed in the present study. The PCs 
in our study represent the independent component patterns of the BOLD activity time courses. 
These components may represent aspects of the BOLD time course related to separate events 
within the memory-guided task.  
The “expression” or the closeness of the shape of a BOLD time course to a certain PC may be 
used to infer additional information on the function of each region for the studied task. During 
the PCA, each region is given a loading value for each PC, which represents how close the 
shape of the actual BOLD time course of a region is to the shape of a PC. Should a PC be 
seen, for example, to relate to an aspect of the memory-guided task e.g. saccade execution, 
then it is possible to suggest that regions showing a BOLD time course shape close to this PC 
(higher loading value) are involved more in saccade execution, and regions showing a shape 
more dissimilar (lower loading value) to this PC are less related to saccade execution. 
Loading value expression can, therefore, be used to differentiate regions on the basis of 
function. Regions showing similar PC expression can also be identified using a cluster 
analysis. This technique, which was employed by Sugiura and colleagues (Sugiura et al., 
2004), was able to separate frontal and parietal clusters using BOLD activity data alone, 
demonstrating that it is possible to group regions into functionally similar groups without 
explicit information provided for the location of each region. A PCA, in summary, allows 
additional information on regional function to be derived from the underlying BOLD time 
course data, and which may not be apparent with simple visual assessment. From the loading 
values determined in the PCA, functionally similar regions can then be grouped together 
using a cluster analysis.  
This study builds from the technique used by Sugiura et al. to investigate functional BOLD 
activity in the memory-guided task in both a PD and a control group. In addition, this study 
utilised a localiser task (using a block design fMRI method – see below) to detect active 
regions of interest – a step which was not employed by Sugiura and colleagues. I aimed to use 
the PCA method to differentiate the roles of active regions. Differences between PD and 
control groups were then examined with PCA and cluster analysis to identify disease-related 
components and group functionally related active regions. 
6.1.5 Functional	MRI	
As previously covered in the introduction (see page 58), fMRI is a neuroimaging technique 
which allows researchers to image physiological activity within the brain. Oxygenated blood 
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and deoxygenated blood have different magnetic resonance signalling properties (different 
magnetic susceptibilities). fMRI works by detecting these signal changes in the blood oxygen 
level during task activity. The difference between an active and inactive region is shown by 
contrast – the difference between intensity in the signal of certain regions during task activity 
and baseline. The experimental design of an fMRI study needs to be properly devised to 
satisfactorily evaluate these differences. Two major classes of fMRI experimental design exist 
– the block design and the event-related design (See sections 1.4.2.1 and 1.4.2.2 pages 62 to 
63 in the introduction chapter for an in-depth explaination of block and event-related fMRI 
design). Both these designs were used in this study. Event-related fMRI was only used in this 
chapter. Because of this, additional detail on how the BOLD activation is modelled in event 
related fMRI designs are discussed below in sections 6.1.5.1 to 6.1.5.3.  
 
6.1.5.1 Modelling	Event-related	design	
Standard general linear modelling is used to test how well the observed data fits the model of 
expected haemodynamic response. The expected BOLD activity can be modelled by 
convolving the onset of each task or “event” with a haemodynamic response function (HRF) 
(Friston et al., 1994). A canonical HRF has been developed which represents the expected 
BOLD signal change dynamics to an activated neural cell (Boynton et al., 1996) and is used 
in this study. Other types of modelling exist using Fourier sets and finite impulse response, 
which assume no prior haemodynamic response shape. These can easily mis-model the 
haemodynamic response, and also can fit noise into the model (Kay et al., 2008). This may 
lead to an “overfit” of the data and misattribute unrelated activity to the task. Thus these other 
forms of modelling are not used in this study to estimate the BOLD response.  
A general linear model may be used to determine which areas of activity most closely 
correspond to the expected task activity (Friston et al., 1995). This can be visualised using 
parametric mapping, with identifies the voxels in which activation most closely matches to 
the expected task activity and can be considered to be “active” for the studied task. These 
“active” voxels can be highlighted on a map of the brain providing a visual image of regions 
which show greater BOLD activity in a task compared to a baseline condition. This analysis is 
undertaken on an individual basis, or first level, and then at a group, or second, level.  
6.1.5.2 Informed	basis	set	
The canonical HRF is the summation of two gamma functions (Boynton et al., 1996) and is a 
widely used estimate of the biological haemodynamic response (Calhoun et al., 2004; 
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Lindquist et al., 2009). Actual haemodynamic response can vary between persons and cortical 
regions (Aguirre et al., 1998; Duann et al., 2002; Handwerker et al., 2004). Using a strict HRF 
function may inaccurately fit the actual response, causing true significant activations to be 
missed (Aguirre et al., 1998). To account for this, derivative functions can be added during 
the first level analysis to account for small changes in time to peak (temporal derivative) and 
width (dispersion derivative) of the haemodynamic response, this being known as the 
informed basis set (Friston et al., 1998). 
 
The beta weights of temporal and dispersion derivatives are typically treated as “regressors of 
no interest”, much like motion correction parameters at the first level and are commonly 
excluded from second level group analysis (Calhoun et al., 2004; Steffener et al., 2010) as the 
addition of beta weights from each derivative has been found to add excessive variation 
between subjects at the second level, leading to a decrease in significance of group differences 
(Cignetti et al., 2016). Techniques exist that add derivative functions into the second level 
group analysis; e.g. combining the canonical beta weights with derivative functions at a 
specific weighted ratio, known as a “derivative boost” (Calhoun et al., 2004; Lindquist et al., 
2009). These approaches are however not yet fully established and more studies are needed to 
validate them (Cignetti et al., 2016). 
6.1.5.3 Event-related	Time	course		
One limitation of using the canonical response is that BOLD activity with a more broad shape 
than described by the canonical shape are unable to be modelled e.g. sustained working 
memory processes (Aguirre et al., 1998; Courtney et al., 1997). There is no established 
“canonical” model of sustained activity and there is debate whether sustained activity can 
even be detected using a univariate GLM analysis as used in this study (Riggall & Postle, 
2012) (see Introduction page 66 for details on the GLM analysis). Another technique can be 
used to directly visualise the BOLD signal change in selected regions of interest and was used 
in our experiment. This is known as the BOLD time course and allows the average BOLD 
percent signal change of every trial to be plotted without any need for prior estimation of 
response shape. This is achieved using a finite impulse response model (FIR) (Glascher, 
2009; Goutte et al., 2000), which is able to determine the average BOLD signal change 
through time. This process is carried out by functional neuroimaging software (my own study 
used a toolbox for SPM called RFXplot - see Glascher (2009) for an overview of the 
software). In brief, the time period to be plotted is parcellated into time segments known as 
"bins". The duration of each bin is effectively the time resolution of the plot – e.g. a one 
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second bin gives a mean BOLD signal change value for every one second segment for the 
duration of the time course. The mean BOLD signal change for each time bin is determined 
using an FIR model and these values are used to plot the time course. Time courses are 
extracted for every participant at the first level and then combined as group averages at the 
second level. Should the specified time period of the plot cover closely spaced overlapping 
trials, the overlapping bins are selectively removed by the software, taking care to preserve 
the most important part of the haemodynamic response, which is considered the peak, usually 
4-5 seconds after onset. If bins for two trials overlap, the first 2 seconds after stimulus onset 
are first removed. If this does not resolve the ongoing overlap, further bins are removed from 
the end of the time course period. This ensures the average BOLD signal of the trials is 
correctly determined despite overlap from closely spaced individual trials. 
6.2 Methods	
6.2.1 Study	participants	
The participants for this study was the same group as described in the reflexive and predictive 
task chapter (Chapter 5 Table 5-2 page 154), with the exclusion of one control participant 
who did not perform the memory-guided saccade task correctly in the scanner. In total then, 
16 PD patients and 15 controls were included in this study. 
6.2.2 Memory-guided	saccadic	eye	movement	task	
The eye movement tasks were initially carried out in the eye movement laboratory at the New 
Zealand Brain Research Institute. A memory-guided saccade task was used for this 
experiment (see Introduction chapter page 28 for an overview of the task). Figure 6-1 
additionally illustrates correctly executed and error trials using an eye-trace example. The eye 
movement tasks were performed in the same sequence that were subsequently presented to the 
participants during MRI scanning. This ensured that they understood how to perform the task 
and also allowed for the precise recording of eye movements using the using the 
SensoriMotoric iView X Hi-speed 1250 Hz video oculography system (SMI Berlin), as 
opposed to the less capable and reliable eye tracker used in the MRI scanner. As previously 
noted, the Avotec eye tracking system proved unreliable in maintaining gaze tracking within 
the scanner. Ideally, trials with error anticipatory saccades should be excluded as these are 
likely to arise from a different mechanism from the main memory-guided task. One effect 
from this is the potential for error saccades to influence activity measured during what is 
named the “memorisation” event, or the event when the flash appears but the participant is 
instructed to maintain fixation on the original stimuli. Should an error reflexive saccade be 
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made at this stage, this would activate a separate reflexive saccade mechanism, rather than the 
expected fixation/spatial memory mechanism for this event.This point is further 
acknowledged during the discussion of the BOLD timecoure results (sections 6.4.3.7 for PPC 
activity and section 6.4.6.2 for FEF activity). 
 
 
Figure 6-1 – Schematic of the difference between a correctly executed memory-guided saccade trial and an 
error trial. The red bars represent the stimulus used in this task through time (x-axis). The y-axis 
represents the amplitude or the visual angle of the presented stimulus. The thin black line represents a 
tracing of the location of a participants gaze. An error trial (B) occurs when an unintended reflexive 
saccade is made to the target flash despite instruction to maintain fixation during this period. In a 
correctly performed trial (A), there should be no saccade executed until the fixation stimulus is 
extinguished. Note, the eye trace (thin black line) is an illustrated example and not from actual results.  
6.2.3 MRI	task	design	
6.2.3.1 Memory-guided	saccade	task	-	block	design	
The block-design task involved a run of the memory-guided task followed by a run of 
fixation, which would form a block design for the fMRI analysis (i.e. 36 seconds spent 
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performing the memory-guided task followed by 36 seconds of fixation). This was repeated 6 
times giving a total time of 7 minutes 12 seconds (36 seconds memory + 36 seconds fixation 
= 72 seconds. 72 seconds × 6 = 432 seconds or 7 minutes 12 seconds) for the block-design 
task. A memory-guided task trial began with an initial fixation phase on a red square target. 
After 0.9, 1.2 or 1.5 seconds (average 1.2 seconds), a peripheral target “flash” of 400 ms 
occurred, ranging from 5, 10 or 15 degrees of visual angle left or right from the fixation 
target. Participants were instructed to keep their gaze on the fixation point when the target 
stimulus flashed but to remember the spatial location of that flash. After an additional 1.4 
seconds, the initial fixation point disappeared and participants were required to make a 
saccade to the remembered location of the “flash”. After 1 second, the location of the 
peripheral flash was re-illuminated and became the fixation point for the next trial. Each trial 
lasted an average of 4 seconds and 9 trials were held in each 36 second block of memory-
guided saccades. The target stimulus amplitudes of each trial were pseudo-randomised with 
the average target amplitude kept the same between leftward and rightward eye movements. 
For fixation, a green square stimulus was projected to the centre of the screen for 36 seconds 
with participants instructed to keep their gaze on the green stimulus.  
6.2.3.2 Memory-guided	saccade	task	-	Event-related	design	
The second part of the memory-guided saccade study was an event-related design. This was 
made up of two runs of 18 memory-guided saccade trials in 378 seconds (6 min 18 seconds). 
The sequences began with a fixation stimulus (red square). After 12, 13 or 14 seconds 
(average 13 seconds) of fixation, a target “flash” stimulus (red square) appeared for 400 ms in 
positions 5, 10 or 15 degrees of visual angle left or right of the fixation stimulus. Participants 
were instructed to keep their eye on the fixation point but to remember the flash location. 
After an additional 5.6 seconds, the fixation stimulus was extinguished and participants were 
required to refixate on the remembered location of the flash. After 2 seconds, the flash 
stimulus reappeared and became the fixation point for the next trial. The target stimulus 
amplitudes between each trial were pseudo-randomised with the average target amplitude kept 
the same between leftward and rightward eye movements. Figure 6-2 illustrates the task 




Figure 6-2 – Timings used for block design and event-related design memory-guided saccade experiments. 
Red bars represent the visual stimulus at certain visual angles (y-axis) through time (x-axis). Dotted grey 
vertical lines represent the beginning and end of each phase of the memory-guided task. The duration of 
each phase is labelled in the diagram (figure durations not to scale). 
 
6.2.3.3 Memory-guided	saccade	task	events	
Each component or “event” of the memory-guided task occurs at a certain time within the trial 
known as an “onset”. The memory-guided task involves the “perceive”, “memory” and 
“saccade” events (Figure 6-3). For the plotting of the BOLD time course, time zero was set at 
the moment when the target “flash” stimulus was presented. This is known as the “perceive” 
event. 400 ms after the flash was extinguished marks the beginning the “memory” period, also 
known as the delay period. After a further 5.6 s, the fixation stimulus extinguished, signalling 





Figure 6-3 – The event-related memory-guided saccade task event names (grey arrows). Each trial begins 
with fixation. This is considered the baseline activity and not designated an “event”. The time point of the 
appearance of the target (peripheral) flash is labelled as the “perceive” event. Following this event, on the 
extinguishing of the flash, the “memory” event occurs with a “delay” period lasting from the 
disappearance of the flash to the disappearance of the fixation stimulus, cueing the participants to make a 
saccade to the remembered location. The “saccade” event occurs at this cue to perform a memory saccade.  
 
6.2.3.4 Trial	jittering	
An interleaved stimulus presentation was used for this study. This technique, sometimes 
called “jittering”, describes the technique of presenting each event so every task cycle aligns 
with a slightly different point to one TR. The fixation duration was randomised to vary by one 
second between trials (12, 13 or 14 seconds; average 13 seconds). This range offset each task 
and avoided the MRI scanner capturing the same points of the haemodynamic response in 
every trial. This allowed a better effective temporal resolution of the haemodynamic response 
as more points of the response are sampled. 
6.2.3.5 MRI	parameters	
MRI parameters used in this study were identical to those in the previous chapter (Chapter 5) 




The block-design task was used as a localiser for the event-related task. That is, areas which 
were seen as significantly active in the block-design task were selected as the regions of 
interest (ROI) for the event-related time course analysis. Coordinates for the ROIs were 
visually determined from the centre of the active regions from the memory-guided block-
design task corresponding to the FEF, SEF, SPL and IPL, DLPFC and insula. From these 
coordinates, active voxels within a 2 mm radius sphere were selected as the region of interest 
for the event-related analysis. The BOLD signal change at each time point of the task was 
calculated and plotted as a time course using RFXplot. The time course plot was aligned with 
the “perceive period” (time of the presentation of the peripheral “flash”) being at zero 
seconds. Two FEF subregions were selected – a medial and lateral. The SEF was selected as 
two subregions with an anterior pre-SEF region and a more posterior SEF region. The insula 
was also selected. While noted in the past as active in memory-guided tasks (Baumann et al., 
2007; Geier et al., 2009), further investigation using event-related fMRI has not been 
undertaken for the insula region. 
6.2.4 Principal	component	analysis	methods	
The individual BOLD time courses for every participant in every selected ROI were entered 
into a PCA. The time course data for each individual comprised of the 20 second period, with 
one observation or value at every second for every individual. Fourteen regions were used in 
the PCA analysis (see Table 6-1), with the ROI coordinates obtained from the block design 
experiment. From this, a 14 × 14 correlation matrix was calculated. From this, a principal 
component analysis was performed (Hastie et al., 2009). The principal components explaining 
80% of the variance were considered meaningful and used in subsequent analyses (these were 
PC1, PC2 and PC3 – see results). When PC loading values are plotted against another for 
every ROI, regions showing close distances between loading value expression show similar 
PC component expression and hence a similar time course activation pattern (Sugiura et al., 
2004).  
6.2.5 Clustering	analysis	
Loading values from the PCA can be analysed using a clustering-based analysis. Using the 
data points with no additional prior information, a clustering analysis will find a specified 
number of clusters by minimising variance between data points within a cluster, while 
maximising variance between each cluster. This will find data clusters of the most closely 
related data points with the most difference from other clusters. A K-means clustering 
analysis was performed with the loading values from the PCA. This determines clusters of 
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regions with similar loading values and hence similar BOLD activation pattern. We selected 
K = 4 (4 clusters) for this study. To select this, we ran K = 3, 4 and 5 cluster analyses. At K = 
3, prefrontal, frontal and parietal cluster were formed. However, the insula regions were 
unable to be differentiated - one insula formed part of the prefrontal cluster and another 
parietal cluster. We considered K = 3 too coarse of a clustering level to allow ROI 
differentiation. At K= 5, clustering differentiation of prefrontal, frontal, parietal and insula 
regions was achieved. However, one frontal and one parietal region formed a separate cluster 
outside of the main parietal and frontal clusters. We felt 5 clusters didn’t offer additional 
meaningful information regarding ROI separation over 4 (for completeness 3 and 5 cluster 
figures are in Appendix Figures 9-14 and 9-15). We decided 4 clusters offered a good 
compromise of ROI differentiation/functional specificity and not over-segmenting and results 
from this cluster analysis are presented in the following results section (Figure 6-22). 
6.3 Results	
6.3.1 Eyelab	results	
Saccade performance measures of memory-guided saccade latency and primary gain are 
reported in Table 6-1 for the block-design task. No significant group difference in latency and 
gain measures were detected between PD and controls for this task. However, PD patients 
made a significantly higher proportion of erroneous anticipatory saccades during the “flash” 
period, despite instruction to hold gaze on the fixation stimulus. Prolonged trials during the 
event-related tasks caused calibration issues with the eye tracker, mainly due to patient head-
drift during the long periods of fixation. Eye movement performance values were thus unable 
to be accurately measured and hence were not able to be reported for the eyelab trials of the 
event-related task. 
Table 6-1 – Group mean and standard deviation (SD) values for memory-guided saccade performance 
measures from the eyelab analysis for the memory-guided block-design task. No significant difference in 
latency or gain was detected between the groups. PD patients, however, generated a significantly higher 
proportion of erroneous anticipatory saccades compared to controls during the “cue” or flash period. 
Task parameter Control (SD) PD (SD) p - value 
      
Memory-guided saccade latency (ms) 313 44.2 293 65.1 0.37 
Memory-guided saccade gain 0.81 0.07 0.76 0.13 0.22 
      







The areas of activity are visualised in two forms below - as overlayed on a transparent brain 
and as slices through the brain. Activation for the control group is shown in Figure 6-4 and 
Table 6-2. PD activity is shown in Figure 6-5 and Table 6-3. The observed pattern of 
activation fits with locations described in previous studies on human eye movement control. 
Namely, the regions corresponding to the FEF, SEF, PEF and PPC and DLPFC are seen 
active for the memory-guided task in the block design in both groups, all which have been 
described to be involved in the memory-guided task (Anderson et al., 1994; Sweeney et al., 
1996). Of note is bilateral activation within the insula, which had not been observed during 










Figure 6-4 – Significant BOLD activity for the memory-guided task activity greater than fixation for the 
control group. The top panel (A) shows cortical activation (dark areas) over a transparent brain. The 
lower panel (B) shows the same cortical activation (orange to yellow areas) over an axial view of the brain. 
The colour scale corresponds to the T value of the activation. Activity is broadly similar to regions seen 
for the PD group (Figure 6-5) and activation can be seen bilaterally in the parietal cortex and frontal 
cortex corresponding to known locations of the FEF, SEF, PEF and PPC. Anterior to this are regions of 
activity consistent with the locations of the DLPFC. Activity in the anterior insula is also seen bilaterally. 









Figure 6-5 –Significant BOLD activity in the PD group in the memory-guided task greater than fixation. 
The top panel (A) shows cortical activation (dark areas) over a transparent brain. The lower panel (B) 
shows the same cortical activation (orange to yellow areas) over an axial slice view of the brain. The colour 
scale corresponds to the T value of the activation. Activity is seen bilaterally in the parietal cortex and 
frontal cortex. Activity is seen throughout the PPC with SPL, IPL with continuous activity joining both 
lobules covering the IPS. Activity is observed in the frontal areas which include the FEF and SEF. 
Anterior to this are regions of activity consistent with the locations of the DLPFC. Activation in the 





Table 6-2 – Locations of BOLD activations greater in the memory-guided task compared to fixation for 
the control group. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
FEF Middle Frontal Gyrus L 10.49 6.44 -34 0 52 
Medial FEF - Superior Frontal Gyrus R 9.75 6.21 16 8 64 
SEF Brodmann area 6 L 11.99 6.85 -2 2 58 
DLPFC Middle Frontal Gyrus L 6.68 5.01 -44 40 34 
DLPFC Superior Frontal Gyrus R 7.94 5.56 28 46 36 
DLPFC Middle Frontal Gyrus R 6.68 5.01 34 48 24 
Inferior Frontal Gyrus L 7.79 5.5 -54 8 16 
      
Parietal lobe           
Inferior Parietal Lobule R 9.68 6.19 32 -56 46 
Inferior Parietal Lobule R 9.59 6.16 46 -48 42 
Subgyral - Adjacent to superior parietal 
lobule L 9.22 6.03 -28 -58 58 
Brodmann area 40  6.68 5.01 62 -48 24 
      
Insula Cortex           
Insula L 9.71 6.2 -36 20 2 
      
Temporal lobe           
Middle Temporal Gyrus L 8.49 5.77 -42 -64 8 
Brodmann area 39 R 6.75 5.05 58 -54 10 
Brodmann area 37 R 5.66 4.5 48 -68 6 
      
Occipital lobe           
Lingual Gyrus L 7.19 5.25 -6 -84 -12 
Middle Occipital Gyrus L 7.17 5.24 -44 -74 -16 
Middle Occipital Gyrus R 6.17 4.77 46 -72 -8 
Cuneus R 5.65 4.49 10 -92 2 
Inferior Occipital Gyrus L 6.98 5.15 -36 -76 -12 
      
Other           
Putamen R 6.11 4.74 22 2 8 





Table 6-3 – Locations of BOLD activations greater in the memory-guided task compared to fixation for 
the PD group. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
FEF Middle Frontal Gyrus L 12.15 6.89 -34 0 50 
SEF Brodmann Area 6 L 12.31 6.93 -4 6 54 
DLPFC - Middle Frontal Gyrus L 8.2 5.66 -42 38 32 
DLPFC Middle Frontal Gyrus R 10.33 6.39 34 46 24 
DLPFC - Superior Frontal Gyrus R 7.84 5.52 28 46 34 
Brodmann area 10 R 7.85 5.52 40 52 14 
      
Parietal lobe           
Brodmann area 40 R 13.03 7.1 46 -46 40 
Superior Parietal Lobule R 11 6.59 30 -58 46 
Precuneus R 10.27 6.37 24 -54 50 
      
Insula Cortex           
Insula Brodmann area 13 L 10.86 6.55 -38 20 2 
      
Temporal lobe           
Middle Temporal Gyrus L 6.28 4.82 -44 -64 8 
Brodmann area 22 Superior temporal gyrus R 5.69 4.52 54 -52 8 
      
Other           
Putamen L  7.91 5.55 -24 -2 8 







Figure 6-6 and Figure 6-7 show regions showing memory-guided saccade BOLD activity 
during the perceive period for control and PD groups respectively. Regions in the SEF are 
seen active in both groups. Within-group analysis showed additional BA 7 and middle 
temporal gyrus activity in the controls, which was not seen in the PD group. Table 6-4 and 
Table 6-5 show the locations of the significant clusters for control and PD within-group 
analysis. When a between-group analysis was performed, however, no significant group 
differences between PD and control groups were found. 
6.3.3.2 Saccade	event	activity	
Figure 6-8 shows the active regions during the “saccade” event for controls. Activity is seen 
in the right middle and inferior frontal gyrus. In addition, Figure 6-9 shows uncorrected data. 
While uncorrected results cannot be considered sufficient to report as significant (see multiple 
comparisons problem, page 68 in the Introduction chapter), the uncorrected images can often 
show useful information about the activity which is overlooked by a stringent corrections 
criteria. In this case, activity in the uncorrected image can be seen in the middle frontal gyrus 
bilaterally, as well as in posterior parietal areas, all areas known to be involved in memory-
guided saccade control. Table 6-6 provides a list of the active regions seen in the corrected 
comparison for the control group. 
Figure 6-10 shows activity during the saccade period for the PD group. Activity in the frontal 
eye fields, supplementary eye fields, DLPFC and posterior parietal cortices are seen. In 
addition, right insula activity is seen for this saccade period. Additionally, Table 6-7 provides 










Figure 6-6 – Significant BOLD activity for the control group during the memory-guided “perceive” event 
greater than fixation. Top panel (A) shows activity (in grey/black) over a transparent brain. The lower 
panel (B) shows activity (in yellow) over an axial view of the brain. Once corrected for multiple 
comparisons (FWE p < 0.05), activity is sparse and seen in the SEF region and in the middle temporal 









Figure 6-7 – Significant BOLD activity for the PD during the “perceive” event greater than fixation. As 
with the previous diagrams, the top panel (A) shows cortical activation (dark areas) over a transparent 
brain. The lower panel (B) shows the same cortical activation (orange to yellow areas) over axial view of 
the brain. The colour scale corresponds to the T value of the activation. Activity for this event involves 







Table 6-4 – Locations of BOLD activations greater in the memory-guided task compared to fixation for 
the ‘perceive’ event for the control group. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
SEF Medial Frontal Gyrus R 6.83 5.13 8 16 52 
SEF Superior Frontal Gyrus R 6.17 4.8 12 10 66 
SEF Medial Frontal Gyrus L 5.8 4.61 -8 14 52 
Medial FEF Brodmann area 6 L 5.6 4.5 -28 -6 50 
Temporal lobe           
Middle Temporal Gyrus R 6.13 4.78 60 -52 4 
      
Parietal lobe           




Table 6-5 – Locations of BOLD activations greater in the memory-guided task compared to fixation for 
the ‘perceive’ event for the PD group. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
Supp motor area R 6.19 4.81 6 18 52 
SEF Brodmann area 6 L  5.86 4.64 -10 10 54 
      
Parietal lobe           
Brodmann area 40 R 6.19 4.81 46 -46 44 










Figure 6-8 – Significant BOLD activity for the control group during the memory-guided “saccade” event 
greater than fixation. Top panel (A) shows activity (in grey/black) over a transparent brain. The lower 
panel (B) shows activity (in yellow) over an axial view of the brain. Once corrected for multiple 










Figure 6-9 – Uncorrected view of the same analysis from above (control group saccade event of the 
memory-guided task greater than fixation). Top panel (A) shows activity (in grey/black) over a 
transparent brain. The lower panel (B) shows activity (in yellow) over an axial view of the brain. In the 
uncorrected image, frontal and parietal activity is seen during the saccade event, much like the block 
design task. It is possible the FWE correction for multiple comparisons applies a too stringent correction 
threshold to allow activity in the event-related design to be detected as strongly as the block design task as 











Figure 6-10 – Significant BOLD activity for the PD group in the saccade event greater than fixation. The 
top panel (A) shows cortical activation (dark areas) over a transparent brain and the lower panel (B) 
shows the same cortical activation (orange to yellow areas) over an axial view of the brain. The colour 
scale corresponds to the T value of the activation. Activity for this event involved significant activity in the 
FEF, SEF and PPC. The FEF activity appeared to be more prominent in the right hemisphere of the brain 
with much smaller significant areas of activation seen on the left FEF. The analysis depicted is corrected 






Table 6-6 – Locations of BOLD activity greater in the saccade event than fixation for the control group in 
the memory-guided task. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
Middle Frontal Gyrus R FEF 6.45 4.94 26 -4 54 
Inferior Frontal Gyrus R 6.44 4.94 50 6 28 
Brodmann area 44 Precentral Gyrus R 5.61 4.5 52 14 10 
	
PD	group	–	Saccade	event	activity	
Table 6-7 – Locations of BOLD activity greater in the saccade event than fixation for the PD group in the 
memory-guided task. 
   MNI coordinates 
Frontal Lobe T value Z value X Y Z 
Medial FEF Middle Frontal Gyrus R 9.25 6.1 26 -2 54 
Lateral FEF Middle Frontal Gyrus R 8.3 5.75 38 -4 56 
Medial FEF Brodmann area 6 L 5.59 4.49 -24 2 62 
Medial FEF Middle Frontal Gyrus FEF L 5.54 4.46 -24 -6 54 
SEF Brodmann area 6 R 6.75 5.09 4 8 64 
Brodmann area 8 R 6.97 5.19 4 20 48 
Supplementary motor area Superior Frontal Gyrus L 5.82 4.61 -10 0 72 
DLPFC Middle Frontal Gyrus R 5.84 4.62 44 40 26 
Brodmann area 44 R 8.81 5.95 52 14 8 
Inferior Frontal Gyrus R 6.61 5.02 52 6 26 
Medial Frontal Gyrus L 6.43 4.93 -5 14 52 
Parietal lobe     
Inferior Parietal Lobule R 9.25 6.1 56 -42 40 
Brodmann area 40 Inferior Parietal Lobule R 8.29 5.75 44 -42 38 
Brodmann area 40 L 6.56 4.99 -40 -48 52 
Brodmann area 40 L 6.53 4.98 -44 -38 46 
Superior Parietal Lobule L 6.65 5.04 -24 -62 56 
Inferior Parietal Lobule L 5.6 4.5 -56 -34 34 
Brodmann area 7 R 5.97 4.69 35 -58 52 
Brodmann area 7 R 5.71 4.55 22 -68 36 
Insula Cortex     
Insula Brodmann area 13 R 6.18 4.8 34 20 6 
Occipital lobe     
Brodmann area 19 Fusiform L 6.18 4.8 -30 -70 -14 
Fusiform Gyrus R 6.16 4.79 30 -68 -12 
Other      




Automatic clustering can often merge adjacent clusters together, missing important, closely 
spaced clusters of activation. ROI were visually identified from the block experiment and the 
results are shown in Table 6-8.  
Table 6-8 – Coordinates of visually identified active ROI from the block design experiment. These regions 
were subsequently used in the event-related time course and PCA analyses. DLPFC – dorsolateral 
prefrontal cortex, FEF – frontal eye field, IPL – inferior parietal lobule, SPL – superior parietal lobule, 
SEF – supplementary eye field. 
  MNI coordinates 
ROI Region X Y Z 
1 L DLPFC -34 46 24 
2 R DLPFC 34 46 24 
3 L Lateral FEF -40 -4 48 
4 R Lateral FEF 42 -2 50 
5 L Medial FEF -29 -2 53 
6 R Medial FEF 24 -6 54 
7 L Insula -36 20 2 
8 R Insula 36 23 2 
9 L Parietal (IPL) -39 -46 46 
10 R Parietal (IPL) 45 -46 47 
11 L Parietal (SPL) -26 -60 55 
12 R Parietal (SPL) 28 -62 48 
13 SEF -1 3 57 
14 Pre SEF -2 20 47 
     






Figure 6-11 to Figure 6-17 show event-related time courses for the selected ROI from Table 
6-8. The time courses showed a common bimodal pattern. An initial peak in signal change is 
seen at 3 to 4 seconds after trial onset and a second peak at 10-12 seconds. The peak sizes also 
differed, with the second peak amplitude being larger than the first peak for most regions. The 
pattern of activation is compatible with the nature of the memory-guided task, with the first 
peak representing activity from the visualisation and initial memory of the flashed peripheral 
target during the “perceive’ event. The second, more pronounced peak, likely represents the 
activity related to the generation of the saccade to the remembered location for the “saccade” 
event.  
The IPS, bilaterally, on visual inspection, showed a group difference between the PD and 
control group for the second peak period: the PD group showed greater activity during the 
second peak. This was evident bilaterally. In contradistinction, the medial FEF visually 
showed a greater BOLD signal for the control group compared to the PD group in the first 
peak, more prominent on the left side. No bilateral group differences in the lateral FEFs were 





Figure 6-11 – The event-related time course of the right and left medial FEF. Time at 0 s represents the 
“perceive” event when the target stimulus was flashed. Error bars show standard error. After this flash, 
we can see an increase in the bold response of both PD and control groups, peaking at 3-4 seconds before 
reducing. After 5.6 seconds in, the fixation point was extinguished, cueing the saccade to the memorised 
position. We can see a larger rise in activation, thought due to saccade generation, from the 6 second mark 
peaking 4 seconds later, before declining. The activity continues to decline to a post-stimulus undershoot 
before returning to baseline as the participant fixates on the new position. Interestingly, there was no 
separate increase in BOLD activity relating to stimulus reappearance after the saccade – possibly due to 
only a small corrective saccade being needed. Both PD and control groups showed very similar levels of 
activation. In the first peak at 3-4 seconds, controls show, on visual inspection, slightly greater BOLD 
signal change than PD in the right medial FEF. In the left medial FEF, during the first peak, we see a 
slight difference in timing between the two groups with PD peaking at 3 seconds and 4 seconds for the 
controls. The peak signal change appears greater in the control group compared to the PD group for the 
first peak, with a greater difference than for the right FEF. The second peak at 10 seconds showed no 




Figure 6-12 – Time courses for the right and left lateral FEF. Error bars show standard error. The 
activation pattern shown here is similar to the medial FEF region, with two-peaks, the first peak at 3 
seconds and the second peak at 10 seconds, believed to correlate with visual attention/initial memorisation 
and saccade generation events respectively. For the right lateral FEF, the PD group, on visual inspection, 
showed a greater BOLD signal compared to controls at the second peak of the task – corresponding to 
saccade generation. This, however, was not evident on the left lateral FEF. No bilateral group differences 




Figure 6-13 – Time courses for pre-SEF and SEF activity during the memory-guided task. The shape of 
the response curve showed a two-peak shape with the second peak being of higher amplitude than the 
first. The approximate timing of the peak is similar to that observed in the FEF (Figure 6-11 and Figure 
6-12), with the first peak at 4 seconds and the second peak at 10 seconds. No bilateral group difference 





Figure 6-14 – Time courses for both PD and controls in the IPL (right – upper image, left – lower image). 
The time course shape is similar other eye control regions, being characterised by two peaks, with a 
higher second peak amplitude compared to the first. A difference in activity can be observed on visual 
inspection between PD and control groups for the second peak. For both left and right IPL regions, the 





Figure 6-15 – Time courses for both left and right SPLs for the memory-guided task. Both sides show the 
two-peak shape typical of other eye movement regions, with the second peak being of higher amplitude 
than the first. This pattern is seen in both PD and controls. Both PD and control time courses show a 
similar shape with the signal change close between the two groups at each time point. No bilateral group 




Figure 6-16 – Time courses for both left and right sided DLPFC activity. The right DLPFC followed the 
two-peak shape seen in other areas of eye movement control. The PD group for the right DLPFC showed 
a higher second peak amplitude than the first whereas both peaks of the control group are roughly equal 
in amplitude. The left DLPFC showed a much different pattern compared to the right. Overall, the 
maximum percent signal change is lower on the left DLPFC compared to the right DLPFC with the left 
DLPFC peaking at roughly 0.16%, compared to the right DLPFC, which showed a 0.4% maximum signal 
change. A three peak pattern can be seen for the PD group, with a third peak seen at 14 seconds. The 
control has the first peak at 3 seconds with no second peak. The decrease in activity after the first peak is 
not linear, with a levelling off close to where the second peak would be expected. With a much lower 
overall percent signal change, it is unclear if the shape of the haemodynamic response relates to 
meaningful task-related activity or if contributions from underlying sustained processes are occurring, 




Figure 6-17 – Time courses for the right and left insula region. The activity showed a very similar pattern 
when comparing both left and right insula regions, with the noted two-peak pattern. The pattern is also 
very similar between the two groups, indicating no pronounced group difference in activity for the insula 
region for memory-guided saccades. The similarity of the BOLD response shape to the response seen in 
known saccade control regions would suggest the insula could potentially operate in a similar way as an 





Figure 6-18 shows the percentage variance explained by each principal component. The 
loading values of each ROI for PC 1 2 and 3 are shown in Figure 6-19, Figure 6-20 and 
Figure 6-21 respectively. Plots of the loading values for PC 2 against PC 3 are shown in 
Figure 6-22. The K-means clustering analysis was used to separate the 14 ROIs into 4 
clusters. One cluster comprises all the frontal and supplementary eye fields. A second cluster 
separated both DLPFCs. The posterior parietal regions were mostly grouped in a third cluster, 
with the left SPL and both anterior insula ROI forming the fourth cluster. Finally, an 
illustration of the shape of each principal component is shown in Figure 6-23. 
 
 
Figure 6-18 – Plot of the variance of the BOLD time courses of every ROI explained by each PC. The first 
three components explained 80% of the variance between the BOLD time courses of every ROI and were 





Figure 6-19 (above) – Loading values for each ROI shown for PC 1. It can be seen that all 14 ROIs were 
loaded strongly positive for PC 1. This indicates a shared common component of BOLD activity shared 
for every ROI for the memory-guided saccade task. 
 
Figure 6-20 – Loading values for each ROI shown for PC 2. In contrast to PC1, PC 2 is differentially 
expressed by each ROI. This indicates this component captures some aspect of their functioning that 
differentiates their contributions to the task, with FEF and SEF regions showing higher PC 2 expression, 
DLPFC and insula regions showing intermediate PC2 expression and posterior parietal areas, in general, 
showing the lowest PC 2 expression. FEF – Frontal eye field, SEF – Supplementary eye field, DLPFC – 




Figure 6-21 – Loading values for each ROI shown for PC 3. The DLPFCs bilaterally were particularly 
negatively loaded on this component. Other regions such as the FEF and posterior parietal cortex regions 
showed weakly positive PC 3 loadings. FEF – Frontal eye field, SEF – Supplementary eye field, DLPFC – 
dorsolateral prefontal cortex, IPL – Inferior parietal lobule, SPL – Superior parietal lobule. 
 
 
Figure 6-22 – The loading values of PC3 vs PC2. Also shown are results from the K-means clustering 
analysis with 4 clusters. Ovals and colours indicate separate clusters. Cluster 1 is formed by both DLPFC. 
Cluster 2 contains all posterior parietal ROI except the L SPL, which is located in cluster 3, along with 




Figure 6-23 – Shape of each principal component. PC 1 (black) follows a two-peak activation pattern. This 
is similar to the general two-peak BOLD activity shape seen in the individual time courses for the 
majority of the ROI and it follows that this PC was strongly expressed by every ROI. PC 2 (red) shows 
peaks before the peaks of PC 1. PC 2, therefore, may represent preparatory or anticipatory activity 
preceding the general task activity that is represented by PC 1. PC 2 is strongly expressed in the FEF and 
SEF regions and negatively expressed for the posterior parietal regions. PC 3 (blue) shows a relatively flat 
shape before a more pronounced peak during the second peak of PC 1. This pronounced peak occurs at 
the time of saccade generation. Therefore, PC3 may represent activity related specifically to saccade 
generation. This PC is negatively expressed by the DLPFC, with all other eye field ROI, along with the 





In this study, we observed BOLD activity in the FEF, SEF, posterior parietal cortex (PPC), 
DLPFC and insula for the memory-guided task. We also found activity within the PPC as two 
continuous clusters - one in the SPL (parietal area A) and one in the IPL (parietal area B), 
with additional activation present in the IPS between these two areas. Parietal areas A and B 
are illustrated in  Figure 6-24. Figure 6-25 and Figure 6-26 illustrate the anatomy of the PPC, 
showing regions within each lobule, such as the supramarginal gyrus and angular gyrus, both 
located within the IPL.  
A subtle difference was found on visual inspection between PD and controls in the IPL 
bilaterally - a greater change of BOLD activity was seen during activity related to memory-
guided saccade generation in PD than the control group. These observations would suggest 
firstly, that the PPC has two regions involved in the memory-guided saccade task, and 
secondly that IPL activity may be altered PD. In the frontal cortex, the medial FEF showed a 
subtly reduced BOLD activity in the memory phase in the PD group, with controls showing a 
slightly higher activity during the first time course peak thought to correspond to inial 
stimulus perceive and memory events. This may indicate altered FEF activity in PD for the 
memory-guided task. No other pronounced bilateral BOLD signal changes were observed 
between PD and control groups. 
6.4.1 Discussion	-	Aims	of	study	
This experiment shows that significant functional changes are not detected for PD in memory-
guided saccades compared to controls, using event related fMRI. This does not support the 
first aim, in testing the hypothesis that eye control regions would show detectable functional 
changes in PD while performing the memory-guided saccade task. 
This study satisfies the second general question of improving our understanding of eye 
movement control by using PCA and cluster analysis. The expression of principal 
components of each region of interest are consistent our present knowledge of eye movement 
control. Notably, this consistency with prior understanding arose despite these analyses 
arising from a completely data driven approach, free of any prior assumptions. The cluster 
analysis was also able to group anatomically and functionally related regions together without 
prior information, supporting the ability of this technique to determine functionally related 





 Figure 6-24 – Active (orange) PPC regions for the memory-guided task. Red squares indicate PPC 
regions selected for the time course analysis. “A” represents the superior parietal lobule (SPL) and “B” 
the inferior (IPL).  
6.4.2 Posterior	parietal	cortex	anatomical	areas	
The PPC consists of the superior parietal lobule (SPL), inferior parietal lobule (IPL) and 
intraparietal sulcus (IPS; Figure 6-25 and Figure 6-26). The inferior parietal lobule consists of 
the supramarginal gyrus (SMG) anteriorly and the angular gyrus (AG) posteriorly. The lower, 
inferior region of the inferior parietal lobule contains the temporal parietal junction (TPJ).  
 
Figure 6-25 – Diagram of the PPC region in the human and primate brain (Bisley & Goldberg, 2010). 
Diagram a (left) represents the human brain and b (right) represents the macaque monkey brain. From 
the human brain: SPL, superior parietal lobule; Ang, angular gyrus; Smg, supramarginal gyrus; IPS, 
intraparietal sulcus; IPL, inferior parietal lobule; TPJ, temporoparietal junction. From the primate 
brain: V1-V4, visual cortices; PO, parieto-occipital area; PIP, posterior intraparietal area; MIP, medial 
intraparietal area; LIP, lateral intraparietal area; VIP, ventral intraparietal area, AIP, anterior 




Figure 6-26 – Human PPC diagram (Hutchinson, Uncapher, & Wagner, 2009). SPL, superior parietal 
lobule; AnG, angular gyrus; SMG, supramarginal gyrus; IPS, intraparietal sulcus; IPL, inferior parietal 
lobule; TPJ, temporoparietal junction. Figure permissions obtained - Creative Commons License 
(Hutchinson et al., 2009). 
 
6.4.3 Parietal	lobe	activity	for	the	memory	task	
During the memory-guided task, subjects shift attention to the target flash while maintaining 
visual fixation on the fixation stimulus, in a process known as covert attention (Corbetta & 
Shulman, 2002). Pierrot-Deseilligny et al. (2002) have described three more processes in the 
memory-guided task that occur after stimulus presentation – spatial integration, memorisation 
and saccade triggering. The PPC has been implicated in all these functions. Here, we will 
attempt to summarise the literature available for this area to help our understanding of these 
parietal areas and what the BOLD activation differences in PD observed in the present study 
might indicate. The following sections on PPC function is complex, given the multitude of 
functions ascribed to posterior parietal subregions and the resulting lack of consensus (See 
section 1.2.3.11 in the introduction). Three subsections cover PPC involvement in each 
process of the memory-guided task. PPC attention-related processes are covered first 
(Sections 6.4.3.1 to 6.4.3.4). The next sections cover PPC spatial-memory processes (section 
6.4.3.6 and 6.4.3.6). The PPC’s role in saccade triggering has already been discussed in the 
introduction section (1.2.3.11) and won’t be repeated here. Finally, section 6.4.3.7 ties these 
functions to my result findings seen in Figure 6-14 (This figure visually depicts increased IPL 





The PPC plays an essential role in visual attention. Most prominently, unilateral brain lesions 
in the PPC cause a condition called visual neglect whereby the patient is unable to attend to 
stimuli and make saccades to the contralateral side of the lesion (Morrow & Sharpe, 1993; 
Moscovitch & Behrmann, 1994). All regions within the PPC – SPL, IPS and IPL have been 
noted to be involved in spatial attention (Friedrich et al., 1998; Posner et al., 1984; 
Vandenberghe et al., 2012). Spatial attention is closely related to saccade programming, with 
attention always being directed to the end-location of a planned saccade – saccades cannot be 
generated to a location different to the attended location (Deubel & Schneider, 1996; Hoffman 
& Subramaniam, 1995; Kowler et al., 1995). 
6.4.3.2 Attention	and	the	LIP	
Within the PPC, the LIP is thought to have both attention and saccade functions (Bisley & 
Goldberg, 2010). Biesley and Golberg argued that the LIP forms a priority map of the world, 
in which attention is given and a saccade generated based on the importance of the object or 
location. The monkey LIP corresponds to the human PEF (Culham et al, 2006) and is located 
in the human IPS (Rushworth et al., 2001) and parts of the SPL (Konen & Kastner, 2008; 
Sereno, 2001). We believe parietal area A seen in our study is the PEF, or the human 
equivalent to the LIP. Sereno (2001) proposed the human homologue of the LIP (PEF) to be 
at coordinates x = 32, y = -68, x = 46 very close to our parietal area A. (Our parietal area A 
has the coordinates of x = 29, y = -58, x = 43). Coordinates from a more recent human study 
(Konen & Kastner, 2008) places regions equivalent to the human LIP within the IPS and SPL, 
also very close to our parietal area A (see Table 6-9 for a comparison of human equivalent 
LIP coordinates between studies).  
Table 6-9 – Talaraich coordinates of potential human LIP locations described by Sereno (2001) and 
Konen & Kastner (2008). Coordinates from parietal area A in our study were transformed from MNI 
space to Talaraich by the methods described by Lacadie, Fulbright, Constable, & Papademetris (2008) to 
allow comparison.  
Study Region   Right     Left   
  x y z x y z 
Sereno 2001 Possible human LIP 32 -68 46 Left coordinates not reported 
        
Konen & Kastner  IPS1 25 −72 39 -25 −72 39 
2008 IPS2 24 −71 48 -24 −71 48 
 SPL1 18 −68 46 -18 −68 46 
        




A review by Corbetta & Shulman (2002) describes the IPS as being part of an attention 
network linked with the FEF, forming what is known as the dorsal attention system. This 
dorsal attention system is thought to mediate "top-down" attention - that is attention 
controlled by cognitive factors such as previous knowledge about the locations to pay 
attention to – as in the memory-guided saccade task. By contrast, the ventral attention system, 
which is described as more to do with unattended attention shifts (e.g. an alarm going off 
unexpectedly) – is not likely to be so relevant to our remembered task. Silver et al. (2005) 
conducted an fMRI study of covert attention whereby stimuli were presented around a central 
fixation point. Participants were asked to identify locations of the peripheral stimuli while 
maintaining fixation. Two regions within the IPS were involved in this covert attention task, 
both of which were reported candidates of the human LIP/PEF. It is likely that parietal area A, 
which we believe to be the PEF/LIP, showed activation that represents, at least in part, the 




A second saccade control area known as area 7a is present in the PPC. Contrary to the LIP, 
which is thought to have both attention and saccade roles, area 7a is thought to be involved 
mostly in directing attention (Steinmetz et al 1995). Stimulation studies have been unable to 
elicit saccades in area 7a (but can in the LIP) (Thier & Andersen, 1998). The discharge of 7a 
neurons have also been found to be related to eye (Andersen et al, 1990) and head position 
(Brotchie et al, 1995) and this link is thought to represent the involvement of area 7a in the 
synthesis of information in directing visual attention (Brotchie et al., 2003). Steinmetz et al. 
(1995) and Mountcastle et al. (1981) noted macaque 7a neurons fired when a peripheral 
stimulus was presented during an active fixation task. A peripheral stimulus presentation 
occurs during fixation in our memory-guided task during the peripheral flash period. We can, 
therefore, expect the human 7a to activate during the memory-guided task relating to 
attention.  
There does not appear to be a consensus on the human region that corresponds to area 7a. 
Hutchinson et al. (2009) suggested the ventral PPC contains area 7a and Konen & Kastner 
(2008) report 7a could also be within certain IPS regions and the SPL. Monkey studies show 
7a to be in the IPL (Andersen et al., 1990) with Leigh & Zee (2000) suggesting it is possible 
the human inferior parietal lobule contains area 7a. However, this would run contrary to the 
more recent study done by Konen & Kastner (2008) suggesting the 7a may comprise regions 
of the IPS and SPL. Our task showed activation in both the superior and inferior parietal 
lobule. Without a firm consensus on the human 7a location, we can only speculate that either 
one of parietal area A or B corresponds to 7a activation during the memory task. Should 
parietal area B represent the human 7a, then it would suggest that 7a might be affected in PD, 
with a different BOLD response curve during the memory-guided task compared to 
unaffected controls. However, this is speculation given the dearth of studies confirming 
parietal area B within the IPL corresponds to the human area 7a. 
6.4.3.4 Attention	and	the	inferior	parietal	lobule	
The IPL is thought to contribute to spatial attention function (Friedrich et al., 1998; Posner et 
al., 1984). However, there is a degree of uncertainty regarding the nature of attention-related 
inferior parietal lobule function. A review by Husain & Nachev (2007) highlights the issues in 
our understanding of the IPL for attention processes. For example, this region does not 
completely fit into the conventionally defined dorsal or ventral attention systems as described 
by Corbetta & Shulman (2002). Husain and Nachev suggested that the IPL contains further 
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subregions which are part of attention networks that are non-spatial in nature e.g. auditory 
attention (Linden et al., 1999) or related to the temporal aspects of attention e.g. sustained 
attention (Husain, 2005). Factors contributing to the uncertainty of IPL function include inter-
individual anatomical variability and the large number of networks involving the IPL 
(Igelström & Graziano, 2017). The IPL has been described as a network “hub”, or an area 
with a particularly high number of network connections, and is involved in a broad range of 
cognitive functions not limited to attention (Igelström & Graziano, 2017). Examples of these 
functions include self-body perception (Blanke et al., 2002), mind-wandering (Buckner et al., 
2008) and a perception-to-action system used to envisage the process of manipulating objects 
in peri-personal space, and which may have allowed humans to first conceptualise the use of 
tools (Kastner et al., 2017). A number of these IPL networks have only recently been found so 
there are few, if any, follow up confirmatory studies. Using resting-state functional 
connectivity imaging, 5 subregions were found in the left IPL and 7 in the right (Wang, Xie, 
et al., 2016; Wang, Zhang, et al., 2016). These subregions were considered to be involved in 
attention processes as well as sensory/motor processing, movement imagination, spatial 
cognition and higher order functions such as social cognition (Wang, Zhang, et al., 2016).  
Non resting-state fMRI studies have implicated the IPL in attention functions. An 
investigation by Perry & Zeki (2000) found the supramarginal gyrus (SMG), particularly the 
right side, to be involved in covert attention (and interestingly, the anterior insula which will 
be discussed later). The angular gyrus, particularly the right side, has been seen to be more 
active in reflexive saccades rather than voluntary (Mort et al., 2003), which the authors 
suggest supports a role for the IPL in exogenous (directed by external stimuli, rather than 
internal volition) attention shifts. With evidence from fMRI and lesion studies for a role of the 
IPL in attention processes, it is highly likely that the activity within parietal area B in the 
present study, located in the IPL, does relate, in part, to attention processes, despite our 
limited understanding of this region. It follows that the BOLD activation differences seen in 
the IPL between groups in our study may well relate to attention process impairments in the 
PD disease state. However, it is equally likely that the differences between the two groups 
reflects a number of other processes or networks in which the IPL is involved. Cognitive 
processes such as movement imagination and spatial cognition are likely to occur during the 
memory-guided task so we cannot necessarily attribute IPL activity group differences to 
altered attention function alone. The activity seen in the IPL in our study appears only as one 
broad region of activation. Higher resolution fMRI scans in the future may be able to visualise 
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differential functional activity during task performance in various IPL subareas defined in the 
recent network studies and provide more insight into the functions of IPL subregions. 
6.4.3.5 Spatial	memory	processes	in	the	PPC	
TMS methodology has indicated that the PPC is critically involved in the initial several 
hundred millisecond period of spatial integration and memorisation of a target (Muri et al, 
1996). Interruption of PPC function via TMS during the early memory period results in 
defective memory-guided saccades (Muri et al., 1996; Oyachi & Ohtsuka, 1995). 
Furthermore, TMS of the PPC immediately following stimulus presentation impairs accuracy 
of the saccade, but not when applied some 500ms after the stimulus presentation, suggesting 
that after the initial several hundred millisecond period, spatial memory is retained elsewhere 
(Brandt et al., 1998; Muri et al., 1996). The PPC has a number of connections to the frontal 
lobe (Cavada & Goldman-Rakic, 1989) and SC (Lynch et al., 1985). Damage to the PPC 
affects memory-guided saccade performance, with patients making saccades with decreased 
gain. However, those with damage to the parietal-SC pathway, but not PPC itself, do not have 
these memory-guided saccade deficits. As a consequence it is widely believed that PPC 
signals for the memory-task are transmitted to the frontal lobe, specifically to the DLPFC 
(Chafee et al., 2011; Chafee & Goldman-Rakic, 2000; Gaymard et al., 1998; O’Sullivan et al., 
1995; Pierrot-Deseilligny et al., 1991; Salazar, 2012; Sweeney et al., 1996) rather than 
directly to the SC. This is felt to occur some 300 ms following initial stimulus presentation 
(Le Heron et al., 2005; Muri et al., 1996).  
More recent event-related functional imaging studies of memory-guided saccades have given 
a differing picture of the role of the PPC in memory-guided saccades. Rather than confirming 
the idea of the PPC being only involved in very early spatial memory as reported in previous 
neurostimulation studies, a number of event-related fMRI studies have described sustained 
activation in the IPS, well after the 300 ms mark, and attributed to memory processes: Brown 
et al. (2004) described a fronto-parietal system that is active for the memory-guided saccade 
task. They report greater activity in the right ventral IPS, right medial FEF and the SEF during 
the delay period of a memory-guided saccade task compared to a comparator visually-guided 
saccade task, and they attributed this increase in activity to be part of working memory 
processes during the delay phase of the memory-guided task. Brignani et al. (2010) observed 
sustained IPL activity during a memory-guided saccade task which they concluded supported 




Other reports have been more cautious in their conclusions. McDowell et al. (2008) in a 
review, describe “robust” delay period-related activity in the PPC in multiple studies 
including Brown et al. (2004) and Brignani et al. (2010), but do not discuss further whether 
this delay period activity is related to memory retention or other processes. Srimal & Curtis 
(2008) reported delay-related BOLD activity in the parietal cortex for the memory-guided 
task. The authors could not determine if the activation was from sustained retaining of the 
memory cue location or if it was a sustained planned motor response for the future. Geier et 
al. (2007), using a memory-guided task comparing short (2 s) and long (10 s) delay periods, 
found a sustained response pattern in the right supramarginal gyrus in the IPL during the 
delay period. The authors attributed this supramarginal gyrus activity to a state of 
preparedness to generate a saccade rather than to the maintenance of spatial coordinates. 
Schluppeck (2006) also used a variable length memory-guided paradigm and found sustained 
activity in IPS1 and IPS 2 regions during the delay period. Schluppeck reported these IPS 
areas to represent potential human homologues of the monkey LIP, and associated with 
attention and memory functions. A memory-guided study by Curtis & D’Esposito (2006) 
utilised a paradigm that included four locations that were briefly illuminated and then 
participants were cued to make a saccade to one of the remembered four locations following a 
delay period. Area IPS did not show sustained activity during the delay in their task but the 
FEF did. On the other hand, the IPS was activated after the participant was cued to make a 
saccade to a memorised location (before the saccade was made). This was taken to imply that 
the FEF was involved in maintaining spatial memory of saccade goals while the IPS was 
especially concerned with conversion of the instructional cue into spatial coordinates for the 
saccade. 
Those reports that suggest that the sustained PPC activation is related to the retention of 
spatial memory of the cue location, particularly for long delays of 10 seconds or over, 
contradict conclusions from earlier TMS studies. Those earlier studies reported that TMS to 
the PPC (where the IPS is located) during a period of several hundred milliseconds after 
stimulus presentation did not disrupt memory-guided saccades. A potential weakness of these 
studies, such as by Geier et al. (2007) arises from using the shape or sustainment of the 
haemodynamic response to make inferences on working memory function. It may not be 
possible to determine if sustained activity represents memory maintenance activity or other 
processes such as response preparation or attention processes simply from the shape of the 
hemodynamic response (Lebedev et al., 2012). Furthermore, sustained delay period activity is 
not consistently seen in regions believed to be involved in task memory processes (Zaksas & 
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Pasternak, 2006). Riggall and Postle (2012) suggest memory storage processes may involve a 
number of distributed cortical regions with subthreshold activity not able to be detected using 
current univariate MRI methods. 
The shape of what is considered delay activity in the haemodynamic response curve varies 
between studies. As previously mentioned, Geier and colleagues ( 2007) compared short (2.5 
s) to long (10 s) delay period memory-guided saccades. They described delay or maintenance 
related activity as a single broad peak. A response curve with a biphasic shape with two peaks 
was described as showing response preparation (see Figure 6-27).  
 
 
Figure 6-27 – Maintenance BOLD activity compared with response preparation-related BOLD activity 
according to Geier et al. (2007). Red traces indicate short delay period trials. Blue traces indicate longer 
trials. Geier and colleagues concluded that maintenance-related activity should not track downward 
during prolonged delay phases. Figure permission obtained (Geier et al., 2007). 
 
By contrast, Brown et al. (2004) compared visually guided saccade activity to memory-guided 
activity with a delay period of 9.8 s. The response curve from the right IPS in their study 
showed a biphasic shape. From the description of the expected time courses provided by 
Geier et al., the shape of the haemodynamic response in Brown’s study would be more 
associated with response rather than maintenance. However, Brown et al. compared the 
BOLD time course of the memory task to a visually guided task and reported that activity in 
the period between the two peaks in the memory-guided task was greater than in the visually-
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guided task. This activation was interpreted as representing maintenance activity, despite the 
time course having a biphasic shape. (See Figure 6-28). 
 
Figure 6-28 – BOLD time courses as found by Brown et al. (2004) during a memory-guided saccade task 
for the ventral intraparietal sulcus (vIPS) and rostral intraparietal sulcus (rIPS) (solid black time course) 
compared to a visually-guided saccade task (dotted black time course). Vertical dotted lines indicate 
events, in order from the left; trial start, stimulus “flash” and reappearance of the fixation stimulus. Both 
graphs show a bimodal shape with two peaks. Delay period activity is greater in both IPS regions in the 
memory-guided task vs visually-guided task. Adapted from Brown et al. (2004) - figure permission 
obtained. 
 
Both parietal regions A and B in the SPL and IPL in our study showed a biphasic response 
similar to the observations of Brown and colleagues. The aim of the present investigation was 
to compare PD and control BOLD activity. The procedure was not set up to optimise 
detection of delay related BOLD activity. We did not vary the delay period and we used a 
relatively short 5 second memory period and did not employ a comparator visually guided 
task. Therefore, whilst on visual inspection, the BOLD response in our experiment appears 
similar to the plots in the study of Brown et al., we cannot confirm that the activity between 
the peaks reflects delay-related activity. 
6.4.3.6 Memory	processes	and	the	inferior	parietal	lobule	
Aside from Brignani et al, (2010), few other studies have described IPL as having visuospatial 
memory-related function. Several have, instead, suggested that the IPL is involved in episodic 
memory (Cabeza et al., 2008), which may also involve regions of the IPS (Wagner et al., 
2005). Baldassano et al. (2016) described a cortical network comprising the caudal IPL as 
well as the retrosplenial complex and anterior parahippocampal region. This network was 
shown to exhibit high resting-state hippocampal coupling, suggesting involvement in episodic 
memory. The relationship of episodic memory and visuospatial memory is unclear but one 
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study found that visuospatial (and verbal) memory performance is related to episodic memory 
retention (Janssen et al., 2015). Of note, parietal lesions do not typically cause episodic 
memory loss. Wagner et al., (2005) have theorised that parietal contribution to episodic 
memory may be such that it is not important for memory expression, or that impairments may 
only be shown under specific conditions which have not been tested.  
Spatial memory and attention processes in PD In memory-guided saccades, hypometria, or the 
undershooting of saccades is a consistent finding in PD compared to controls (Lueck et al., 
1992; Lueck et al., 1990). Le Heron et al., (2005) found impairments in the percentage error 
in final eye position for PD patients with memory delay periods of 3 seconds. Chan et al. 
(2005) also found PD patients to make undershooting memory-guided saccades and were less 
able to make memorised sequences of eye movements correctly. They suggested that there is 
a deficit in spatial working memory in PD that leads to the difficulty in generating the correct 
saccade sequence. A number of other investigations have also revealed working memory 
impairments in PD. Helmuth et al. (2000) found deficits in PD in learning a finger button 
pressing sequence. They, however, found no impairment in PD patients when learning a 
spatial location sequence. Ketcham et al. (2003) reported that PD patients had impairment 
transforming spatial information into motor action. They suggested that this problem is 
related to dopamine depletion in the caudate nucleus. Rottschy et al. (2013) used a typing-
sequence recall task to investigate working memory in PD. PD subjects had mostly decreased 
activation during the memorisation and execution of their memory task in regions that 
included the superior parietal lobule, intraparietal sulcus and right inferior parietal lobule. 
There was also increased activation in the posterior parahippocampal gyrus and the authors 
suggested that detrimental aberrant activity in this region was responsible for impaired 
performance in PD. 
Our fMRI study employed a very similar paradigm to that in the study by Le Heron and 
colleagues (2005), differing only in the delay period (ours being 5.7 seconds versus 3.0 
seconds). We found altered activity in the IPL in the PD group during the memory-guided 
saccade task. The difference in IPL activation was seen during the latter of the two activation 
peaks, and corresponding to the time we would expect to see neural activity during the 
saccade. No difference was seen between PD and controls during the memory delay period 
before the saccade. It seems less likely then that the difference in activation between PD and 
controls is related to working memory during the delay. Previous studies suggest the PPC is 
only involved in very early memorisation, only in the first 300 ms and not the entire 5.7 
seconds of memory needed for our study. More likely, this IPL activity difference may relate 
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to memory retrieval at the time of the saccade, or the use of visuospatial information to direct 
a voluntary saccade to the remembered location.  
 
It is possible that the increase in IPL activity seen in PD could represent aberrant activity 
similar to that described by Rottschy et al. (2013). The IPL is thought to be involved in the 
visuospatial integration process which calculates saccade amplitude (Pierrot-Deseilligny et al., 
1995). Drawing from the proposals by Helmuth et al. (2000) and Ketcham et al. (2003) 
regarding an impairment of the visuospatial to motor movement conversion in PD (in finger-
pointing tasks), it is possible that aberrant activity in the IPL seen in the present study could 
also reflect impairment of visuospatial memory to oculomotor movement conversion.  
Another possibility is that altered BOLD activity in PD could potentially be related to the 
memory retrieval processes in the memory-guided task. More activity in PD at the point of 
saccade generation may represent a higher percentage change necessary to recall/utilise 
visuospatial memory information, leading to the impairments in final eye position seen in the 
Le Heron et al. study.  
Geier et al. (2007) concluded that sustained activity in the IPL represents preparedness to 
make a saccade to an area. IPL is also active in voluntary saccade planning (Ptak et al., 2011). 
TMS over bilateral IPL impairs sustained spatial attention (Lee et al., 2013). If preparedness 
to make a saccade to a certain location is linked with sustained attention process to that 
location, then the altered activation we observed in the IPL could reflect impaired visuospatial 
sustained attention processes in PD. If attention to the planned saccade location is impaired, 
this could lead to the inaccurate memory saccades consistently encountered in PD. 
6.4.3.7 Memory	guided	saccade	generation	in	PD	
The PPC plays a critical role in saccades and in particular, the LIP is strongly active during 
remembered saccades (Sweeney et al., 1996). Pierrot-Deseilligny et al., (2002) describes the 
LIP as being involved in triggering reflexive saccades to targets in the visual environment. 
The LIP is also active in monkeys when withholding a saccade and is thought to be involved 
in planning anticipated saccadic movement (Barash et al., 1991; Pare & Wurtz, 1997). 
The IPL has a particular role in saccades directed by a reflexive shift of attention. Mort et al. 
(2003) reported activation in the angular gyrus (in particular the right side) during a reflexive 
saccade task greater than a predictive task. Perry & Zeki (2000) observed that the 
supramarginal gyrus (located within the IPL) was activated with covert attention shifts and 
reflexive saccades, especially the right supramarginal gyrus. Sheliga et al. (1995) describe a 
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premotor theory of attention, whereby attention shifts - which activate saccade generating 
areas - can activate these same regions even when saccades are not executed. 
With these understandings, we can generate an explanation for our observations of increased 
BOLD activity in the IPL in the PD group which we propose reflects increased IPL activation 
during attention shifts in PD. Drawing from the premotor theory of Sheliga et al. (1995) and 
the theory of attention by  Bisley & Goldberg (2010) where attention-related activity is 
thought to relate to priority, with saccades automatically generated to the highest attention 
points, increased IPL activity during attention shifting processes could reflect the assignation 
of a higher priority to each attention shift, and as a result predispose PD to generate more 
erroneous anticipatory saccades. However, that the timing of the BOLD signal changes 
between PD and controls, with greater IPL activity only seen during the later “saccade” event 
rather than the “perceive” event when erroneous reflexive saccades are made, is counter to 
this proposal. Additionally, it is possible that the number of trials was not sufficient to permit 
the development of a true group difference during the “perceive” event. Alternatively, it might 
be that any true effect is masked or confounded by PD participants’ making more erroneous 
anticipatory saccades. Future studies using more reliable eye-tracking equipment in the MRI 
scanner may be able to identify and exclude, or specifically study error trials to ascertain the 
effects of erroneous anticipatory saccades on BOLD activity.  
Chan et al. (2005) discussed the notion of adaptive behaviour in PD. Since PD patients are 
slower to initiate voluntary goal-directed movement, the saccade inhibition threshold may be 
set lower to help facilitate movement. Saccade initiation may need to be bolstered by a more 
readily activated attention switching system in PD. This, in turn, could give rise to a 
compensatory increase in activity in the IPL and reflected in our observations of increased 
IPL activity during the saccade period in PD compared to controls. 
As mentioned previously, a limitation of our study was that we were unable to determine the 
proportion of anticipatory saccades made within the MRI scanner. Our equipment could not 
reliably track and capture erroneous saccades during MRI scanning, which means we could 
not specifically exclude error trials during analysis. A possible reason for the difference 
between PD and controls in IPL activity may relate to the PD group simply making more 
saccades. This possibility though is made less likely by the timing of the IPL activation 
difference. The difference in the BOLD response between the groups was around the second 
peak relating to the “saccade” event rather than the first peak relating to the “perceive” event. 
The second peak is more related to the time of saccade generation to the memorised location, 
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and at the expected timing for a correct remembered saccade. The first peak, which occurs 
during the period when erroneous anticipatory saccades are made, showed no difference 
between PD and control groups in the IPL. Should erroneous anticipatory saccades be causing 
an activation difference, a higher number of saccades made by the PD group should equate to 
greater BOLD activity in saccadic eye fields during the “perceive” event. As no group 
difference was seen during this event period, it becomes less likely that the differences seen in 
IPL activity are explained purely by an increased number of erroneous anticipatory saccades 
by the PD group. 
6.4.4 DLPFC	
No significant group activation differences in the DLPFC were present in either block or 
event-related experiments. Clear DLPFC activity was detected in the memory-guided task for 
both PD and control groups in our block design experiment. No significant DLPFC activation, 
however, was detected in either “perceive” (initial appearance of target stimulus “flash) or 
saccade (generating saccade to memorised location) events in PD and control groups. This 
observation (of the absence of DLPFC activity in the event-related paradigm) may be 
explained by the block paradigm simply having a higher number of trials (54 memory trials in 
the block experiment vs 18 trials in the memory experiment). However, this may also relate to 
the nature of sustained delay period activity during the memory period, being sufficiently 
different from the canonical haemodynamic response to be able to be detected in a whole-
brain analysis using GLM (see pages 194 to 195 in the introduction section of this chapter for 
further explanation). In the following sections, I discuss DLPFC function and location and 
how this relates to DLPFC activity differences detected in our memory-guided tasks. 
The DLPFC is believed to be involved in the process of spatial memory (Curtis, 2006; Curtis 
& D’Esposito, 2003). There are several theories regarding the nature of DLPFC involvement 
in working memory; whether it participates in all components of short-term memory storage, 
manipulation and utilisation, or only one component (Levy & Goldman-Rakic, 2000). The 
DLPFC may also contain functional divisions, each with separate contributions in handling 
different information types and for different cognitive tasks (Cieslik et al., 2013). The 
DLPFC, not being a specific eye field, has not been reported to play a role in saccade 
generation. However, through its role in working memory, DLPFC dysfunction in PD is 
thought to cause performance deficits in memory-guided saccades (Le Heron et al., 2005; 




The DLPFC is located within the frontal cortex in Brodmann areas 46 and 9 and is thought to 
comprise several subregions. Levy & Goldman-Rakic (2000) suggested that the DLPFC is 
segregated according to the type of sensory information being processed, with some regions 
responsible for visuospatial processing and others for nonspatial processing such as faces and 
object recognition. In a review, Cieslik et al. (2013) posited that the DLPFC can be separated 
into two subregions: anterior-ventral and posterior-dorsal. The anterior-ventral region appears 
to be more involved in attention and action inhibition processes and tasks requiring conflict 
resolution - examples being the go/no-go task (in which stimuli are presented in a continuous 
stream and participants perform a binary decision to respond or not to each stimulus), and the 
Stroop task (a task that assesses executive functions of selective attention and cognitive 
flexibility). The posterior-dorsal DLPFC appears to be more related to action execution and 
working memory; for example, the n-back task – in which, from a continuous stream of 
stimuli, subjects are asked to recall whether the current stimulus is the same as one presented 
n steps ago.  
6.4.4.2 DLPFC	and	memory	timing	
DLPFC activity is related to the memory delay period time (Muri et al., 1996; Nyffeler et al., 
2002; Pierrot-Deseilligny et al., 2003). Muri et al. (1996) described the PPC as being involved 
in very early memorisation – in the first 300 ms with the DLPFC having a role after this initial 
memorisation period. A review by Pierrot-Deseilligny et al. (2002) concluded that the DLPFC 
was involved in the memorisation phase about 1 second after the target presentation and for 
up to some 20 seconds subsequently. For delays longer than this time, Pierrot-Deseilligny and 
colleagues suggested that the critical structure was the parahippocampal cortex in the medial 
temporal lobe. 
TMS over the DLPFC induces inaccuracy of memory-guided saccades (Muri et al., 1996). 
Likewise, prefrontal cortex (PFC) lesions also cause scattered and inaccurate memory-guided 
saccades (Funahashi et al., 1993; Ploner et al., 1999). TMS over medial frontal gyrus/DLPFC 
during the delay period of a memory-guided saccade impaired its accuracy, whereas TMS 
over the medial frontal gyrus/DLPFC around the time of target presentation or saccade 
execution had no such effect (Brandt et al., 1998; Muri et al., 1996). These observations are 
consistent with the notion that the PPC is involved in very early working memory around the 
time of target presentation and DLPFC is more involved during the delay period. Tanaka et al. 
(2014) found that single pulse TMS over the left DLPFC during a saccade and over the right 
DLPFC 100 ms after a saccade induced improved performance on a visual working memory 
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task that required the memorisation and reporting of changes in the orientation of a visual 
stimulus. Though their paradigm did encompass a memory-guided saccade task, they 
suggested that TMS over the DLPFC improves recall after making a saccade by the TMS 
wiping the DLPFC free of irrelevant spatial information stored during the saccade. This in 
turn implies that the DLPFC might form a live dynamic system of updating and storage of 
visual information during saccades. 
6.4.4.3 DLPFC	delay-related	activity	
A number of electrophysiology studies in the monkey have shown delay-phase memory 
activity in the DLPFC - for a review see Curtis (2006). This sustained activity was thought to 
represent either the maintenance of sensory or motor information or the neural code for the 
planned movement. Takeda & Funahashi (2004) separated memorised spatial location from 
saccade location. They observed that activity in the DLPFC initially coded for the memorised 
spatial location but then, midway through the memory delay period, coded for the planned 
movement. Thus DLPFC activity may represent both spatial memory and planned movement 
at different time points of the memory-guided task. 
fMRI studies have provided a mixed picture of DLPFC activation during the memory period. 
Baumann et al. (2007) found that the medial frontal gyrus (MFG; containing the DLPFC) was 
active in their block memory task (1 second delay) but not in their event-related memory task 
(9 second delay). Heide et al. (2001) did not observe DLPFC activation in their memory 
saccade study and postulated that the DLPFC is only active during retention times above 500 
ms, a delay period that their experiment did not exceed. In contrast, our block design 
experiment, using a 2 seconds delay, showed robust DLPFC activation. Our event-related 
experiment though, with a memory period of 5.6 seconds, failed to detect significant DLPFC 
activation during the “perceive” and “saccade” events, with the “memory” event not assessed 
in our paradigm. As described earlier, the HRF for sustained memory processes isn’t 
modelled by the canonical HRF used in the present study. In addition, sustained cortical 
activity during working memory processes are thought to be subtle and often subthreshold 
using current fMRI detection methods (Riggall & Postle, 2012). As discussed previously, one 
explanation for observing DLPFC activity in the block experiment only might be that the 
event-related experiment contained fewer total trials, due to longer trial duration, compared to 
the block experiment, thereby providing less overall statistical power. Our experiment was 
also not designed to compare different memory durations. Activations in the block and event-
related experiments are unable to be directly compared using a voxel-based analysis as these 
were separate scan procedures. Future studies may be able to address this by using rapid 
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event-related design methods and thus providing more power, combined block and event-
related fMRI designs, or varying the memory period within a single scan run to allow a direct 
comparison between different memory periods. 
6.4.4.4 DLPFC	and	reflexive	saccade	disinhibition	
DLPFC (and FEF) lesions cause disruption in inhibition of reflexive saccades (Guitton et al., 
1985; Ploner et al., 2005). In the eye movement laboratory, we found PD patients made 
significantly more erroneous anticipatory saccades than controls during the flash period (30% 
vs. 11%), indicating impaired reflexive saccade inhibition. One explanation for this 
abnormality could be that DLPFC function was compromised in the PD patients. This is 
speculative however as no significant difference was seen in DLPFC activation in fMRI data. 
This speculation could be specifically investigated in future studies once more reliable MRI 
compatible eye tracking systems are available. 
6.4.5 Insula	
Bilateral anterior insula activation was noted in our experiment for the memory-guided task. 
Insula activation in memory-guided tasks has been noted before in previous studies. A PET 
study by Anderson et al. (1994) noted insula activation in their memory-guided task with the 
authors surmising that the insula had a role in spatial attention, memory, or motivational 
aspects of oculomotor control. Similarly, Baumann et al. (2007) noted left insula activation 
(in a combined region with the superior temporal gyrus and caudate nucleus) for the memory-
guided task but did not explore further. 
The shape of the insula BOLD activation time course in the present study was very similar to 
that observed in the classic eye fields (e.g. PPC, FEF, SEF). However, we observed insula 
activation only in the memory-guided saccade task and not in more simple reflexive and 
predictive tasks (see results in Chapter 5 page 159). These findings suggest that the insula 
plays role in memory and other higher-order cognitive processes harnessed in the memory-
guided task and are not integral to the less cognitively demanding reflexive and predictive 
tasks. 
The insula is involved in aspects of attention and decision making (Weller et al, 2009) and 
proposed to be part of an overlapping attention and working memory cortical network (LaBar 
et al., 1999). In fMRI studies, the insula has shown activity during tasks comprising object 
recognition and detection of salient or relevant stimuli (Downar et al., 2002) as well as letter 
identification, motor timing, object naming and visual search tasks (Dosenbach et al., 2006). 
Perry & Zeki (2000) found the anterior insula (along with the supramarginal gyrus in the IPL 
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as discussed in the parietal cortex section previously) to be active during both a matching task 
- where participants made saccades to a peripheral object when the object shape matched a 
central fixation stimulus - and covert attention shifts whereby participants, having identified 
that no peripheral object matched the shape of a central fixation stimulus, did not make a 
saccade. Interestingly, the anterior insula was more responsive to ipsilateral rather than 
contralateral stimuli as seen in most cortical regions. The memory-guided task involves a 
number of task elements with participants needing to actively withhold a saccade, attend to 
the surroundings of the fixation stimuli, memorise a spatial location and to generate a saccade 
during specific points in the task. It is therefore possible that the insula activation in the 
memory-guided task reflected covert attention and cognitive processing of the individual 
components within the memory task, whereas the less complex predictive and reflexive 
saccade tasks did not require the same degree of task processing and so insula activation was 
not seen.   
The insula plays a role in vestibular function. The vestibular system is important to the control 
of eye movements by integrating information about relative body and eye positioning in 
external space and, for example, memory-guided saccades become inaccurate if patients are 
rotated during the delay period (Israël et al., 1995; Israël et al., 1999). Specific cortical 
regions that receive vestibular input have been identified in primate studies with Eickhoff et 
al. (2006) describing the primary vestibular region in monkey to be the parieto-insula 
vestibular cortex (PIVC), an area with dense vestibular inputs. Eickhoff et al. suggested the 
human equivalent is located in the posterior parieto-insular cortex. One could speculate then 
that the insula activation in our study might relate to the integration of body positioning and 
vestibular function with spatial perception and memory. However, not only were the 
participants motionless in the scanner, but the location of insula activation in our study was 
the anterior insula, whereas the PIVC is believed to be located in the posterior insula 
(Eickhoff et al., 2006). 
6.4.6 Frontal	Eye	Field	
The FEF is well known to be involved in eye movement control and was active in all our 
saccade tasks. Early studies using the macaque monkey precisely located the monkey FEF 
equivalent by direct microstimulation. The localisation of the FEF has been more variable 
when identified with other techniques such as fMRI and TMS in humans. In their review, 
Vernet  et al. (2014) described the FEF as being located in the lateral aspect of the precentral 
sulcus and the most dorsal aspect of the superior frontal sulcus. 
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The FEF is reported to be involved in fixation (Petit et al 1995), reflexive and memory 
saccades, with or without visual cues (Fox et al 1985), and even suppressed or imagined 
saccades (Law et al 1997). Studies by Bruce & Goldberg (1985) and Robinson & Fuchs 
(1969) described saccade size-specific-neurons within the FEF, with larger saccades being 
evoked from regions in the dorsomedial portion and smaller saccades from the ventrolateral 
region. It has been suggested the FEF has two foci of activation – medial and lateral - and 
there exist several ideas, some conflicting, regarding the functional split between these two 
regions (Gagnon et al., 2002; McDowell et al., 2005; Simo, 2005). There is a more extensive 
discussion on the FEF medial and lateral split in the previous chapter (Chapter 5). 
 
6.4.6.1 FEF	function	during	memory	delay	period	
Functional imaging studies of the memory-guided saccade task have shown the FEF to be 
active during working memory delay (Brown et al., 2004; Geier et al., 2007). This delay 
period activity may either represent the maintenance of a spatial image of the location or 
planned motor outputs responsible for moving the eyes to the new location (Curtis, 2006). 
Curtis & D’Esposito (2006) reported that the FEF might be more involved in holding the 
motor plan for making the saccade rather than retaining the spatial memory of the location. 
However, Srimal & Curtis (2008) found sustained FEF activity in the delay period for both a 
memory-guided task, in which a saccade was generated, and a spatial item recognition task in 
which no saccade executed. The authors suggested that FEF activity may not be related to 
saccade planning but rather, attention to the spatial location of the stimulus cue. Others have 
supported this notion of the FEF being involved in maintaining spatial information, 
irrespective of the need to generate a saccade (Armstrong et al., 2009; Clark, Noudoost, & 
Moore, 2012). Brignani et al. (2010) reported that the activity of the FEF during the delay 
phase was not consistent during the whole of the memory period as expected if the region was 
maintaining spatial information. Instead, the FEF was predominantly active only during the 
initial memory phase. The authors concluded that the FEF is involved in converting the initial 
spatial representation of the target to a motor plan.  
6.4.6.2 FEF	and	anticipatory	saccades	
On visual inspection, the present study showed the medial FEF was less active in PD 
compared to controls during the early peak in the BOLD time course. This effect was present 
bilaterally but was more prominent on the left medial FEF. There were no other bilateral 
frontal eye field differences seen between groups. 
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The activation impairment in the medial FEF in the PD group was observed in the first peak 
period. This is the period where the flash is first seen (“perceive” event), whereby the subject 
is instructed to hold gaze while remembering the location of the flash. This is also the time 
when an error reflexive saccade can be made to the flash. In the eye movement laboratory, PD 
patients were seen to make significantly more error reflexive saccades during the memory 
delay period than controls. As discussed earlier, we were unable to measure the frequency of 
error saccades in scanner trials due to limitations in the eye tracking equipment. With PD 
patients making significantly more anticipatory saccades in the eye movement laboratory, 
however, it is reasonable to assume that the same behaviour persisted within the scanner. 
Error reflexive saccades are more commonly studied as part of the antisaccade task where, 
through a similar mechanism, a peripheral stimulus triggers a reflexive saccade to the target 
despite instruction otherwise. Ptak et al. (2011) showed that error saccades in an antisaccade 
task were associated with stronger EEG activity in the right FEF. Further, Pa et al. (2015) 
reported that right lateral FEF activation inversely correlated with antisaccade performance 
(percentage correct saccades) in healthy elderly and suggested that an elevated signal 
represented aberrant neural activity that was detrimental to performance. In contradistinction, 
in the present study PD patients exhibited decreased BOLD signal compared to controls. 
Pertinently, Guitton et al. (1985) reported that FEF lesions resulted in saccade disinhibition in 
some patients to targets both ipsilateral and contralateral to the lesion. Thus, the diminished 
FEF activation in the PD group might be the basis for their failure to inhibit error anticipatory 
saccades. 
FEF activation differences between the two groups could relate to differences in other 
functions such as spatial memory, rather than direct saccade execution. This notion is 
supported by the observation that the activation differences were seen at the time of flash 
presentation and the initial memorisation period, rather than the saccade period. PD subjects 
make more inaccurate memory-guided saccades (Chan et al., 2005; Le Heron et al., 2005; 
Lueck, Crawford, et al., 1992; Lueck et al., 1990). If impairment in working memory 
processes or the ability to convert spatial information to motor commands is the cause of 
memory-guided saccade inaccuracy, then it would be expected that associated impaired 
BOLD activity would be in the first peak, as indeed we observed. As previously discussed, 
working memory processes have been described as diffusely distributed throughout multiple 
cortical regions and sub threshold when measured using the GLM analysis technique 
employed in the present study (Riggall & Postle, 2012). Hence, there is the possibility that 
any true group differences related to working memory in the FEF, that may have been present, 
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may not have been detectable with our methodology. A distinction between medial and lateral 
FEF involvement for spatial memory processes has not been described in the literature (Curtis 
& D’Esposito, 2006). In conclusion then, the medial FEF activation reduction seen in the PD 
group might potentially have been due to spatial memory process impairments, but this 
speculation is not supported by the prevailing literature. 
6.4.7 SEF	
The SEF is located on the dorsomedial surface of each hemisphere in the postero-medial 
portion of the superior frontal gyrus within the medial portion of BA6 (Petit et al., 1996). The 
SEF activates in relation to memory-guided saccades, antisaccades, predictive saccades and 
reflexive saccades (Alvarez et al., 2010; Kimmig et al., 2001; Lu et al., 2002; O’Driscoll et 
al., 1995; Petit et al., 1996; Schall, 1991).  
The SEF seems to be important for encoding the order of remembered saccade sequences 
(Isoda, 2002). However, Parton et al. (2007) studied a patient with a highly focal lesion in the 
SEF. The patient showed no impairment in generating the correct sequence for multi-step 
memory saccades but showed hypometria (reduced saccade amplitude) in both single and 
multi-step memory saccades tasks. In that study they noted how similar the deficits were to 
those in PD. Nachev et al. (2008), in a review of the supplementary motor complex (SMC; 
containing the SEF), highlighted a number of studies showing reduced SMC activity in PD 
(Buhmann et al., 2003; Grafton, 2004; Playford et al., 1992). It is surprising then that we were 
not able to discern any impairment in SEF activation in our PD group compared to controls. 
6.4.8 PCA	findings	and	discussion	
PC1 alone explains over 70% of the variance of all the analysed time courses (Figure 6-18 
page 225). The shape of PC1 was very close to the shape of the average BOLD time course, 
with two peaks corresponding to the initial perceive/memorisation event and the saccade 
event respectively (results - Figure 6-23 page 228). Figure 6-19 (results, page 226) showed 
that all ROIs expressed this component, indicating that they shared a common component of 
their temporal activation. PC2 and 3, however, revealed more functional specialization across 
the various ROIs. 
As PC1 is expressed in every region, this PC reveals that BOLD activity in all regions during 
the memory-guided task conforms to a general pattern, as visualised by the PC 1 time course. 
This finding is in accordance with the results from the block design voxel-based analysis, in 
which active regions showed activity related to a model made by convolving an HRF with 
stimulus onset and durations. The active regions found in the block design study, all 
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exhibiting activity significantly similar to the HRF convolved model, were used as the ROI 
for the time course analysis. As PC1 explains a significant majority of the variance of the 
BOLD time course of every region, this component offers little differentiation in regional 
contribution to the task. PC1 may therefore represent general memory-guided related activity 




Figure 6-29 – Plot of the PC loading value clusters as previously shown in the results section. Illustrative 
vertical dotted lines show approximately the cluster differentiation based on PC2 loading values – The 
FEF and SEF cluster show a higher PC2 expression. DLPFC and insula cluster regions show intermediate 
expression and parietal cluster regions show the least expression. 
PC2 encompasses roughly 7% of the total variance between all the time course plots in every 
region. The shape of the principal component appears to show a first peak or “hump” at 2.5 
seconds, before the time of the first peak of PC1. PC2 shows a second “hump” at 10 seconds, 
which is about 2 seconds before the second peak of PC1. PC2 may, therefore, represent 
preparatory-related BOLD activity, before saccade events occur, e.g. these may represent 
memory retrieval or attention shifting processes, which occur before a volitional saccade is 
generated. PC2 offers better differentiation of cortical regions compared to PC1. In the 
clustering graph, the parietal cluster shows a low (negative) “expression” of PC2, with 
frontal/supplementary eye field clusters showing more expression of this PC. The DLPFC, 









clusters (Figure 6-29). These findings suggest that frontal saccade-related regions are 
involved in pre-saccade and memory-related processes that occur before memory-guided 
saccade generation. This is in agreement with a study by Connolly et al. (2002) who, using 
another volitional saccade task (the antisaccade), found the FEF and not parietal regions (IPS) 
to show preparatory activity, coding readiness and saccade intention, prior to saccade 
generation. This conclusion fits a general theory that the FEF are more concerned with 
volitional saccades, whereas the PPC is more concerned with reflexive-type saccades. 
Correspondingly there are differences in preparatory activity in these regions for reflexive and 
volitional saccade tasks and highlighted by the PC differences seen in the present study.  
 
 
Figure 6-30 – Plot of the PC loading value clusters as previously shown in the results section. The dotted 
horizontal line illustrates approximately the cluster differentiation based on PC3 loading values – The eye 
fields - FEF and SEF along with the PPC regions show a higher PC3 expression. The DLPFC show lower 
expression of PC3. 
 
PC3 explains approximately 5% of the variance between all the BOLD time courses. The 
shape of PC3 appears to show a relatively flat period during the first perceive/memory event, 
with a more raised peak at the second saccade event, suggesting that this PC is related to 
activity during saccade generation. From the cluster analysis, the eye field region clusters - 
PPC, SEF and FEF - exhibit a higher expression of this PC whereas the DLPFC cluster shows 









field activity being unsurprisingly related to saccade events in keeping with current 
understanding. The DLPFC regions show a lower (negative) expression of this PC, indicating 
a relatively weaker relationship with saccade generation. Again, this finding is entirely 
consistent with our understanding of the DLPFC, which is known to be involved in general 
executive function and memory processes, rather than specifically dedicated to the generation 
of saccades. 
The clustering analysis, with no prior information on the function of each region, showed the 
PC loading values of the FEF and SEF regions to form one cluster, both DLPFCs forming a 
second, and most of the PPC in a third, with only the left PPC (SPL) and both insula regions 
forming a separate fourth cluster (See results Figure 6-22 page 227). Overall there was a 
consistent clustering pattern, so that related bilateral regions of similar function clustered 
together. 
The clustering of the left SPL with the insula cortices likely reflects asymmetry in parietal 
cortex function, which has been noted in previous studies, particularly relating to attention 
processes (Perry & Zeki, 2000). The PPC has been widely implicated in attention (Corbetta & 
Shulman, 2002; Vandenberghe et al., 2012). The right IPL (note inferior parietal lobule) 
exhibits activity relating to covert and externally guided attention shifts (Perry & Zeki, 2000), 
suggesting attention processes in the PPC may be divided unilaterally. In our study, there was 
no clustering distinction between the IPLs - the right IPL in our study was found to cluster 
with the left IPL. Instead, it was the SPL (superior parietal lobule), which showed a 
lateralised distinction, which doesn’t fit exactly with what was proposed by Perry and Zeki. 
However, at least one study has reported potential lateralisation of SPL function – in a human 
lesion study, participants having right SPL lesions performed a visuospatial manipulation task 
(Spatial Span - Backward task, which involving reordering a memorised spatial sequence 
backwards) significantly worse than participants with left-sided SPL lesions (Koenigs et al., 
2009). The study by Koenigs and colleagues was limited by the relatively small sample of 
left-sided lesions (n = 4) compared to right (n = 9), however, this does raise the possibility 
that lateralised processes occurring in the SPL, related to a currently unstudied visuospatial 
function, may be responsible for the non-bilateral clustering of the SPL observed in our study. 
The study of Sugiura et al. (2004) served as the catalyst for performing the PCA analysis of 
the memory-guided BOLD time courses in our study. Both our study and that of Sugiura et al. 
were able to use clustering analysis, without explicit training, to group ROI into frontal and 
parietal regions, or at least groups that were consistent with different functional roles, using 
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BOLD time course data in the memory-guided task. There are some differences in findings 
between the two studies. Sugiura et al. did not detect or investigate activation within the 
DLPFC regions, and which are known to be involved in the memory-guided task. DLPFC 
activity was identified in our study in the block task and these regions were then examined in 
our event-related analysis. Our study also identified bilateral anterior insula activation, again 
not detected by Sugiura and colleagues. It is possible that these differences arise from 
differing methods employed to identify ROI. Sugiura and colleagues determined their ROI 
from the same event-related task session used for the PCA analysis. Our study employed a 
separate block-design task session which served as the localiser for ROIs for the subsequent 
event-related PCI analysis. As previously discussed, in using a separate block-design localizer 
paradigm, we were able to get participants to perform many more trials within each run, 
compared to the event-related runs (54 trials in the block task vs 18 in the event-related task). 
It was only from the block design runs that we were able to detect clear, bilateral DLPFC 
activity. DLPFC activation was not evident in the whole-brain analysis of the event-related 
results, both in our study and that of Sugiura et al. A likely explanation for this lack of 
expected detection is the relatively small BOLD signal changes in the DLPFC during the 
memory task. Thus, this comparatively subtle BOLD activity might only be able to be 
detected through repeated summation of closely spaced trials in a block design. Another 
reason why DLPFC activity may not be detected in the whole-brain event-related analysis is 
differences in the time series shape of BOLD activation, also previously noted. If DLPFC 
activity relates to prolonged working-memory processes, the BOLD signal may not follow the 
canonical HRF shape. In the whole-brain analysis for the event-related experiment, only 
regions determined to show activity most closely correlated to the canonical HRF were 
detected. The methodology would be less likely to detect regions showing responses deviating 
from the canonical HRF shape in the task. This potential limitation is less of an issue in the 
block design, since activity summates across numerous trials, giving a broad activity curve, 
regardless of the shape of the BOLD response in any individual trial. 
Another region of activation not detected by Sugiura et al. was the insula. Bilateral anterior 
insula activity was seen prominently in the whole-brain block design session in our study, yet 
only weakly in the event-related session (significant activity was seen only in the right insula 
for the PD group and not at all in controls). This illustrates the advantages of the additional 
step employed by this study by using a separate block-design localizer task to identify ROI, 
being able to detect activity which may not be seen if using only an event-related design.  
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Conversely, Sugiura et al. found active occipital regions in their experiment and included this 
in their PCA analysis. Our experiment did detect small clusters of memory-guided occipital 
activity in the control group in the block-design task, but this was not observed in the PD 
group. The difference between the two studies may be due to a difference in the memory-
guided saccade paradigm used. Sugiura and colleagues employed a design where all possible 
“flash” stimulus locations were presented during the saccade execution period, with the 
participants needing to generate a saccade to the memorised location of the cue, selected from 
the various presented locations. The memory-guided task used in our study requires the 
participant to make a memory-guided saccade to an empty, cue-less space. It would, therefore, 
make sense that occipital regions would be activated much more in the Sugiura paradigm 
given the additional visual stimulation. 
Differences in the memory-guided paradigm may explain another variation in findings 
between the two investigations. Sugiura et al. reported parietal areas to have sustained activity 
during the delay period, or the period before saccade execution, resulting in a single-humped 
BOLD time course shape. Parietal regions in our study did not show this pattern for sustained 
delay period activity, and instead exhibited a double-peaked shape. This difference may have 
arisen from different working-memory processes demanded by the different memory-guided 
task paradigms. Delay period working memory processes needed to maintain target location 
can be coded in the sensory domain (memory of a location within an internal sensory map), or 
in the motor domain (as a pre-programmed saccade to the target). In the Sugiura et.al. study, 
all possible locations of the “cue” were presented before the participant executed a saccade; a 
strategy they argued that supported a predominantly sensory domain pathway that retained the 
memory-guided saccade location in order to select the specific memorised cue location from a 
selection of presented targets, as opposed to a programmed motor command to a memorised 
location. This sensory-domain maintenance of target location was argued to fit with a role of 
the PPC in visuospatial attention (Mesulam, 1981) and leading to sustained PPC activity 
during the delay phase. A sensory-domain PPC-related memory process did not likely pertain 
to our study as no spatial information was provided during the saccade-execution phase 
(participants executed a memorised saccade to a location on a blank screen), and consequently 
an absence of the delay period activity in the posterior parietal regions that was observed by 
Sugiura and colleagues. We suggest that a motor-domain working memory pathway was 
predominantly recruited by our memory-guided task. This pathway is proposed to involve the 
frontal region (Mesulam, 1981; Sugiura et al., 2004) and is likely the basis for the higher PC2 
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expression in the frontal eye fields and which we posit represents preparatory activity prior to 
memory-saccade generation in our study. 
Bilateral IPL regions, and to a lesser extent, the medial FEFs, showed subtle group 
differences; with the PD group exhibiting increased IPL BOLD activity during the saccade 
event and reduced medial FEF during the perceive event compared to controls. These 
findings, however, were not reflected as a separate principal component and identifying the 
IPL and FEF as disease-affected regions. Clustering analysis also did not separate out these 
subregions from the general parietal and frontal clusters. That PCA did not detect any specific 
PD component suggests that group differences in BOLD time course activation are small and 
may not be able to be detected using the PCA technique, a conclusion that might be addressed 
in any future studies.  
6.5 Conclusion	
This study has highlighted a number of potential areas and mechanisms by which memory-
guided saccade performance is affected in PD. PD subjects make more anticipatory errors and 
more inaccurate saccades than controls. This could be the result of impaired working memory 
processes, attention processes or both saccade generation and inhibition processes. From our 
results, we propose that the PPC, particularly the IPL, is implicated in these impairments. 
Understanding of theories behind saccadic impairment in PD is not aided by the complexity 
of the IPL. This area is known to be extremely difficult to study due to the multiplicity of 
functions, many of which are overlapping. We are only starting to understand the number of 
networks and functions that are linked to the IPL. It would seem the only firm conclusion we 
can make is that more research is needed in the future to further establish the role of the IPL 
in the variety of processes involved in the memory-guided saccade. 
PCA and clustering analysis was able to cluster groups of functionally similar regions 
together from BOLD time course data alone. This ability supports the use of this technique to 
determine functionally related regions using the PCs of time course data from event-related 
studies. The lack of clustering of PD regions overall suggests that the group differences in 
BOLD time course detected using event-related fMRI technique are subtle at least in the 





Another limitation was that the PD patients recruited to this study were mostly unaffected by 
cognitive impairment or had only mild cognitive impairment, with no dementia/major 
cognitive impairment at the time of the study. We were uncertain of the ability of more 
severely impaired patients to perform the eye movement tasks correctly in the MRI scanner. 
This proved to be a valid concern, as a number of patients with mild PD fell asleep in the 
scanner due to fatigue. This does, however, mean that our patients were limited to relatively 
early stage of PD, where differences in performance and disease status are not as apparent. 
Recruitment of a PD patient population with a greater spread of disease severity might yield 
more prominent results but some thought would need to go into designing the procedures so 
as to be understood correctly and at the same time minimizing fatigue. 
Any differences contributing to the performance deficit may not be great enough to be 
detected using the current resolution of our MRI scanner. PD saccade performance deficits are 
subtle and the functional differences are likely to be small. It is possible some minor changes 
in neural activity may occur in regions too small or close together to cause a significant 
BOLD signal change. This is particularly so for the PPC which has tightly located subregions. 
In the future MRI scanners with greater spatial and/or temporal resolution could provide more 
detailed data, both spatially and temporally, of cortical activity during saccade tasks. 
As discussed, the eye tracking system we used within the MRI scanner is crude and inaccurate 
compared to the system used in the eye movement laboratory. This MRI compatible eye 
tracking system was unable to reliably detect error anticipatory saccades and often would lose 
tracking and on occasions could not be properly calibrated. As a camera, it did allow us to 
determine if the overall sequence for the task was being correctly performed. As a 
consequence, the data of one participant had to be excluded due to overwhelming errors in 
task execution. The in-scanner camera system also allowed us to ensure patients were 
continuing to performing the task and had not drifted off to sleep. Beyond this, the eye 
tracking system used in the fMRI provided very limited information and a superior system 










In this thesis, I have compared saccadic eye movement performance in PD with a range of 
MRI techniques - structural T1, ASL, DTI and fMRI. The objective was to gain further 
understanding of the causes of characteristic eye movement deficits in PD. Overall, the 
studies in this thesis show eye movement performance changes between groups are not 
reflected by a corresponding detectable change using brain imaging. In Chapter 3, I failed to 
detect PD-specific changes in grey matter volume, perfusion or white matter integrity related 
to eye movement performance. Chapter 5 and 6 did not demonstrate significant functional 
activity differences during reflexive, predictive and memory-guided saccade tasks in PD 
compared to controls.  As differences on the whole were not significant even at the group 
level, this means these measures are even less likely to be useful at an individual level.  
Chapter 4 was able to show broad association of eye movement performance with the degree 
of expression of a PD-specific perfusion pattern. However the variability in this association 
was large and one cannot therefore usefully predict individual perfusion pattern expression 
through eye movement performance alone. These results therefore mean that we are unable to 
provide supporting evidence for the use of eye movements in determining PD severity, at least 
at the cross-sectional level.  
These experiments however have resulted in novel findings in general eye movement control. 
In Chapter 5, I identified that FEF activity appeared to be divided into subregions, with 
medial FEF regions appearing to be more involved in predictive saccades rather than 
reflexive. These findings contribute to our general knowledge of eye movement control. 
Chapter 6 showed the PCA technique is able to detect information within a BOLD response 
during the memory-guided saccade task, which can be used to group functionally-related 
regions. This satisfies the broader aim of improving our understanding of eye movement 
control in general. 
The studies in this thesis used patients representing a cross-section of mild-moderate PD 
progression and offer a point of comparison for future studies. On a longitudinal level, 
changes in eye movement performance may still be able to provide useful information on PD 
progression within each subject. However, with my studies being of a cross-sectional design, 
they are unable to answer this question, and this is left for future studies. The study 
participants are part of a longitudinal study, with ongoing follow-up scanning and eye 
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movement recordings. Future studies will be able to build upon the results of this current 
study, potentially using targeted techniques for the identified regions. 
7.1.1 Chapter	3	-	Structural,	ASL,	DTI	and	eye	movement	correlation	
In this chapter, comparisons were made between a range of MRI scanning techniques and 
reflexive, predictive, memory-guided and antisaccades, representing both volitional and 
visually-guided saccades types. A voxel-based whole-brain comparison found group-level 
correlation differences in the left temporal pole, precuneus and caudate nucleus with eye 
movement performance. Overall, few regions of correlation arose amongst the extensive 
number of comparisons, indicating minor structural and perfusion differences in eye 
movement control regions between PD and controls when studied using a whole-brain voxel-
based approach and there are suspicions that the results may have arisn from artefacts. As the 
current results stand however, it is interesting to note that several regions, namely, the left 
temporal pole and precuneus, which were seen to correlate with eye movements and show 
group differences, are known to have integrative functions, relating to a wide variety of 
cognitive tasks not limited to eye movements. It may be possible then that entire cortical 
networks, which involve the left temporal pole and precuneus, are disrupted in PD, rather than 
single brain regions. This potential network disruption in PD, involving a number of brain 
regions, may not be able to be detected using the current voxel-based method. Network 
analysis could, therefore, potentially be used to study eye movement deficits in PD, which 
was further explored in Chapter 4.  
7.1.2 Chapter	4	–ASL	PD-perfusion	pattern	and	eye	movement	correlation	
In this chapter, I compared a previously described ASL-derived PD-related perfusion pattern 
with eye movement performance in PD. This pattern, described by a network score indicating 
the extent of pattern expression within an individual, is thought to represent general PD status, 
as it correlates with both PD motor scores and cognitive impairment measures. This 
hypothesis was tested using a comparison of the network score with eye movement 
performance measures thought to be characteristically impaired in PD. In addition, previously 
in Chapter 3, I found group differences in voxel-level comparisons with eye movement 
performance in certain cortical regions known to have integrative functions. This may suggest 
PD-related changes may occur across a network of widespread cortical areas. Thus, a network 
comparison may provide insight into the sources of PD-related eye movement dysfunction. A 
consistent pattern of correlation was found between expression of the network score and all 
tested eye movement tasks - that is, higher network scores were associated with increasing 
eye movement performance deficits. Multiple comparisons showed a strong multicollinear 
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effect, indicating correlation between predictors. This supports the idea that the ASL PD-
related perfusion pattern, as it correlates with measures of both PD motor status and cognitive 
impairment, along with eye movement performance, may represent a general marker of PD 
progression. Alongside the network score correlation findings, this chapter indicated that 
memory-guided saccade latency deteriorated steeply past a threshold network score. This 
effect was also seen past certain UPDRS and cognitive Z-score thresholds. This raises the 
possibility of using memory-guided saccade latency as a marker point of PD progression in 
the future. 
7.1.3 Chapter	5	–	fMRI	of	reflexive	and	predictive	saccade	tasks	in	PD	
In this chapter, I investigated reflexive and predictive saccades in PD using a blocked fMRI 
design. A within-group analysis showed significant activity in the FEF, PPC and SEF for the 
reflexive task and predictive tasks. No significant group difference in cortical activity for 
either predictive or reflexive saccades was seen between PD and control groups. However, a 
difference in between-task activity was detected in the medial and lateral FEF. The medial 
FEF showed greater activity in the reflexive task compared to the predictive task. This 
indicates that regions of the FEF may operate as functional subunits, one of which may be 
more strongly involved in reflexive saccades. This finding is novel and has not been directly 
reported before. This may be a site for future investigations. 
7.1.4 Chapter	6	-	fMRI	of	memory-guided	saccades	in	PD	
In this chapter, I investigated memory-guided saccades using both a blocked and event-related 
fMRI design. In the block design task, significant activity in the FEF, PPC, DLPFC, SEF and 
insula was seen for both PD and control groups. However, a between-group analysis revealed 
no difference. An event-related time course analysis showed subtle between-group task 
activation differences, seen most clearly in the inferior parietal lobule bilaterally, with the PD 
group showing a greater BOLD signal change during the saccade event. PCA of all the BOLD 
time courses of regions found to be active in the block design was performed, with a K-means 
clustering analysis of the loading values of PC expression of each region of interest. This 
cluster analysis, from the time course data only, was able to identify groups of functionally-
related regions without any prior information of region function. This helps to validate the 





Overall, the observed group differences between PD and controls were subtle, with the 
majority of comparisons revealing no significant group difference. This may implicate that 
VBA, or whole-brain analysis techniques, may not be sensitive enough to detect changes, 
particularly if those changes are widespread and involve distributed changes in a network of 
brain regions. However, the group differences that were observed in this study were novel 
findings that have not been previously reported before. This adds to our understanding of eye 
movement control and of potential differences in PD contributing to saccade performance 
impairment. In future studies, investigators might consider more targeted MRI techniques to 
investigate changes in the discussed regions, rather than a whole-brain approach. Subtly 
decreased frontal and increased parietal BOLD signal change seen in fMRI of memory-guided 
saccades (Chapter 6) generally support previous studies reporting frontal hypoactivity and 
parietal hyperactivity in PD for other volitional saccade tasks such as self-paced saccades 
(Rieger et al., 2008) and antisaccades (Lemos et al., 2016). However, this study made an 
additional comparison of a perfusion network score to eye movement performance. Increased 
network score expression, indicating a more severe network of cerebral hypoperfusion, was 
associated with impaired saccade performance in PD. This perfusion network describes a 
number of regions showing characteristic hypoperfusion in PD, including the posterior 
parietal cortex. The implication of this is that if posterior parietal hypoperfusion is present in 
PD, relative increases in BOLD signal may not necessarily mean hyperactivity, but rather the 
increase in the BOLD activity detected in the PD group is only proportionately increased from 
a lower baseline BOLD signal. The increased BOLD signal change may, therefore, simply 
reflect a higher percentage change from baseline, not actual parietal cortex hyperactivity as 
reported by past studies (Lemos et al., 2016; Rieger et al., 2008). 
The results of this study strongly suggest that the FEF may operate as functional subunits for 
components of the predictive and reflexive task. While previous studies have described 
possible medial and lateral FEF subunits, no study has explicitly stated the unique 
involvement of the medial FEF in reflexive saccades compared to predictive saccades. This 
has implications for our overall knowledge of cortical eye movement control, with these 
findings contributing to this understanding.  
The fMRI technique used, while not showing extensive between-group difference, 
demonstrated strong within-group task activity. The implication for future research is that the 
number of trials and durations are sufficient to detect significant task activity for the saccade 
paradigms used. The ability of the PCA/cluster analysis to functionally group-related regions, 
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independent of any prior information, shows that in regions that are all functionally-related to 
the task, there is temporal information in the BOLD response that allows us to purpose some 
degree of functional specialization and commonality between clusters of regions.  
7.1.6 Study	limitations	and	future	work	
DTI scans in the whole-brain VBA (Chapter 3) showed artefacts, potentially from inaccurate 
normalisation. This indicates a need for future studies to use more refined analysis techniques 
specifically to minimise these effects. A tract-based skeleton approach for DTI could be used 
to minimise the effect of distortion and mis-normalisation as described in Smith et al. (2006) 
and Melzer et al. (2013). This skeleton approach can be used at a whole-brain level, selected 
regions or selected tracts. Using diffusion MRI, future studies may also use tractography 
analysis seeded from the identified areas in this study, particularly from the FEF subregions 
and dense functional areas such as within the PPC. These will allow connections to other 
cortical/subcortical regions to be seen, which will provide more information on the functions 
of these regions and possible changes in PD. More advanced diffusion MRI techniques may 
be used such as High Angular Resolution Diffusion Imaging (HARDI) or diffusional kurtosis 
imaging. Single voxels often contain fibre tracts running in multiple directions, however, DTI 
can only provide one diffusion direction per voxel. HARDI measures a higher number of 
diffusion gradient directions than DTI, which allows better detection of multidirectional fibres 
within a single voxel (Tournier et al., 2008; Tuch et al., 2002). The randomness of water 
diffusion itself may also be used to provide information on tissue type. A simplistic model of 
the probability of water diffusion can be described by a Gaussian distribution. Different tissue 
types, however, may cause diffusion probability to differ from the Gaussian distribution. 
Diffusional kurtosis imaging is a diffusion technique which can determine tissue structure 
based on the extent of non-Gaussian water diffusion behaviour (Jensen et al., 2005). These 
more advanced diffusion techniques should provide more accurate and sensitive information 
about the integrity of the white matter, and may, therefore, provide additional information for 
the future development of PD biomarkers. 
Future studies could explore the identified regions with an ROI approach. Such an approach 
would limit the multiple comparisons problem. In fMRI scans, limiting the scan area to 
defined regions would also allow closer scan slices, allowing increased spatial resolution, and 
also better temporal resolution, shortening TR and allowing more detailed time course plots. 
Future fMRI investigations using the memory-guided task may compare different memory 
period lengths. This current study used only a single delay period duration. Le Heron, 
MacAskill, & Anderson (2005) found memory-guided saccade performance to be less 
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impaired in longer delay (over 20 seconds) compared to shorter delay periods (several 
seconds) in PD. Their theory was that the long-delay memory pathway bypasses areas, such 
as the DLPFC, which are thought to be affected in PD, leading to less impaired performance 
during longer delays. Future fMRI studies could therefore contrast activity in the DLPFC, for 
example, between short and long delay working memory tasks to confirm this theory. This 
could also show other regions, not limited to the DLPFC, which may be affected in PD, 
related to working-memory processes for short and long durations. More advanced eye-
tracking hardware, able to provide accurate measurements during scanning may be employed 
for future studies. Accurate eye-tracking can allow the exclusion of error trials. Activity from 
error trials may also be compared to correct trials and baseline activity, allowing comparisons 
which may detect different cortical processes responsible for the error trials in PD. These 
differences may help us understand the source of increased PD saccade disinhibition. 
This current study uses only a cross-section of data from a point in time of a group of patients 
enrolled in a longitudinal study. The future development of the biomarkers based on eye 
movements and imaging will need to compare changes in saccade measures and MRI scans 
over the progression of the disease. In Chapter 4, memory-guided saccade latency was seen to 
steeply decline past a certain threshold in network score expression, as it did with UPDRS and 
cognitive Z-score. Longitudinal eye movement studies could investigate the possibility of a 
memory-guided saccade latency value cut-off point as a marker of disease progression. Using 
longitudinal data collected over time, we may assess whether individual participants show this 
drop off pattern of decline in memory-guided saccade latency at certain points of disease 
progression and cognitive impairment. 
As described in Chapter 4, all eye movement tasks studied showed a correlation with the ASL 
network score. The network score itself describes hypoperfusion in areas including the middle 
frontal gyrus (containing the FEF) and posterior parietal-occipital cortex (containing the PPC) 
– regions which have been reported to be affected in PD (Lemos et al., 2016; Rieger et al., 
2008) and also showing subtle between-group differences between PD and controls during 
memory-guided saccades (Chapter 6). Imaging findings of regions showing group differences 
associated with saccade performance may allow eye movement measures to be developed as a 
more cost-efficient marker of changes detected in imaging. Future developments of the ASL 
network score may be compared to eye-movement performance longitudinally to compare 
changes over time to validate this possibility. Imaging comparisons with eye movements are 
also not limited to MRI scans. Other potential future imaging markers of PD progression, 
such as values derived from PET or SPECT or transcranial sonography, may also be 
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compared to eye movement performance to cross-validate the potential of other imaging 
measures as future biomarkers. 
7.1.7 Final	conclusion	
In this thesis, I found a number of imaging and eye movement association differences 
between PD and control groups. From these, I have been able to compare analysis techniques 
and suggest avenues for future research. In addition, our knowledge of the associations 
between eye-movements and disease-related cerebral changes detected by imaging has grown. 
Finally, I was able to find functional subregions within the FEF and also attempted to clarify 
the current literature regarding PPC function using our results, contributing one small step in 
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Figure 9-1 to Figure 9-10 show findings from voxel-based comparisons not pictured in the 
results section.  
Voxels showing increases in grey matter volume relative to increasing memory-guided 
saccade latency in controls - within-group analysis 
     
Figure 9-1 – Glass brain images in three planes showing significant voxels of positive correlation 
(increasing grey matter volume correlated with increasing memory-guided saccade latency) in the control 
group. Images are corrected for multiple comparisons (FWE p < 0.05). Scattered subgyral clusters were 
found to be significant. 
Voxels showing a more positive association between grey matter volume and memory-
guided saccade latency in controls than PD – between-group analysis 
 
 
Figure 9-2 – Significant voxels showing more positive correlation (increasing grey matter volume 
correlated with increasing memory-guided saccade latency) in the control group compared to the PD 
group. Images corrected for multiple comparisons (FWE p < 0.05). Scattered subgyral clusters were found 










Voxels showing increases in FA relative to increasing antisaccade gain in controls - within-
group analysis 
 
Figure 9-3 – Significant voxels showing positive correlation (increasing DTI FA value correlated with 
increasing antisaccade gain) in the control group. Images corrected for multiple comparisons (FWE p < 
0.05). A single cluster in the right Brodmann area 8 was significant. 
 
Voxels showing increases in MD relative to increased reflexive latency in PDs - within-
group analysis 
           
Figure 9-4 – Significant voxels showing positive correlation (increasing DTI MD value correlated with 
increasing reflexive latency) in the PD group. Images corrected for multiple comparisons (FWE p < 0.05). 










Voxels showing increases in MD relative to increased memory-guided latency in PDs - 
within-group analysis 
 
Figure 9-5 – Significant voxels showing positive correlation (increasing DTI MD value correlated with 
increasing memory-guided latency) in the PD group. Images corrected for multiple comparisons (FWE p 
< 0.05). Small clusters in the left insula cortex were significant. 
 
 
Voxels showing increases in MD relative to increased reflexive gain in PD within-group 
analysis 
 
Figure 9-6 – Significant voxels showing positive correlation (increasing DTI MD value correlated with 
increasing reflexive gain) in the PD group. Images corrected for multiple comparisons (FWE p < 0.05). An 








Voxels showing decreases in MD relative to increased reflexive gain in contols - within-
group analysis 
 
       
Figure 9-7 – Significant voxels showing negative correlation (decreasing DTI MD value correlated with 
increasing reflexive gain) in the control group. Images corrected for multiple comparisons (FWE p < 
0.05). Subgyral clusters were found to be significant. 
 
Voxels showing a more negative association between MD and reflexive gain in PD than 
controls – between-group analysis 
 
Figure 9-8 – Voxels of significantly more negative correlation (decreasing DTI MD values correlated with 
increasing reflexive gain) in the PD group compared to the control group. Images corrected for multiple 
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Voxels showing decreases in grey matter volume relative to increased cognitive Z-score in 
PD - within-group analysis 
 
Figure 9-9 – Significant voxels showing negative correlation (decreasing grey matter volume correlated 
with increasing cognitive Z-score) in the PD group. Images corrected for multiple comparisons (FWE p < 
0.05). A subgyral cluster was found to be significant. 
 
Voxels showing decreases in ASL perfusion relative to increased cognitive MDS-UPDRS 
Part III score in PDs - within-group analysis 
 
 
Figure 9-10 – Significant voxels of negative correlation (decreasing ASL perfusion values correlated with 
increasing MDS-UPDRS part III score) in the PD group. Images corrected for multiple comparisons 











Figure 9-11 – Linear regressions between UPDRS part III score and reflexive, predictive, memory-guided 
and antisaccade primary gain (left graph column) and latency (right graph column). The x-axis represents 
the network score of each participant. The y-axis represents primary gain/latency in each task. Straight 
lines indicate least squares regressions for each measure. The grey intervals around each regression line 
indicate the 95% confidence interval of the regression. The cognitive category of PD participants (normal 




Table 9-1 – P and R squared values for each eye movement and UPDRS comparison. Eye movement 
performance measures and UPRDS-III score are significantly correlated for every task analysed. 
  Estimate (gain) Std. Error t value p-value r squared 
Reflexive gain 
Intercept 0.94 0.02 41 < 0.001  
UPDRS III -0.001 per point < 0.001 -3 0.004 0.11 
Predictive gain 
Intercept 0.85 0.03 25   
UPDRS III -0.003 per point < 0.001 -3.3 0.001 0.14 
Memory-guided gain 
Intercept 0.90 0.07 24 < 0.001  
UPDRS III -0.004 per point < 0.001 -5 < 0.001 0.28 
Antisaccade gain 
Intercept 0.90 0.06 14.7 < 0.001  
UPDRS III -0.003 per point 0.001 -2.6 0.011 0.09 
       
  Estimate (ms) Std. Error t value p-value r squared 
Reflexive latency 
Intercept 182 10.2 17.9 < 0.001  
UPDRS III 1.3 per point 0.2 5.7 < 0.001 0.33 
Predictive latency 
Intercept 24 24.9 1 0.33  
UPDRS III 2.3 per point 0.6 4.1 < 0.001 0.19 
Memory-guided latency 
Intercept 137 40 3.4 0.001  
UPDRS III 7.8 per point 0.9 8.6 < 0.001 0.53 
Antisaccade latency 
Intercept 358 35 10 < 0.001  







Figure 9-12 – Linear regressions between cognitive Z-score and reflexive, predictive, memory-guided and 
antisaccade primary gain. The x-axis represents the network score of each participant. The y-axis 
represents primary gain in each task. Straight lines indicate least squares regressions for each measure. 
The grey intervals around each regression line indicate the 95% confidence interval of the regression. The 
cognitive category of PD participants (normal (PDN), mild cognitive impairment (PD-MCI) or dementia 




Figure 9-13 – Linear regressions between cognitive Z-score and reflexive, predictive, memory-guided and 
antisaccade latency. The x-axis represents the network score of each participant. The y-axis represents 
latency (ms) in each task. Straight lines indicate least squares regressions for each measure. The grey 
intervals around each regression line indicate the 95% confidence interval of the regression. The cognitive 
category of PD participants (normal (PDN), mild cognitive impairment (PD-MCI) or dementia (PDD)) is 
indicated by the colour of the plotted points. 
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Table 9-2 – P and R squared values for each eye movement and cognitive Z-score comparison. Eye 
movement performance measures and cognitive Z-score are significantly correlated for every task 
analysed. 
  Estimate (gain) Std. Error t value p-value r squared 
Reflexive gain 
Intercept 0.90 0.01 79 < 0.001  
Cognitive Z-score 0.05 per point 0.01 4.4 < 0.001 0.22 
Predictive gain 
Intercept 0.76 0.02 42 < 0.001  
Cognitive Z-score 0.04 per point 0.02 2.4 0.019 0.07 
Memory-guided gain 
Intercept 0.77 0.02 39 < 0.001  
Cognitive Z-score 0.1 per point 0.02 4.6 < 0.001 0.24 
Antisaccade gain 
Intercept 0.79 0.03 25 < 0.001  
Cognitive Z-score 0.11 per point 0.03 3.0 0.003 0.12 
      
  Estimate (ms) Std. Error t value p-value r squared 
Reflexive latency 
Intercept 221 5.5 40 < 0.001  
Cognitive Z-score -31 per point 5.8 -5.4 < 0.001 0.3 
Predictive latency 
Intercept 97 14 7.0 < 0.001  
Cognitive Z-score -42 per point 14 -3.0 0.005 0.1 
Memory-guided latency 
Intercept 375 22 17 < 0.001  
Cognitive Z-score -185 per point 25 -7.4 < 0.001 0.46 
Antisaccade latency 
Intercept 478 19 25 < 0.001  








9-14 – PCA Clustering K = 3 (3 clusters). Regions plotted against loading values for PC2 and PC3. Colour 
of points and dotted grey ovals indicates cluster. 
 
 
9-15 – PCA Clustering K = 5 (5 clusters). Regions plotted against loading values for PC2 and PC3. Colour 
of points and dotted grey ovals indicates cluster 
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Table 9-3 - The UK Parkinson’s Disease Society’s Brain Bank diagnostic criteria (Hughes et al., 1992). 
UK PARKINSON’S DISEASE SOCIETY BRAIN BANK CLINICAL DIAGNOSTIC 
CRITERIA 
 
Step 1. Diagnosis of Parkinsonian Syndrome  
• Bradykinesia  
• At least one of the following  
o Muscular rigidity  
o 4-6 Hz rest tremor  
o Postural instability not caused by primary visual, vestibular, cerebellar, or proprioceptive 
dysfunction  
 
Step 2 Exclusion criteria for Parkinson’s disease  
• History of repeated strokes with stepwise progression of parkinsonian features  
• History of repeated head injury  
• History of definite encephalitis  
• Oculogyric crises  
• Neuroleptic treatment at onset of symptoms  
• More than one affected relative  
• Sustained remission  
• Strictly unilateral features after 3 years  
• Supranuclear gaze palsy  
• Cerebellar signs  
• Early severe autonomic involvement  
• Early severe dementia with disturbances of memory, language, and praxis  
• Babinski sign  
• Presence of cerebral tumor or communication hydrocephalus on imaging study  
• Negative response to large doses of levodopa in absence of malabsorption  
• MPTP exposure  
 
Step 3 supportive prospective positive criteria for Parkinson’s disease  
Three or more required for diagnosis of definite Parkinson’s disease in combination with step one  
• Unilateral onset  
• Rest tremor present  
• Progressive disorder  
• Persistent asymmetry affecting side of onset most  
• Excellent response (70-100%) to levodopa  
• Severe levodopa-induced chorea  
• Levodopa response for 5 years or more  
• Clinical course of ten years or more  
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